cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	FDR	beta	r	Traits	SNP_position	Gene_position
ACC	cis	rs9326248	0.817	rs1242127	ENSG00000254851.1	RP11-109L13.1	11.09	2.61e-15	6.08e-08	0.98	0.84	Blood protein levels;	chr11:117205848	chr11:117135528~117138582:+
ACC	cis	rs9326248	1	rs664971	ENSG00000254851.1	RP11-109L13.1	10.22	4.9e-14	1.43e-07	0.93	0.82	Blood protein levels;	chr11:117200141	chr11:117135528~117138582:+
ACC	cis	rs858239	0.539	rs57864591	ENSG00000230658.1	KLHL7-AS1	9.72	2.73e-13	4.9e-07	1.03	0.8	Cerebrospinal fluid biomarker levels;	chr7:23144805	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs4294098	ENSG00000230658.1	KLHL7-AS1	9.72	2.73e-13	4.9e-07	1.03	0.8	Cerebrospinal fluid biomarker levels;	chr7:23146376	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs7791200	ENSG00000230658.1	KLHL7-AS1	9.61	4.1e-13	5.98e-07	1.03	0.8	Cerebrospinal fluid biomarker levels;	chr7:23142502	chr7:23101228~23105703:-
ACC	cis	rs858239	0.509	rs57611130	ENSG00000230658.1	KLHL7-AS1	9.61	4.1e-13	5.98e-07	1.03	0.8	Cerebrospinal fluid biomarker levels;	chr7:23144933	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7787110	ENSG00000230658.1	KLHL7-AS1	9.58	4.44e-13	6.1e-07	1.01	0.8	Cerebrospinal fluid biomarker levels;	chr7:23098855	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7341483	ENSG00000230658.1	KLHL7-AS1	-9.28	1.3e-12	6.94e-07	-1.05	-0.79	Cerebrospinal fluid biomarker levels;	chr7:23088038	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs4504540	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23146579	chr7:23101228~23105703:-
ACC	cis	rs858239	0.509	rs6975524	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23146833	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6955726	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23147072	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6955969	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23147080	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6976957	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23147714	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6956828	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23147728	chr7:23101228~23105703:-
ACC	cis	rs858239	0.509	rs6962213	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23148490	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs10280815	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23148751	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs10225608	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23149289	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs28624974	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23149317	chr7:23101228~23105703:-
ACC	cis	rs5850	0.557	rs10270788	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Blood protein levels;	chr7:23149381	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs28716381	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23149396	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs1358442	ENSG00000230658.1	KLHL7-AS1	9.26	1.36e-12	6.94e-07	1.01	0.79	Cerebrospinal fluid biomarker levels;	chr7:23150120	chr7:23101228~23105703:-
ACC	cis	rs858239	0.571	rs2390755	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23151097	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs4365988	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23151252	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs4295546	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23151402	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs10279194	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23151464	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs3950345	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23151495	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs2178140	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23152006	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs2178139	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23152017	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs2141306	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23152045	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs2141305	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23152280	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6945510	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23152621	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6965833	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23152747	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6949363	ENSG00000230658.1	KLHL7-AS1	9.26	1.4e-12	6.94e-07	1.03	0.79	Cerebrospinal fluid biomarker levels;	chr7:23152775	chr7:23101228~23105703:-
ACC	cis	rs916888	0.821	rs199513	ENSG00000262539.1	RP11-259G18.3	-9.23	1.53e-12	7.43e-07	-1.04	-0.79	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779566	chr17:46259551~46260606:-
ACC	cis	rs858239	0.601	rs6948469	ENSG00000230658.1	KLHL7-AS1	9.1	2.4e-12	1.14e-06	1	0.78	Cerebrospinal fluid biomarker levels;	chr7:23135147	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6975852	ENSG00000230658.1	KLHL7-AS1	9.06	2.83e-12	1.23e-06	1.01	0.78	Cerebrospinal fluid biomarker levels;	chr7:23147035	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs10247268	ENSG00000230658.1	KLHL7-AS1	9.06	2.83e-12	1.23e-06	1.01	0.78	Cerebrospinal fluid biomarker levels;	chr7:23147560	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6461694	ENSG00000230658.1	KLHL7-AS1	9.06	2.83e-12	1.23e-06	1.01	0.78	Cerebrospinal fluid biomarker levels;	chr7:23148160	chr7:23101228~23105703:-
ACC	cis	rs858239	0.508	rs7805071	ENSG00000230658.1	KLHL7-AS1	9.06	2.83e-12	1.23e-06	1.01	0.78	Cerebrospinal fluid biomarker levels;	chr7:23150593	chr7:23101228~23105703:-
ACC	cis	rs858239	0.508	rs7805085	ENSG00000230658.1	KLHL7-AS1	9.06	2.83e-12	1.23e-06	1.01	0.78	Cerebrospinal fluid biomarker levels;	chr7:23150624	chr7:23101228~23105703:-
ACC	cis	rs858239	0.632	rs13438452	ENSG00000230658.1	KLHL7-AS1	9.04	2.97e-12	1.26e-06	0.97	0.78	Cerebrospinal fluid biomarker levels;	chr7:23134563	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs10254544	ENSG00000230658.1	KLHL7-AS1	9.02	3.23e-12	1.26e-06	1.03	0.78	Cerebrospinal fluid biomarker levels;	chr7:23180616	chr7:23101228~23105703:-
ACC	cis	rs858239	0.508	rs10242104	ENSG00000230658.1	KLHL7-AS1	9.02	3.23e-12	1.26e-06	1.03	0.78	Cerebrospinal fluid biomarker levels;	chr7:23180831	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7785842	ENSG00000230658.1	KLHL7-AS1	9.01	3.3e-12	1.26e-06	0.99	0.78	Cerebrospinal fluid biomarker levels;	chr7:23102087	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7456915	ENSG00000230658.1	KLHL7-AS1	9.01	3.3e-12	1.26e-06	0.99	0.78	Cerebrospinal fluid biomarker levels;	chr7:23103430	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs10233039	ENSG00000230658.1	KLHL7-AS1	9.01	3.3e-12	1.26e-06	0.99	0.78	Cerebrospinal fluid biomarker levels;	chr7:23103494	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs1468592	ENSG00000230658.1	KLHL7-AS1	-8.98	3.77e-12	1.38e-06	-0.99	-0.78	Cerebrospinal fluid biomarker levels;	chr7:23101028	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs28646184	ENSG00000230658.1	KLHL7-AS1	8.98	3.77e-12	1.38e-06	0.99	0.78	Cerebrospinal fluid biomarker levels;	chr7:23099976	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs10235786	ENSG00000230658.1	KLHL7-AS1	8.92	4.58e-12	1.62e-06	0.97	0.78	Cerebrospinal fluid biomarker levels;	chr7:23100321	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs929507	ENSG00000230658.1	KLHL7-AS1	8.86	5.73e-12	1.94e-06	0.95	0.78	Cerebrospinal fluid biomarker levels;	chr7:23127045	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs929508	ENSG00000230658.1	KLHL7-AS1	8.86	5.73e-12	1.94e-06	0.95	0.78	Cerebrospinal fluid biomarker levels;	chr7:23127090	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs4628176	ENSG00000230658.1	KLHL7-AS1	8.81	6.93e-12	2.31e-06	0.99	0.77	Cerebrospinal fluid biomarker levels;	chr7:23102947	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs870476	ENSG00000230658.1	KLHL7-AS1	8.8	7.02e-12	2.31e-06	0.97	0.77	Cerebrospinal fluid biomarker levels;	chr7:23153652	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6461691	ENSG00000230658.1	KLHL7-AS1	8.76	8.07e-12	2.62e-06	0.99	0.77	Cerebrospinal fluid biomarker levels;	chr7:23099726	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs6461693	ENSG00000230658.1	KLHL7-AS1	-8.75	8.44e-12	2.63e-06	-0.97	-0.77	Cerebrospinal fluid biomarker levels;	chr7:23120514	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6461692	ENSG00000230658.1	KLHL7-AS1	8.71	9.77e-12	2.63e-06	1	0.77	Cerebrospinal fluid biomarker levels;	chr7:23100076	chr7:23101228~23105703:-
ACC	cis	rs858239	0.537	rs2286272	ENSG00000230658.1	KLHL7-AS1	8.7	1.01e-11	2.63e-06	1.02	0.77	Cerebrospinal fluid biomarker levels;	chr7:23184748	chr7:23101228~23105703:-
ACC	cis	rs858239	0.537	rs6955115	ENSG00000230658.1	KLHL7-AS1	8.7	1.01e-11	2.63e-06	1.02	0.77	Cerebrospinal fluid biomarker levels;	chr7:23187525	chr7:23101228~23105703:-
ACC	cis	rs858239	0.537	rs10279691	ENSG00000230658.1	KLHL7-AS1	8.7	1.01e-11	2.63e-06	1.02	0.77	Cerebrospinal fluid biomarker levels;	chr7:23188768	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs2014768	ENSG00000230658.1	KLHL7-AS1	8.6	1.43e-11	2.63e-06	1.04	0.77	Cerebrospinal fluid biomarker levels;	chr7:23082821	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs10256361	ENSG00000230658.1	KLHL7-AS1	8.6	1.43e-11	2.63e-06	1.04	0.77	Cerebrospinal fluid biomarker levels;	chr7:23084266	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6978827	ENSG00000230658.1	KLHL7-AS1	8.6	1.43e-11	2.63e-06	1.04	0.77	Cerebrospinal fluid biomarker levels;	chr7:23085925	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs9691762	ENSG00000230658.1	KLHL7-AS1	8.6	1.43e-11	2.63e-06	1.04	0.77	Cerebrospinal fluid biomarker levels;	chr7:23086303	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7790157	ENSG00000230658.1	KLHL7-AS1	8.6	1.43e-11	2.63e-06	1.04	0.77	Cerebrospinal fluid biomarker levels;	chr7:23087379	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6960001	ENSG00000230658.1	KLHL7-AS1	8.6	1.43e-11	2.63e-06	1.04	0.77	Cerebrospinal fluid biomarker levels;	chr7:23091257	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs10237755	ENSG00000230658.1	KLHL7-AS1	8.6	1.43e-11	2.63e-06	1.04	0.77	Cerebrospinal fluid biomarker levels;	chr7:23091945	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6961131	ENSG00000230658.1	KLHL7-AS1	8.6	1.43e-11	2.63e-06	1.04	0.77	Cerebrospinal fluid biomarker levels;	chr7:23095171	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs10270695	ENSG00000230658.1	KLHL7-AS1	-8.59	1.52e-11	2.63e-06	-0.98	-0.77	Cerebrospinal fluid biomarker levels;	chr7:23149369	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs13438188	ENSG00000230658.1	KLHL7-AS1	-8.58	1.55e-11	2.63e-06	-0.94	-0.77	Cerebrospinal fluid biomarker levels;	chr7:23104578	chr7:23101228~23105703:-
ACC	cis	rs858239	0.632	rs7811903	ENSG00000230658.1	KLHL7-AS1	8.58	1.55e-11	2.63e-06	1.05	0.77	Cerebrospinal fluid biomarker levels;	chr7:23079437	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7776644	ENSG00000230658.1	KLHL7-AS1	8.58	1.55e-11	2.63e-06	1.05	0.77	Cerebrospinal fluid biomarker levels;	chr7:23079688	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7776649	ENSG00000230658.1	KLHL7-AS1	8.58	1.55e-11	2.63e-06	1.05	0.77	Cerebrospinal fluid biomarker levels;	chr7:23079698	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs7805206	ENSG00000230658.1	KLHL7-AS1	8.56	1.67e-11	2.74e-06	0.88	0.76	Cerebrospinal fluid biomarker levels;	chr7:23120591	chr7:23101228~23105703:-
ACC	cis	rs858239	0.632	rs1985769	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23082887	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs2003555	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23083296	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs10256359	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23084258	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs28499396	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23084479	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7784929	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23084658	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7789237	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23085094	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs4321896	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23088437	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7799422	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23088794	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs28483572	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23092166	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs61292332	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23092243	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs59073109	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23093607	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs7788821	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23094026	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6956595	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23094637	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6961406	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23095272	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6461690	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23095915	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs6967419	ENSG00000230658.1	KLHL7-AS1	8.53	1.88e-11	2.74e-06	1.04	0.76	Cerebrospinal fluid biomarker levels;	chr7:23096691	chr7:23101228~23105703:-
ACC	cis	rs858239	0.632	rs6952947	ENSG00000230658.1	KLHL7-AS1	-8.44	2.62e-11	3.45e-06	-1.01	-0.76	Cerebrospinal fluid biomarker levels;	chr7:23081423	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs10278700	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23120910	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs10263110	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23120932	chr7:23101228~23105703:-
ACC	cis	rs858239	0.57	rs10271613	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23122967	chr7:23101228~23105703:-
ACC	cis	rs858239	0.57	rs10242166	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23123180	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs11982002	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23123651	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs15775	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23125082	chr7:23101228~23105703:-
ACC	cis	rs858239	0.57	rs6968242	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23127792	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs1981665	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23128350	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs3735228	ENSG00000230658.1	KLHL7-AS1	8.4	2.97e-11	3.69e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23130808	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs764533	ENSG00000230658.1	KLHL7-AS1	8.38	3.16e-11	3.86e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23114256	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs13438179	ENSG00000230658.1	KLHL7-AS1	8.37	3.27e-11	3.92e-06	0.93	0.76	Cerebrospinal fluid biomarker levels;	chr7:23104232	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs10256524	ENSG00000230658.1	KLHL7-AS1	8.37	3.27e-11	3.92e-06	0.93	0.76	Cerebrospinal fluid biomarker levels;	chr7:23105328	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs2072368	ENSG00000230658.1	KLHL7-AS1	8.37	3.27e-11	3.92e-06	0.93	0.76	Cerebrospinal fluid biomarker levels;	chr7:23106493	chr7:23101228~23105703:-
ACC	cis	rs875971	0.638	rs6960778	ENSG00000226824.5	RP4-756H11.3	8.37	3.32e-11	3.93e-06	0.83	0.76	Aortic root size;	chr7:66606610	chr7:66654538~66669855:+
ACC	cis	rs858239	0.6	rs10266123	ENSG00000230658.1	KLHL7-AS1	8.37	3.36e-11	3.93e-06	1.01	0.76	Cerebrospinal fluid biomarker levels;	chr7:23096868	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs6969733	ENSG00000230658.1	KLHL7-AS1	8.36	3.43e-11	3.93e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23128758	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs4440529	ENSG00000230658.1	KLHL7-AS1	8.36	3.43e-11	3.93e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23129132	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs4599714	ENSG00000230658.1	KLHL7-AS1	8.36	3.43e-11	3.93e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23129182	chr7:23101228~23105703:-
ACC	cis	rs858239	0.541	rs4624924	ENSG00000230658.1	KLHL7-AS1	8.36	3.43e-11	3.93e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23129224	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs10278776	ENSG00000230658.1	KLHL7-AS1	8.36	3.43e-11	3.93e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23130140	chr7:23101228~23105703:-
ACC	cis	rs858239	0.571	rs6953020	ENSG00000230658.1	KLHL7-AS1	8.36	3.43e-11	3.93e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23132513	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs6971002	ENSG00000230658.1	KLHL7-AS1	8.36	3.43e-11	3.93e-06	0.94	0.76	Cerebrospinal fluid biomarker levels;	chr7:23132685	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6461695	ENSG00000230658.1	KLHL7-AS1	8.35	3.56e-11	4.06e-06	1.01	0.76	Cerebrospinal fluid biomarker levels;	chr7:23158165	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs73272048	ENSG00000230658.1	KLHL7-AS1	8.33	3.81e-11	4.24e-06	0.95	0.76	Cerebrospinal fluid biomarker levels;	chr7:23113034	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs11984129	ENSG00000230658.1	KLHL7-AS1	8.33	3.81e-11	4.24e-06	0.95	0.76	Cerebrospinal fluid biomarker levels;	chr7:23113058	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs1558313	ENSG00000230658.1	KLHL7-AS1	8.33	3.81e-11	4.24e-06	0.95	0.76	Cerebrospinal fluid biomarker levels;	chr7:23116460	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs6962526	ENSG00000230658.1	KLHL7-AS1	8.33	3.81e-11	4.24e-06	0.95	0.76	Cerebrospinal fluid biomarker levels;	chr7:23118614	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs6971673	ENSG00000230658.1	KLHL7-AS1	8.33	3.81e-11	4.24e-06	0.95	0.76	Cerebrospinal fluid biomarker levels;	chr7:23119904	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs4140959	ENSG00000230658.1	KLHL7-AS1	8.33	3.9e-11	4.31e-06	0.91	0.76	Cerebrospinal fluid biomarker levels;	chr7:23131157	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs10255228	ENSG00000230658.1	KLHL7-AS1	8.32	3.96e-11	4.37e-06	0.95	0.76	Cerebrospinal fluid biomarker levels;	chr7:23119244	chr7:23101228~23105703:-
ACC	cis	rs858239	0.539	rs2103281	ENSG00000230658.1	KLHL7-AS1	8.3	4.21e-11	4.62e-06	1	0.76	Cerebrospinal fluid biomarker levels;	chr7:23154612	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.962	rs2065664	ENSG00000231760.4	RP11-350J20.5	8.25	5.15e-11	5.29e-06	0.9	0.75	Lung cancer;	chr6:149762485	chr6:149796151~149826294:-
ACC	cis	rs916888	0.773	rs9896243	ENSG00000262539.1	RP11-259G18.3	8.17	6.76e-11	6.58e-06	0.85	0.75	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46748690	chr17:46259551~46260606:-
ACC	cis	rs858239	0.6	rs10488077	ENSG00000230658.1	KLHL7-AS1	8.17	6.83e-11	6.58e-06	0.93	0.75	Cerebrospinal fluid biomarker levels;	chr7:23104563	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs10241208	ENSG00000230658.1	KLHL7-AS1	8.17	6.83e-11	6.58e-06	0.93	0.75	Cerebrospinal fluid biomarker levels;	chr7:23105295	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs764534	ENSG00000230658.1	KLHL7-AS1	8.16	7.16e-11	6.58e-06	0.95	0.75	Cerebrospinal fluid biomarker levels;	chr7:23114316	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs2068459	ENSG00000230658.1	KLHL7-AS1	8.16	7.16e-11	6.58e-06	0.95	0.75	Cerebrospinal fluid biomarker levels;	chr7:23114694	chr7:23101228~23105703:-
ACC	cis	rs858239	0.669	rs10950940	ENSG00000230658.1	KLHL7-AS1	-8.16	7.23e-11	6.62e-06	-0.97	-0.75	Cerebrospinal fluid biomarker levels;	chr7:23157197	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.962	rs7818	ENSG00000231760.4	RP11-350J20.5	8.15	7.38e-11	6.73e-06	0.88	0.75	Lung cancer;	chr6:149810956	chr6:149796151~149826294:-
ACC	cis	rs858239	0.6	rs4409314	ENSG00000230658.1	KLHL7-AS1	8.12	8.1e-11	6.96e-06	1.01	0.75	Cerebrospinal fluid biomarker levels;	chr7:23088333	chr7:23101228~23105703:-
ACC	cis	rs858239	0.537	rs6942981	ENSG00000230658.1	KLHL7-AS1	8.12	8.24e-11	6.96e-06	1.01	0.75	Cerebrospinal fluid biomarker levels;	chr7:23191929	chr7:23101228~23105703:-
ACC	cis	rs858239	0.6	rs2072369	ENSG00000230658.1	KLHL7-AS1	8.11	8.56e-11	6.96e-06	0.93	0.75	Cerebrospinal fluid biomarker levels;	chr7:23106570	chr7:23101228~23105703:-
ACC	cis	rs801193	1	rs3778909	ENSG00000226824.5	RP4-756H11.3	-8.1	8.78e-11	6.96e-06	-0.83	-0.75	Aortic root size;	chr7:66790659	chr7:66654538~66669855:+
ACC	cis	rs858239	0.601	rs12539331	ENSG00000230658.1	KLHL7-AS1	8.08	9.41e-11	6.96e-06	0.95	0.75	Cerebrospinal fluid biomarker levels;	chr7:23111711	chr7:23101228~23105703:-
ACC	cis	rs801193	0.773	rs801207	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66555603	chr7:66654538~66669855:+
ACC	cis	rs875971	0.543	rs801191	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66567968	chr7:66654538~66669855:+
ACC	cis	rs875971	0.508	rs6947808	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66580095	chr7:66654538~66669855:+
ACC	cis	rs875971	0.508	rs10242423	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66594188	chr7:66654538~66669855:+
ACC	cis	rs875971	0.508	rs10253883	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66596151	chr7:66654538~66669855:+
ACC	cis	rs875971	0.508	rs10950045	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66601386	chr7:66654538~66669855:+
ACC	cis	rs801193	0.839	rs6968619	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66603880	chr7:66654538~66669855:+
ACC	cis	rs801193	0.839	rs12534943	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66605533	chr7:66654538~66669855:+
ACC	cis	rs801193	0.805	rs12532355	ENSG00000226824.5	RP4-756H11.3	8.07	9.78e-11	6.96e-06	0.81	0.75	Aortic root size;	chr7:66605597	chr7:66654538~66669855:+
ACC	cis	rs801193	0.844	rs732465	ENSG00000226824.5	RP4-756H11.3	-8.07	9.78e-11	6.96e-06	-0.81	-0.75	Aortic root size;	chr7:66533463	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs12698534	ENSG00000226824.5	RP4-756H11.3	-8.06	1.02e-10	6.96e-06	-0.8	-0.75	Aortic root size;	chr7:66521858	chr7:66654538~66669855:+
ACC	cis	rs875971	0.619	rs12533585	ENSG00000226824.5	RP4-756H11.3	-8.06	1.02e-10	6.96e-06	-0.8	-0.75	Aortic root size;	chr7:66519618	chr7:66654538~66669855:+
ACC	cis	rs875971	0.619	rs2302918	ENSG00000226824.5	RP4-756H11.3	-8.06	1.02e-10	6.96e-06	-0.8	-0.75	Aortic root size;	chr7:66535945	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs28698552	ENSG00000226824.5	RP4-756H11.3	-8.06	1.02e-10	6.96e-06	-0.8	-0.75	Aortic root size;	chr7:66540031	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs62465434	ENSG00000226824.5	RP4-756H11.3	-8.06	1.02e-10	6.96e-06	-0.8	-0.75	Aortic root size;	chr7:66540165	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs13224319	ENSG00000226824.5	RP4-756H11.3	-8.06	1.02e-10	6.96e-06	-0.8	-0.75	Aortic root size;	chr7:66542376	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs801217	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66545590	chr7:66654538~66669855:+
ACC	cis	rs875971	0.638	rs801216	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66546680	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs801211	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66550702	chr7:66654538~66669855:+
ACC	cis	rs875971	0.638	rs801205	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66557157	chr7:66654538~66669855:+
ACC	cis	rs875971	0.617	rs810400	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66557902	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs801192	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66566965	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs801190	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66568046	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs3857686	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66571204	chr7:66654538~66669855:+
ACC	cis	rs875971	0.638	rs3898855	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66571411	chr7:66654538~66669855:+
ACC	cis	rs875971	0.638	rs10278816	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66572000	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs10281080	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66577454	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs10950044	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66577989	chr7:66654538~66669855:+
ACC	cis	rs6952407	1	rs6952407	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Cotinine glucuronidation;	chr7:66580525	chr7:66654538~66669855:+
ACC	cis	rs875971	0.638	rs10249404	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66581737	chr7:66654538~66669855:+
ACC	cis	rs875971	0.619	rs10278371	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66586553	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs1968127	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66591816	chr7:66654538~66669855:+
ACC	cis	rs875971	0.638	rs6460305	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66595421	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs10272357	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66598087	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs79009421	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66603522	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs6460308	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66619753	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs7807930	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66622178	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs7807944	ENSG00000226824.5	RP4-756H11.3	8.06	1.02e-10	6.96e-06	0.8	0.75	Aortic root size;	chr7:66622208	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2707856	ENSG00000226824.5	RP4-756H11.3	-8.06	1.04e-10	7.05e-06	-0.81	-0.75	Aortic root size;	chr7:66746023	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs2013222	ENSG00000226824.5	RP4-756H11.3	8.04	1.11e-10	7.42e-06	0.8	0.74	Aortic root size;	chr7:66570949	chr7:66654538~66669855:+
ACC	cis	rs858239	0.6	rs6967475	ENSG00000230658.1	KLHL7-AS1	8.01	1.21e-10	7.84e-06	1.03	0.74	Cerebrospinal fluid biomarker levels;	chr7:23089363	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs6980224	ENSG00000230658.1	KLHL7-AS1	8	1.26e-10	7.98e-06	0.91	0.74	Cerebrospinal fluid biomarker levels;	chr7:23109518	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs10224327	ENSG00000230658.1	KLHL7-AS1	7.97	1.44e-10	8.97e-06	0.95	0.74	Cerebrospinal fluid biomarker levels;	chr7:23122201	chr7:23101228~23105703:-
ACC	cis	rs10256972	0.577	rs2949179	ENSG00000229043.2	AC091729.9	-7.95	1.51e-10	8.98e-06	-0.95	-0.74	Endometriosis;Longevity;	chr7:1170249	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.504	rs2949178	ENSG00000229043.2	AC091729.9	-7.95	1.51e-10	8.98e-06	-0.95	-0.74	Endometriosis;Longevity;	chr7:1170289	chr7:1160374~1165267:+
ACC	cis	rs801193	1	rs2659915	ENSG00000226824.5	RP4-756H11.3	-7.94	1.57e-10	9.29e-06	-0.79	-0.74	Aortic root size;	chr7:66688114	chr7:66654538~66669855:+
ACC	cis	rs858239	0.601	rs73272053	ENSG00000230658.1	KLHL7-AS1	7.93	1.62e-10	9.43e-06	0.97	0.74	Cerebrospinal fluid biomarker levels;	chr7:23115906	chr7:23101228~23105703:-
ACC	cis	rs875971	0.628	rs6974355	ENSG00000226824.5	RP4-756H11.3	-7.93	1.63e-10	9.43e-06	-0.8	-0.74	Aortic root size;	chr7:66376994	chr7:66654538~66669855:+
ACC	cis	rs875971	0.706	rs1643374	ENSG00000226824.5	RP4-756H11.3	-7.93	1.63e-10	9.43e-06	-0.8	-0.74	Aortic root size;	chr7:66407695	chr7:66654538~66669855:+
ACC	cis	rs875971	0.666	rs13242072	ENSG00000226824.5	RP4-756H11.3	7.93	1.63e-10	9.43e-06	0.8	0.74	Aortic root size;	chr7:66301001	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs3764903	ENSG00000226824.5	RP4-756H11.3	7.92	1.68e-10	9.7e-06	0.8	0.74	Aortic root size;	chr7:66633495	chr7:66654538~66669855:+
ACC	cis	rs875971	0.638	rs35986979	ENSG00000226824.5	RP4-756H11.3	7.92	1.69e-10	9.72e-06	0.8	0.74	Aortic root size;	chr7:66624003	chr7:66654538~66669855:+
ACC	cis	rs875971	0.642	rs35526611	ENSG00000226824.5	RP4-756H11.3	7.92	1.69e-10	9.72e-06	0.8	0.74	Aortic root size;	chr7:66629021	chr7:66654538~66669855:+
ACC	cis	rs875971	0.66	rs10263935	ENSG00000226824.5	RP4-756H11.3	-7.91	1.77e-10	1.01e-05	-0.8	-0.74	Aortic root size;	chr7:66631041	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.591	rs6968988	ENSG00000229043.2	AC091729.9	-7.87	2.08e-10	1.16e-05	-0.97	-0.74	Endometriosis;Longevity;	chr7:1129983	chr7:1160374~1165267:+
ACC	cis	rs9322193	0.923	rs7769101	ENSG00000231760.4	RP11-350J20.5	7.85	2.22e-10	1.18e-05	0.85	0.74	Lung cancer;	chr6:149848768	chr6:149796151~149826294:-
ACC	cis	rs875971	0.66	rs801193	ENSG00000226824.5	RP4-756H11.3	7.83	2.37e-10	1.25e-05	0.78	0.74	Aortic root size;	chr7:66565625	chr7:66654538~66669855:+
ACC	cis	rs858239	0.568	rs6970694	ENSG00000230658.1	KLHL7-AS1	7.82	2.49e-10	1.28e-05	1	0.73	Cerebrospinal fluid biomarker levels;	chr7:23211209	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs28673077	ENSG00000230658.1	KLHL7-AS1	7.82	2.49e-10	1.28e-05	1	0.73	Cerebrospinal fluid biomarker levels;	chr7:23211235	chr7:23101228~23105703:-
ACC	cis	rs875971	0.508	rs10258739	ENSG00000226824.5	RP4-756H11.3	7.82	2.49e-10	1.28e-05	0.81	0.73	Aortic root size;	chr7:66597948	chr7:66654538~66669855:+
ACC	cis	rs801193	0.844	rs2244022	ENSG00000226824.5	RP4-756H11.3	-7.81	2.51e-10	1.28e-05	-0.81	-0.73	Aortic root size;	chr7:66737443	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.552	rs6978842	ENSG00000229043.2	AC091729.9	-7.81	2.53e-10	1.28e-05	-0.94	-0.73	Endometriosis;Longevity;	chr7:1164963	chr7:1160374~1165267:+
ACC	cis	rs801193	1	rs10252765	ENSG00000226824.5	RP4-756H11.3	-7.8	2.59e-10	1.28e-05	-0.82	-0.73	Aortic root size;	chr7:66763745	chr7:66654538~66669855:+
ACC	cis	rs801193	0.967	rs2707849	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66687725	chr7:66654538~66669855:+
ACC	cis	rs801193	0.967	rs2707841	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66692033	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2659912	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66693012	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2707836	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66695448	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs4717310	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66696020	chr7:66654538~66669855:+
ACC	cis	rs801193	0.844	rs7779971	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66696803	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2659906	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66700323	chr7:66654538~66669855:+
ACC	cis	rs801193	0.935	rs11772264	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66711400	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs7782320	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66712111	chr7:66654538~66669855:+
ACC	cis	rs801193	0.935	rs2659899	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66721734	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs62466793	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66726530	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs62466794	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66726592	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs1553609	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66732152	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs1553610	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66732246	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2707845	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66733811	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2707850	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66738883	chr7:66654538~66669855:+
ACC	cis	rs801193	0.967	rs1110414	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66740595	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs7783924	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66744070	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs7789184	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66745208	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2707854	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66747610	chr7:66654538~66669855:+
ACC	cis	rs801193	0.967	rs2707853	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66749023	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2659889	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66752125	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs3800812	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66758474	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs4279493	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66761633	chr7:66654538~66669855:+
ACC	cis	rs801193	0.761	rs2659888	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66765184	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs4717319	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66777606	chr7:66654538~66669855:+
ACC	cis	rs801193	0.904	rs4718403	ENSG00000226824.5	RP4-756H11.3	-7.8	2.67e-10	1.28e-05	-0.8	-0.73	Aortic root size;	chr7:66777742	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.923	rs2342765	ENSG00000231760.4	RP11-350J20.5	7.78	2.86e-10	1.36e-05	0.87	0.73	Lung cancer;	chr6:149858873	chr6:149796151~149826294:-
ACC	cis	rs801193	1	rs2659909	ENSG00000226824.5	RP4-756H11.3	-7.75	3.15e-10	1.49e-05	-0.79	-0.73	Aortic root size;	chr7:66695292	chr7:66654538~66669855:+
ACC	cis	rs858239	0.699	rs955187	ENSG00000230658.1	KLHL7-AS1	-7.74	3.26e-10	1.54e-05	-0.93	-0.73	Cerebrospinal fluid biomarker levels;	chr7:23154986	chr7:23101228~23105703:-
ACC	cis	rs853679	0.506	rs1150711	ENSG00000216901.1	AL022393.7	7.73	3.38e-10	1.59e-05	0.82	0.73	Depression;	chr6:28240757	chr6:28176188~28176674:+
ACC	cis	rs9322193	0.847	rs56103941	ENSG00000231760.4	RP11-350J20.5	7.73	3.46e-10	1.62e-05	0.84	0.73	Lung cancer;	chr6:149816095	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs12174035	ENSG00000231760.4	RP11-350J20.5	7.7	3.78e-10	1.76e-05	0.84	0.73	Lung cancer;	chr6:149763311	chr6:149796151~149826294:-
ACC	cis	rs858239	0.601	rs987257	ENSG00000230658.1	KLHL7-AS1	7.7	3.84e-10	1.78e-05	0.89	0.73	Cerebrospinal fluid biomarker levels;	chr7:23108221	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs1034963	ENSG00000230658.1	KLHL7-AS1	7.7	3.84e-10	1.78e-05	0.89	0.73	Cerebrospinal fluid biomarker levels;	chr7:23108854	chr7:23101228~23105703:-
ACC	cis	rs858239	0.57	rs10235467	ENSG00000230658.1	KLHL7-AS1	7.7	3.84e-10	1.78e-05	0.89	0.73	Cerebrospinal fluid biomarker levels;	chr7:23109189	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.962	rs3763162	ENSG00000231760.4	RP11-350J20.5	-7.68	4.1e-10	1.89e-05	-0.84	-0.73	Lung cancer;	chr6:149819674	chr6:149796151~149826294:-
ACC	cis	rs9326248	0.52	rs236919	ENSG00000254851.1	RP11-109L13.1	-7.67	4.23e-10	1.94e-05	-0.72	-0.73	Blood protein levels;	chr11:117224645	chr11:117135528~117138582:+
ACC	cis	rs9322193	0.923	rs7753812	ENSG00000231760.4	RP11-350J20.5	7.66	4.44e-10	2.01e-05	0.82	0.73	Lung cancer;	chr6:149690150	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs12195866	ENSG00000231760.4	RP11-350J20.5	7.66	4.44e-10	2.01e-05	0.82	0.73	Lung cancer;	chr6:149693334	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9285524	ENSG00000231760.4	RP11-350J20.5	7.66	4.44e-10	2.01e-05	0.82	0.73	Lung cancer;	chr6:149694122	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10872645	ENSG00000231760.4	RP11-350J20.5	7.66	4.44e-10	2.01e-05	0.82	0.73	Lung cancer;	chr6:149742840	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs12211511	ENSG00000231760.4	RP11-350J20.5	7.66	4.44e-10	2.01e-05	0.82	0.73	Lung cancer;	chr6:149745206	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs12175504	ENSG00000231760.4	RP11-350J20.5	7.64	4.76e-10	2.14e-05	0.82	0.73	Lung cancer;	chr6:149664079	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs62439843	ENSG00000231760.4	RP11-350J20.5	7.64	4.76e-10	2.14e-05	0.82	0.73	Lung cancer;	chr6:149676521	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.772	rs7738696	ENSG00000231760.4	RP11-350J20.5	7.63	4.97e-10	2.23e-05	0.83	0.73	Lung cancer;	chr6:149848985	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs7743823	ENSG00000231760.4	RP11-350J20.5	7.63	4.97e-10	2.23e-05	0.83	0.73	Lung cancer;	chr6:149849744	chr6:149796151~149826294:-
ACC	cis	rs858239	0.699	rs858260	ENSG00000230658.1	KLHL7-AS1	7.62	5.12e-10	2.26e-05	0.97	0.73	Cerebrospinal fluid biomarker levels;	chr7:23173315	chr7:23101228~23105703:-
ACC	cis	rs875971	0.66	rs10215132	ENSG00000226824.5	RP4-756H11.3	7.6	5.4e-10	2.36e-05	0.79	0.73	Aortic root size;	chr7:66589419	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.923	rs6913486	ENSG00000231760.4	RP11-350J20.5	-7.59	5.62e-10	2.36e-05	-0.91	-0.73	Lung cancer;	chr6:149705060	chr6:149796151~149826294:-
ACC	cis	rs875971	0.638	rs7793569	ENSG00000226824.5	RP4-756H11.3	7.59	5.73e-10	2.36e-05	0.79	0.72	Aortic root size;	chr7:66651646	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs6975195	ENSG00000226824.5	RP4-756H11.3	7.59	5.73e-10	2.36e-05	0.79	0.72	Aortic root size;	chr7:66659787	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs3857688	ENSG00000226824.5	RP4-756H11.3	7.59	5.73e-10	2.36e-05	0.79	0.72	Aortic root size;	chr7:66662819	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2286684	ENSG00000226824.5	RP4-756H11.3	7.59	5.73e-10	2.36e-05	0.79	0.72	Aortic root size;	chr7:66664843	chr7:66654538~66669855:+
ACC	cis	rs801193	0.935	rs2286683	ENSG00000226824.5	RP4-756H11.3	7.59	5.73e-10	2.36e-05	0.79	0.72	Aortic root size;	chr7:66664856	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs10274773	ENSG00000226824.5	RP4-756H11.3	7.59	5.73e-10	2.36e-05	0.79	0.72	Aortic root size;	chr7:66668591	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.884	rs7769115	ENSG00000231760.4	RP11-350J20.5	7.59	5.74e-10	2.37e-05	0.83	0.72	Lung cancer;	chr6:149848796	chr6:149796151~149826294:-
ACC	cis	rs10256972	0.552	rs7805591	ENSG00000229043.2	AC091729.9	-7.57	6.03e-10	2.45e-05	-0.91	-0.72	Endometriosis;Longevity;	chr7:1171109	chr7:1160374~1165267:+
ACC	cis	rs9322193	0.884	rs9397036	ENSG00000231760.4	RP11-350J20.5	7.57	6.05e-10	2.45e-05	0.85	0.72	Lung cancer;	chr6:149851787	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs9383864	ENSG00000231760.4	RP11-350J20.5	7.57	6.05e-10	2.45e-05	0.85	0.72	Lung cancer;	chr6:149851969	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs9383865	ENSG00000231760.4	RP11-350J20.5	7.57	6.05e-10	2.45e-05	0.85	0.72	Lung cancer;	chr6:149852043	chr6:149796151~149826294:-
ACC	cis	rs801193	1	rs17566701	ENSG00000226824.5	RP4-756H11.3	-7.57	6.17e-10	2.5e-05	-0.79	-0.72	Aortic root size;	chr7:66728196	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2055682	ENSG00000226824.5	RP4-756H11.3	-7.56	6.38e-10	2.58e-05	-0.8	-0.72	Aortic root size;	chr7:66795302	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs11773829	ENSG00000226824.5	RP4-756H11.3	7.55	6.54e-10	2.6e-05	0.79	0.72	Aortic root size;	chr7:66676087	chr7:66654538~66669855:+
ACC	cis	rs801193	0.935	rs3800820	ENSG00000226824.5	RP4-756H11.3	7.55	6.54e-10	2.6e-05	0.79	0.72	Aortic root size;	chr7:66682191	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2003301	ENSG00000226824.5	RP4-756H11.3	7.55	6.54e-10	2.6e-05	0.79	0.72	Aortic root size;	chr7:66682669	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs7788576	ENSG00000226824.5	RP4-756H11.3	7.55	6.54e-10	2.6e-05	0.79	0.72	Aortic root size;	chr7:66683315	chr7:66654538~66669855:+
ACC	cis	rs801193	0.935	rs2659916	ENSG00000226824.5	RP4-756H11.3	-7.55	6.54e-10	2.6e-05	-0.79	-0.72	Aortic root size;	chr7:66686365	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs6958520	ENSG00000226824.5	RP4-756H11.3	-7.55	6.54e-10	2.6e-05	-0.79	-0.72	Aortic root size;	chr7:66686466	chr7:66654538~66669855:+
ACC	cis	rs801193	1	rs2420824	ENSG00000226824.5	RP4-756H11.3	7.54	6.85e-10	2.72e-05	0.79	0.72	Aortic root size;	chr7:66666129	chr7:66654538~66669855:+
ACC	cis	rs858239	0.665	rs6964665	ENSG00000230658.1	KLHL7-AS1	7.53	6.97e-10	2.76e-05	0.97	0.72	Cerebrospinal fluid biomarker levels;	chr7:23171733	chr7:23101228~23105703:-
ACC	cis	rs801193	1	rs10234018	ENSG00000226824.5	RP4-756H11.3	7.53	7.19e-10	2.84e-05	0.79	0.72	Aortic root size;	chr7:66681297	chr7:66654538~66669855:+
ACC	cis	rs858239	0.636	rs7808488	ENSG00000230658.1	KLHL7-AS1	7.51	7.52e-10	2.96e-05	0.92	0.72	Cerebrospinal fluid biomarker levels;	chr7:23182251	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs6461702	ENSG00000230658.1	KLHL7-AS1	7.45	9.52e-10	3.68e-05	0.98	0.72	Cerebrospinal fluid biomarker levels;	chr7:23209654	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.923	rs958953	ENSG00000231760.4	RP11-350J20.5	7.4	1.14e-09	4.34e-05	0.83	0.72	Lung cancer;	chr6:149840735	chr6:149796151~149826294:-
ACC	cis	rs801193	1	rs7785213	ENSG00000226824.5	RP4-756H11.3	7.4	1.15e-09	4.37e-05	0.78	0.72	Aortic root size;	chr7:66673991	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.886	rs4870055	ENSG00000231760.4	RP11-350J20.5	7.39	1.19e-09	4.46e-05	0.82	0.72	Lung cancer;	chr6:149848433	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs9480009	ENSG00000231760.4	RP11-350J20.5	7.38	1.21e-09	4.46e-05	0.81	0.72	Lung cancer;	chr6:149758502	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10747276	ENSG00000231760.4	RP11-350J20.5	7.38	1.21e-09	4.46e-05	0.81	0.72	Lung cancer;	chr6:149758739	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs10872646	ENSG00000231760.4	RP11-350J20.5	7.38	1.24e-09	4.46e-05	0.81	0.72	Lung cancer;	chr6:149746539	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs12528279	ENSG00000231760.4	RP11-350J20.5	7.38	1.24e-09	4.46e-05	0.81	0.72	Lung cancer;	chr6:149750892	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.809	rs9479808	ENSG00000231760.4	RP11-350J20.5	7.38	1.24e-09	4.46e-05	0.81	0.72	Lung cancer;	chr6:149751328	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs62441284	ENSG00000231760.4	RP11-350J20.5	7.38	1.24e-09	4.46e-05	0.81	0.72	Lung cancer;	chr6:149751542	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10782316	ENSG00000231760.4	RP11-350J20.5	7.38	1.24e-09	4.46e-05	0.81	0.72	Lung cancer;	chr6:149752755	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs11155677	ENSG00000231760.4	RP11-350J20.5	7.38	1.24e-09	4.46e-05	0.81	0.72	Lung cancer;	chr6:149756953	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4870050	ENSG00000231760.4	RP11-350J20.5	7.38	1.25e-09	4.46e-05	0.82	0.72	Lung cancer;	chr6:149838917	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs7752089	ENSG00000231760.4	RP11-350J20.5	7.38	1.25e-09	4.46e-05	0.82	0.72	Lung cancer;	chr6:149839298	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4242279	ENSG00000231760.4	RP11-350J20.5	7.38	1.25e-09	4.46e-05	0.82	0.72	Lung cancer;	chr6:149839815	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4870052	ENSG00000231760.4	RP11-350J20.5	7.38	1.25e-09	4.46e-05	0.82	0.72	Lung cancer;	chr6:149839978	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs2275045	ENSG00000231760.4	RP11-350J20.5	7.38	1.25e-09	4.46e-05	0.82	0.72	Lung cancer;	chr6:149842775	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs2184370	ENSG00000231760.4	RP11-350J20.5	7.38	1.25e-09	4.46e-05	0.82	0.72	Lung cancer;	chr6:149843242	chr6:149796151~149826294:-
ACC	cis	rs875971	0.825	rs4587224	ENSG00000226824.5	RP4-756H11.3	7.37	1.26e-09	4.48e-05	0.89	0.71	Aortic root size;	chr7:66271195	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.527	rs28671326	ENSG00000229043.2	AC091729.9	-7.37	1.28e-09	4.51e-05	-0.88	-0.71	Endometriosis;Longevity;	chr7:1135337	chr7:1160374~1165267:+
ACC	cis	rs875971	0.825	rs1000464	ENSG00000226824.5	RP4-756H11.3	7.36	1.3e-09	4.59e-05	0.88	0.71	Aortic root size;	chr7:66312922	chr7:66654538~66669855:+
ACC	cis	rs801193	0.904	rs4718405	ENSG00000226824.5	RP4-756H11.3	-7.34	1.4e-09	4.89e-05	-0.79	-0.71	Aortic root size;	chr7:66789659	chr7:66654538~66669855:+
ACC	cis	rs801193	0.967	rs2420827	ENSG00000226824.5	RP4-756H11.3	7.34	1.42e-09	4.98e-05	0.78	0.71	Aortic root size;	chr7:66682114	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.962	rs35443312	ENSG00000231760.4	RP11-350J20.5	7.33	1.48e-09	5.14e-05	0.82	0.71	Lung cancer;	chr6:149670625	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs35031906	ENSG00000231760.4	RP11-350J20.5	7.33	1.48e-09	5.14e-05	0.82	0.71	Lung cancer;	chr6:149677438	chr6:149796151~149826294:-
ACC	cis	rs10256972	0.567	rs2949185	ENSG00000229043.2	AC091729.9	-7.33	1.49e-09	5.17e-05	-0.88	-0.71	Endometriosis;Longevity;	chr7:1169377	chr7:1160374~1165267:+
ACC	cis	rs9322193	0.962	rs3805752	ENSG00000231760.4	RP11-350J20.5	7.32	1.53e-09	5.23e-05	0.81	0.71	Lung cancer;	chr6:149795490	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.847	rs12210605	ENSG00000231760.4	RP11-350J20.5	7.32	1.53e-09	5.23e-05	0.81	0.71	Lung cancer;	chr6:149817267	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9371199	ENSG00000231760.4	RP11-350J20.5	7.32	1.53e-09	5.23e-05	0.81	0.71	Lung cancer;	chr6:149817526	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs7740784	ENSG00000231760.4	RP11-350J20.5	7.32	1.53e-09	5.23e-05	0.81	0.71	Lung cancer;	chr6:149833364	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs2342764	ENSG00000231760.4	RP11-350J20.5	7.32	1.53e-09	5.23e-05	0.81	0.71	Lung cancer;	chr6:149835068	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.886	rs4870049	ENSG00000231760.4	RP11-350J20.5	7.32	1.53e-09	5.23e-05	0.81	0.71	Lung cancer;	chr6:149837058	chr6:149796151~149826294:-
ACC	cis	rs2882667	0.69	rs311602	ENSG00000253404.1	AC034243.1	7.32	1.54e-09	5.25e-05	1.04	0.71	Age-related hearing impairment (SNP x SNP interaction);	chr5:138717370	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs930063	ENSG00000253404.1	AC034243.1	7.32	1.54e-09	5.25e-05	1.04	0.71	Age-related hearing impairment (SNP x SNP interaction);	chr5:138717929	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs930062	ENSG00000253404.1	AC034243.1	7.32	1.54e-09	5.25e-05	1.04	0.71	Age-related hearing impairment (SNP x SNP interaction);	chr5:138717934	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.658	rs172664	ENSG00000253404.1	AC034243.1	7.32	1.54e-09	5.25e-05	1.04	0.71	Age-related hearing impairment (SNP x SNP interaction);	chr5:138720617	chr5:138744434~138753309:-
ACC	cis	rs875971	0.577	rs35072105	ENSG00000226824.5	RP4-756H11.3	7.3	1.64e-09	5.57e-05	0.79	0.71	Aortic root size;	chr7:66144830	chr7:66654538~66669855:+
ACC	cis	rs858239	0.73	rs858279	ENSG00000230658.1	KLHL7-AS1	7.28	1.74e-09	5.8e-05	0.88	0.71	Cerebrospinal fluid biomarker levels;	chr7:23211386	chr7:23101228~23105703:-
ACC	cis	rs858239	0.601	rs10239760	ENSG00000230658.1	KLHL7-AS1	7.27	1.87e-09	6.05e-05	0.9	0.71	Cerebrospinal fluid biomarker levels;	chr7:23110331	chr7:23101228~23105703:-
ACC	cis	rs875971	0.558	rs4433015	ENSG00000226824.5	RP4-756H11.3	7.26	1.89e-09	6.1e-05	0.8	0.71	Aortic root size;	chr7:66174736	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.884	rs7744105	ENSG00000231760.4	RP11-350J20.5	7.25	2e-09	6.43e-05	0.86	0.71	Lung cancer;	chr6:149849308	chr6:149796151~149826294:-
ACC	cis	rs858239	0.67	rs3807452	ENSG00000230658.1	KLHL7-AS1	-7.24	2.02e-09	6.48e-05	-0.84	-0.71	Cerebrospinal fluid biomarker levels;	chr7:23122462	chr7:23101228~23105703:-
ACC	cis	rs10256972	0.577	rs6962809	ENSG00000229043.2	AC091729.9	-7.23	2.09e-09	6.58e-05	-0.91	-0.71	Endometriosis;Longevity;	chr7:1169253	chr7:1160374~1165267:+
ACC	cis	rs9322193	0.923	rs10782317	ENSG00000231760.4	RP11-350J20.5	-7.21	2.28e-09	7.12e-05	-0.82	-0.71	Lung cancer;	chr6:149753911	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.847	rs868375	ENSG00000231760.4	RP11-350J20.5	7.21	2.3e-09	7.17e-05	0.83	0.71	Lung cancer;	chr6:149844905	chr6:149796151~149826294:-
ACC	cis	rs858239	0.699	rs1881200	ENSG00000230658.1	KLHL7-AS1	-7.2	2.38e-09	7.36e-05	-0.9	-0.71	Cerebrospinal fluid biomarker levels;	chr7:23162018	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.923	rs9371207	ENSG00000231760.4	RP11-350J20.5	7.2	2.4e-09	7.39e-05	0.81	0.71	Lung cancer;	chr6:149858087	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs2880436	ENSG00000231760.4	RP11-350J20.5	7.2	2.4e-09	7.39e-05	0.81	0.71	Lung cancer;	chr6:149859123	chr6:149796151~149826294:-
ACC	cis	rs10256972	0.706	rs12701969	ENSG00000229043.2	AC091729.9	-7.2	2.4e-09	7.39e-05	-0.83	-0.71	Endometriosis;Longevity;	chr7:1082213	chr7:1160374~1165267:+
ACC	cis	rs801193	0.967	rs34356500	ENSG00000226824.5	RP4-756H11.3	-7.19	2.46e-09	7.55e-05	-0.77	-0.71	Aortic root size;	chr7:66771620	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.528	rs7784607	ENSG00000229043.2	AC091729.9	-7.18	2.52e-09	7.71e-05	-0.87	-0.71	Endometriosis;Longevity;	chr7:1139058	chr7:1160374~1165267:+
ACC	cis	rs801193	0.901	rs4273746	ENSG00000226824.5	RP4-756H11.3	7.17	2.66e-09	8.09e-05	0.81	0.71	Aortic root size;	chr7:66836124	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.923	rs12176034	ENSG00000231760.4	RP11-350J20.5	7.17	2.7e-09	8.15e-05	0.8	0.7	Lung cancer;	chr6:149800557	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs880245	ENSG00000231760.4	RP11-350J20.5	-7.16	2.7e-09	8.15e-05	-0.81	-0.7	Lung cancer;	chr6:149846262	chr6:149796151~149826294:-
ACC	cis	rs2882667	0.69	rs288016	ENSG00000253404.1	AC034243.1	-7.16	2.74e-09	8.15e-05	-1.07	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138859299	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs160405	ENSG00000253404.1	AC034243.1	7.16	2.74e-09	8.15e-05	1.07	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138748387	chr5:138744434~138753309:-
ACC	cis	rs858239	0.699	rs1881201	ENSG00000230658.1	KLHL7-AS1	-7.15	2.85e-09	8.39e-05	-0.88	-0.7	Cerebrospinal fluid biomarker levels;	chr7:23154394	chr7:23101228~23105703:-
ACC	cis	rs801193	1	rs13239306	ENSG00000226824.5	RP4-756H11.3	7.14	3e-09	8.8e-05	0.78	0.7	Aortic root size;	chr7:66671030	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs160403	ENSG00000253404.1	AC034243.1	7.13	3.1e-09	9.06e-05	1.01	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138722793	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288025	ENSG00000253404.1	AC034243.1	7.12	3.18e-09	9.22e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138887944	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288022	ENSG00000253404.1	AC034243.1	7.12	3.18e-09	9.22e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888586	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.598	rs288020	ENSG00000253404.1	AC034243.1	7.12	3.18e-09	9.22e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888609	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.591	rs56322405	ENSG00000253404.1	AC034243.1	-7.12	3.18e-09	9.22e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138837693	chr5:138744434~138753309:-
ACC	cis	rs875971	0.54	rs781152	ENSG00000226824.5	RP4-756H11.3	-7.11	3.27e-09	9.3e-05	-0.8	-0.7	Aortic root size;	chr7:66014585	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.727	rs781151	ENSG00000226824.5	RP4-756H11.3	-7.11	3.27e-09	9.3e-05	-0.8	-0.7	Calcium levels;	chr7:66014891	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs3749664	ENSG00000253404.1	AC034243.1	7.1	3.43e-09	9.3e-05	1.09	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138935732	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.628	rs311606	ENSG00000253404.1	AC034243.1	7.1	3.44e-09	9.3e-05	1.02	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138709551	chr5:138744434~138753309:-
ACC	cis	rs1150668	0.699	rs2394049	ENSG00000216901.1	AL022393.7	7.1	3.44e-09	9.3e-05	0.81	0.7	Pubertal anthropometrics;	chr6:28271903	chr6:28176188~28176674:+
ACC	cis	rs2882667	0.728	rs10037071	ENSG00000253404.1	AC034243.1	7.1	3.47e-09	9.3e-05	1.12	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138942158	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.728	rs7722413	ENSG00000253404.1	AC034243.1	7.1	3.47e-09	9.3e-05	1.12	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138942562	chr5:138744434~138753309:-
ACC	cis	rs9322193	0.884	rs1108889	ENSG00000231760.4	RP11-350J20.5	7.08	3.66e-09	9.3e-05	0.81	0.7	Lung cancer;	chr6:149845433	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.847	rs880246	ENSG00000231760.4	RP11-350J20.5	7.08	3.66e-09	9.3e-05	0.81	0.7	Lung cancer;	chr6:149845972	chr6:149796151~149826294:-
ACC	cis	rs2882667	0.69	rs7714455	ENSG00000253404.1	AC034243.1	-7.08	3.74e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138818281	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825669	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138731258	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs1703211	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138740587	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1627698	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138741777	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1703212	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138742863	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1651032	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138743151	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1725335	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138745541	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs160406	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138748032	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs700616	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138752184	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs700617	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138752290	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs700618	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138752429	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs1095374	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138759517	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs700620	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138762247	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.659	rs700621	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138762741	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs700623	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138762993	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs700624	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138763332	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs700625	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138763908	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs2940595	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138765348	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.587	rs2174972	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138766229	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs851278	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138767577	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs2693963	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138770637	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1567313	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138775013	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.589	rs825770	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138779530	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825769	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138779666	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs700627	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138783711	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825758	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138791288	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825754	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138796200	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.722	rs825751	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138798180	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825748	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138800378	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825746	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138800930	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825762	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138801981	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825761	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138802318	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.62	rs3789151	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138809771	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.722	rs4835649	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138810534	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.587	rs6596450	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138810831	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs12517514	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138814430	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6873425	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138819556	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs884470	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138820236	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6877187	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138823655	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6860780	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138824367	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs3804199	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138826440	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.722	rs2011462	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138827083	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs4835705	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138827887	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6884198	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138828618	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs4835706	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138829037	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6421921	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138831581	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1039789	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138835734	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1039788	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138835812	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1828188	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138836307	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs4835707	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138838831	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6887841	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138840221	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs12656942	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138840769	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.686	rs62381196	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138841000	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.72	rs56044552	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138841265	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs7710288	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138844049	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.621	rs55901834	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138844094	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs4835708	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138844204	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1976568	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138844627	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6880786	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138845874	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs9327826	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138846318	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.587	rs1848506	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138846768	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1848505	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138846841	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs1972072	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138849604	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs6863054	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138853166	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs288019	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138855704	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.587	rs288015	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138859528	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288014	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138860104	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288013	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138860128	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs176381	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138861042	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288011	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138864250	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288010	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138864340	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs495638	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138865253	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10038162	ENSG00000253404.1	AC034243.1	-7.07	3.89e-09	9.3e-05	-1.08	-0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138901066	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs160399	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138727552	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs274119	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138728530	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs274118	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138729198	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs274117	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138729359	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.659	rs311595	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138736183	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs160404	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138748580	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1828187	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138836531	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10043478	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138853022	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288042	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138867345	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288041	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138868322	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288039	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138870511	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288038	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138871844	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288033	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138878405	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288031	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138880377	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288030	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138880594	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288023	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888359	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs176382	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138891078	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs7446631	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138891376	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.599	rs288008	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138893632	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288004	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138895956	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs2662543	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138898441	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.659	rs12719515	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138905629	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs17207772	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138906131	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs13172507	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138907409	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs13177415	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138914251	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs13181762	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138914417	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.659	rs10056014	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920329	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.598	rs10078179	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920410	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs13158360	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138922488	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs2351463	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138923113	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs2016720	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138928369	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs891996	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138932127	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs3763016	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138935043	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.628	rs3749663	ENSG00000253404.1	AC034243.1	7.07	3.89e-09	9.3e-05	1.08	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138935498	chr5:138744434~138753309:-
ACC	cis	rs801193	0.967	rs3800823	ENSG00000226824.5	RP4-756H11.3	7.06	4.01e-09	9.57e-05	0.77	0.7	Aortic root size;	chr7:66682123	chr7:66654538~66669855:+
ACC	cis	rs9326248	0.52	rs6589602	ENSG00000254851.1	RP11-109L13.1	-7.06	4.04e-09	9.63e-05	-0.73	-0.7	Blood protein levels;	chr11:117166349	chr11:117135528~117138582:+
ACC	cis	rs875971	0.862	rs6460307	ENSG00000226824.5	RP4-756H11.3	-7.05	4.11e-09	9.77e-05	-0.87	-0.7	Aortic root size;	chr7:66595884	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.552	rs2949195	ENSG00000229043.2	AC091729.9	-7.03	4.42e-09	0.000102	-0.86	-0.7	Endometriosis;Longevity;	chr7:1163069	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.567	rs2960835	ENSG00000229043.2	AC091729.9	-7.03	4.42e-09	0.000102	-0.86	-0.7	Endometriosis;Longevity;	chr7:1163327	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.552	rs2949192	ENSG00000229043.2	AC091729.9	-7.03	4.42e-09	0.000102	-0.86	-0.7	Endometriosis;Longevity;	chr7:1164205	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.553	rs4236381	ENSG00000229043.2	AC091729.9	-7.01	4.82e-09	0.000108	-0.88	-0.7	Endometriosis;Longevity;	chr7:1126087	chr7:1160374~1165267:+
ACC	cis	rs9322193	0.923	rs9800736	ENSG00000231760.4	RP11-350J20.5	7	4.87e-09	0.000108	0.77	0.7	Lung cancer;	chr6:149661281	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs62439837	ENSG00000231760.4	RP11-350J20.5	7	4.87e-09	0.000108	0.77	0.7	Lung cancer;	chr6:149670380	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs66516768	ENSG00000231760.4	RP11-350J20.5	7	4.87e-09	0.000108	0.77	0.7	Lung cancer;	chr6:149671999	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs62439840	ENSG00000231760.4	RP11-350J20.5	7	4.87e-09	0.000108	0.77	0.7	Lung cancer;	chr6:149674639	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs9393175	ENSG00000231760.4	RP11-350J20.5	7	4.87e-09	0.000108	0.77	0.7	Lung cancer;	chr6:149677587	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs7450246	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149702517	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9383812	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149712355	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.847	rs9383844	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149716268	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9478291	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149729434	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9688350	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149730977	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs9688699	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149733680	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9767652	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149734502	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10782314	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149735527	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9479494	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149739108	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs56397000	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149739347	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9800806	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149740350	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9688517	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149740655	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs9689702	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149740720	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10872644	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149741819	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10782315	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149743093	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs1572229	ENSG00000231760.4	RP11-350J20.5	7	4.97e-09	0.000108	0.76	0.7	Lung cancer;	chr6:149743841	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs12526675	ENSG00000231760.4	RP11-350J20.5	-7	4.97e-09	0.000108	-0.76	-0.7	Lung cancer;	chr6:149729540	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10782318	ENSG00000231760.4	RP11-350J20.5	6.99	5.07e-09	0.000109	0.77	0.7	Lung cancer;	chr6:149754137	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs3924871	ENSG00000231760.4	RP11-350J20.5	6.99	5.19e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149662080	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs35961297	ENSG00000231760.4	RP11-350J20.5	6.99	5.19e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149667929	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs35830138	ENSG00000231760.4	RP11-350J20.5	6.99	5.19e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149668635	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs35967444	ENSG00000231760.4	RP11-350J20.5	6.99	5.19e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149675588	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs62439842	ENSG00000231760.4	RP11-350J20.5	6.99	5.19e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149675847	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9767123	ENSG00000231760.4	RP11-350J20.5	6.99	5.2e-09	0.000109	0.77	0.7	Lung cancer;	chr6:149660323	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs62439836	ENSG00000231760.4	RP11-350J20.5	6.99	5.2e-09	0.000109	0.77	0.7	Lung cancer;	chr6:149669173	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4869812	ENSG00000231760.4	RP11-350J20.5	6.99	5.2e-09	0.000109	0.77	0.7	Lung cancer;	chr6:149669447	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4870267	ENSG00000231760.4	RP11-350J20.5	6.99	5.2e-09	0.000109	0.77	0.7	Lung cancer;	chr6:149671572	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs4380763	ENSG00000231760.4	RP11-350J20.5	6.99	5.2e-09	0.000109	0.77	0.7	Lung cancer;	chr6:149678086	chr6:149796151~149826294:-
ACC	cis	rs2882667	0.69	rs1059110	ENSG00000253404.1	AC034243.1	6.99	5.22e-09	0.000109	1.09	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138930857	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10068280	ENSG00000253404.1	AC034243.1	6.99	5.22e-09	0.000109	1.09	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138931394	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs13178601	ENSG00000253404.1	AC034243.1	6.99	5.22e-09	0.000109	1.09	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138931688	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs9327830	ENSG00000253404.1	AC034243.1	6.99	5.22e-09	0.000109	1.09	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138936560	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs7709789	ENSG00000253404.1	AC034243.1	6.99	5.22e-09	0.000109	1.09	0.7	Age-related hearing impairment (SNP x SNP interaction);	chr5:138938762	chr5:138744434~138753309:-
ACC	cis	rs9322193	0.923	rs7767622	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149681766	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4421206	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149682891	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs3798761	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149683643	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs9322210	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149695440	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4354168	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149696642	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4455682	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149700161	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs11155674	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149711111	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs2185352	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149714640	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs4870529	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149716436	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9767309	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149716807	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs12174349	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149718012	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs2297932	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149718225	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs2297930	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149718360	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs2297928	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149718584	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs17745062	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149721079	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs62441279	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149721194	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9479094	ENSG00000231760.4	RP11-350J20.5	6.98	5.39e-09	0.000109	0.76	0.7	Lung cancer;	chr6:149725083	chr6:149796151~149826294:-
ACC	cis	rs10256972	0.552	rs2960830	ENSG00000229043.2	AC091729.9	-6.96	5.65e-09	0.000109	-0.87	-0.69	Endometriosis;Longevity;	chr7:1161005	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.552	rs2960831	ENSG00000229043.2	AC091729.9	-6.96	5.65e-09	0.000109	-0.87	-0.69	Endometriosis;Longevity;	chr7:1161556	chr7:1160374~1165267:+
ACC	cis	rs2739330	0.892	rs4822455	ENSG00000273295.1	AP000350.5	6.96	5.82e-09	0.000109	0.7	0.69	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913109	chr22:23901432~23907068:-
ACC	cis	rs9322193	0.923	rs12660304	ENSG00000231760.4	RP11-350J20.5	6.95	5.95e-09	0.000109	0.76	0.69	Lung cancer;	chr6:149739647	chr6:149796151~149826294:-
ACC	cis	rs875971	0.862	rs12537823	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66255897	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6460302	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66495270	chr7:66654538~66669855:+
ACC	cis	rs875971	0.798	rs6460304	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66499741	chr7:66654538~66669855:+
ACC	cis	rs875971	0.798	rs12698522	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66502354	chr7:66654538~66669855:+
ACC	cis	rs875971	0.83	rs28714531	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66503250	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6945775	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66503987	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs12698526	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66504118	chr7:66654538~66669855:+
ACC	cis	rs875971	0.798	rs57739047	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66507579	chr7:66654538~66669855:+
ACC	cis	rs875971	0.83	rs6950137	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66511623	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs11763189	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66518542	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs13232191	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66521661	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs35378740	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66522725	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10950043	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66523623	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs17747530	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66529742	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs13226170	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66534311	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs2420611	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66534333	chr7:66654538~66669855:+
ACC	cis	rs875971	0.767	rs61348003	ENSG00000226824.5	RP4-756H11.3	-6.94	6.2e-09	0.000109	-0.85	-0.69	Aortic root size;	chr7:66540947	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6460282	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66226259	chr7:66654538~66669855:+
ACC	cis	rs875971	0.756	rs4718328	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66228350	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs4718330	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66250256	chr7:66654538~66669855:+
ACC	cis	rs875971	0.825	rs6951503	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66253949	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10282433	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66256452	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10276077	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66263424	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs1875057	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66266868	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6960446	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66268272	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10224872	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66294786	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs2901152	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66300017	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10263690	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66301466	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10250544	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66301574	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs949930	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66301835	chr7:66654538~66669855:+
ACC	cis	rs875971	0.895	rs12531677	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66304099	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs7798630	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66306492	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs11984115	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66308872	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs11773628	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66517644	chr7:66654538~66669855:+
ACC	cis	rs875971	0.861	rs801215	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66546951	chr7:66654538~66669855:+
ACC	cis	rs875971	0.756	rs2901210	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66552518	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs13536	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66554203	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs801209	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66554403	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs801206	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66556979	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs801204	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66557934	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs801203	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66558025	chr7:66654538~66669855:+
ACC	cis	rs875971	0.825	rs801202	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66558942	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs801195	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66561128	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs801194	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66563508	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs2024192	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66576460	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6955837	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66578155	chr7:66654538~66669855:+
ACC	cis	rs875971	0.825	rs10281499	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66583979	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs4718377	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66584691	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10278014	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66586277	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs1968126	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66592017	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6460306	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66595806	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6971059	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66602045	chr7:66654538~66669855:+
ACC	cis	rs875971	0.789	rs7808013	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66606209	chr7:66654538~66669855:+
ACC	cis	rs875971	0.825	rs7384021	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66612917	chr7:66654538~66669855:+
ACC	cis	rs875971	0.825	rs66981195	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66614048	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs3926380	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66615658	chr7:66654538~66669855:+
ACC	cis	rs875971	0.825	rs1860472	ENSG00000226824.5	RP4-756H11.3	6.94	6.2e-09	0.000109	0.85	0.69	Aortic root size;	chr7:66617736	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6944374	ENSG00000226824.5	RP4-756H11.3	6.94	6.22e-09	0.000109	0.82	0.69	Aortic root size;	chr7:66221942	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.923	rs9322209	ENSG00000231760.4	RP11-350J20.5	6.94	6.22e-09	0.000109	0.76	0.69	Lung cancer;	chr6:149691226	chr6:149796151~149826294:-
ACC	cis	rs9326248	0.52	rs2735183	ENSG00000254851.1	RP11-109L13.1	-6.94	6.25e-09	0.000109	-0.75	-0.69	Blood protein levels;	chr11:117144479	chr11:117135528~117138582:+
ACC	cis	rs9326248	0.539	rs7120565	ENSG00000254851.1	RP11-109L13.1	-6.93	6.31e-09	0.000109	-0.72	-0.69	Blood protein levels;	chr11:117172233	chr11:117135528~117138582:+
ACC	cis	rs9322193	0.884	rs9371201	ENSG00000231760.4	RP11-350J20.5	6.92	6.64e-09	0.000114	0.82	0.69	Lung cancer;	chr6:149823865	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9371486	ENSG00000231760.4	RP11-350J20.5	6.92	6.64e-09	0.000114	0.82	0.69	Lung cancer;	chr6:149832090	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs9322206	ENSG00000231760.4	RP11-350J20.5	6.9	7.02e-09	0.00012	0.8	0.69	Lung cancer;	chr6:149641481	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.962	rs9688750	ENSG00000231760.4	RP11-350J20.5	6.9	7.02e-09	0.00012	0.8	0.69	Lung cancer;	chr6:149657633	chr6:149796151~149826294:-
ACC	cis	rs4853012	0.838	rs4563249	ENSG00000217702.2	RP11-287D1.4	6.9	7.09e-09	0.000121	0.75	0.69	Gestational age at birth (maternal effect);	chr2:74126889	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.838	rs72915068	ENSG00000217702.2	RP11-287D1.4	6.9	7.09e-09	0.000121	0.75	0.69	Gestational age at birth (maternal effect);	chr2:74129058	chr2:74130583~74135395:+
ACC	cis	rs9322193	0.961	rs9027	ENSG00000231760.4	RP11-350J20.5	6.9	7.26e-09	0.000124	0.79	0.69	Lung cancer;	chr6:149594921	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs10872647	ENSG00000231760.4	RP11-350J20.5	6.89	7.32e-09	0.000124	0.82	0.69	Lung cancer;	chr6:149758687	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs10872648	ENSG00000231760.4	RP11-350J20.5	6.89	7.32e-09	0.000124	0.82	0.69	Lung cancer;	chr6:149758699	chr6:149796151~149826294:-
ACC	cis	rs2882667	0.652	rs874115	ENSG00000253404.1	AC034243.1	6.89	7.48e-09	0.000125	1.09	0.69	Age-related hearing impairment (SNP x SNP interaction);	chr5:138944367	chr5:138744434~138753309:-
ACC	cis	rs10256972	0.552	rs2960837	ENSG00000229043.2	AC091729.9	-6.89	7.52e-09	0.000125	-0.88	-0.69	Endometriosis;Longevity;	chr7:1164321	chr7:1160374~1165267:+
ACC	cis	rs875971	0.862	rs778734	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66349862	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs778686	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66370923	chr7:66654538~66669855:+
ACC	cis	rs875971	0.767	rs1643394	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66371107	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs778684	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66371416	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs778680	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66375427	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs2909688	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66376625	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs11769079	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66377141	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs1695820	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66379576	chr7:66654538~66669855:+
ACC	cis	rs875971	0.83	rs778715	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66384222	chr7:66654538~66669855:+
ACC	cis	rs875971	0.83	rs809025	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66384832	chr7:66654538~66669855:+
ACC	cis	rs875971	0.83	rs778711	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66386670	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs1083554	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66387354	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs778707	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66392040	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs778705	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66396128	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs778702	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66399848	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs778697	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66405439	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs1643375	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66407690	chr7:66654538~66669855:+
ACC	cis	rs875971	0.798	rs7789615	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66413674	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6962717	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66418748	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6978028	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66421313	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6947339	ENSG00000226824.5	RP4-756H11.3	-6.88	7.59e-09	0.000125	-0.86	-0.69	Aortic root size;	chr7:66423483	chr7:66654538~66669855:+
ACC	cis	rs875971	0.895	rs6460278	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66197749	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6460279	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66197774	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs28491091	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66204077	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs880166	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66205775	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6952182	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66218330	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6964437	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66221457	chr7:66654538~66669855:+
ACC	cis	rs875971	0.789	rs10260426	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66271055	chr7:66654538~66669855:+
ACC	cis	rs875971	0.792	rs6971752	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66272999	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10950033	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66274686	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs11760844	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66274896	chr7:66654538~66669855:+
ACC	cis	rs875971	0.79	rs10257911	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66278783	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs4149461	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66279745	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs7796162	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66280771	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs4236208	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66284091	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10261398	ENSG00000226824.5	RP4-756H11.3	6.88	7.79e-09	0.000126	0.85	0.69	Aortic root size;	chr7:66285177	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.923	rs1934534	ENSG00000231760.4	RP11-350J20.5	6.86	8.13e-09	0.000131	0.73	0.69	Lung cancer;	chr6:149711896	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.651	rs9322188	ENSG00000231760.4	RP11-350J20.5	-6.86	8.25e-09	0.000133	-0.82	-0.69	Lung cancer;	chr6:149588355	chr6:149796151~149826294:-
ACC	cis	rs858239	0.636	rs28706766	ENSG00000230658.1	KLHL7-AS1	6.85	8.47e-09	0.000136	0.79	0.69	Cerebrospinal fluid biomarker levels;	chr7:23130215	chr7:23101228~23105703:-
ACC	cis	rs858239	0.665	rs858306	ENSG00000230658.1	KLHL7-AS1	6.85	8.47e-09	0.000136	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23203135	chr7:23101228~23105703:-
ACC	cis	rs858239	0.633	rs858300	ENSG00000230658.1	KLHL7-AS1	6.85	8.47e-09	0.000136	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23205012	chr7:23101228~23105703:-
ACC	cis	rs858239	0.698	rs858295	ENSG00000230658.1	KLHL7-AS1	6.85	8.47e-09	0.000136	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23205950	chr7:23101228~23105703:-
ACC	cis	rs858239	0.73	rs858290	ENSG00000230658.1	KLHL7-AS1	6.85	8.47e-09	0.000136	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23208417	chr7:23101228~23105703:-
ACC	cis	rs858239	0.73	rs858289	ENSG00000230658.1	KLHL7-AS1	6.85	8.47e-09	0.000136	0.89	0.69	Cerebrospinal fluid biomarker levels;	chr7:23208539	chr7:23101228~23105703:-
ACC	cis	rs2882667	0.69	rs11750163	ENSG00000253404.1	AC034243.1	6.84	9.06e-09	0.000145	0.99	0.69	Age-related hearing impairment (SNP x SNP interaction);	chr5:138705920	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs311608	ENSG00000253404.1	AC034243.1	6.84	9.06e-09	0.000145	0.99	0.69	Age-related hearing impairment (SNP x SNP interaction);	chr5:138708000	chr5:138744434~138753309:-
ACC	cis	rs875971	0.862	rs709596	ENSG00000226824.5	RP4-756H11.3	-6.82	9.57e-09	0.000152	-0.86	-0.69	Aortic root size;	chr7:66360926	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs778724	ENSG00000226824.5	RP4-756H11.3	-6.82	9.57e-09	0.000152	-0.86	-0.69	Aortic root size;	chr7:66364304	chr7:66654538~66669855:+
ACC	cis	rs801193	0.875	rs13227951	ENSG00000226824.5	RP4-756H11.3	6.82	9.64e-09	0.000152	0.8	0.69	Aortic root size;	chr7:66748121	chr7:66654538~66669855:+
ACC	cis	rs875971	0.54	rs736270	ENSG00000226824.5	RP4-756H11.3	-6.8	1.05e-08	0.000164	-0.77	-0.69	Aortic root size;	chr7:65963835	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs1880556	ENSG00000226824.5	RP4-756H11.3	-6.79	1.06e-08	0.000165	-0.76	-0.69	Aortic root size;	chr7:65967557	chr7:66654538~66669855:+
ACC	cis	rs858239	0.665	rs858305	ENSG00000230658.1	KLHL7-AS1	-6.79	1.06e-08	0.000165	-0.88	-0.69	Cerebrospinal fluid biomarker levels;	chr7:23203211	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.923	rs4870509	ENSG00000231760.4	RP11-350J20.5	6.79	1.06e-08	0.000165	0.75	0.69	Lung cancer;	chr6:149702212	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9322214	ENSG00000231760.4	RP11-350J20.5	6.79	1.06e-08	0.000165	0.75	0.69	Lung cancer;	chr6:149703986	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.887	rs9767113	ENSG00000231760.4	RP11-350J20.5	6.79	1.06e-08	0.000165	0.75	0.69	Lung cancer;	chr6:149718157	chr6:149796151~149826294:-
ACC	cis	rs858239	0.67	rs6967526	ENSG00000230658.1	KLHL7-AS1	6.79	1.09e-08	0.000169	0.81	0.69	Cerebrospinal fluid biomarker levels;	chr7:23119622	chr7:23101228~23105703:-
ACC	cis	rs875971	0.522	rs781144	ENSG00000226824.5	RP4-756H11.3	-6.78	1.11e-08	0.000171	-0.77	-0.68	Aortic root size;	chr7:65975357	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs1617484	ENSG00000226824.5	RP4-756H11.3	-6.78	1.11e-08	0.000171	-0.77	-0.68	Aortic root size;	chr7:65998108	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs2008188	ENSG00000226824.5	RP4-756H11.3	-6.78	1.12e-08	0.000171	-0.76	-0.68	Aortic root size;	chr7:65964026	chr7:66654538~66669855:+
ACC	cis	rs875971	0.505	rs6955582	ENSG00000226824.5	RP4-756H11.3	-6.78	1.12e-08	0.000171	-0.76	-0.68	Aortic root size;	chr7:65966699	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.727	rs1880555	ENSG00000226824.5	RP4-756H11.3	-6.78	1.12e-08	0.000171	-0.76	-0.68	Calcium levels;	chr7:65967580	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.701	rs781143	ENSG00000226824.5	RP4-756H11.3	-6.78	1.12e-08	0.000171	-0.76	-0.68	Calcium levels;	chr7:65974892	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.701	rs781145	ENSG00000226824.5	RP4-756H11.3	-6.78	1.12e-08	0.000171	-0.76	-0.68	Calcium levels;	chr7:65975383	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.727	rs2658585	ENSG00000226824.5	RP4-756H11.3	-6.78	1.12e-08	0.000171	-0.76	-0.68	Calcium levels;	chr7:65996954	chr7:66654538~66669855:+
ACC	cis	rs875971	0.54	rs1723268	ENSG00000226824.5	RP4-756H11.3	-6.78	1.12e-08	0.000171	-0.76	-0.68	Aortic root size;	chr7:66008093	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs2949690	ENSG00000226824.5	RP4-756H11.3	6.78	1.12e-08	0.000171	0.76	0.68	Aortic root size;	chr7:66018255	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs709604	ENSG00000226824.5	RP4-756H11.3	6.78	1.12e-08	0.000171	0.76	0.68	Aortic root size;	chr7:66032447	chr7:66654538~66669855:+
ACC	cis	rs875971	0.505	rs1723275	ENSG00000226824.5	RP4-756H11.3	6.78	1.12e-08	0.000171	0.76	0.68	Aortic root size;	chr7:66039646	chr7:66654538~66669855:+
ACC	cis	rs875971	0.505	rs2462573	ENSG00000226824.5	RP4-756H11.3	6.78	1.12e-08	0.000171	0.76	0.68	Aortic root size;	chr7:66042405	chr7:66654538~66669855:+
ACC	cis	rs875971	0.505	rs1167386	ENSG00000226824.5	RP4-756H11.3	6.78	1.12e-08	0.000171	0.76	0.68	Aortic root size;	chr7:66048109	chr7:66654538~66669855:+
ACC	cis	rs875971	0.505	rs1167385	ENSG00000226824.5	RP4-756H11.3	6.78	1.12e-08	0.000171	0.76	0.68	Aortic root size;	chr7:66048321	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs9942422	ENSG00000253404.1	AC034243.1	6.78	1.13e-08	0.000172	1.01	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138936847	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.554	rs1368425	ENSG00000253404.1	AC034243.1	6.78	1.13e-08	0.000173	1.07	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138944528	chr5:138744434~138753309:-
ACC	cis	rs10256972	0.706	rs12701970	ENSG00000229043.2	AC091729.9	-6.77	1.15e-08	0.000174	-0.77	-0.68	Endometriosis;Longevity;	chr7:1082322	chr7:1160374~1165267:+
ACC	cis	rs2882667	0.658	rs10076442	ENSG00000253404.1	AC034243.1	6.77	1.16e-08	0.000174	1.08	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138941090	chr5:138744434~138753309:-
ACC	cis	rs858239	0.867	rs10250602	ENSG00000230658.1	KLHL7-AS1	6.77	1.16e-08	0.000174	0.87	0.68	Cerebrospinal fluid biomarker levels;	chr7:23264082	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.884	rs11155679	ENSG00000231760.4	RP11-350J20.5	6.76	1.18e-08	0.000176	0.82	0.68	Lung cancer;	chr6:149758881	chr6:149796151~149826294:-
ACC	cis	rs875971	0.825	rs28480509	ENSG00000226824.5	RP4-756H11.3	6.76	1.19e-08	0.000178	0.85	0.68	Aortic root size;	chr7:66634237	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.706	rs4285396	ENSG00000229043.2	AC091729.9	-6.76	1.2e-08	0.000179	-0.77	-0.68	Endometriosis;Longevity;	chr7:1084102	chr7:1160374~1165267:+
ACC	cis	rs2882667	0.69	rs700629	ENSG00000253404.1	AC034243.1	-6.74	1.28e-08	0.000189	-1.04	-0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138788305	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825749	ENSG00000253404.1	AC034243.1	-6.74	1.28e-08	0.000189	-1.04	-0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138800232	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs884469	ENSG00000253404.1	AC034243.1	-6.74	1.28e-08	0.000189	-1.04	-0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138820270	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6596456	ENSG00000253404.1	AC034243.1	-6.74	1.28e-08	0.000189	-1.04	-0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138831808	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288012	ENSG00000253404.1	AC034243.1	-6.74	1.28e-08	0.000189	-1.04	-0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138860584	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs423469	ENSG00000253404.1	AC034243.1	6.74	1.28e-08	0.000189	1.04	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138898427	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs13174008	ENSG00000253404.1	AC034243.1	6.74	1.28e-08	0.000189	1.04	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138922220	chr5:138744434~138753309:-
ACC	cis	rs875971	0.862	rs778736	ENSG00000226824.5	RP4-756H11.3	-6.73	1.35e-08	0.000195	-0.84	-0.68	Aortic root size;	chr7:66348861	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs2088655	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66330724	chr7:66654538~66669855:+
ACC	cis	rs875971	0.895	rs10447522	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66331087	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs7783779	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66331639	chr7:66654538~66669855:+
ACC	cis	rs875971	0.928	rs2036263	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66335210	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10240949	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66339430	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs7782704	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66340379	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs2088653	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66343621	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6460293	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66345205	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6959268	ENSG00000226824.5	RP4-756H11.3	6.73	1.35e-08	0.000195	0.84	0.68	Aortic root size;	chr7:66347979	chr7:66654538~66669855:+
ACC	cis	rs853679	0.527	rs853693	ENSG00000216901.1	AL022393.7	6.72	1.36e-08	0.000196	0.82	0.68	Depression;	chr6:28314871	chr6:28176188~28176674:+
ACC	cis	rs9322193	1	rs9322193	ENSG00000231760.4	RP11-350J20.5	6.71	1.45e-08	0.000207	0.79	0.68	Lung cancer;	chr6:149598007	chr6:149796151~149826294:-
ACC	cis	rs9322193	1	rs9377229	ENSG00000231760.4	RP11-350J20.5	6.71	1.45e-08	0.000207	0.79	0.68	Lung cancer;	chr6:149607655	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9322197	ENSG00000231760.4	RP11-350J20.5	6.71	1.45e-08	0.000207	0.79	0.68	Lung cancer;	chr6:149622577	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs9688858	ENSG00000231760.4	RP11-350J20.5	6.71	1.45e-08	0.000207	0.79	0.68	Lung cancer;	chr6:149637911	chr6:149796151~149826294:-
ACC	cis	rs4853012	0.838	rs12619982	ENSG00000217702.2	RP11-287D1.4	6.7	1.51e-08	0.000215	0.73	0.68	Gestational age at birth (maternal effect);	chr2:74128895	chr2:74130583~74135395:+
ACC	cis	rs9322193	0.884	rs2064521	ENSG00000231760.4	RP11-350J20.5	-6.69	1.54e-08	0.000219	-0.74	-0.68	Lung cancer;	chr6:149625336	chr6:149796151~149826294:-
ACC	cis	rs2882667	0.69	rs9327831	ENSG00000253404.1	AC034243.1	6.67	1.66e-08	0.000234	1.05	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138936597	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs6862845	ENSG00000253404.1	AC034243.1	6.67	1.66e-08	0.000234	1.05	0.68	Age-related hearing impairment (SNP x SNP interaction);	chr5:138937456	chr5:138744434~138753309:-
ACC	cis	rs9322193	0.923	rs9767105	ENSG00000231760.4	RP11-350J20.5	6.67	1.67e-08	0.000235	0.72	0.68	Lung cancer;	chr6:149659591	chr6:149796151~149826294:-
ACC	cis	rs875971	0.862	rs6460290	ENSG00000226824.5	RP4-756H11.3	6.66	1.7e-08	0.000239	0.84	0.68	Aortic root size;	chr7:66344119	chr7:66654538~66669855:+
ACC	cis	rs858239	1	rs156407	ENSG00000230658.1	KLHL7-AS1	6.64	1.87e-08	0.000261	0.91	0.68	Cerebrospinal fluid biomarker levels;	chr7:23276020	chr7:23101228~23105703:-
ACC	cis	rs9326248	0.501	rs4938351	ENSG00000254851.1	RP11-109L13.1	-6.63	1.9e-08	0.000264	-0.72	-0.68	Blood protein levels;	chr11:117151636	chr11:117135528~117138582:+
ACC	cis	rs10256972	0.552	rs6953538	ENSG00000229043.2	AC091729.9	-6.62	1.96e-08	0.00027	-0.84	-0.68	Endometriosis;Longevity;	chr7:1157338	chr7:1160374~1165267:+
ACC	cis	rs9322193	0.923	rs9766004	ENSG00000231760.4	RP11-350J20.5	6.62	2.01e-08	0.000276	0.72	0.68	Lung cancer;	chr6:149754363	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.961	rs9767713	ENSG00000231760.4	RP11-350J20.5	6.61	2.05e-08	0.00028	0.75	0.68	Lung cancer;	chr6:149588241	chr6:149796151~149826294:-
ACC	cis	rs875971	0.755	rs10228885	ENSG00000226824.5	RP4-756H11.3	6.61	2.07e-08	0.00028	0.84	0.68	Aortic root size;	chr7:66315542	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs3893216	ENSG00000226824.5	RP4-756H11.3	6.61	2.07e-08	0.00028	0.84	0.68	Aortic root size;	chr7:66325720	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs6958294	ENSG00000226824.5	RP4-756H11.3	6.61	2.07e-08	0.00028	0.84	0.68	Aortic root size;	chr7:66329809	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.63	rs13235747	ENSG00000229043.2	AC091729.9	-6.6	2.12e-08	0.000285	-0.76	-0.68	Endometriosis;Longevity;	chr7:1089487	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.641	rs12702017	ENSG00000229043.2	AC091729.9	-6.6	2.12e-08	0.000285	-0.76	-0.68	Endometriosis;Longevity;	chr7:1089777	chr7:1160374~1165267:+
ACC	cis	rs6903823	0.508	rs1150721	ENSG00000216901.1	AL022393.7	6.6	2.12e-08	0.000285	0.8	0.68	Pulmonary function;	chr6:28287263	chr6:28176188~28176674:+
ACC	cis	rs2455601	0.529	rs2653569	ENSG00000254860.4	TMEM9B-AS1	6.6	2.13e-08	0.000286	0.74	0.68	Schizophrenia;	chr11:8965431	chr11:8964675~8977527:+
ACC	cis	rs1150668	0.799	rs1150705	ENSG00000216901.1	AL022393.7	6.6	2.17e-08	0.000288	0.8	0.67	Pubertal anthropometrics;	chr6:28226008	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.799	rs1150707	ENSG00000216901.1	AL022393.7	6.6	2.17e-08	0.000288	0.8	0.67	Pubertal anthropometrics;	chr6:28229827	chr6:28176188~28176674:+
ACC	cis	rs801193	0.569	rs2659908	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66695835	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs2659907	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66699045	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs7782587	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66701485	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs4717315	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66713338	chr7:66654538~66669855:+
ACC	cis	rs801193	0.527	rs2707837	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66716086	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs2707824	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66724256	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs2659893	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66735006	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs2659892	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66735318	chr7:66654538~66669855:+
ACC	cis	rs801193	0.548	rs2659891	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66736127	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs2707847	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66737884	chr7:66654538~66669855:+
ACC	cis	rs801193	0.548	rs7805152	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66744266	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs11772819	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66752983	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs11761542	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66753209	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs7800620	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66758701	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs13226966	ENSG00000226824.5	RP4-756H11.3	-6.6	2.18e-08	0.000288	-0.83	-0.67	Aortic root size;	chr7:66768636	chr7:66654538~66669855:+
ACC	cis	rs1150668	0.799	rs9301	ENSG00000216901.1	AL022393.7	6.57	2.37e-08	0.000312	0.8	0.67	Pubertal anthropometrics;	chr6:28324929	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.799	rs853684	ENSG00000216901.1	AL022393.7	6.57	2.37e-08	0.000312	0.8	0.67	Pubertal anthropometrics;	chr6:28326773	chr6:28176188~28176674:+
ACC	cis	rs801193	0.569	rs10950050	ENSG00000226824.5	RP4-756H11.3	-6.57	2.44e-08	0.000319	-0.8	-0.67	Aortic root size;	chr7:66774601	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.884	rs11155675	ENSG00000231760.4	RP11-350J20.5	6.56	2.45e-08	0.00032	0.78	0.67	Lung cancer;	chr6:149742883	chr6:149796151~149826294:-
ACC	cis	rs858239	0.669	rs1006709	ENSG00000230658.1	KLHL7-AS1	6.56	2.47e-08	0.000322	0.81	0.67	Cerebrospinal fluid biomarker levels;	chr7:23100480	chr7:23101228~23105703:-
ACC	cis	rs2882667	0.69	rs906695	ENSG00000253404.1	AC034243.1	6.55	2.54e-08	0.000332	1.04	0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:138803588	chr5:138744434~138753309:-
ACC	cis	rs11763147	1	rs11763147	ENSG00000226824.5	RP4-756H11.3	6.55	2.56e-08	0.000333	0.75	0.67	Corneal structure;	chr7:65861834	chr7:66654538~66669855:+
ACC	cis	rs9326248	0.861	rs1871757	ENSG00000254851.1	RP11-109L13.1	-6.55	2.63e-08	0.000342	-0.92	-0.67	Blood protein levels;	chr11:117159865	chr11:117135528~117138582:+
ACC	cis	rs17711722	0.653	rs2460421	ENSG00000226824.5	RP4-756H11.3	6.54	2.73e-08	0.000353	0.77	0.67	Calcium levels;	chr7:66026136	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs10807697	ENSG00000226824.5	RP4-756H11.3	-6.53	2.74e-08	0.000354	-0.76	-0.67	Aortic root size;	chr7:65951183	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.577	rs4999286	ENSG00000229043.2	AC091729.9	-6.53	2.78e-08	0.000359	-0.86	-0.67	Endometriosis;Longevity;	chr7:1159870	chr7:1160374~1165267:+
ACC	cis	rs1150668	0.768	rs1150716	ENSG00000216901.1	AL022393.7	6.52	2.88e-08	0.000372	0.79	0.67	Pubertal anthropometrics;	chr6:28294921	chr6:28176188~28176674:+
ACC	cis	rs2882667	0.69	rs9327827	ENSG00000253404.1	AC034243.1	6.52	2.89e-08	0.000373	0.96	0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:138846639	chr5:138744434~138753309:-
ACC	cis	rs6903823	0.508	rs1778484	ENSG00000216901.1	AL022393.7	6.51	2.95e-08	0.000379	0.79	0.67	Pulmonary function;	chr6:28273021	chr6:28176188~28176674:+
ACC	cis	rs6903823	0.508	rs1150724	ENSG00000216901.1	AL022393.7	6.51	2.95e-08	0.000379	0.79	0.67	Pulmonary function;	chr6:28282459	chr6:28176188~28176674:+
ACC	cis	rs875971	0.54	rs4717275	ENSG00000226824.5	RP4-756H11.3	6.5	3.06e-08	0.000387	0.75	0.67	Aortic root size;	chr7:65800193	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs1917563	ENSG00000226824.5	RP4-756H11.3	6.5	3.06e-08	0.000387	0.75	0.67	Aortic root size;	chr7:65950660	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs4718285	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Aortic root size;	chr7:65827018	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs4718286	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Aortic root size;	chr7:65827777	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs4502988	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Aortic root size;	chr7:65832759	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.585	rs6942660	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Calcium levels;	chr7:65837419	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.64	rs13237956	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Calcium levels;	chr7:65853042	chr7:66654538~66669855:+
ACC	cis	rs875971	0.516	rs6945322	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Aortic root size;	chr7:65871069	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.701	rs55773927	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Calcium levels;	chr7:65872915	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.727	rs35850374	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Calcium levels;	chr7:65892789	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.701	rs4467826	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Calcium levels;	chr7:65903721	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs7784623	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Aortic root size;	chr7:65930047	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs34973832	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Aortic root size;	chr7:65931217	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.74	rs7809991	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Calcium levels;	chr7:65941231	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs6960048	ENSG00000226824.5	RP4-756H11.3	-6.5	3.06e-08	0.000387	-0.75	-0.67	Aortic root size;	chr7:65943052	chr7:66654538~66669855:+
ACC	cis	rs2739330	0.828	rs4822454	ENSG00000273295.1	AP000350.5	6.5	3.07e-08	0.000388	0.7	0.67	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913021	chr22:23901432~23907068:-
ACC	cis	rs875971	1	rs1565531	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66198126	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6963646	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66220780	chr7:66654538~66669855:+
ACC	cis	rs875971	0.965	rs10267430	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66278036	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs10257427	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66278221	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs10215948	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66282799	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs55748098	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66298631	chr7:66654538~66669855:+
ACC	cis	rs875971	0.965	rs9969301	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66316668	chr7:66654538~66669855:+
ACC	cis	rs875971	0.867	rs1002053	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66333558	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6460292	ENSG00000226824.5	RP4-756H11.3	6.5	3.1e-08	0.000389	0.76	0.67	Aortic root size;	chr7:66345088	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.81	rs62439811	ENSG00000231760.4	RP11-350J20.5	6.5	3.13e-08	0.000391	0.75	0.67	Lung cancer;	chr6:149640416	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs57938011	ENSG00000231760.4	RP11-350J20.5	6.5	3.13e-08	0.000391	0.75	0.67	Lung cancer;	chr6:149642969	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs11155670	ENSG00000231760.4	RP11-350J20.5	6.5	3.13e-08	0.000391	0.75	0.67	Lung cancer;	chr6:149644992	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs12529698	ENSG00000231760.4	RP11-350J20.5	6.5	3.13e-08	0.000391	0.75	0.67	Lung cancer;	chr6:149650951	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.887	rs3777949	ENSG00000231760.4	RP11-350J20.5	6.5	3.15e-08	0.000393	0.74	0.67	Lung cancer;	chr6:149596021	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs12174716	ENSG00000231760.4	RP11-350J20.5	6.49	3.23e-08	0.000401	0.75	0.67	Lung cancer;	chr6:149644487	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9800871	ENSG00000231760.4	RP11-350J20.5	6.49	3.23e-08	0.000401	0.75	0.67	Lung cancer;	chr6:149644540	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9800614	ENSG00000231760.4	RP11-350J20.5	6.49	3.23e-08	0.000401	0.75	0.67	Lung cancer;	chr6:149644604	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs11155671	ENSG00000231760.4	RP11-350J20.5	6.49	3.23e-08	0.000401	0.75	0.67	Lung cancer;	chr6:149650996	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9689723	ENSG00000231760.4	RP11-350J20.5	6.49	3.23e-08	0.000401	0.75	0.67	Lung cancer;	chr6:149655935	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9968911	ENSG00000231760.4	RP11-350J20.5	6.49	3.23e-08	0.000401	0.75	0.67	Lung cancer;	chr6:149657419	chr6:149796151~149826294:-
ACC	cis	rs858239	0.965	rs156429	ENSG00000230658.1	KLHL7-AS1	6.48	3.29e-08	0.000407	0.81	0.67	Cerebrospinal fluid biomarker levels;	chr7:23266401	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.923	rs9689716	ENSG00000231760.4	RP11-350J20.5	6.48	3.29e-08	0.000407	0.74	0.67	Lung cancer;	chr6:149655662	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9322207	ENSG00000231760.4	RP11-350J20.5	6.48	3.29e-08	0.000407	0.74	0.67	Lung cancer;	chr6:149657185	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9322208	ENSG00000231760.4	RP11-350J20.5	6.48	3.29e-08	0.000407	0.74	0.67	Lung cancer;	chr6:149658547	chr6:149796151~149826294:-
ACC	cis	rs875971	0.83	rs6976714	ENSG00000226824.5	RP4-756H11.3	-6.48	3.36e-08	0.000414	-0.84	-0.67	Aortic root size;	chr7:66426474	chr7:66654538~66669855:+
ACC	cis	rs875971	0.767	rs12668005	ENSG00000226824.5	RP4-756H11.3	-6.48	3.36e-08	0.000414	-0.84	-0.67	Aortic root size;	chr7:66444034	chr7:66654538~66669855:+
ACC	cis	rs875971	0.651	rs2420596	ENSG00000226824.5	RP4-756H11.3	-6.48	3.36e-08	0.000414	-0.84	-0.67	Aortic root size;	chr7:66450996	chr7:66654538~66669855:+
ACC	cis	rs875971	0.52	rs2420597	ENSG00000226824.5	RP4-756H11.3	-6.48	3.36e-08	0.000414	-0.84	-0.67	Aortic root size;	chr7:66450999	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs11765791	ENSG00000226824.5	RP4-756H11.3	-6.48	3.36e-08	0.000414	-0.84	-0.67	Aortic root size;	chr7:66471587	chr7:66654538~66669855:+
ACC	cis	rs17711722	1	rs17711722	ENSG00000226824.5	RP4-756H11.3	6.48	3.39e-08	0.000417	0.75	0.67	Calcium levels;	chr7:65806210	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.675	rs6947132	ENSG00000226824.5	RP4-756H11.3	6.48	3.39e-08	0.000417	0.75	0.67	Calcium levels;	chr7:65808508	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6956179	ENSG00000226824.5	RP4-756H11.3	6.44	3.81e-08	0.000464	0.75	0.67	Aortic root size;	chr7:66341672	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs10515504	ENSG00000253404.1	AC034243.1	-6.44	3.82e-08	0.000465	-1.04	-0.67	Age-related hearing impairment (SNP x SNP interaction);	chr5:138887305	chr5:138744434~138753309:-
ACC	cis	rs6903823	0.508	rs1150718	ENSG00000216901.1	AL022393.7	6.44	3.85e-08	0.000468	0.79	0.67	Pulmonary function;	chr6:28289170	chr6:28176188~28176674:+
ACC	cis	rs6903823	0.508	rs1233660	ENSG00000216901.1	AL022393.7	6.44	3.85e-08	0.000468	0.79	0.67	Pulmonary function;	chr6:28292472	chr6:28176188~28176674:+
ACC	cis	rs4853012	0.941	rs2421752	ENSG00000217702.2	RP11-287D1.4	6.44	3.93e-08	0.000477	0.77	0.67	Gestational age at birth (maternal effect);	chr2:74114488	chr2:74130583~74135395:+
ACC	cis	rs875971	0.825	rs1129531	ENSG00000226824.5	RP4-756H11.3	6.43	3.99e-08	0.000485	0.83	0.67	Aortic root size;	chr7:66154117	chr7:66654538~66669855:+
ACC	cis	rs875971	0.898	rs6977501	ENSG00000226824.5	RP4-756H11.3	6.43	4.03e-08	0.000487	0.77	0.67	Aortic root size;	chr7:66228355	chr7:66654538~66669855:+
ACC	cis	rs875971	0.965	rs6971509	ENSG00000226824.5	RP4-756H11.3	6.43	4.03e-08	0.000487	0.77	0.67	Aortic root size;	chr7:66249983	chr7:66654538~66669855:+
ACC	cis	rs875971	0.838	rs2173570	ENSG00000226824.5	RP4-756H11.3	6.43	4.03e-08	0.000487	0.77	0.67	Aortic root size;	chr7:66297976	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs937495	ENSG00000226824.5	RP4-756H11.3	6.43	4.03e-08	0.000487	0.77	0.67	Aortic root size;	chr7:66314811	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs709597	ENSG00000226824.5	RP4-756H11.3	6.43	4.03e-08	0.000487	0.77	0.67	Aortic root size;	chr7:66360996	chr7:66654538~66669855:+
ACC	cis	rs1150668	0.699	rs12214383	ENSG00000216901.1	AL022393.7	-6.43	4.04e-08	0.000489	-0.75	-0.67	Pubertal anthropometrics;	chr6:28255953	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.699	rs1531681	ENSG00000216901.1	AL022393.7	6.42	4.15e-08	0.000498	0.74	0.66	Pubertal anthropometrics;	chr6:28259100	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.799	rs1736891	ENSG00000216901.1	AL022393.7	6.42	4.18e-08	5e-04	0.79	0.66	Pubertal anthropometrics;	chr6:28219323	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.699	rs1736895	ENSG00000216901.1	AL022393.7	6.41	4.3e-08	0.000512	0.74	0.66	Pubertal anthropometrics;	chr6:28252048	chr6:28176188~28176674:+
ACC	cis	rs10256972	0.568	rs1133043	ENSG00000229043.2	AC091729.9	-6.41	4.31e-08	0.000514	-0.76	-0.66	Endometriosis;Longevity;	chr7:1093669	chr7:1160374~1165267:+
ACC	cis	rs2739330	0.76	rs1007888	ENSG00000273295.1	AP000350.5	6.4	4.43e-08	0.000528	0.67	0.66	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23898914	chr22:23901432~23907068:-
ACC	cis	rs875971	0.862	rs9791712	ENSG00000226824.5	RP4-756H11.3	6.4	4.53e-08	0.000535	0.84	0.66	Aortic root size;	chr7:66640176	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs9791713	ENSG00000226824.5	RP4-756H11.3	6.4	4.53e-08	0.000535	0.84	0.66	Aortic root size;	chr7:66640211	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs17031	ENSG00000253404.1	AC034243.1	6.39	4.63e-08	0.000543	1	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138934853	chr5:138744434~138753309:-
ACC	cis	rs9322193	0.923	rs9766037	ENSG00000231760.4	RP11-350J20.5	6.38	4.75e-08	0.000545	0.74	0.66	Lung cancer;	chr6:149616921	chr6:149796151~149826294:-
ACC	cis	rs916888	0.61	rs142167	ENSG00000262539.1	RP11-259G18.3	-6.38	4.76e-08	0.000545	-0.69	-0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46717868	chr17:46259551~46260606:-
ACC	cis	rs2882667	0.69	rs700619	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138753060	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825672	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138759954	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.652	rs700622	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138762862	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs7722965	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138764766	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1976562	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138774905	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs825759	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138790250	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs825760	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138804285	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs7709770	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138813650	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs4835703	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138815048	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs4835704	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138815636	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6596453	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138816202	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.622	rs34645817	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138816944	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs7736925	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138818841	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs883333	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138819781	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6596455	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138831416	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs995177	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138833874	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs7710300	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138834793	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs2351247	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138849456	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.619	rs6861556	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138852351	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288018	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138856727	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288017	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138857826	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs167009	ENSG00000253404.1	AC034243.1	-6.38	4.85e-08	0.000545	-1.02	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138864768	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs311599	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138718994	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs311597	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138720212	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs160402	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138723599	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs160398	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138727750	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.658	rs311592	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138734506	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288040	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138869205	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288036	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138875206	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288035	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138876728	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288032	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138879639	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288028	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138886300	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288026	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138886905	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288024	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888103	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288021	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138888594	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288009	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138892973	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs185956	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138894574	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.658	rs288003	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138896266	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288002	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138896398	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10044401	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138901868	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10067361	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138905185	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs12186373	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138912885	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.628	rs10076629	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920272	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.659	rs11750067	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920589	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10054682	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138923754	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs11953339	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138923853	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs9327828	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138925859	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10155636	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138926301	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs11749163	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138926981	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.728	rs10068766	ENSG00000253404.1	AC034243.1	6.38	4.85e-08	0.000545	1.02	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138941095	chr5:138744434~138753309:-
ACC	cis	rs875971	0.965	rs28682868	ENSG00000226824.5	RP4-756H11.3	6.37	4.93e-08	0.000545	0.77	0.66	Aortic root size;	chr7:66224822	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs9986696	ENSG00000226824.5	RP4-756H11.3	6.37	4.93e-08	0.000545	0.77	0.66	Aortic root size;	chr7:66239589	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs709595	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66352346	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs811880	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66353659	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs778726	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66363744	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs778723	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66364510	chr7:66654538~66669855:+
ACC	cis	rs875971	0.767	rs1695815	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66366357	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs778685	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66371189	chr7:66654538~66669855:+
ACC	cis	rs875971	0.929	rs778682	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66372947	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs11765965	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66377234	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs1643388	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66379575	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs778722	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66379841	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs778721	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66380410	chr7:66654538~66669855:+
ACC	cis	rs875971	0.929	rs778712	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66384991	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs778710	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66389847	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs778708	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66391332	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs778706	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66395437	chr7:66654538~66669855:+
ACC	cis	rs875971	0.895	rs778700	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66401463	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs778699	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66403303	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs778696	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66405826	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs778694	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66406571	chr7:66654538~66669855:+
ACC	cis	rs875971	0.929	rs778692	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66407462	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs4718343	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66409301	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs4718344	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66409394	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs1968225	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66409786	chr7:66654538~66669855:+
ACC	cis	rs875971	0.737	rs7803424	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66415618	chr7:66654538~66669855:+
ACC	cis	rs875971	0.83	rs7799834	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66415707	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6460295	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66417741	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs6978721	ENSG00000226824.5	RP4-756H11.3	-6.37	4.93e-08	0.000545	-0.77	-0.66	Aortic root size;	chr7:66418217	chr7:66654538~66669855:+
ACC	cis	rs875971	0.83	rs12673450	ENSG00000226824.5	RP4-756H11.3	-6.36	5.13e-08	0.000566	-0.86	-0.66	Aortic root size;	chr7:66544233	chr7:66654538~66669855:+
ACC	cis	rs2739330	0.76	rs1007888	ENSG00000225282.1	AP000350.6	6.36	5.14e-08	0.000567	0.65	0.66	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23898914	chr22:23926900~23929574:+
ACC	cis	rs875971	0.522	rs1701760	ENSG00000226824.5	RP4-756H11.3	-6.36	5.15e-08	0.000568	-0.74	-0.66	Aortic root size;	chr7:66008701	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs6890932	ENSG00000253404.1	AC034243.1	6.36	5.18e-08	0.00057	1.03	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138910639	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs6872423	ENSG00000253404.1	AC034243.1	6.36	5.18e-08	0.00057	1.03	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138911089	chr5:138744434~138753309:-
ACC	cis	rs875971	0.83	rs4718358	ENSG00000226824.5	RP4-756H11.3	-6.35	5.29e-08	0.000579	-0.77	-0.66	Aortic root size;	chr7:66508681	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs7792762	ENSG00000226824.5	RP4-756H11.3	-6.35	5.29e-08	0.000579	-0.77	-0.66	Aortic root size;	chr7:66539151	chr7:66654538~66669855:+
ACC	cis	rs858239	0.511	rs10256996	ENSG00000230658.1	KLHL7-AS1	-6.35	5.29e-08	0.000579	-0.85	-0.66	Cerebrospinal fluid biomarker levels;	chr7:23105676	chr7:23101228~23105703:-
ACC	cis	rs2882667	0.69	rs288007	ENSG00000253404.1	AC034243.1	6.35	5.37e-08	0.000587	1.03	0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138894939	chr5:138744434~138753309:-
ACC	cis	rs2732480	1	rs2732480	ENSG00000258273.1	RP11-370I10.4	6.35	5.44e-08	0.000587	0.86	0.66	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48342520	chr12:48333755~48333901:-
ACC	cis	rs2882667	0.69	rs160400	ENSG00000253404.1	AC034243.1	-6.33	5.78e-08	0.000613	-0.97	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138727330	chr5:138744434~138753309:-
ACC	cis	rs6903823	0.527	rs4713158	ENSG00000216901.1	AL022393.7	6.33	5.79e-08	0.000613	0.79	0.66	Pulmonary function;	chr6:28309994	chr6:28176188~28176674:+
ACC	cis	rs9322193	0.847	rs4870054	ENSG00000231760.4	RP11-350J20.5	6.33	5.82e-08	0.000616	0.74	0.66	Lung cancer;	chr6:149848402	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs1125	ENSG00000231760.4	RP11-350J20.5	6.33	5.86e-08	0.00062	0.76	0.66	Lung cancer;	chr6:149658280	chr6:149796151~149826294:-
ACC	cis	rs4853012	0.838	rs60964317	ENSG00000217702.2	RP11-287D1.4	6.33	5.87e-08	0.00062	0.74	0.66	Gestational age at birth (maternal effect);	chr2:74116296	chr2:74130583~74135395:+
ACC	cis	rs801193	0.569	rs35070132	ENSG00000226824.5	RP4-756H11.3	-6.32	5.89e-08	0.000623	-0.83	-0.66	Aortic root size;	chr7:66773096	chr7:66654538~66669855:+
ACC	cis	rs875971	0.522	rs9530	ENSG00000226824.5	RP4-756H11.3	-6.32	5.95e-08	0.000628	-0.78	-0.66	Aortic root size;	chr7:65960907	chr7:66654538~66669855:+
ACC	cis	rs6903823	0.508	rs1150726	ENSG00000216901.1	AL022393.7	6.32	5.97e-08	0.00063	0.78	0.66	Pulmonary function;	chr6:28275265	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.835	rs203869	ENSG00000216901.1	AL022393.7	6.32	5.98e-08	0.000631	0.81	0.66	Pubertal anthropometrics;	chr6:28073041	chr6:28176188~28176674:+
ACC	cis	rs9322193	0.923	rs55993747	ENSG00000231760.4	RP11-350J20.5	6.32	6.02e-08	0.000632	0.73	0.66	Lung cancer;	chr6:149622016	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.847	rs12191643	ENSG00000231760.4	RP11-350J20.5	6.32	6.02e-08	0.000632	0.73	0.66	Lung cancer;	chr6:149628912	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9800686	ENSG00000231760.4	RP11-350J20.5	6.32	6.02e-08	0.000632	0.73	0.66	Lung cancer;	chr6:149634464	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs55849538	ENSG00000231760.4	RP11-350J20.5	6.32	6.02e-08	0.000632	0.73	0.66	Lung cancer;	chr6:149635330	chr6:149796151~149826294:-
ACC	cis	rs4853012	0.941	rs7571083	ENSG00000217702.2	RP11-287D1.4	6.31	6.13e-08	0.000642	0.76	0.66	Gestational age at birth (maternal effect);	chr2:74115133	chr2:74130583~74135395:+
ACC	cis	rs1150668	0.768	rs1233713	ENSG00000216901.1	AL022393.7	6.31	6.29e-08	0.000644	0.78	0.66	Pubertal anthropometrics;	chr6:28230503	chr6:28176188~28176674:+
ACC	cis	rs9322193	1	rs9377228	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149600862	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.924	rs9498382	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149610982	chr6:149796151~149826294:-
ACC	cis	rs9322193	1	rs9399693	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149612718	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9377230	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149613607	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9404048	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149616188	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9767554	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149616860	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9505982	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149618465	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.886	rs9485408	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149618888	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9322196	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149619645	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs1080670	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149620161	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10782310	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149622458	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10782311	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149622592	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs10782312	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149622669	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs10747275	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149622782	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.886	rs9322198	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149623772	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.847	rs12234128	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149627553	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs57012784	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149627691	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9505823	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149628899	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.847	rs62439808	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149629690	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9322200	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149630078	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9689599	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149631973	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs9688794	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149632121	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9800580	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149632845	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.884	rs11155669	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149633501	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.887	rs9505824	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149633663	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9505826	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149633912	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9322204	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149636047	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9766886	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149637048	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9688861	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149637924	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs9689084	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149639648	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.923	rs7740278	ENSG00000231760.4	RP11-350J20.5	6.31	6.32e-08	0.000644	0.73	0.66	Lung cancer;	chr6:149640116	chr6:149796151~149826294:-
ACC	cis	rs875971	0.895	rs3857684	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66473171	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs6978429	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66494889	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs4718357	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66495891	chr7:66654538~66669855:+
ACC	cis	rs875971	0.929	rs12535036	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66499076	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs12533997	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66500390	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs12532998	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66502472	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs12698523	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66503126	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6970030	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66503692	chr7:66654538~66669855:+
ACC	cis	rs875971	0.928	rs6970357	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66503891	chr7:66654538~66669855:+
ACC	cis	rs875971	0.929	rs10950041	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66508888	chr7:66654538~66669855:+
ACC	cis	rs875971	0.929	rs6970860	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66511647	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6957199	ENSG00000226824.5	RP4-756H11.3	-6.3	6.47e-08	0.000653	-0.77	-0.66	Aortic root size;	chr7:66513532	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.681	rs12702016	ENSG00000229043.2	AC091729.9	-6.3	6.49e-08	0.000655	-0.75	-0.66	Endometriosis;Longevity;	chr7:1089756	chr7:1160374~1165267:+
ACC	cis	rs172166	0.585	rs149963	ENSG00000216901.1	AL022393.7	6.29	6.64e-08	0.00067	0.83	0.66	Cardiac Troponin-T levels;	chr6:28049354	chr6:28176188~28176674:+
ACC	cis	rs916888	0.821	rs199513	ENSG00000214401.4	KANSL1-AS1	-6.29	6.77e-08	0.000683	-0.98	-0.66	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46779566	chr17:46193576~46196723:+
ACC	cis	rs875971	0.862	rs778720	ENSG00000226824.5	RP4-756H11.3	6.29	6.81e-08	0.000686	0.77	0.66	Aortic root size;	chr7:66381288	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs9327829	ENSG00000253404.1	AC034243.1	-6.28	6.94e-08	0.000698	-1	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138925982	chr5:138744434~138753309:-
ACC	cis	rs875971	0.755	rs76288834	ENSG00000226824.5	RP4-756H11.3	6.28	7.01e-08	0.000705	0.84	0.66	Aortic root size;	chr7:66604815	chr7:66654538~66669855:+
ACC	cis	rs2739330	0.731	rs2000468	ENSG00000225282.1	AP000350.6	6.27	7.2e-08	0.000724	0.64	0.66	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899424	chr22:23926900~23929574:+
ACC	cis	rs1891275	0.513	rs1539041	ENSG00000228701.1	TNKS2-AS1	-6.26	7.49e-08	0.000749	-0.77	-0.66	Intelligence (multi-trait analysis);	chr10:91817384	chr10:91782839~91798291:-
ACC	cis	rs2882667	0.728	rs13181830	ENSG00000253404.1	AC034243.1	-6.26	7.56e-08	0.000755	-1.08	-0.66	Age-related hearing impairment (SNP x SNP interaction);	chr5:138944727	chr5:138744434~138753309:-
ACC	cis	rs875971	1	rs1544549	ENSG00000226824.5	RP4-756H11.3	6.26	7.58e-08	0.000755	0.77	0.66	Aortic root size;	chr7:66625676	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs2420820	ENSG00000226824.5	RP4-756H11.3	6.26	7.58e-08	0.000755	0.77	0.66	Aortic root size;	chr7:66626920	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs10274883	ENSG00000226824.5	RP4-756H11.3	6.26	7.58e-08	0.000755	0.82	0.66	Aortic root size;	chr7:66651104	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs881285	ENSG00000226824.5	RP4-756H11.3	6.26	7.58e-08	0.000755	0.82	0.66	Aortic root size;	chr7:66654433	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs3846973	ENSG00000226824.5	RP4-756H11.3	6.26	7.58e-08	0.000755	0.82	0.66	Aortic root size;	chr7:66655048	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs2013908	ENSG00000226824.5	RP4-756H11.3	6.26	7.58e-08	0.000755	0.82	0.66	Aortic root size;	chr7:66656082	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs13242290	ENSG00000226824.5	RP4-756H11.3	6.26	7.58e-08	0.000755	0.82	0.66	Aortic root size;	chr7:66656898	chr7:66654538~66669855:+
ACC	cis	rs11155671	0.53	rs1334510	ENSG00000268592.3	RAET1E-AS1	6.25	7.66e-08	0.000763	0.74	0.66	Testicular germ cell tumor;	chr6:149880043	chr6:149863494~149919507:+
ACC	cis	rs875971	1	rs2036264	ENSG00000226824.5	RP4-756H11.3	6.24	7.89e-08	0.000782	0.77	0.65	Aortic root size;	chr7:66334917	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs7783613	ENSG00000226824.5	RP4-756H11.3	6.24	7.89e-08	0.000782	0.77	0.65	Aortic root size;	chr7:66340274	chr7:66654538~66669855:+
ACC	cis	rs875971	0.964	rs778735	ENSG00000226824.5	RP4-756H11.3	-6.24	7.89e-08	0.000782	-0.77	-0.65	Aortic root size;	chr7:66349822	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6979382	ENSG00000226824.5	RP4-756H11.3	-6.24	7.89e-08	0.000782	-0.77	-0.65	Aortic root size;	chr7:66421388	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6961990	ENSG00000226824.5	RP4-756H11.3	-6.24	7.89e-08	0.000782	-0.77	-0.65	Aortic root size;	chr7:66423583	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs10071381	ENSG00000253404.1	AC034243.1	6.24	7.96e-08	0.000788	1.03	0.65	Age-related hearing impairment (SNP x SNP interaction);	chr5:138937159	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.728	rs10068786	ENSG00000253404.1	AC034243.1	6.24	7.96e-08	0.000788	1.03	0.65	Age-related hearing impairment (SNP x SNP interaction);	chr5:138941255	chr5:138744434~138753309:-
ACC	cis	rs172166	0.561	rs149973	ENSG00000216901.1	AL022393.7	6.24	7.98e-08	0.000789	0.76	0.65	Cardiac Troponin-T levels;	chr6:28015835	chr6:28176188~28176674:+
ACC	cis	rs172166	0.561	rs149974	ENSG00000216901.1	AL022393.7	6.24	7.98e-08	0.000789	0.76	0.65	Cardiac Troponin-T levels;	chr6:28017318	chr6:28176188~28176674:+
ACC	cis	rs853679	0.527	rs853690	ENSG00000216901.1	AL022393.7	6.24	8.03e-08	0.000794	0.79	0.65	Depression;	chr6:28317705	chr6:28176188~28176674:+
ACC	cis	rs875971	0.893	rs62465470	ENSG00000226824.5	RP4-756H11.3	6.23	8.21e-08	0.000807	0.76	0.65	Aortic root size;	chr7:66136231	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs4368860	ENSG00000226824.5	RP4-756H11.3	6.23	8.21e-08	0.000807	0.76	0.65	Aortic root size;	chr7:66143495	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs1983372	ENSG00000226824.5	RP4-756H11.3	6.23	8.21e-08	0.000807	0.76	0.65	Aortic root size;	chr7:66146364	chr7:66654538~66669855:+
ACC	cis	rs1150668	0.799	rs2142730	ENSG00000216901.1	AL022393.7	6.23	8.21e-08	0.000807	0.77	0.65	Pubertal anthropometrics;	chr6:28298372	chr6:28176188~28176674:+
ACC	cis	rs875971	0.965	rs7794930	ENSG00000226824.5	RP4-756H11.3	6.23	8.28e-08	0.000813	0.73	0.65	Aortic root size;	chr7:66313559	chr7:66654538~66669855:+
ACC	cis	rs801193	0.66	rs1962050	ENSG00000226824.5	RP4-756H11.3	6.23	8.29e-08	0.000814	0.83	0.65	Aortic root size;	chr7:66775021	chr7:66654538~66669855:+
ACC	cis	rs1799949	0.965	rs8176198	ENSG00000198496.9	NBR2	-6.22	8.5e-08	0.000833	-0.84	-0.65	Menopause (age at onset);	chr17:43078520	chr17:43125610~43153671:+
ACC	cis	rs875971	0.862	rs28470208	ENSG00000226824.5	RP4-756H11.3	6.22	8.55e-08	0.000836	0.77	0.65	Aortic root size;	chr7:66119713	chr7:66654538~66669855:+
ACC	cis	rs7188445	0.592	rs17767281	ENSG00000261390.4	RP11-345M22.2	-6.21	8.97e-08	0.000868	-0.82	-0.65	Urate levels;	chr16:79708544	chr16:79715232~79770563:-
ACC	cis	rs801193	0.548	rs2109297	ENSG00000226824.5	RP4-756H11.3	6.21	8.98e-08	0.000868	0.81	0.65	Aortic root size;	chr7:66657397	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs6978178	ENSG00000226824.5	RP4-756H11.3	6.21	8.98e-08	0.000868	0.81	0.65	Aortic root size;	chr7:66658097	chr7:66654538~66669855:+
ACC	cis	rs801193	0.591	rs721717	ENSG00000226824.5	RP4-756H11.3	6.21	8.98e-08	0.000868	0.81	0.65	Aortic root size;	chr7:66665305	chr7:66654538~66669855:+
ACC	cis	rs801193	0.569	rs6951302	ENSG00000226824.5	RP4-756H11.3	6.21	8.98e-08	0.000868	0.81	0.65	Aortic root size;	chr7:66667525	chr7:66654538~66669855:+
ACC	cis	rs801193	0.591	rs4506088	ENSG00000226824.5	RP4-756H11.3	6.21	8.98e-08	0.000868	0.81	0.65	Aortic root size;	chr7:66670470	chr7:66654538~66669855:+
ACC	cis	rs11155671	0.53	rs1334510	ENSG00000231760.4	RP11-350J20.5	6.21	9.02e-08	0.000871	0.73	0.65	Testicular germ cell tumor;	chr6:149880043	chr6:149796151~149826294:-
ACC	cis	rs875971	0.862	rs1612452	ENSG00000226824.5	RP4-756H11.3	6.21	9.1e-08	0.000877	0.77	0.65	Aortic root size;	chr7:66108909	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs1167390	ENSG00000226824.5	RP4-756H11.3	6.21	9.1e-08	0.000877	0.77	0.65	Aortic root size;	chr7:66110906	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs35034167	ENSG00000226824.5	RP4-756H11.3	6.21	9.1e-08	0.000877	0.77	0.65	Aortic root size;	chr7:66115179	chr7:66654538~66669855:+
ACC	cis	rs2882667	0.69	rs825677	ENSG00000253404.1	AC034243.1	-6.2	9.4e-08	0.000904	-1.02	-0.65	Age-related hearing impairment (SNP x SNP interaction);	chr5:138769081	chr5:138744434~138753309:-
ACC	cis	rs801193	0.613	rs2659900	ENSG00000226824.5	RP4-756H11.3	-6.19	9.73e-08	0.000931	-0.76	-0.65	Aortic root size;	chr7:66719456	chr7:66654538~66669855:+
ACC	cis	rs2739330	0.76	rs1002286	ENSG00000273295.1	AP000350.5	-6.18	9.85e-08	0.000933	-0.65	-0.65	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23901432~23907068:-
ACC	cis	rs4853012	0.793	rs6707619	ENSG00000217702.2	RP11-287D1.4	6.18	1e-07	0.000941	0.75	0.65	Gestational age at birth (maternal effect);	chr2:74117529	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.838	rs6707729	ENSG00000217702.2	RP11-287D1.4	6.18	1e-07	0.000941	0.75	0.65	Gestational age at birth (maternal effect);	chr2:74117558	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.793	rs6723185	ENSG00000217702.2	RP11-287D1.4	6.18	1e-07	0.000941	0.75	0.65	Gestational age at birth (maternal effect);	chr2:74117757	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.941	rs60291089	ENSG00000217702.2	RP11-287D1.4	6.18	1e-07	0.000941	0.75	0.65	Gestational age at birth (maternal effect);	chr2:74117763	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.838	rs58759652	ENSG00000217702.2	RP11-287D1.4	6.18	1e-07	0.000941	0.75	0.65	Gestational age at birth (maternal effect);	chr2:74117775	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.838	rs60705299	ENSG00000217702.2	RP11-287D1.4	6.18	1e-07	0.000941	0.75	0.65	Gestational age at birth (maternal effect);	chr2:74118243	chr2:74130583~74135395:+
ACC	cis	rs853679	0.527	rs1997660	ENSG00000216901.1	AL022393.7	6.18	1.01e-07	0.000952	0.79	0.65	Depression;	chr6:28301886	chr6:28176188~28176674:+
ACC	cis	rs853679	0.527	rs9468333	ENSG00000216901.1	AL022393.7	6.18	1.01e-07	0.000952	0.79	0.65	Depression;	chr6:28303421	chr6:28176188~28176674:+
ACC	cis	rs172166	0.516	rs1225715	ENSG00000216901.1	AL022393.7	-6.18	1.02e-07	0.000954	-0.76	-0.65	Cardiac Troponin-T levels;	chr6:28145595	chr6:28176188~28176674:+
ACC	cis	rs172166	0.56	rs203878	ENSG00000216901.1	AL022393.7	6.16	1.06e-07	0.000994	0.8	0.65	Cardiac Troponin-T levels;	chr6:28081218	chr6:28176188~28176674:+
ACC	cis	rs875971	0.862	rs908915	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66149664	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs7809814	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66150410	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs7786892	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66163889	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs2420174	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66180374	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs2420173	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66180412	chr7:66654538~66669855:+
ACC	cis	rs875971	0.862	rs4718319	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66187797	chr7:66654538~66669855:+
ACC	cis	rs875971	0.723	rs28391294	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66189328	chr7:66654538~66669855:+
ACC	cis	rs875971	0.83	rs6967708	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66192326	chr7:66654538~66669855:+
ACC	cis	rs875971	0.895	rs7782806	ENSG00000226824.5	RP4-756H11.3	6.16	1.07e-07	0.000998	0.79	0.65	Aortic root size;	chr7:66192910	chr7:66654538~66669855:+
ACC	cis	rs11155671	0.53	rs4458704	ENSG00000231760.4	RP11-350J20.5	6.15	1.1e-07	0.00102	0.72	0.65	Testicular germ cell tumor;	chr6:149911743	chr6:149796151~149826294:-
ACC	cis	rs4853012	0.838	rs72911122	ENSG00000217702.2	RP11-287D1.4	6.15	1.11e-07	0.00103	0.74	0.65	Gestational age at birth (maternal effect);	chr2:74116992	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.838	rs59570457	ENSG00000217702.2	RP11-287D1.4	6.15	1.11e-07	0.00103	0.74	0.65	Gestational age at birth (maternal effect);	chr2:74117155	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.539	rs9789534	ENSG00000217702.2	RP11-287D1.4	6.15	1.13e-07	0.00105	0.7	0.65	Gestational age at birth (maternal effect);	chr2:74135863	chr2:74130583~74135395:+
ACC	cis	rs11155671	0.53	rs9397398	ENSG00000231760.4	RP11-350J20.5	6.14	1.14e-07	0.00106	0.73	0.65	Testicular germ cell tumor;	chr6:149872467	chr6:149796151~149826294:-
ACC	cis	rs7188445	0.614	rs62043313	ENSG00000261390.4	RP11-345M22.2	-6.14	1.14e-07	0.00106	-0.82	-0.65	Urate levels;	chr16:79710237	chr16:79715232~79770563:-
ACC	cis	rs801193	0.66	rs2659914	ENSG00000226824.5	RP4-756H11.3	-6.14	1.15e-07	0.00106	-0.75	-0.65	Aortic root size;	chr7:66691927	chr7:66654538~66669855:+
ACC	cis	rs801193	0.591	rs2707839	ENSG00000226824.5	RP4-756H11.3	-6.14	1.15e-07	0.00106	-0.75	-0.65	Aortic root size;	chr7:66728097	chr7:66654538~66669855:+
ACC	cis	rs801193	0.636	rs2659895	ENSG00000226824.5	RP4-756H11.3	-6.14	1.15e-07	0.00106	-0.75	-0.65	Aortic root size;	chr7:66731484	chr7:66654538~66669855:+
ACC	cis	rs801193	0.66	rs974239	ENSG00000226824.5	RP4-756H11.3	-6.14	1.15e-07	0.00106	-0.75	-0.65	Aortic root size;	chr7:66748504	chr7:66654538~66669855:+
ACC	cis	rs801193	0.66	rs1016265	ENSG00000226824.5	RP4-756H11.3	-6.14	1.15e-07	0.00106	-0.75	-0.65	Aortic root size;	chr7:66749580	chr7:66654538~66669855:+
ACC	cis	rs801193	0.66	rs4610622	ENSG00000226824.5	RP4-756H11.3	-6.14	1.15e-07	0.00106	-0.75	-0.65	Aortic root size;	chr7:66759510	chr7:66654538~66669855:+
ACC	cis	rs801193	0.66	rs10950049	ENSG00000226824.5	RP4-756H11.3	-6.14	1.15e-07	0.00106	-0.75	-0.65	Aortic root size;	chr7:66765873	chr7:66654538~66669855:+
ACC	cis	rs10256972	0.591	rs10229680	ENSG00000229043.2	AC091729.9	-6.14	1.15e-07	0.00106	-0.77	-0.65	Endometriosis;Longevity;	chr7:1118929	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.567	rs7782651	ENSG00000229043.2	AC091729.9	-6.14	1.15e-07	0.00106	-0.77	-0.65	Endometriosis;Longevity;	chr7:1120259	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.591	rs6950319	ENSG00000229043.2	AC091729.9	-6.14	1.15e-07	0.00106	-0.77	-0.65	Endometriosis;Longevity;	chr7:1121688	chr7:1160374~1165267:+
ACC	cis	rs2882667	0.69	rs160401	ENSG00000253404.1	AC034243.1	-6.13	1.22e-07	0.00112	-0.93	-0.65	Age-related hearing impairment (SNP x SNP interaction);	chr5:138725652	chr5:138744434~138753309:-
ACC	cis	rs7188445	0.556	rs7203910	ENSG00000261390.4	RP11-345M22.2	-6.12	1.27e-07	0.00116	-0.78	-0.65	Urate levels;	chr16:79711722	chr16:79715232~79770563:-
ACC	cis	rs2882667	0.659	rs288037	ENSG00000253404.1	AC034243.1	6.11	1.28e-07	0.00118	1	0.65	Age-related hearing impairment (SNP x SNP interaction);	chr5:138872752	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs311596	ENSG00000253404.1	AC034243.1	-6.1	1.36e-07	0.00124	-0.94	-0.65	Age-related hearing impairment (SNP x SNP interaction);	chr5:138736393	chr5:138744434~138753309:-
ACC	cis	rs4853012	0.838	rs4452177	ENSG00000217702.2	RP11-287D1.4	6.09	1.4e-07	0.00128	0.73	0.65	Gestational age at birth (maternal effect);	chr2:74118079	chr2:74130583~74135395:+
ACC	cis	rs9487094	0.6	rs1885690	ENSG00000260273.1	RP11-425D10.10	6.08	1.44e-07	0.00131	0.72	0.64	Height;	chr6:109351795	chr6:109382795~109383666:+
ACC	cis	rs9399135	0.636	rs7749106	ENSG00000232876.1	CTA-212D2.2	-6.08	1.45e-07	0.00133	-0.71	-0.64	Red blood cell count;	chr6:134947004	chr6:135055033~135060550:+
ACC	cis	rs172166	0.516	rs1225710	ENSG00000216901.1	AL022393.7	-6.06	1.52e-07	0.00139	-0.76	-0.64	Cardiac Troponin-T levels;	chr6:28132862	chr6:28176188~28176674:+
ACC	cis	rs10256972	0.516	rs12702081	ENSG00000229043.2	AC091729.9	-6.06	1.57e-07	0.00142	-0.71	-0.64	Endometriosis;Longevity;	chr7:1101892	chr7:1160374~1165267:+
ACC	cis	rs2739330	0.753	rs4822452	ENSG00000273295.1	AP000350.5	6.06	1.57e-07	0.00143	0.66	0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23912176	chr22:23901432~23907068:-
ACC	cis	rs2739330	0.796	rs2154594	ENSG00000273295.1	AP000350.5	-6.05	1.63e-07	0.00147	-0.7	-0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911868	chr22:23901432~23907068:-
ACC	cis	rs9322193	0.923	rs4869750	ENSG00000231760.4	RP11-350J20.5	6.03	1.7e-07	0.00153	0.76	0.64	Lung cancer;	chr6:149855996	chr6:149796151~149826294:-
ACC	cis	rs853679	0.527	rs707907	ENSG00000216901.1	AL022393.7	6.02	1.76e-07	0.00158	0.77	0.64	Depression;	chr6:28323463	chr6:28176188~28176674:+
ACC	cis	rs2739330	0.731	rs2000468	ENSG00000273295.1	AP000350.5	6.02	1.77e-07	0.00159	0.65	0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23899424	chr22:23901432~23907068:-
ACC	cis	rs875971	0.862	rs10256544	ENSG00000226824.5	RP4-756H11.3	-6.02	1.8e-07	0.00161	-0.76	-0.64	Aortic root size;	chr7:66210141	chr7:66654538~66669855:+
ACC	cis	rs2739330	0.791	rs4822458	ENSG00000225282.1	AP000350.6	6.02	1.82e-07	0.00162	0.63	0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23923472	chr22:23926900~23929574:+
ACC	cis	rs9399135	1	rs4896130	ENSG00000232876.1	CTA-212D2.2	-5.99	1.98e-07	0.00174	-0.66	-0.64	Red blood cell count;	chr6:135033980	chr6:135055033~135060550:+
ACC	cis	rs4853012	0.941	rs4852329	ENSG00000217702.2	RP11-287D1.4	5.99	1.98e-07	0.00174	0.74	0.64	Gestational age at birth (maternal effect);	chr2:74127417	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.838	rs6715351	ENSG00000217702.2	RP11-287D1.4	5.99	1.98e-07	0.00174	0.75	0.64	Gestational age at birth (maternal effect);	chr2:74118992	chr2:74130583~74135395:+
ACC	cis	rs4853012	0.838	rs61521879	ENSG00000217702.2	RP11-287D1.4	5.99	1.98e-07	0.00174	0.75	0.64	Gestational age at birth (maternal effect);	chr2:74119081	chr2:74130583~74135395:+
ACC	cis	rs875971	0.895	rs7788984	ENSG00000226824.5	RP4-756H11.3	-5.99	2e-07	0.00175	-0.76	-0.64	Aortic root size;	chr7:66450629	chr7:66654538~66669855:+
ACC	cis	rs4853012	0.838	rs4429500	ENSG00000217702.2	RP11-287D1.4	5.98	2.05e-07	0.00179	0.7	0.64	Gestational age at birth (maternal effect);	chr2:74118209	chr2:74130583~74135395:+
ACC	cis	rs2739330	0.892	rs4822455	ENSG00000225282.1	AP000350.6	5.98	2.05e-07	0.00179	0.63	0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913109	chr22:23926900~23929574:+
ACC	cis	rs875971	1	rs6945843	ENSG00000226824.5	RP4-756H11.3	5.98	2.07e-07	0.00181	0.75	0.64	Aortic root size;	chr7:66269796	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.961	rs2064520	ENSG00000231760.4	RP11-350J20.5	5.97	2.11e-07	0.00184	0.7	0.64	Lung cancer;	chr6:149603650	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs9383940	ENSG00000231760.4	RP11-350J20.5	5.97	2.12e-07	0.00185	0.73	0.64	Testicular germ cell tumor;	chr6:149904923	chr6:149796151~149826294:-
ACC	cis	rs858239	0.669	rs1990365	ENSG00000230658.1	KLHL7-AS1	5.97	2.14e-07	0.00186	0.81	0.64	Cerebrospinal fluid biomarker levels;	chr7:23076347	chr7:23101228~23105703:-
ACC	cis	rs2882667	0.587	rs825674	ENSG00000253404.1	AC034243.1	-5.96	2.23e-07	0.0019	-1.01	-0.64	Age-related hearing impairment (SNP x SNP interaction);	chr5:138767031	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs700626	ENSG00000253404.1	AC034243.1	-5.96	2.23e-07	0.0019	-1.01	-0.64	Age-related hearing impairment (SNP x SNP interaction);	chr5:138782249	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs311601	ENSG00000253404.1	AC034243.1	5.96	2.23e-07	0.0019	1.01	0.64	Age-related hearing impairment (SNP x SNP interaction);	chr5:138717697	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs288029	ENSG00000253404.1	AC034243.1	5.96	2.23e-07	0.0019	1.01	0.64	Age-related hearing impairment (SNP x SNP interaction);	chr5:138881616	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10078079	ENSG00000253404.1	AC034243.1	5.96	2.23e-07	0.0019	1.01	0.64	Age-related hearing impairment (SNP x SNP interaction);	chr5:138920450	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10463975	ENSG00000253404.1	AC034243.1	5.96	2.23e-07	0.0019	1.01	0.64	Age-related hearing impairment (SNP x SNP interaction);	chr5:138927560	chr5:138744434~138753309:-
ACC	cis	rs875971	1	rs6961717	ENSG00000226824.5	RP4-756H11.3	5.95	2.27e-07	0.00192	0.72	0.64	Aortic root size;	chr7:66122550	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs2087647	ENSG00000226824.5	RP4-756H11.3	5.95	2.27e-07	0.00192	0.72	0.64	Aortic root size;	chr7:66128201	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs6958484	ENSG00000226824.5	RP4-756H11.3	5.95	2.27e-07	0.00192	0.72	0.64	Aortic root size;	chr7:66134459	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs4718307	ENSG00000226824.5	RP4-756H11.3	5.95	2.27e-07	0.00192	0.72	0.64	Aortic root size;	chr7:66146001	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs7801282	ENSG00000226824.5	RP4-756H11.3	5.95	2.27e-07	0.00192	0.72	0.64	Aortic root size;	chr7:66148700	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs55962648	ENSG00000226824.5	RP4-756H11.3	5.95	2.27e-07	0.00192	0.72	0.64	Aortic root size;	chr7:66160764	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs2420168	ENSG00000226824.5	RP4-756H11.3	5.95	2.27e-07	0.00192	0.72	0.64	Aortic root size;	chr7:66165644	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs11974219	ENSG00000226824.5	RP4-756H11.3	5.95	2.27e-07	0.00192	0.72	0.64	Aortic root size;	chr7:66182423	chr7:66654538~66669855:+
ACC	cis	rs11155671	0.53	rs9968871	ENSG00000231760.4	RP11-350J20.5	5.95	2.29e-07	0.00193	0.73	0.64	Testicular germ cell tumor;	chr6:149888060	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs9969044	ENSG00000231760.4	RP11-350J20.5	5.95	2.29e-07	0.00193	0.73	0.64	Testicular germ cell tumor;	chr6:149888068	chr6:149796151~149826294:-
ACC	cis	rs9399137	0.507	rs4896118	ENSG00000232876.1	CTA-212D2.2	5.94	2.41e-07	0.00202	0.86	0.64	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134954927	chr6:135055033~135060550:+
ACC	cis	rs9487094	0.689	rs2884037	ENSG00000260273.1	RP11-425D10.10	5.93	2.48e-07	0.00208	0.7	0.64	Height;	chr6:109354092	chr6:109382795~109383666:+
ACC	cis	rs2739330	0.791	rs4822458	ENSG00000273295.1	AP000350.5	5.93	2.48e-07	0.00208	0.64	0.64	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23923472	chr22:23901432~23907068:-
ACC	cis	rs858239	0.536	rs6956974	ENSG00000230658.1	KLHL7-AS1	-5.93	2.51e-07	0.0021	-0.75	-0.63	Cerebrospinal fluid biomarker levels;	chr7:23212699	chr7:23101228~23105703:-
ACC	cis	rs9399135	0.967	rs4896120	ENSG00000232876.1	CTA-212D2.2	-5.92	2.59e-07	0.00216	-0.67	-0.63	Red blood cell count;	chr6:134972374	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs6909975	ENSG00000232876.1	CTA-212D2.2	-5.92	2.61e-07	0.00218	-0.66	-0.63	Red blood cell count;	chr6:134994432	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs7773126	ENSG00000232876.1	CTA-212D2.2	-5.92	2.61e-07	0.00218	-0.66	-0.63	Red blood cell count;	chr6:134997252	chr6:135055033~135060550:+
ACC	cis	rs858239	1	rs199351	ENSG00000230658.1	KLHL7-AS1	5.91	2.63e-07	0.0022	0.76	0.63	Cerebrospinal fluid biomarker levels;	chr7:23260430	chr7:23101228~23105703:-
ACC	cis	rs801193	0.66	rs2659897	ENSG00000226824.5	RP4-756H11.3	5.91	2.66e-07	0.00221	0.74	0.63	Aortic root size;	chr7:66722728	chr7:66654538~66669855:+
ACC	cis	rs9399135	0.967	rs6923827	ENSG00000232876.1	CTA-212D2.2	-5.9	2.76e-07	0.0023	-0.65	-0.63	Red blood cell count;	chr6:135014244	chr6:135055033~135060550:+
ACC	cis	rs9399135	1	rs35123050	ENSG00000232876.1	CTA-212D2.2	-5.89	2.82e-07	0.00235	-0.67	-0.63	Red blood cell count;	chr6:134981602	chr6:135055033~135060550:+
ACC	cis	rs9399135	1	rs6569988	ENSG00000232876.1	CTA-212D2.2	-5.89	2.88e-07	0.0024	-0.66	-0.63	Red blood cell count;	chr6:135031165	chr6:135055033~135060550:+
ACC	cis	rs9487094	0.666	rs12529733	ENSG00000260273.1	RP11-425D10.10	5.88	2.97e-07	0.00244	0.71	0.63	Height;	chr6:109332929	chr6:109382795~109383666:+
ACC	cis	rs875971	1	rs875971	ENSG00000226824.5	RP4-756H11.3	5.88	2.99e-07	0.00245	0.73	0.63	Aortic root size;	chr7:66152608	chr7:66654538~66669855:+
ACC	cis	rs1577917	0.655	rs1059307	ENSG00000203875.9	SNHG5	5.88	3e-07	0.00246	0.68	0.63	Response to antipsychotic treatment;	chr6:85678170	chr6:85660950~85678736:-
ACC	cis	rs801193	0.613	rs2016325	ENSG00000226824.5	RP4-756H11.3	5.88	3.01e-07	0.00247	0.72	0.63	Aortic root size;	chr7:66858513	chr7:66654538~66669855:+
ACC	cis	rs858239	0.712	rs200717	ENSG00000230658.1	KLHL7-AS1	5.88	3.02e-07	0.00247	0.8	0.63	Cerebrospinal fluid biomarker levels;	chr7:23352652	chr7:23101228~23105703:-
ACC	cis	rs9487094	0.689	rs9487064	ENSG00000260273.1	RP11-425D10.10	5.87	3.1e-07	0.00254	0.69	0.63	Height;	chr6:109346560	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs9487066	ENSG00000260273.1	RP11-425D10.10	5.87	3.1e-07	0.00254	0.69	0.63	Height;	chr6:109347707	chr6:109382795~109383666:+
ACC	cis	rs2739330	0.828	rs2186366	ENSG00000273295.1	AP000350.5	-5.87	3.11e-07	0.00254	-0.66	-0.63	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911926	chr22:23901432~23907068:-
ACC	cis	rs9399135	1	rs4475342	ENSG00000232876.1	CTA-212D2.2	-5.85	3.28e-07	0.00267	-0.65	-0.63	Red blood cell count;	chr6:134962210	chr6:135055033~135060550:+
ACC	cis	rs950027	0.549	rs1719250	ENSG00000259520.4	CTD-2651B20.3	-5.85	3.29e-07	0.00267	-0.74	-0.63	Response to fenofibrate (adiponectin levels);	chr15:45317575	chr15:45251580~45279251:-
ACC	cis	rs1799949	1	rs8176126	ENSG00000198496.9	NBR2	5.85	3.33e-07	0.0027	0.87	0.63	Menopause (age at onset);	chr17:43107032	chr17:43125610~43153671:+
ACC	cis	rs875971	1	rs11971949	ENSG00000226824.5	RP4-756H11.3	5.83	3.51e-07	0.00279	0.73	0.63	Aortic root size;	chr7:66161027	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs11974264	ENSG00000226824.5	RP4-756H11.3	5.83	3.51e-07	0.00279	0.73	0.63	Aortic root size;	chr7:66182595	chr7:66654538~66669855:+
ACC	cis	rs875971	1	rs1540651	ENSG00000226824.5	RP4-756H11.3	5.83	3.51e-07	0.00279	0.73	0.63	Aortic root size;	chr7:66185134	chr7:66654538~66669855:+
ACC	cis	rs2455601	0.744	rs2568085	ENSG00000254860.4	TMEM9B-AS1	-5.83	3.53e-07	0.0028	-0.71	-0.63	Schizophrenia;	chr11:8954201	chr11:8964675~8977527:+
ACC	cis	rs2882667	0.69	rs11954103	ENSG00000253404.1	AC034243.1	5.82	3.67e-07	0.00291	1.01	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138933459	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs10045605	ENSG00000253404.1	AC034243.1	5.82	3.67e-07	0.00291	1.01	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138936458	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.654	rs10044432	ENSG00000253404.1	AC034243.1	5.82	3.67e-07	0.00291	1.01	0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138939207	chr5:138744434~138753309:-
ACC	cis	rs2739330	0.828	rs5760107	ENSG00000273295.1	AP000350.5	5.82	3.69e-07	0.00291	0.64	0.63	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910410	chr22:23901432~23907068:-
ACC	cis	rs684232	0.897	rs1237094	ENSG00000262920.4	RP11-1260E13.1	5.82	3.7e-07	0.00292	0.69	0.63	Prostate cancer;	chr17:716602	chr17:321392~322453:+
ACC	cis	rs2739330	0.828	rs5751770	ENSG00000273295.1	AP000350.5	5.81	3.8e-07	0.003	0.63	0.63	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910655	chr22:23901432~23907068:-
ACC	cis	rs11155671	0.53	rs9371215	ENSG00000268592.3	RAET1E-AS1	5.81	3.84e-07	0.00303	0.73	0.63	Testicular germ cell tumor;	chr6:149873162	chr6:149863494~149919507:+
ACC	cis	rs2739330	0.789	rs5760109	ENSG00000273295.1	AP000350.5	5.81	3.86e-07	0.00304	0.64	0.63	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910751	chr22:23901432~23907068:-
ACC	cis	rs2739330	0.76	rs1002286	ENSG00000225282.1	AP000350.6	-5.81	3.88e-07	0.00305	-0.61	-0.63	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23926900~23929574:+
ACC	cis	rs9399137	0.507	rs4896128	ENSG00000232876.1	CTA-212D2.2	5.8	3.97e-07	0.00312	0.7	0.63	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:135028618	chr6:135055033~135060550:+
ACC	cis	rs801193	0.636	rs10233806	ENSG00000226824.5	RP4-756H11.3	5.79	4.17e-07	0.00326	0.74	0.63	Aortic root size;	chr7:66653261	chr7:66654538~66669855:+
ACC	cis	rs9487094	0.666	rs736830	ENSG00000260273.1	RP11-425D10.10	5.79	4.18e-07	0.00327	0.72	0.63	Height;	chr6:109392096	chr6:109382795~109383666:+
ACC	cis	rs2882667	0.628	rs13171173	ENSG00000253404.1	AC034243.1	-5.78	4.24e-07	0.00331	-0.98	-0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138706775	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.69	rs1651358	ENSG00000253404.1	AC034243.1	-5.78	4.24e-07	0.00331	-1.02	-0.63	Age-related hearing impairment (SNP x SNP interaction);	chr5:138745318	chr5:138744434~138753309:-
ACC	cis	rs2732480	0.557	rs923397	ENSG00000258273.1	RP11-370I10.4	-5.78	4.26e-07	0.00332	-0.85	-0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48326609	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.557	rs2409004	ENSG00000258273.1	RP11-370I10.4	-5.78	4.26e-07	0.00332	-0.85	-0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48327668	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2450994	ENSG00000258273.1	RP11-370I10.4	-5.78	4.26e-07	0.00332	-0.85	-0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48328049	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.557	rs2732441	ENSG00000258273.1	RP11-370I10.4	-5.78	4.26e-07	0.00332	-0.85	-0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48329541	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2732448	ENSG00000258273.1	RP11-370I10.4	-5.78	4.26e-07	0.00332	-0.85	-0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48336817	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2732466	ENSG00000258273.1	RP11-370I10.4	-5.78	4.26e-07	0.00332	-0.85	-0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48338676	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.557	rs2634682	ENSG00000258273.1	RP11-370I10.4	-5.78	4.26e-07	0.00332	-0.85	-0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48339160	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2634680	ENSG00000258273.1	RP11-370I10.4	-5.78	4.26e-07	0.00332	-0.85	-0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48340781	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2634684	ENSG00000258273.1	RP11-370I10.4	5.78	4.26e-07	0.00332	0.85	0.63	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48337092	chr12:48333755~48333901:-
ACC	cis	rs9326248	0.53	rs2000615	ENSG00000254851.1	RP11-109L13.1	-5.78	4.28e-07	0.00333	-0.98	-0.63	Blood protein levels;	chr11:117045103	chr11:117135528~117138582:+
ACC	cis	rs11155671	0.53	rs9397398	ENSG00000268592.3	RAET1E-AS1	5.78	4.3e-07	0.00335	0.72	0.63	Testicular germ cell tumor;	chr6:149872467	chr6:149863494~149919507:+
ACC	cis	rs2739330	0.685	rs4822453	ENSG00000273295.1	AP000350.5	5.77	4.39e-07	0.00341	0.63	0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23912675	chr22:23901432~23907068:-
ACC	cis	rs36715	1	rs36702	ENSG00000245937.6	LINC01184	5.77	4.45e-07	0.00346	0.84	0.62	Breast cancer;	chr5:128217031	chr5:127940426~128083172:-
ACC	cis	rs2739330	0.828	rs5760108	ENSG00000273295.1	AP000350.5	5.77	4.46e-07	0.00347	0.62	0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910481	chr22:23901432~23907068:-
ACC	cis	rs1150688	1	rs1150688	ENSG00000216901.1	AL022393.7	5.76	4.57e-07	0.00354	0.74	0.62	Autism spectrum disorder or schizophrenia;	chr6:28195002	chr6:28176188~28176674:+
ACC	cis	rs9399135	0.636	rs4646871	ENSG00000232876.1	CTA-212D2.2	5.75	4.76e-07	0.00368	0.67	0.62	Red blood cell count;	chr6:134944479	chr6:135055033~135060550:+
ACC	cis	rs2880765	0.835	rs7180923	ENSG00000259295.5	CSPG4P12	5.75	4.83e-07	0.00374	0.74	0.62	Coronary artery disease;	chr15:85507659	chr15:85191438~85213905:+
ACC	cis	rs7188445	0.592	rs4404082	ENSG00000261390.4	RP11-345M22.2	5.75	4.84e-07	0.00374	0.72	0.62	Urate levels;	chr16:79716615	chr16:79715232~79770563:-
ACC	cis	rs2739330	0.796	rs1006771	ENSG00000273295.1	AP000350.5	5.74	4.97e-07	0.00383	0.67	0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23971817	chr22:23901432~23907068:-
ACC	cis	rs9487094	0.689	rs1074766	ENSG00000260273.1	RP11-425D10.10	5.74	4.97e-07	0.00383	0.71	0.62	Height;	chr6:109360263	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs9487070	ENSG00000260273.1	RP11-425D10.10	5.74	4.97e-07	0.00383	0.71	0.62	Height;	chr6:109361200	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs8465	ENSG00000260273.1	RP11-425D10.10	5.74	4.97e-07	0.00383	0.71	0.62	Height;	chr6:109367335	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.666	rs974034	ENSG00000260273.1	RP11-425D10.10	5.74	4.97e-07	0.00383	0.71	0.62	Height;	chr6:109368228	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs3818933	ENSG00000260273.1	RP11-425D10.10	5.74	4.97e-07	0.00383	0.71	0.62	Height;	chr6:109370741	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs9487076	ENSG00000260273.1	RP11-425D10.10	5.74	4.97e-07	0.00383	0.71	0.62	Height;	chr6:109371524	chr6:109382795~109383666:+
ACC	cis	rs1799949	0.896	rs8176086	ENSG00000198496.9	NBR2	-5.73	5.12e-07	0.00394	-0.82	-0.62	Menopause (age at onset);	chr17:43122761	chr17:43125610~43153671:+
ACC	cis	rs172166	0.538	rs1150686	ENSG00000216901.1	AL022393.7	5.73	5.13e-07	0.00394	0.73	0.62	Cardiac Troponin-T levels;	chr6:28193493	chr6:28176188~28176674:+
ACC	cis	rs9487094	0.696	rs1853330	ENSG00000260273.1	RP11-425D10.10	5.73	5.14e-07	0.00395	0.71	0.62	Height;	chr6:109375548	chr6:109382795~109383666:+
ACC	cis	rs7208859	0.623	rs56325146	ENSG00000263531.1	RP13-753N3.1	5.71	5.48e-07	0.0042	1.21	0.62	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30824006	chr17:30863921~30864940:-
ACC	cis	rs172166	0.538	rs149956	ENSG00000216901.1	AL022393.7	5.71	5.54e-07	0.00425	0.74	0.62	Cardiac Troponin-T levels;	chr6:28068473	chr6:28176188~28176674:+
ACC	cis	rs2739330	0.828	rs4820572	ENSG00000273295.1	AP000350.5	5.71	5.59e-07	0.00428	0.62	0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23908168	chr22:23901432~23907068:-
ACC	cis	rs9399135	0.967	rs4895434	ENSG00000232876.1	CTA-212D2.2	-5.71	5.59e-07	0.00428	-0.65	-0.62	Red blood cell count;	chr6:134972227	chr6:135055033~135060550:+
ACC	cis	rs9399135	1	rs4895435	ENSG00000232876.1	CTA-212D2.2	-5.71	5.59e-07	0.00428	-0.65	-0.62	Red blood cell count;	chr6:134972325	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs4896123	ENSG00000232876.1	CTA-212D2.2	-5.71	5.59e-07	0.00428	-0.65	-0.62	Red blood cell count;	chr6:134974272	chr6:135055033~135060550:+
ACC	cis	rs12550612	0.561	rs11784599	ENSG00000253616.4	RP11-875O11.3	5.71	5.59e-07	0.00428	0.75	0.62	Myeloid white cell count;Granulocyte count;Neutrophil count;Sum basophil neutrophil counts;White blood cell count;Sum neutrophil eosinophil counts;	chr8:23074609	chr8:23071377~23074488:-
ACC	cis	rs916888	0.821	rs199499	ENSG00000262539.1	RP11-259G18.3	5.7	5.81e-07	0.00443	0.87	0.62	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46788132	chr17:46259551~46260606:-
ACC	cis	rs2486288	0.656	rs11631021	ENSG00000259520.4	CTD-2651B20.3	5.68	6.04e-07	0.00461	0.77	0.62	Glomerular filtration rate;	chr15:45264631	chr15:45251580~45279251:-
ACC	cis	rs10256972	0.591	rs11766651	ENSG00000229043.2	AC091729.9	-5.68	6.19e-07	0.0047	-0.75	-0.62	Endometriosis;Longevity;	chr7:1122010	chr7:1160374~1165267:+
ACC	cis	rs1577917	0.655	rs2842605	ENSG00000203875.9	SNHG5	-5.67	6.3e-07	0.00476	-0.68	-0.62	Response to antipsychotic treatment;	chr6:85625432	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.655	rs2758849	ENSG00000203875.9	SNHG5	-5.67	6.3e-07	0.00476	-0.68	-0.62	Response to antipsychotic treatment;	chr6:85634578	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.655	rs2758848	ENSG00000203875.9	SNHG5	-5.67	6.3e-07	0.00476	-0.68	-0.62	Response to antipsychotic treatment;	chr6:85637887	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.681	rs4348284	ENSG00000203875.9	SNHG5	-5.67	6.3e-07	0.00476	-0.68	-0.62	Response to antipsychotic treatment;	chr6:85640676	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.727	rs9344539	ENSG00000203875.9	SNHG5	-5.67	6.3e-07	0.00476	-0.68	-0.62	Response to antipsychotic treatment;	chr6:85643903	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.771	rs9362232	ENSG00000203875.9	SNHG5	-5.67	6.3e-07	0.00476	-0.68	-0.62	Response to antipsychotic treatment;	chr6:85643904	chr6:85660950~85678736:-
ACC	cis	rs2739330	0.796	rs5760106	ENSG00000273295.1	AP000350.5	-5.67	6.31e-07	0.00476	-0.61	-0.62	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23908458	chr22:23901432~23907068:-
ACC	cis	rs2732480	0.577	rs2634693	ENSG00000258273.1	RP11-370I10.4	-5.66	6.48e-07	0.00483	-0.85	-0.62	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48312715	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2634691	ENSG00000258273.1	RP11-370I10.4	-5.66	6.48e-07	0.00483	-0.85	-0.62	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48314476	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.557	rs2732454	ENSG00000258273.1	RP11-370I10.4	-5.66	6.48e-07	0.00483	-0.85	-0.62	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48325894	chr12:48333755~48333901:-
ACC	cis	rs172166	0.561	rs149976	ENSG00000216901.1	AL022393.7	-5.66	6.52e-07	0.00486	-0.73	-0.62	Cardiac Troponin-T levels;	chr6:28019998	chr6:28176188~28176674:+
ACC	cis	rs9399135	1	rs11754265	ENSG00000232876.1	CTA-212D2.2	-5.66	6.62e-07	0.00492	-0.65	-0.62	Red blood cell count;	chr6:135035078	chr6:135055033~135060550:+
ACC	cis	rs2732480	0.577	rs2634678	ENSG00000258273.1	RP11-370I10.4	-5.66	6.66e-07	0.00494	-0.84	-0.62	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48341755	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2732479	ENSG00000258273.1	RP11-370I10.4	-5.66	6.66e-07	0.00494	-0.84	-0.62	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48342477	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.537	rs1061986	ENSG00000258273.1	RP11-370I10.4	-5.66	6.66e-07	0.00494	-0.84	-0.62	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48342656	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2732481	ENSG00000258273.1	RP11-370I10.4	-5.66	6.66e-07	0.00494	-0.84	-0.62	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48343202	chr12:48333755~48333901:-
ACC	cis	rs11155671	0.53	rs9371215	ENSG00000231760.4	RP11-350J20.5	5.66	6.68e-07	0.00495	0.7	0.62	Testicular germ cell tumor;	chr6:149873162	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.851	rs9322194	ENSG00000231760.4	RP11-350J20.5	5.66	6.68e-07	0.00496	0.71	0.62	Lung cancer;	chr6:149599113	chr6:149796151~149826294:-
ACC	cis	rs9487094	0.67	rs11755641	ENSG00000260273.1	RP11-425D10.10	5.65	6.77e-07	0.00502	0.71	0.62	Height;	chr6:109586733	chr6:109382795~109383666:+
ACC	cis	rs7208859	0.573	rs216443	ENSG00000263531.1	RP13-753N3.1	5.65	6.83e-07	0.00506	1.28	0.62	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30604853	chr17:30863921~30864940:-
ACC	cis	rs2882667	0.964	rs12108892	ENSG00000253404.1	AC034243.1	5.65	6.83e-07	0.00506	0.86	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:138963941	chr5:138744434~138753309:-
ACC	cis	rs7188445	0.592	rs7196490	ENSG00000261390.4	RP11-345M22.2	-5.64	7.01e-07	0.00518	-0.7	-0.62	Urate levels;	chr16:79718572	chr16:79715232~79770563:-
ACC	cis	rs2732480	0.967	rs2732469	ENSG00000258273.1	RP11-370I10.4	-5.64	7.04e-07	0.00519	-0.83	-0.62	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48319149	chr12:48333755~48333901:-
ACC	cis	rs858239	0.536	rs6961109	ENSG00000230658.1	KLHL7-AS1	5.64	7.05e-07	0.0052	0.75	0.62	Cerebrospinal fluid biomarker levels;	chr7:23212794	chr7:23101228~23105703:-
ACC	cis	rs2882667	0.69	rs825747	ENSG00000253404.1	AC034243.1	-5.64	7.08e-07	0.00522	-0.91	-0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:138800896	chr5:138744434~138753309:-
ACC	cis	rs7188445	0.556	rs7194711	ENSG00000261390.4	RP11-345M22.2	-5.64	7.12e-07	0.00524	-0.72	-0.62	Urate levels;	chr16:79715134	chr16:79715232~79770563:-
ACC	cis	rs801193	0.548	rs6975044	ENSG00000226824.5	RP4-756H11.3	-5.64	7.12e-07	0.00525	-0.8	-0.62	Aortic root size;	chr7:66762495	chr7:66654538~66669855:+
ACC	cis	rs858239	0.899	rs2268747	ENSG00000230658.1	KLHL7-AS1	5.64	7.14e-07	0.00525	0.83	0.62	Cerebrospinal fluid biomarker levels;	chr7:23273843	chr7:23101228~23105703:-
ACC	cis	rs9487094	0.689	rs9487069	ENSG00000260273.1	RP11-425D10.10	5.64	7.14e-07	0.00526	0.68	0.62	Height;	chr6:109358652	chr6:109382795~109383666:+
ACC	cis	rs9322193	0.504	rs7771014	ENSG00000268592.3	RAET1E-AS1	5.63	7.37e-07	0.00541	0.7	0.62	Lung cancer;	chr6:149884310	chr6:149863494~149919507:+
ACC	cis	rs2882667	0.628	rs311607	ENSG00000253404.1	AC034243.1	5.63	7.43e-07	0.00545	0.95	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:138709231	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.628	rs311605	ENSG00000253404.1	AC034243.1	5.63	7.43e-07	0.00545	0.95	0.62	Age-related hearing impairment (SNP x SNP interaction);	chr5:138710150	chr5:138744434~138753309:-
ACC	cis	rs10256972	0.616	rs4585652	ENSG00000229043.2	AC091729.9	-5.62	7.52e-07	0.00551	-0.73	-0.61	Endometriosis;Longevity;	chr7:1105760	chr7:1160374~1165267:+
ACC	cis	rs875971	1	rs6946143	ENSG00000226824.5	RP4-756H11.3	-5.62	7.67e-07	0.00561	-0.7	-0.61	Aortic root size;	chr7:66114735	chr7:66654538~66669855:+
ACC	cis	rs2739330	0.892	rs4822455	ENSG00000218537.1	MIF-AS1	5.62	7.71e-07	0.00563	0.67	0.61	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913109	chr22:23894426~23898930:-
ACC	cis	rs858239	1	rs858239	ENSG00000230658.1	KLHL7-AS1	5.62	7.72e-07	0.00564	0.72	0.61	Cerebrospinal fluid biomarker levels;	chr7:23246696	chr7:23101228~23105703:-
ACC	cis	rs9399135	0.967	rs1590975	ENSG00000232876.1	CTA-212D2.2	-5.61	7.76e-07	0.00566	-0.64	-0.61	Red blood cell count;	chr6:135030950	chr6:135055033~135060550:+
ACC	cis	rs9487094	0.67	rs1885691	ENSG00000260273.1	RP11-425D10.10	5.61	7.83e-07	0.0057	0.72	0.61	Height;	chr6:109382188	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.644	rs3757230	ENSG00000260273.1	RP11-425D10.10	5.61	7.83e-07	0.0057	0.72	0.61	Height;	chr6:109383239	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.644	rs3757231	ENSG00000260273.1	RP11-425D10.10	5.61	7.83e-07	0.0057	0.72	0.61	Height;	chr6:109383248	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.666	rs4946970	ENSG00000260273.1	RP11-425D10.10	5.61	7.83e-07	0.0057	0.72	0.61	Height;	chr6:109384807	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.62	rs6939953	ENSG00000260273.1	RP11-425D10.10	5.61	7.83e-07	0.0057	0.72	0.61	Height;	chr6:109390116	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.666	rs3757235	ENSG00000260273.1	RP11-425D10.10	5.61	7.83e-07	0.0057	0.72	0.61	Height;	chr6:109390638	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs9480936	ENSG00000260273.1	RP11-425D10.10	5.61	7.83e-07	0.0057	0.69	0.61	Height;	chr6:109358227	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.666	rs746794	ENSG00000260273.1	RP11-425D10.10	5.61	7.98e-07	0.0058	0.72	0.61	Height;	chr6:109391534	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.643	rs730089	ENSG00000260273.1	RP11-425D10.10	5.61	7.98e-07	0.0058	0.72	0.61	Height;	chr6:109393881	chr6:109382795~109383666:+
ACC	cis	rs858239	0.899	rs858271	ENSG00000230658.1	KLHL7-AS1	5.6	8.05e-07	0.00585	0.72	0.61	Cerebrospinal fluid biomarker levels;	chr7:23238664	chr7:23101228~23105703:-
ACC	cis	rs9487094	0.666	rs4946967	ENSG00000260273.1	RP11-425D10.10	5.6	8.08e-07	0.00586	0.67	0.61	Height;	chr6:109357369	chr6:109382795~109383666:+
ACC	cis	rs801193	0.591	rs9986881	ENSG00000226824.5	RP4-756H11.3	-5.6	8.14e-07	0.0059	-0.76	-0.61	Aortic root size;	chr7:66708053	chr7:66654538~66669855:+
ACC	cis	rs858239	0.899	rs5850	ENSG00000230658.1	KLHL7-AS1	5.6	8.2e-07	0.00594	0.82	0.61	Cerebrospinal fluid biomarker levels;	chr7:23274928	chr7:23101228~23105703:-
ACC	cis	rs858239	1	rs199357	ENSG00000230658.1	KLHL7-AS1	-5.59	8.34e-07	0.00603	-0.71	-0.61	Cerebrospinal fluid biomarker levels;	chr7:23248690	chr7:23101228~23105703:-
ACC	cis	rs1387259	0.929	rs11168460	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48203582	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs7297824	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48204867	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs7315820	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48205155	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs11168464	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48208332	chr12:48333755~48333901:-
ACC	cis	rs1387259	0.899	rs7307566	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48210899	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs11168468	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48218682	chr12:48333755~48333901:-
ACC	cis	rs1387259	0.931	rs11168474	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48227601	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs12829841	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48234956	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.523	rs34286639	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48235261	chr12:48333755~48333901:-
ACC	cis	rs1387259	0.929	rs11168484	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48239806	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs1387257	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48242883	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs12828309	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48247377	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs1552550	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48249568	chr12:48333755~48333901:-
ACC	cis	rs1387259	0.79	rs2732445	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48251750	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs2932093	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48254488	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs2450991	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48257838	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs2450986	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48267905	chr12:48333755~48333901:-
ACC	cis	rs1387259	0.929	rs2634666	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48269887	chr12:48333755~48333901:-
ACC	cis	rs1387259	0.929	rs2956703	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48276511	chr12:48333755~48333901:-
ACC	cis	rs1387259	0.931	rs1107654	ENSG00000258273.1	RP11-370I10.4	-5.59	8.43e-07	0.00604	-0.81	-0.61	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48287314	chr12:48333755~48333901:-
ACC	cis	rs11155671	0.53	rs6557133	ENSG00000231760.4	RP11-350J20.5	5.59	8.44e-07	0.00605	0.75	0.61	Testicular germ cell tumor;	chr6:149874248	chr6:149796151~149826294:-
ACC	cis	rs853679	0.527	rs853683	ENSG00000216901.1	AL022393.7	5.59	8.59e-07	0.00615	0.71	0.61	Depression;	chr6:28327262	chr6:28176188~28176674:+
ACC	cis	rs11155671	0.53	rs9968871	ENSG00000268592.3	RAET1E-AS1	5.58	8.72e-07	0.00623	0.72	0.61	Testicular germ cell tumor;	chr6:149888060	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs9969044	ENSG00000268592.3	RAET1E-AS1	5.58	8.72e-07	0.00623	0.72	0.61	Testicular germ cell tumor;	chr6:149888068	chr6:149863494~149919507:+
ACC	cis	rs36715	1	rs40527	ENSG00000245937.6	LINC01184	5.58	8.75e-07	0.00625	0.83	0.61	Breast cancer;	chr5:128214560	chr5:127940426~128083172:-
ACC	cis	rs2732480	0.557	rs2732484	ENSG00000258273.1	RP11-370I10.4	-5.58	8.92e-07	0.00635	-0.84	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48343462	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs2732486	ENSG00000258273.1	RP11-370I10.4	-5.58	8.92e-07	0.00635	-0.84	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48344051	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.517	rs2634676	ENSG00000258273.1	RP11-370I10.4	-5.58	8.92e-07	0.00635	-0.84	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48344453	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs1489109	ENSG00000258273.1	RP11-370I10.4	-5.58	8.92e-07	0.00635	-0.84	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48344997	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.577	rs1489108	ENSG00000258273.1	RP11-370I10.4	-5.58	8.92e-07	0.00635	-0.84	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48344998	chr12:48333755~48333901:-
ACC	cis	rs1799949	1	rs35070007	ENSG00000198496.9	NBR2	5.57	9.02e-07	0.0064	0.78	0.61	Menopause (age at onset);	chr17:43164730	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.773	rs2137990	ENSG00000198496.9	NBR2	5.57	9.02e-07	0.0064	0.78	0.61	Menopause (age at onset);	chr17:43165879	chr17:43125610~43153671:+
ACC	cis	rs7188445	0.615	rs4340340	ENSG00000261390.4	RP11-345M22.2	-5.56	9.29e-07	0.00654	-0.7	-0.61	Urate levels;	chr16:79716720	chr16:79715232~79770563:-
ACC	cis	rs10256972	0.681	rs6979076	ENSG00000229043.2	AC091729.9	5.56	9.33e-07	0.00656	0.64	0.61	Endometriosis;Longevity;	chr7:1076611	chr7:1160374~1165267:+
ACC	cis	rs9399135	0.66	rs4646868	ENSG00000232876.1	CTA-212D2.2	-5.56	9.51e-07	0.00668	-0.68	-0.61	Red blood cell count;	chr6:134950808	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.66	rs4267967	ENSG00000232876.1	CTA-212D2.2	-5.56	9.51e-07	0.00668	-0.68	-0.61	Red blood cell count;	chr6:134951339	chr6:135055033~135060550:+
ACC	cis	rs2739330	0.76	rs1002286	ENSG00000231271.1	AP000350.8	-5.56	9.53e-07	0.00669	-0.63	-0.61	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23949918~23954042:+
ACC	cis	rs9326248	0.53	rs6589589	ENSG00000254851.1	RP11-109L13.1	-5.55	9.62e-07	0.00673	-0.95	-0.61	Blood protein levels;	chr11:117061712	chr11:117135528~117138582:+
ACC	cis	rs4853012	0.775	rs12465641	ENSG00000217702.2	RP11-287D1.4	-5.55	9.64e-07	0.00674	-0.63	-0.61	Gestational age at birth (maternal effect);	chr2:74110588	chr2:74130583~74135395:+
ACC	cis	rs597539	0.652	rs636049	ENSG00000250508.1	RP11-757G1.6	-5.55	9.67e-07	0.00676	-1.04	-0.61	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68899730	chr11:68870664~68874542:+
ACC	cis	rs9487094	0.689	rs699700	ENSG00000260273.1	RP11-425D10.10	5.55	9.69e-07	0.00678	0.69	0.61	Height;	chr6:109367528	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs11251	ENSG00000260273.1	RP11-425D10.10	5.55	9.69e-07	0.00678	0.69	0.61	Height;	chr6:109368704	chr6:109382795~109383666:+
ACC	cis	rs597539	0.518	rs35093305	ENSG00000250508.1	RP11-757G1.6	-5.55	9.84e-07	0.00686	-0.92	-0.61	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68963260	chr11:68870664~68874542:+
ACC	cis	rs597539	0.58	rs7935851	ENSG00000250508.1	RP11-757G1.6	-5.55	9.84e-07	0.00686	-0.92	-0.61	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68963653	chr11:68870664~68874542:+
ACC	cis	rs858239	0.932	rs199355	ENSG00000230658.1	KLHL7-AS1	5.55	9.88e-07	0.00688	0.7	0.61	Cerebrospinal fluid biomarker levels;	chr7:23256914	chr7:23101228~23105703:-
ACC	cis	rs2732480	0.5	rs2450989	ENSG00000258273.1	RP11-370I10.4	5.55	9.89e-07	0.00689	0.8	0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48259625	chr12:48333755~48333901:-
ACC	cis	rs9399135	0.66	rs9376072	ENSG00000232876.1	CTA-212D2.2	-5.54	1e-06	0.00698	-0.66	-0.61	Red blood cell count;	chr6:134959381	chr6:135055033~135060550:+
ACC	cis	rs9399135	1	rs1014021	ENSG00000232876.1	CTA-212D2.2	5.54	1.01e-06	0.00704	0.61	0.61	Red blood cell count;	chr6:135013462	chr6:135055033~135060550:+
ACC	cis	rs9322193	0.504	rs7771014	ENSG00000231760.4	RP11-350J20.5	5.54	1.02e-06	0.00706	0.68	0.61	Lung cancer;	chr6:149884310	chr6:149796151~149826294:-
ACC	cis	rs2732480	0.538	rs1387260	ENSG00000258273.1	RP11-370I10.4	-5.54	1.02e-06	0.00707	-0.83	-0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48309308	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.538	rs1387259	ENSG00000258273.1	RP11-370I10.4	5.54	1.02e-06	0.00707	0.83	0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48309739	chr12:48333755~48333901:-
ACC	cis	rs858239	1	rs199347	ENSG00000230658.1	KLHL7-AS1	5.54	1.02e-06	0.00707	0.71	0.61	Cerebrospinal fluid biomarker levels;	chr7:23254127	chr7:23101228~23105703:-
ACC	cis	rs9487094	0.517	rs3778474	ENSG00000260273.1	RP11-425D10.10	5.54	1.02e-06	0.00709	0.69	0.61	Height;	chr6:109374782	chr6:109382795~109383666:+
ACC	cis	rs36715	1	rs36705	ENSG00000245937.6	LINC01184	5.54	1.03e-06	0.00712	0.82	0.61	Breast cancer;	chr5:128218794	chr5:127940426~128083172:-
ACC	cis	rs2486288	0.656	rs9921035	ENSG00000259520.4	CTD-2651B20.3	5.53	1.04e-06	0.00719	0.71	0.61	Glomerular filtration rate;	chr15:45254462	chr15:45251580~45279251:-
ACC	cis	rs11155671	0.53	rs9383912	ENSG00000268592.3	RAET1E-AS1	5.53	1.05e-06	0.00723	0.7	0.61	Testicular germ cell tumor;	chr6:149885479	chr6:149863494~149919507:+
ACC	cis	rs858239	0.932	rs858272	ENSG00000230658.1	KLHL7-AS1	5.53	1.05e-06	0.00728	0.71	0.61	Cerebrospinal fluid biomarker levels;	chr7:23237166	chr7:23101228~23105703:-
ACC	cis	rs858239	1	rs858240	ENSG00000230658.1	KLHL7-AS1	5.53	1.05e-06	0.00728	0.71	0.61	Cerebrospinal fluid biomarker levels;	chr7:23244618	chr7:23101228~23105703:-
ACC	cis	rs36715	0.953	rs2617613	ENSG00000245937.6	LINC01184	5.53	1.06e-06	0.0073	0.83	0.61	Breast cancer;	chr5:128216897	chr5:127940426~128083172:-
ACC	cis	rs36715	0.868	rs2546147	ENSG00000245937.6	LINC01184	5.53	1.06e-06	0.0073	0.83	0.61	Breast cancer;	chr5:128216898	chr5:127940426~128083172:-
ACC	cis	rs2732480	0.577	rs2634681	ENSG00000258273.1	RP11-370I10.4	5.52	1.08e-06	0.00738	0.81	0.61	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48339301	chr12:48333755~48333901:-
ACC	cis	rs11155671	0.53	rs9383940	ENSG00000268592.3	RAET1E-AS1	5.52	1.08e-06	0.00741	0.71	0.61	Testicular germ cell tumor;	chr6:149904923	chr6:149863494~149919507:+
ACC	cis	rs9487094	0.644	rs13201430	ENSG00000260273.1	RP11-425D10.10	5.52	1.09e-06	0.00745	0.7	0.61	Height;	chr6:109634847	chr6:109382795~109383666:+
ACC	cis	rs172166	0.561	rs149971	ENSG00000216901.1	AL022393.7	5.52	1.09e-06	0.00747	0.72	0.61	Cardiac Troponin-T levels;	chr6:28014374	chr6:28176188~28176674:+
ACC	cis	rs9399137	0.507	rs7768278	ENSG00000232876.1	CTA-212D2.2	-5.52	1.11e-06	0.00757	-0.7	-0.61	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134953819	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs7748708	ENSG00000232876.1	CTA-212D2.2	-5.52	1.11e-06	0.00757	-0.7	-0.61	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134954004	chr6:135055033~135060550:+
ACC	cis	rs11155671	0.53	rs9397420	ENSG00000231760.4	RP11-350J20.5	-5.51	1.12e-06	0.00764	-0.68	-0.61	Testicular germ cell tumor;	chr6:149885645	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs9383912	ENSG00000231760.4	RP11-350J20.5	5.51	1.13e-06	0.00773	0.68	0.61	Testicular germ cell tumor;	chr6:149885479	chr6:149796151~149826294:-
ACC	cis	rs763121	0.962	rs138711	ENSG00000273076.1	RP3-508I15.22	5.51	1.14e-06	0.00776	0.65	0.61	Menopause (age at onset);	chr22:38743908	chr22:38743495~38743910:+
ACC	cis	rs9399137	0.507	rs7771310	ENSG00000232876.1	CTA-212D2.2	-5.51	1.14e-06	0.00779	-0.71	-0.61	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134951397	chr6:135055033~135060550:+
ACC	cis	rs11155671	0.53	rs7758033	ENSG00000231760.4	RP11-350J20.5	5.51	1.15e-06	0.00783	0.68	0.61	Testicular germ cell tumor;	chr6:149886999	chr6:149796151~149826294:-
ACC	cis	rs8040855	0.599	rs1964724	ENSG00000259295.5	CSPG4P12	-5.5	1.16e-06	0.0079	-0.71	-0.61	Bulimia nervosa;	chr15:85183269	chr15:85191438~85213905:+
ACC	cis	rs8040855	0.579	rs28521166	ENSG00000259295.5	CSPG4P12	-5.5	1.16e-06	0.0079	-0.71	-0.61	Bulimia nervosa;	chr15:85184801	chr15:85191438~85213905:+
ACC	cis	rs8040855	0.599	rs6496800	ENSG00000259295.5	CSPG4P12	-5.5	1.16e-06	0.0079	-0.71	-0.61	Bulimia nervosa;	chr15:85185055	chr15:85191438~85213905:+
ACC	cis	rs12550612	0.614	rs11135696	ENSG00000253616.4	RP11-875O11.3	5.5	1.16e-06	0.00791	0.76	0.61	Myeloid white cell count;Granulocyte count;Neutrophil count;Sum basophil neutrophil counts;White blood cell count;Sum neutrophil eosinophil counts;	chr8:23084410	chr8:23071377~23074488:-
ACC	cis	rs2739330	0.791	rs4822458	ENSG00000250470.1	AP000351.3	5.5	1.17e-06	0.008	0.65	0.61	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23923472	chr22:23976904~23977585:-
ACC	cis	rs11155671	0.53	rs9383577	ENSG00000268592.3	RAET1E-AS1	5.5	1.19e-06	0.00805	0.69	0.61	Testicular germ cell tumor;	chr6:149886059	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs9383914	ENSG00000268592.3	RAET1E-AS1	5.5	1.19e-06	0.00805	0.69	0.61	Testicular germ cell tumor;	chr6:149886098	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.517	rs9397058	ENSG00000268592.3	RAET1E-AS1	5.5	1.19e-06	0.00805	0.69	0.61	Testicular germ cell tumor;	chr6:149886113	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs7768626	ENSG00000268592.3	RAET1E-AS1	5.5	1.19e-06	0.00805	0.69	0.61	Testicular germ cell tumor;	chr6:149886826	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs7768665	ENSG00000268592.3	RAET1E-AS1	5.5	1.19e-06	0.00805	0.69	0.61	Testicular germ cell tumor;	chr6:149886888	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs7758020	ENSG00000268592.3	RAET1E-AS1	5.5	1.19e-06	0.00805	0.69	0.61	Testicular germ cell tumor;	chr6:149886975	chr6:149863494~149919507:+
ACC	cis	rs1799949	0.894	rs36062488	ENSG00000198496.9	NBR2	5.5	1.19e-06	0.00805	0.77	0.61	Menopause (age at onset);	chr17:43185455	chr17:43125610~43153671:+
ACC	cis	rs11155671	0.53	rs9383577	ENSG00000231760.4	RP11-350J20.5	5.49	1.21e-06	0.00818	0.68	0.61	Testicular germ cell tumor;	chr6:149886059	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs9383914	ENSG00000231760.4	RP11-350J20.5	5.49	1.21e-06	0.00818	0.68	0.61	Testicular germ cell tumor;	chr6:149886098	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.517	rs9397058	ENSG00000231760.4	RP11-350J20.5	5.49	1.21e-06	0.00818	0.68	0.61	Testicular germ cell tumor;	chr6:149886113	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs7768626	ENSG00000231760.4	RP11-350J20.5	5.49	1.21e-06	0.00818	0.68	0.61	Testicular germ cell tumor;	chr6:149886826	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs7768665	ENSG00000231760.4	RP11-350J20.5	5.49	1.21e-06	0.00818	0.68	0.61	Testicular germ cell tumor;	chr6:149886888	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs7758020	ENSG00000231760.4	RP11-350J20.5	5.49	1.21e-06	0.00818	0.68	0.61	Testicular germ cell tumor;	chr6:149886975	chr6:149796151~149826294:-
ACC	cis	rs2739330	0.76	rs1002286	ENSG00000250470.1	AP000351.3	-5.49	1.22e-06	0.00824	-0.64	-0.61	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23976904~23977585:-
ACC	cis	rs858239	1	rs199348	ENSG00000230658.1	KLHL7-AS1	5.48	1.25e-06	0.00844	0.71	0.61	Cerebrospinal fluid biomarker levels;	chr7:23253479	chr7:23101228~23105703:-
ACC	cis	rs6920372	0.708	rs13198852	ENSG00000260273.1	RP11-425D10.10	5.48	1.25e-06	0.00844	0.74	0.61	Height;	chr6:109747119	chr6:109382795~109383666:+
ACC	cis	rs6920372	0.748	rs12528392	ENSG00000260273.1	RP11-425D10.10	5.48	1.25e-06	0.00844	0.74	0.61	Height;	chr6:109747411	chr6:109382795~109383666:+
ACC	cis	rs6920372	0.692	rs11153216	ENSG00000260273.1	RP11-425D10.10	5.48	1.25e-06	0.00844	0.74	0.61	Height;	chr6:109748819	chr6:109382795~109383666:+
ACC	cis	rs6920372	0.748	rs2025147	ENSG00000260273.1	RP11-425D10.10	5.48	1.25e-06	0.00844	0.74	0.61	Height;	chr6:109749564	chr6:109382795~109383666:+
ACC	cis	rs6920372	0.748	rs12190372	ENSG00000260273.1	RP11-425D10.10	5.48	1.25e-06	0.00844	0.74	0.61	Height;	chr6:109763331	chr6:109382795~109383666:+
ACC	cis	rs7208859	0.623	rs426434	ENSG00000263531.1	RP13-753N3.1	5.48	1.26e-06	0.00848	1.19	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30598335	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.562	rs11650923	ENSG00000263531.1	RP13-753N3.1	5.48	1.26e-06	0.00848	1.08	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30681149	chr17:30863921~30864940:-
ACC	cis	rs1799949	0.929	rs799906	ENSG00000198496.9	NBR2	-5.48	1.27e-06	0.00848	-0.77	-0.6	Menopause (age at onset);	chr17:43126099	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs799908	ENSG00000198496.9	NBR2	-5.48	1.27e-06	0.00848	-0.77	-0.6	Menopause (age at onset);	chr17:43126899	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.93	rs1554063	ENSG00000198496.9	NBR2	-5.48	1.27e-06	0.00848	-0.77	-0.6	Menopause (age at onset);	chr17:43135128	chr17:43125610~43153671:+
ACC	cis	rs11155671	0.53	rs7758033	ENSG00000268592.3	RAET1E-AS1	5.48	1.28e-06	0.00856	0.69	0.6	Testicular germ cell tumor;	chr6:149886999	chr6:149863494~149919507:+
ACC	cis	rs9326248	0.53	rs10732856	ENSG00000254851.1	RP11-109L13.1	-5.47	1.28e-06	0.00857	-0.94	-0.6	Blood protein levels;	chr11:117036397	chr11:117135528~117138582:+
ACC	cis	rs7208859	0.573	rs73267829	ENSG00000263531.1	RP13-753N3.1	5.47	1.3e-06	0.00866	1.08	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30676921	chr17:30863921~30864940:-
ACC	cis	rs9399135	0.935	rs4445070	ENSG00000232876.1	CTA-212D2.2	-5.47	1.31e-06	0.00874	-0.62	-0.6	Red blood cell count;	chr6:134988074	chr6:135055033~135060550:+
ACC	cis	rs1799949	0.965	rs35521261	ENSG00000198496.9	NBR2	-5.47	1.33e-06	0.00882	-0.79	-0.6	Menopause (age at onset);	chr17:43161595	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.896	rs33933393	ENSG00000198496.9	NBR2	-5.47	1.33e-06	0.00882	-0.79	-0.6	Menopause (age at onset);	chr17:43165415	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs33946455	ENSG00000198496.9	NBR2	-5.47	1.33e-06	0.00882	-0.79	-0.6	Menopause (age at onset);	chr17:43169829	chr17:43125610~43153671:+
ACC	cis	rs12550612	0.567	rs7834950	ENSG00000253616.4	RP11-875O11.3	5.46	1.33e-06	0.00883	0.75	0.6	Myeloid white cell count;Granulocyte count;Neutrophil count;Sum basophil neutrophil counts;White blood cell count;Sum neutrophil eosinophil counts;	chr8:23084305	chr8:23071377~23074488:-
ACC	cis	rs12550612	0.614	rs6983885	ENSG00000253616.4	RP11-875O11.3	5.46	1.33e-06	0.00883	0.75	0.6	Myeloid white cell count;Granulocyte count;Neutrophil count;Sum basophil neutrophil counts;White blood cell count;Sum neutrophil eosinophil counts;	chr8:23087574	chr8:23071377~23074488:-
ACC	cis	rs9399135	0.967	rs7750300	ENSG00000232876.1	CTA-212D2.2	-5.46	1.36e-06	0.00898	-0.64	-0.6	Red blood cell count;	chr6:135029812	chr6:135055033~135060550:+
ACC	cis	rs11155671	0.53	rs9322228	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149888173	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs7774787	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149888296	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs2342767	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149888581	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs7764376	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149889208	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs6933882	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149889666	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs6939761	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149889858	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs3823021	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149889863	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs4869763	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149890548	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs4869764	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149890692	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs7756850	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149891460	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs9371542	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149891949	chr6:149863494~149919507:+
ACC	cis	rs11155671	0.53	rs9371223	ENSG00000268592.3	RAET1E-AS1	5.46	1.36e-06	0.00898	0.7	0.6	Testicular germ cell tumor;	chr6:149893670	chr6:149863494~149919507:+
ACC	cis	rs1799949	1	rs4340367	ENSG00000198496.9	NBR2	-5.45	1.39e-06	0.00914	-0.79	-0.6	Menopause (age at onset);	chr17:43155755	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs4792981	ENSG00000198496.9	NBR2	-5.45	1.39e-06	0.00914	-0.79	-0.6	Menopause (age at onset);	chr17:43156257	chr17:43125610~43153671:+
ACC	cis	rs2880765	0.835	rs4536419	ENSG00000259295.5	CSPG4P12	5.45	1.39e-06	0.00916	0.73	0.6	Coronary artery disease;	chr15:85496240	chr15:85191438~85213905:+
ACC	cis	rs9399137	0.507	rs6923512	ENSG00000232876.1	CTA-212D2.2	5.45	1.4e-06	0.00922	0.74	0.6	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:135014130	chr6:135055033~135060550:+
ACC	cis	rs17711722	0.523	rs313812	ENSG00000226824.5	RP4-756H11.3	5.45	1.41e-06	0.00922	0.78	0.6	Calcium levels;	chr7:66040056	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.523	rs365896	ENSG00000226824.5	RP4-756H11.3	5.45	1.41e-06	0.00922	0.78	0.6	Calcium levels;	chr7:66045710	chr7:66654538~66669855:+
ACC	cis	rs1387259	0.859	rs2054905	ENSG00000258273.1	RP11-370I10.4	-5.45	1.41e-06	0.00925	-0.82	-0.6	Obstructive sleep apnea trait (apnea hypopnea index);	chr12:48294168	chr12:48333755~48333901:-
ACC	cis	rs2732480	0.5	rs2732461	ENSG00000258273.1	RP11-370I10.4	-5.45	1.41e-06	0.00925	-0.82	-0.6	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48299019	chr12:48333755~48333901:-
ACC	cis	rs9326248	0.53	rs7121347	ENSG00000254851.1	RP11-109L13.1	-5.45	1.42e-06	0.00928	-0.93	-0.6	Blood protein levels;	chr11:116996493	chr11:117135528~117138582:+
ACC	cis	rs9326248	0.53	rs7114963	ENSG00000254851.1	RP11-109L13.1	-5.45	1.42e-06	0.00928	-0.93	-0.6	Blood protein levels;	chr11:117005267	chr11:117135528~117138582:+
ACC	cis	rs7115242	0.72	rs10790169	ENSG00000254851.1	RP11-109L13.1	-5.45	1.42e-06	0.00928	-0.93	-0.6	Age-related disease endophenotypes;Age-related diseases, mortality and associated endophenotypes;	chr11:117006443	chr11:117135528~117138582:+
ACC	cis	rs7551345	0.653	rs2050815	ENSG00000269967.1	RP11-84A19.4	5.44	1.46e-06	0.00953	0.74	0.6	Schizophrenia;	chr1:31217692	chr1:31851913~31921841:-
ACC	cis	rs36715	0.953	rs36700	ENSG00000245937.6	LINC01184	5.44	1.46e-06	0.00958	0.82	0.6	Breast cancer;	chr5:128215581	chr5:127940426~128083172:-
ACC	cis	rs36715	0.909	rs152906	ENSG00000245937.6	LINC01184	5.44	1.46e-06	0.00958	0.82	0.6	Breast cancer;	chr5:128216148	chr5:127940426~128083172:-
ACC	cis	rs875971	1	rs10244498	ENSG00000226824.5	RP4-756H11.3	-5.43	1.49e-06	0.00967	-0.71	-0.6	Aortic root size;	chr7:66651069	chr7:66654538~66669855:+
ACC	cis	rs597539	0.654	rs619727	ENSG00000250508.1	RP11-757G1.6	-5.43	1.49e-06	0.00967	-1.08	-0.6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68860067	chr11:68870664~68874542:+
ACC	cis	rs11155671	0.53	rs4458704	ENSG00000268592.3	RAET1E-AS1	5.43	1.49e-06	0.00967	0.68	0.6	Testicular germ cell tumor;	chr6:149911743	chr6:149863494~149919507:+
ACC	cis	rs12550612	0.614	rs4268128	ENSG00000253616.4	RP11-875O11.3	5.43	1.49e-06	0.00968	0.78	0.6	Myeloid white cell count;Granulocyte count;Neutrophil count;Sum basophil neutrophil counts;White blood cell count;Sum neutrophil eosinophil counts;	chr8:23080343	chr8:23071377~23074488:-
ACC	cis	rs2732480	0.538	rs2732462	ENSG00000258273.1	RP11-370I10.4	-5.43	1.51e-06	0.00978	-0.79	-0.6	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48302601	chr12:48333755~48333901:-
ACC	cis	rs916888	0.773	rs9896243	ENSG00000214401.4	KANSL1-AS1	5.42	1.53e-06	0.00994	0.77	0.6	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46748690	chr17:46193576~46196723:+
ACC	cis	rs2486288	0.656	rs7167146	ENSG00000259520.4	CTD-2651B20.3	-5.42	1.54e-06	0.00999	-0.78	-0.6	Glomerular filtration rate;	chr15:45279188	chr15:45251580~45279251:-
ACC	cis	rs9487094	0.666	rs13219952	ENSG00000260273.1	RP11-425D10.10	5.42	1.57e-06	0.0102	0.7	0.6	Height;	chr6:109391084	chr6:109382795~109383666:+
ACC	cis	rs5850	0.602	rs1005786	ENSG00000230658.1	KLHL7-AS1	5.42	1.57e-06	0.0102	0.76	0.6	Blood protein levels;	chr7:23106218	chr7:23101228~23105703:-
ACC	cis	rs9487094	0.666	rs2211288	ENSG00000260273.1	RP11-425D10.10	5.42	1.57e-06	0.0102	0.71	0.6	Height;	chr6:109383848	chr6:109382795~109383666:+
ACC	cis	rs11155671	0.53	rs9397420	ENSG00000268592.3	RAET1E-AS1	-5.42	1.58e-06	0.0102	-0.68	-0.6	Testicular germ cell tumor;	chr6:149885645	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.576	rs7452592	ENSG00000231760.4	RP11-350J20.5	5.42	1.59e-06	0.0103	0.94	0.6	Lung cancer;	chr6:149875445	chr6:149796151~149826294:-
ACC	cis	rs9399135	0.967	rs13199205	ENSG00000232876.1	CTA-212D2.2	-5.41	1.59e-06	0.0103	-0.63	-0.6	Red blood cell count;	chr6:134965367	chr6:135055033~135060550:+
ACC	cis	rs858239	0.72	rs10227559	ENSG00000230658.1	KLHL7-AS1	5.41	1.59e-06	0.0103	0.73	0.6	Cerebrospinal fluid biomarker levels;	chr7:23232525	chr7:23101228~23105703:-
ACC	cis	rs858239	0.806	rs10268610	ENSG00000230658.1	KLHL7-AS1	5.41	1.59e-06	0.0103	0.73	0.6	Cerebrospinal fluid biomarker levels;	chr7:23235145	chr7:23101228~23105703:-
ACC	cis	rs950027	0.549	rs11070452	ENSG00000259520.4	CTD-2651B20.3	5.41	1.63e-06	0.0105	0.72	0.6	Response to fenofibrate (adiponectin levels);	chr15:45302638	chr15:45251580~45279251:-
ACC	cis	rs2732480	0.577	rs2732457	ENSG00000258273.1	RP11-370I10.4	5.41	1.64e-06	0.0106	0.81	0.6	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48364596	chr12:48333755~48333901:-
ACC	cis	rs2486288	0.656	rs8039352	ENSG00000259520.4	CTD-2651B20.3	5.4	1.7e-06	0.0109	0.71	0.6	Glomerular filtration rate;	chr15:45259592	chr15:45251580~45279251:-
ACC	cis	rs597539	0.652	rs584108	ENSG00000250508.1	RP11-757G1.6	5.4	1.7e-06	0.011	0.9	0.6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68862814	chr11:68870664~68874542:+
ACC	cis	rs983545	0.8	rs6783752	ENSG00000272498.1	RP11-415F23.3	5.39	1.72e-06	0.011	0.68	0.6	Blood protein levels;	chr3:16924895	chr3:16339308~16339871:+
ACC	cis	rs983545	0.8	rs7629676	ENSG00000272498.1	RP11-415F23.3	5.39	1.72e-06	0.011	0.68	0.6	Blood protein levels;	chr3:16925506	chr3:16339308~16339871:+
ACC	cis	rs2486288	0.656	rs11637364	ENSG00000259520.4	CTD-2651B20.3	5.39	1.74e-06	0.011	0.76	0.6	Glomerular filtration rate;	chr15:45287040	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs8039153	ENSG00000259520.4	CTD-2651B20.3	5.39	1.74e-06	0.011	0.76	0.6	Glomerular filtration rate;	chr15:45287615	chr15:45251580~45279251:-
ACC	cis	rs7208859	0.623	rs56163556	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30774850	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73269923	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30775553	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs7220289	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30776744	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs55811708	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30777713	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs8075163	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30779292	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.706	rs8075107	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Body mass index;	chr17:30779631	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs7223209	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780202	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs7223404	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780345	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9916725	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780453	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9916727	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780454	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73269945	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30781741	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9897728	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30781786	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs1054400	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30782936	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs1054397	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30783178	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9890558	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30783337	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9912283	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30783355	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs3752020	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784107	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9890855	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784689	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9893422	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784697	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9891166	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784884	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73269974	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30785366	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs34756112	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30785998	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs60724269	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30786255	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs76633166	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30786347	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs1061346	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30787211	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs1061343	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30787258	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73269988	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30791127	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9899525	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30793278	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.524	rs11653098	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30795483	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9911784	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30797562	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9911997	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30797630	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9890862	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30798432	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs78071511	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30801136	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs2035494	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30803375	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs3794796	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30803862	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9915566	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30805140	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs8064686	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30807821	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs11654035	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30809408	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11657369	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30809450	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs8075341	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30809547	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73271842	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30810137	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs8077116	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30813144	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.524	rs28760584	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30813999	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs7212991	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30816731	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs7208441	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30816845	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs28627615	ENSG00000263531.1	RP13-753N3.1	5.39	1.75e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30818799	chr17:30863921~30864940:-
ACC	cis	rs1799949	1	rs2271574	ENSG00000198496.9	NBR2	-5.39	1.75e-06	0.011	-0.78	-0.6	Menopause (age at onset);	chr17:43175631	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs33994002	ENSG00000198496.9	NBR2	-5.39	1.75e-06	0.011	-0.78	-0.6	Menopause (age at onset);	chr17:43176801	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs33920795	ENSG00000198496.9	NBR2	-5.39	1.75e-06	0.011	-0.78	-0.6	Menopause (age at onset);	chr17:43176993	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs33918839	ENSG00000198496.9	NBR2	-5.39	1.75e-06	0.011	-0.78	-0.6	Menopause (age at onset);	chr17:43177155	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11653231	ENSG00000198496.9	NBR2	-5.39	1.75e-06	0.011	-0.78	-0.6	Menopause (age at onset);	chr17:43179443	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs1399323	ENSG00000198496.9	NBR2	-5.39	1.75e-06	0.011	-0.78	-0.6	Menopause (age at onset);	chr17:43180313	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs35954893	ENSG00000198496.9	NBR2	-5.39	1.75e-06	0.011	-0.78	-0.6	Menopause (age at onset);	chr17:43181769	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.93	rs4445938	ENSG00000198496.9	NBR2	-5.39	1.75e-06	0.011	-0.78	-0.6	Menopause (age at onset);	chr17:43185883	chr17:43125610~43153671:+
ACC	cis	rs2739330	0.828	rs4822454	ENSG00000225282.1	AP000350.6	5.39	1.75e-06	0.011	0.6	0.6	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913021	chr22:23926900~23929574:+
ACC	cis	rs9322193	0.607	rs10457852	ENSG00000231760.4	RP11-350J20.5	5.39	1.76e-06	0.011	0.82	0.6	Lung cancer;	chr6:149880584	chr6:149796151~149826294:-
ACC	cis	rs1799949	1	rs35668327	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43121078	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.93	rs3765640	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43124230	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs8176077	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43124331	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11655505	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43126360	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs4793204	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43127281	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs12947782	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43127865	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs33945274	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43128056	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs33925201	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43128665	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11653069	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43131360	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs2175957	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43134805	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs33988650	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43135863	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11656097	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43138596	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs2292595	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43138657	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11658754	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43140722	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.93	rs33968979	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43145975	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs12952790	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43147590	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs12950607	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43147911	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11079056	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43148782	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs12936816	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43149692	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs33926631	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43152446	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs1960605	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43153380	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs2037076	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43153866	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs12950779	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43154506	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.929	rs12937015	ENSG00000198496.9	NBR2	-5.38	1.77e-06	0.011	-0.79	-0.6	Menopause (age at onset);	chr17:43155456	chr17:43125610~43153671:+
ACC	cis	rs11155671	0.53	rs2342769	ENSG00000268592.3	RAET1E-AS1	5.38	1.77e-06	0.011	0.69	0.6	Testicular germ cell tumor;	chr6:149895371	chr6:149863494~149919507:+
ACC	cis	rs7208859	0.623	rs170051	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30587135	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs1347360	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30587514	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.51	rs216402	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30590108	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs216434	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30595317	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs216436	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30595882	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11651857	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30599344	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs216439	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30600866	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs216442	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30604179	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs216445	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30606558	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs216446	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30606700	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs609063	ENSG00000263531.1	RP13-753N3.1	5.38	1.78e-06	0.011	1.17	0.6	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30624495	chr17:30863921~30864940:-
ACC	cis	rs17711722	0.565	rs73372653	ENSG00000226824.5	RP4-756H11.3	-5.38	1.79e-06	0.011	-0.77	-0.6	Calcium levels;	chr7:65977808	chr7:66654538~66669855:+
ACC	cis	rs950027	0.62	rs872192	ENSG00000259520.4	CTD-2651B20.3	-5.38	1.81e-06	0.0111	-0.67	-0.6	Response to fenofibrate (adiponectin levels);	chr15:45322304	chr15:45251580~45279251:-
ACC	cis	rs950027	0.62	rs1617634	ENSG00000259520.4	CTD-2651B20.3	-5.38	1.81e-06	0.0111	-0.67	-0.6	Response to fenofibrate (adiponectin levels);	chr15:45323380	chr15:45251580~45279251:-
ACC	cis	rs1577917	0.561	rs3087978	ENSG00000203875.9	SNHG5	5.38	1.82e-06	0.0112	0.65	0.6	Response to antipsychotic treatment;	chr6:85678505	chr6:85660950~85678736:-
ACC	cis	rs1799949	1	rs4793215	ENSG00000198496.9	NBR2	-5.38	1.82e-06	0.0112	-0.78	-0.6	Menopause (age at onset);	chr17:43166915	chr17:43125610~43153671:+
ACC	cis	rs11155671	0.53	rs2342770	ENSG00000268592.3	RAET1E-AS1	5.37	1.85e-06	0.0114	0.7	0.6	Testicular germ cell tumor;	chr6:149895549	chr6:149863494~149919507:+
ACC	cis	rs5763662	1	rs2106430	ENSG00000253352.7	TUG1	-5.37	1.85e-06	0.0114	-1.51	-0.6	LDL cholesterol levels;LDL cholesterol;	chr22:30201146	chr22:30970677~30979395:+
ACC	cis	rs858239	0.932	rs858275	ENSG00000230658.1	KLHL7-AS1	5.37	1.86e-06	0.0114	0.69	0.6	Cerebrospinal fluid biomarker levels;	chr7:23254525	chr7:23101228~23105703:-
ACC	cis	rs597539	0.615	rs629426	ENSG00000250508.1	RP11-757G1.6	-5.37	1.86e-06	0.0114	-0.95	-0.6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68903636	chr11:68870664~68874542:+
ACC	cis	rs1002796	0.713	rs7420658	ENSG00000234936.1	AC010883.5	-5.37	1.87e-06	0.0115	-1.05	-0.6	Immunoglobulin A vasculitis;	chr2:43092906	chr2:43229573~43233394:+
ACC	cis	rs858239	0.932	rs1637190	ENSG00000230658.1	KLHL7-AS1	5.36	1.9e-06	0.0116	0.7	0.6	Cerebrospinal fluid biomarker levels;	chr7:23229446	chr7:23101228~23105703:-
ACC	cis	rs1799949	0.965	rs9646413	ENSG00000198496.9	NBR2	-5.36	1.92e-06	0.0118	-0.77	-0.6	Menopause (age at onset);	chr17:43348789	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs9897425	ENSG00000198496.9	NBR2	-5.36	1.92e-06	0.0118	-0.77	-0.6	Menopause (age at onset);	chr17:43352811	chr17:43125610~43153671:+
ACC	cis	rs1577917	0.559	rs1173418	ENSG00000203875.9	SNHG5	5.36	1.92e-06	0.0118	0.62	0.6	Response to antipsychotic treatment;	chr6:85693198	chr6:85660950~85678736:-
ACC	cis	rs1799949	1	rs1973646	ENSG00000198496.9	NBR2	-5.36	1.93e-06	0.0118	-0.78	-0.6	Menopause (age at onset);	chr17:43158478	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs8176202	ENSG00000198496.9	NBR2	-5.35	1.97e-06	0.012	-0.8	-0.6	Menopause (age at onset);	chr17:43078211	chr17:43125610~43153671:+
ACC	cis	rs6920372	0.799	rs9480947	ENSG00000260273.1	RP11-425D10.10	5.34	2.06e-06	0.0126	0.71	0.6	Height;	chr6:109397362	chr6:109382795~109383666:+
ACC	cis	rs1799949	0.894	rs71367985	ENSG00000198496.9	NBR2	-5.34	2.07e-06	0.0126	-0.76	-0.6	Menopause (age at onset);	chr17:43222443	chr17:43125610~43153671:+
ACC	cis	rs1577917	0.56	rs9450288	ENSG00000203875.9	SNHG5	5.34	2.08e-06	0.0127	0.66	0.6	Response to antipsychotic treatment;	chr6:85511868	chr6:85660950~85678736:-
ACC	cis	rs7208859	0.623	rs79607958	ENSG00000263531.1	RP13-753N3.1	5.34	2.09e-06	0.0127	1.17	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30607530	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs75136574	ENSG00000263531.1	RP13-753N3.1	5.34	2.09e-06	0.0127	1.17	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30607531	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs77544470	ENSG00000263531.1	RP13-753N3.1	5.34	2.09e-06	0.0127	1.17	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30607532	chr17:30863921~30864940:-
ACC	cis	rs2732480	0.538	rs2468943	ENSG00000258273.1	RP11-370I10.4	5.33	2.15e-06	0.013	0.68	0.59	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48353466	chr12:48333755~48333901:-
ACC	cis	rs11155671	0.53	rs9322228	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149888173	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs7774787	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149888296	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs2342767	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149888581	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs7764376	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149889208	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs6933882	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149889666	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs6939761	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149889858	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs3823021	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149889863	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs4869763	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149890548	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs4869764	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149890692	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs7756850	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149891460	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs9371542	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149891949	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs9371223	ENSG00000231760.4	RP11-350J20.5	5.33	2.16e-06	0.0131	0.68	0.59	Testicular germ cell tumor;	chr6:149893670	chr6:149796151~149826294:-
ACC	cis	rs858239	0.899	rs10262243	ENSG00000230658.1	KLHL7-AS1	5.33	2.17e-06	0.0131	0.72	0.59	Cerebrospinal fluid biomarker levels;	chr7:23251368	chr7:23101228~23105703:-
ACC	cis	rs9399137	0.507	rs10484496	ENSG00000232876.1	CTA-212D2.2	-5.33	2.18e-06	0.0131	-0.67	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134978544	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs13214669	ENSG00000232876.1	CTA-212D2.2	-5.33	2.18e-06	0.0131	-0.67	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134978821	chr6:135055033~135060550:+
ACC	cis	rs597539	0.652	rs513359	ENSG00000250508.1	RP11-757G1.6	5.33	2.18e-06	0.0132	0.93	0.59	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68902028	chr11:68870664~68874542:+
ACC	cis	rs858239	0.796	rs433395	ENSG00000230658.1	KLHL7-AS1	5.33	2.18e-06	0.0132	0.75	0.59	Cerebrospinal fluid biomarker levels;	chr7:23362336	chr7:23101228~23105703:-
ACC	cis	rs9326248	0.53	rs7950364	ENSG00000254851.1	RP11-109L13.1	-5.33	2.18e-06	0.0132	-0.94	-0.59	Blood protein levels;	chr11:117028170	chr11:117135528~117138582:+
ACC	cis	rs858239	0.899	rs1881203	ENSG00000230658.1	KLHL7-AS1	5.32	2.22e-06	0.0133	0.72	0.59	Cerebrospinal fluid biomarker levels;	chr7:23253189	chr7:23101228~23105703:-
ACC	cis	rs7208859	0.623	rs56378576	ENSG00000263531.1	RP13-753N3.1	5.32	2.23e-06	0.0134	1.05	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30683102	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs35916850	ENSG00000263531.1	RP13-753N3.1	5.32	2.23e-06	0.0134	1.05	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30684155	chr17:30863921~30864940:-
ACC	cis	rs4835473	0.932	rs7683686	ENSG00000251600.4	RP11-673E1.1	-5.32	2.26e-06	0.0135	-0.74	-0.59	Immature fraction of reticulocytes;	chr4:143784352	chr4:143912331~143982454:+
ACC	cis	rs1577917	0.655	rs6454472	ENSG00000203875.9	SNHG5	5.31	2.27e-06	0.0136	0.64	0.59	Response to antipsychotic treatment;	chr6:85514335	chr6:85660950~85678736:-
ACC	cis	rs1799949	1	rs12944430	ENSG00000198496.9	NBR2	-5.31	2.28e-06	0.0136	-0.77	-0.59	Menopause (age at onset);	chr17:43178803	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.794	rs116409325	ENSG00000198496.9	NBR2	-5.31	2.28e-06	0.0136	-0.77	-0.59	Menopause (age at onset);	chr17:43368092	chr17:43125610~43153671:+
ACC	cis	rs6920372	0.731	rs9386799	ENSG00000260273.1	RP11-425D10.10	5.31	2.28e-06	0.0136	0.66	0.59	Height;	chr6:109333398	chr6:109382795~109383666:+
ACC	cis	rs1577917	0.655	rs9450311	ENSG00000203875.9	SNHG5	5.31	2.29e-06	0.0137	0.64	0.59	Response to antipsychotic treatment;	chr6:85666868	chr6:85660950~85678736:-
ACC	cis	rs9399135	0.967	rs4388304	ENSG00000232876.1	CTA-212D2.2	-5.31	2.3e-06	0.0137	-0.6	-0.59	Red blood cell count;	chr6:134988459	chr6:135055033~135060550:+
ACC	cis	rs1577917	0.655	rs2842600	ENSG00000203875.9	SNHG5	-5.31	2.31e-06	0.0138	-0.64	-0.59	Response to antipsychotic treatment;	chr6:85615914	chr6:85660950~85678736:-
ACC	cis	rs2739330	0.685	rs4822453	ENSG00000225282.1	AP000350.6	5.31	2.34e-06	0.0139	0.58	0.59	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23912675	chr22:23926900~23929574:+
ACC	cis	rs11155671	0.53	rs6935829	ENSG00000231760.4	RP11-350J20.5	5.3	2.37e-06	0.0141	0.67	0.59	Testicular germ cell tumor;	chr6:149896675	chr6:149796151~149826294:-
ACC	cis	rs11155671	0.53	rs6935829	ENSG00000268592.3	RAET1E-AS1	5.3	2.37e-06	0.0141	0.68	0.59	Testicular germ cell tumor;	chr6:149896675	chr6:149863494~149919507:+
ACC	cis	rs296381	0.598	rs76234461	ENSG00000259108.2	CTD-3098H1.2	5.3	2.37e-06	0.0141	1.25	0.59	Blood metabolite levels;	chr19:47850161	chr19:47863483~47865341:-
ACC	cis	rs296381	0.598	rs10426277	ENSG00000259108.2	CTD-3098H1.2	5.3	2.37e-06	0.0141	1.25	0.59	Blood metabolite levels;	chr19:47850904	chr19:47863483~47865341:-
ACC	cis	rs296381	0.598	rs10408997	ENSG00000259108.2	CTD-3098H1.2	5.3	2.37e-06	0.0141	1.25	0.59	Blood metabolite levels;	chr19:47852502	chr19:47863483~47865341:-
ACC	cis	rs853679	0.657	rs1778483	ENSG00000216901.1	AL022393.7	5.3	2.41e-06	0.0143	0.67	0.59	Depression;	chr6:28273214	chr6:28176188~28176674:+
ACC	cis	rs853679	0.657	rs1778482	ENSG00000216901.1	AL022393.7	5.3	2.41e-06	0.0143	0.67	0.59	Depression;	chr6:28273215	chr6:28176188~28176674:+
ACC	cis	rs36715	1	rs36715	ENSG00000245937.6	LINC01184	5.3	2.41e-06	0.0143	0.8	0.59	Breast cancer;	chr5:128227188	chr5:127940426~128083172:-
ACC	cis	rs1799949	0.965	rs11650132	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43174070	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11654731	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43174923	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs11651623	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43177830	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs11657883	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43178007	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs11656945	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43178248	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11653460	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43179289	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs11650913	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43179580	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs12936831	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43179799	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.93	rs35292991	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43181999	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs11658499	ENSG00000198496.9	NBR2	-5.29	2.45e-06	0.0144	-0.77	-0.59	Menopause (age at onset);	chr17:43182732	chr17:43125610~43153671:+
ACC	cis	rs296381	0.641	rs17272617	ENSG00000259108.2	CTD-3098H1.2	-5.29	2.45e-06	0.0144	-1.13	-0.59	Blood metabolite levels;	chr19:47854103	chr19:47863483~47865341:-
ACC	cis	rs950027	0.572	rs12910764	ENSG00000259520.4	CTD-2651B20.3	5.29	2.45e-06	0.0145	0.66	0.59	Response to fenofibrate (adiponectin levels);	chr15:45317162	chr15:45251580~45279251:-
ACC	cis	rs1577917	0.655	rs12203963	ENSG00000203875.9	SNHG5	5.29	2.46e-06	0.0145	0.64	0.59	Response to antipsychotic treatment;	chr6:85513598	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.681	rs4707211	ENSG00000203875.9	SNHG5	5.29	2.46e-06	0.0145	0.64	0.59	Response to antipsychotic treatment;	chr6:85522992	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.629	rs6927475	ENSG00000203875.9	SNHG5	5.29	2.49e-06	0.0146	0.64	0.59	Response to antipsychotic treatment;	chr6:85497055	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.629	rs9450285	ENSG00000203875.9	SNHG5	5.29	2.49e-06	0.0146	0.64	0.59	Response to antipsychotic treatment;	chr6:85498378	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.56	rs12193777	ENSG00000203875.9	SNHG5	5.29	2.49e-06	0.0146	0.64	0.59	Response to antipsychotic treatment;	chr6:85536991	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.655	rs9444351	ENSG00000203875.9	SNHG5	5.29	2.49e-06	0.0146	0.64	0.59	Response to antipsychotic treatment;	chr6:85538081	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.655	rs7766485	ENSG00000203875.9	SNHG5	5.29	2.49e-06	0.0146	0.64	0.59	Response to antipsychotic treatment;	chr6:85553837	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.61	rs11752795	ENSG00000203875.9	SNHG5	5.29	2.49e-06	0.0146	0.64	0.59	Response to antipsychotic treatment;	chr6:85577411	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.655	rs9444354	ENSG00000203875.9	SNHG5	5.29	2.49e-06	0.0146	0.64	0.59	Response to antipsychotic treatment;	chr6:85582217	chr6:85660950~85678736:-
ACC	cis	rs1577917	0.566	rs2842611	ENSG00000203875.9	SNHG5	-5.29	2.49e-06	0.0146	-0.64	-0.59	Response to antipsychotic treatment;	chr6:85592316	chr6:85660950~85678736:-
ACC	cis	rs2882667	0.964	rs11739351	ENSG00000253404.1	AC034243.1	5.29	2.5e-06	0.0146	0.87	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:138976053	chr5:138744434~138753309:-
ACC	cis	rs1799949	0.965	rs8176087	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43118649	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs8176083	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43123134	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs33961729	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43135907	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11657835	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43139936	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs1135214	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43140306	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11652332	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43143472	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs4793212	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43150733	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs34534709	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43150923	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs34059614	ENSG00000198496.9	NBR2	-5.29	2.51e-06	0.0146	-0.77	-0.59	Menopause (age at onset);	chr17:43151054	chr17:43125610~43153671:+
ACC	cis	rs9487094	0.689	rs7754650	ENSG00000260273.1	RP11-425D10.10	5.28	2.54e-06	0.0148	0.76	0.59	Height;	chr6:109405536	chr6:109382795~109383666:+
ACC	cis	rs929843	1	rs929843	ENSG00000226232.7	RP11-419C5.2	-5.28	2.57e-06	0.0149	-0.92	-0.59	Menarche (age at onset);	chr16:70011845	chr16:69976388~69996188:-
ACC	cis	rs858239	1	rs156425	ENSG00000230658.1	KLHL7-AS1	-5.28	2.6e-06	0.0151	-0.77	-0.59	Cerebrospinal fluid biomarker levels;	chr7:23269500	chr7:23101228~23105703:-
ACC	cis	rs858239	1	rs156421	ENSG00000230658.1	KLHL7-AS1	5.28	2.6e-06	0.0151	0.77	0.59	Cerebrospinal fluid biomarker levels;	chr7:23272868	chr7:23101228~23105703:-
ACC	cis	rs858239	0.932	rs1728313	ENSG00000230658.1	KLHL7-AS1	5.28	2.6e-06	0.0151	0.69	0.59	Cerebrospinal fluid biomarker levels;	chr7:23231412	chr7:23101228~23105703:-
ACC	cis	rs7188445	0.592	rs7199794	ENSG00000261390.4	RP11-345M22.2	5.27	2.69e-06	0.0156	0.69	0.59	Urate levels;	chr16:79708296	chr16:79715232~79770563:-
ACC	cis	rs9399135	0.967	rs9321481	ENSG00000232876.1	CTA-212D2.2	5.26	2.72e-06	0.0157	0.61	0.59	Red blood cell count;	chr6:135031510	chr6:135055033~135060550:+
ACC	cis	rs2486288	0.656	rs8041702	ENSG00000259520.4	CTD-2651B20.3	5.26	2.72e-06	0.0157	0.73	0.59	Glomerular filtration rate;	chr15:45254895	chr15:45251580~45279251:-
ACC	cis	rs858239	0.896	rs1637193	ENSG00000230658.1	KLHL7-AS1	5.26	2.74e-06	0.0158	0.68	0.59	Cerebrospinal fluid biomarker levels;	chr7:23220632	chr7:23101228~23105703:-
ACC	cis	rs9487094	0.67	rs2024850	ENSG00000260273.1	RP11-425D10.10	-5.26	2.75e-06	0.0159	-0.75	-0.59	Height;	chr6:109497253	chr6:109382795~109383666:+
ACC	cis	rs2739330	0.791	rs4822458	ENSG00000231271.1	AP000350.8	5.26	2.76e-06	0.0159	0.62	0.59	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23923472	chr22:23949918~23954042:+
ACC	cis	rs9487094	0.67	rs11754340	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109584789	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs13199135	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109588639	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12193719	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109589051	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.644	rs1960325	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109592105	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12528781	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109608105	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.626	rs1980591	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109618620	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.696	rs12191353	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109620772	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.626	rs12192776	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109634150	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12194157	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109640141	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12197950	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109642186	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs7767525	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109646187	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.504	rs71541003	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109652694	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs3899233	ENSG00000260273.1	RP11-425D10.10	5.26	2.76e-06	0.0159	0.7	0.59	Height;	chr6:109655791	chr6:109382795~109383666:+
ACC	cis	rs7208859	0.623	rs8067035	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30775170	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs8067338	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30775327	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs4055105	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30775532	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.636	rs12946563	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Body mass index;	chr17:30776148	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs8081299	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30777278	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs8068645	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30777324	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.706	rs2322197	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Body mass index;	chr17:30778787	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.562	rs8078897	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30779239	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9914499	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30780570	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs12006	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30783634	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs3752021	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30784025	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs1061342	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30787445	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs55938328	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30789992	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs55961983	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30792268	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs7222803	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30792879	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.568	rs7213925	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Body mass index;	chr17:30794616	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11658945	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30795491	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11657990	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30797182	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11650982	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30802937	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9915546	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30805126	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs8070182	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30808576	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9895815	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30811015	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs7214313	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30811578	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.706	rs73271850	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Body mass index;	chr17:30815122	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs7208088	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30816649	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs7220999	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30822280	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs55638872	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30822534	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs8078182	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30822646	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9899268	ENSG00000263531.1	RP13-753N3.1	5.26	2.8e-06	0.0159	1.15	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30823237	chr17:30863921~30864940:-
ACC	cis	rs2882667	0.964	rs12055237	ENSG00000253404.1	AC034243.1	5.25	2.81e-06	0.0159	0.82	0.59	Age-related hearing impairment (SNP x SNP interaction);	chr5:138971617	chr5:138744434~138753309:-
ACC	cis	rs17826219	0.706	rs28469200	ENSG00000263531.1	RP13-753N3.1	5.25	2.82e-06	0.0159	1.13	0.59	Body mass index;	chr17:30806554	chr17:30863921~30864940:-
ACC	cis	rs7617773	0.925	rs6442105	ENSG00000229759.1	MRPS18AP1	-5.25	2.82e-06	0.0159	-0.62	-0.59	Coronary artery disease;	chr3:48140836	chr3:48256350~48256938:-
ACC	cis	rs7617773	1	rs9832957	ENSG00000229759.1	MRPS18AP1	-5.25	2.82e-06	0.0159	-0.62	-0.59	Coronary artery disease;	chr3:48143776	chr3:48256350~48256938:-
ACC	cis	rs7188445	0.787	rs7189954	ENSG00000261390.4	RP11-345M22.2	5.25	2.83e-06	0.016	0.75	0.59	Urate levels;	chr16:79701150	chr16:79715232~79770563:-
ACC	cis	rs9399137	0.507	rs4520025	ENSG00000232876.1	CTA-212D2.2	-5.25	2.84e-06	0.016	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134957481	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs4451150	ENSG00000232876.1	CTA-212D2.2	-5.25	2.84e-06	0.016	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134957925	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.561	rs11753985	ENSG00000232876.1	CTA-212D2.2	-5.25	2.84e-06	0.016	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134959300	chr6:135055033~135060550:+
ACC	cis	rs1150668	0.796	rs1124132	ENSG00000216901.1	AL022393.7	5.25	2.88e-06	0.0162	0.68	0.59	Pubertal anthropometrics;	chr6:28412544	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.796	rs2531832	ENSG00000216901.1	AL022393.7	5.25	2.88e-06	0.0162	0.68	0.59	Pubertal anthropometrics;	chr6:28421445	chr6:28176188~28176674:+
ACC	cis	rs597539	0.615	rs583182	ENSG00000250508.1	RP11-757G1.6	-5.25	2.89e-06	0.0163	-0.84	-0.59	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68911166	chr11:68870664~68874542:+
ACC	cis	rs1799949	0.859	rs11657004	ENSG00000198496.9	NBR2	-5.25	2.89e-06	0.0163	-0.74	-0.59	Menopause (age at onset);	chr17:43365383	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.931	rs34474989	ENSG00000198496.9	NBR2	-5.25	2.89e-06	0.0163	-0.74	-0.59	Menopause (age at onset);	chr17:43368042	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.931	rs9912203	ENSG00000198496.9	NBR2	5.25	2.89e-06	0.0163	0.74	0.59	Menopause (age at onset);	chr17:43367777	chr17:43125610~43153671:+
ACC	cis	rs17572109	0.666	rs11696005	ENSG00000261338.2	RP11-378A13.1	-5.25	2.9e-06	0.0163	-0.87	-0.59	Platelet count;Platelet distribution width;Mean platelet volume;	chr2:218364918	chr2:218255319~218257366:+
ACC	cis	rs858239	0.899	rs28635122	ENSG00000230658.1	KLHL7-AS1	5.24	2.92e-06	0.0164	0.79	0.59	Cerebrospinal fluid biomarker levels;	chr7:23270562	chr7:23101228~23105703:-
ACC	cis	rs858239	0.899	rs7794684	ENSG00000230658.1	KLHL7-AS1	5.24	2.92e-06	0.0164	0.79	0.59	Cerebrospinal fluid biomarker levels;	chr7:23271186	chr7:23101228~23105703:-
ACC	cis	rs1799949	1	rs8074136	ENSG00000198496.9	NBR2	-5.24	2.94e-06	0.0164	-0.77	-0.59	Menopause (age at onset);	chr17:43190296	chr17:43125610~43153671:+
ACC	cis	rs12716641	0.632	rs13256091	ENSG00000254543.1	HSPD1P2	-5.23	3.09e-06	0.0172	-0.69	-0.59	IgA nephropathy;	chr8:7039166	chr8:7891003~7892555:-
ACC	cis	rs3750552	1	rs3750552	ENSG00000224958.4	PGM5-AS1	5.23	3.12e-06	0.0173	0.74	0.59	Bipolar disorder;	chr9:69328086	chr9:68355189~68357852:-
ACC	cis	rs1799949	1	rs4793229	ENSG00000198496.9	NBR2	5.23	3.12e-06	0.0173	0.76	0.59	Menopause (age at onset);	chr17:43340966	chr17:43125610~43153671:+
ACC	cis	rs17711722	0.522	rs6957759	ENSG00000226824.5	RP4-756H11.3	-5.22	3.13e-06	0.0174	-0.77	-0.59	Calcium levels;	chr7:65806798	chr7:66654538~66669855:+
ACC	cis	rs9399137	0.507	rs13196486	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134962736	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs6918512	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134963701	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs4594969	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134964448	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs13064	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134966395	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs12664898	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134967525	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs56164974	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134967578	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs12663810	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134968644	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs35571217	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134969217	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs11757723	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134970155	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs4580893	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134976524	chr6:135055033~135060550:+
ACC	cis	rs9389248	0.737	rs56358308	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	High light scatter reticulocyte percentage of red cells;	chr6:134985842	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs11754021	ENSG00000232876.1	CTA-212D2.2	-5.22	3.14e-06	0.0174	-0.68	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134987237	chr6:135055033~135060550:+
ACC	cis	rs9326248	0.53	rs7940310	ENSG00000254851.1	RP11-109L13.1	-5.22	3.18e-06	0.0176	-0.93	-0.59	Blood protein levels;	chr11:117153765	chr11:117135528~117138582:+
ACC	cis	rs9326248	0.53	rs7112513	ENSG00000254851.1	RP11-109L13.1	-5.22	3.18e-06	0.0176	-0.93	-0.59	Blood protein levels;	chr11:117166645	chr11:117135528~117138582:+
ACC	cis	rs9399137	0.507	rs13209780	ENSG00000232876.1	CTA-212D2.2	-5.22	3.19e-06	0.0176	-0.67	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:135023657	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs4896129	ENSG00000232876.1	CTA-212D2.2	-5.22	3.19e-06	0.0176	-0.67	-0.59	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:135028707	chr6:135055033~135060550:+
ACC	cis	rs296381	0.561	rs62128816	ENSG00000259108.2	CTD-3098H1.2	5.22	3.21e-06	0.0177	1.23	0.59	Blood metabolite levels;	chr19:47846773	chr19:47863483~47865341:-
ACC	cis	rs296381	0.561	rs58784223	ENSG00000259108.2	CTD-3098H1.2	5.22	3.21e-06	0.0177	1.23	0.59	Blood metabolite levels;	chr19:47847236	chr19:47863483~47865341:-
ACC	cis	rs296381	0.561	rs62128818	ENSG00000259108.2	CTD-3098H1.2	5.22	3.21e-06	0.0177	1.23	0.59	Blood metabolite levels;	chr19:47847835	chr19:47863483~47865341:-
ACC	cis	rs983545	0.8	rs1837698	ENSG00000272498.1	RP11-415F23.3	5.22	3.21e-06	0.0177	0.66	0.59	Blood protein levels;	chr3:16917583	chr3:16339308~16339871:+
ACC	cis	rs983545	0.8	rs1441039	ENSG00000272498.1	RP11-415F23.3	5.22	3.21e-06	0.0177	0.66	0.59	Blood protein levels;	chr3:16917827	chr3:16339308~16339871:+
ACC	cis	rs7208859	0.673	rs56846352	ENSG00000263531.1	RP13-753N3.1	5.22	3.21e-06	0.0177	1.14	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30792170	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs7211776	ENSG00000263531.1	RP13-753N3.1	5.22	3.21e-06	0.0177	1.14	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30793178	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9912122	ENSG00000263531.1	RP13-753N3.1	5.22	3.21e-06	0.0177	1.14	0.59	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30813698	chr17:30863921~30864940:-
ACC	cis	rs11155671	0.53	rs2342770	ENSG00000231760.4	RP11-350J20.5	5.21	3.24e-06	0.0178	0.67	0.59	Testicular germ cell tumor;	chr6:149895549	chr6:149796151~149826294:-
ACC	cis	rs8040855	0.579	rs6496797	ENSG00000259295.5	CSPG4P12	-5.21	3.28e-06	0.018	-0.69	-0.59	Bulimia nervosa;	chr15:85183624	chr15:85191438~85213905:+
ACC	cis	rs9389248	0.708	rs7750574	ENSG00000232876.1	CTA-212D2.2	-5.21	3.31e-06	0.0182	-0.67	-0.59	High light scatter reticulocyte percentage of red cells;	chr6:135029794	chr6:135055033~135060550:+
ACC	cis	rs11155671	0.53	rs2342769	ENSG00000231760.4	RP11-350J20.5	5.21	3.35e-06	0.0184	0.67	0.59	Testicular germ cell tumor;	chr6:149895371	chr6:149796151~149826294:-
ACC	cis	rs9487094	0.626	rs4947016	ENSG00000260273.1	RP11-425D10.10	5.2	3.39e-06	0.0186	0.71	0.59	Height;	chr6:109740895	chr6:109382795~109383666:+
ACC	cis	rs597539	0.689	rs596874	ENSG00000250508.1	RP11-757G1.6	5.2	3.43e-06	0.0188	0.82	0.58	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68863406	chr11:68870664~68874542:+
ACC	cis	rs9322193	0.923	rs12174035	ENSG00000268592.3	RAET1E-AS1	5.2	3.43e-06	0.0188	0.68	0.58	Lung cancer;	chr6:149763311	chr6:149863494~149919507:+
ACC	cis	rs7950069	0.57	rs45465296	ENSG00000246100.3	LINC00900	-5.2	3.46e-06	0.0189	-0.98	-0.58	Orofacial clefts;	chr11:115342532	chr11:115754248~115760627:-
ACC	cis	rs9487094	1	rs9480933	ENSG00000260273.1	RP11-425D10.10	5.19	3.5e-06	0.0191	0.73	0.58	Height;	chr6:109350188	chr6:109382795~109383666:+
ACC	cis	rs1799949	0.536	rs4793227	ENSG00000198496.9	NBR2	-5.19	3.51e-06	0.0192	-0.74	-0.58	Menopause (age at onset);	chr17:43334882	chr17:43125610~43153671:+
ACC	cis	rs9487094	0.961	rs1358998	ENSG00000260273.1	RP11-425D10.10	-5.19	3.51e-06	0.0192	-0.74	-0.58	Height;	chr6:109380015	chr6:109382795~109383666:+
ACC	cis	rs9322193	0.923	rs12176034	ENSG00000268592.3	RAET1E-AS1	5.19	3.52e-06	0.0192	0.68	0.58	Lung cancer;	chr6:149800557	chr6:149863494~149919507:+
ACC	cis	rs3812049	0.667	rs6888037	ENSG00000245937.6	LINC01184	5.19	3.52e-06	0.0192	0.76	0.58	Lymphocyte counts;Red cell distribution width;	chr5:128070567	chr5:127940426~128083172:-
ACC	cis	rs2799081	1	rs2799081	ENSG00000216901.1	AL022393.7	5.19	3.54e-06	0.0193	0.72	0.58	Myopia;	chr6:28302807	chr6:28176188~28176674:+
ACC	cis	rs9399135	0.967	rs4376365	ENSG00000232876.1	CTA-212D2.2	-5.19	3.54e-06	0.0193	-0.6	-0.58	Red blood cell count;	chr6:134986602	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs13218642	ENSG00000232876.1	CTA-212D2.2	-5.19	3.54e-06	0.0193	-0.6	-0.58	Red blood cell count;	chr6:134988802	chr6:135055033~135060550:+
ACC	cis	rs17711722	0.522	rs4642526	ENSG00000226824.5	RP4-756H11.3	-5.19	3.58e-06	0.0194	-0.76	-0.58	Calcium levels;	chr7:65751755	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.522	rs62469933	ENSG00000226824.5	RP4-756H11.3	-5.19	3.58e-06	0.0194	-0.76	-0.58	Calcium levels;	chr7:65800652	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.565	rs4717276	ENSG00000226824.5	RP4-756H11.3	-5.19	3.58e-06	0.0194	-0.76	-0.58	Calcium levels;	chr7:65829754	chr7:66654538~66669855:+
ACC	cis	rs17711722	0.565	rs4275112	ENSG00000226824.5	RP4-756H11.3	5.19	3.58e-06	0.0194	0.76	0.58	Calcium levels;	chr7:65733651	chr7:66654538~66669855:+
ACC	cis	rs7208859	0.673	rs11651802	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30832642	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs17826219	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30834827	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs61223749	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30836729	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs3764420	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30837136	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs3764421	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30840635	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11651858	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30843700	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs36056619	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30845266	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9909497	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30846210	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11080135	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30849463	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9894876	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30855002	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73277967	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30857148	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs60020217	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30858036	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs73277974	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30862851	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73277978	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30864431	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11657391	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30867269	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs58089675	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30869746	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73263755	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30871954	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9899349	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30873104	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11652358	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30878462	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11656845	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30879146	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9891179	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30881142	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9891413	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30881191	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73263776	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30884313	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11650271	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30886925	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73263785	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30887790	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs55904046	ENSG00000263531.1	RP13-753N3.1	5.18	3.62e-06	0.0194	1.15	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30888373	chr17:30863921~30864940:-
ACC	cis	rs9487094	0.67	rs12197838	ENSG00000260273.1	RP11-425D10.10	5.18	3.64e-06	0.0195	0.68	0.58	Height;	chr6:109672088	chr6:109382795~109383666:+
ACC	cis	rs2880765	0.835	rs7178991	ENSG00000259295.5	CSPG4P12	5.18	3.66e-06	0.0196	0.71	0.58	Coronary artery disease;	chr15:85507713	chr15:85191438~85213905:+
ACC	cis	rs1150668	0.796	rs1005125	ENSG00000216901.1	AL022393.7	5.18	3.67e-06	0.0196	0.67	0.58	Pubertal anthropometrics;	chr6:28399578	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.764	rs9368565	ENSG00000216901.1	AL022393.7	-5.18	3.67e-06	0.0196	-0.67	-0.58	Pubertal anthropometrics;	chr6:28377433	chr6:28176188~28176674:+
ACC	cis	rs1150668	0.796	rs1052215	ENSG00000216901.1	AL022393.7	-5.18	3.67e-06	0.0196	-0.67	-0.58	Pubertal anthropometrics;	chr6:28380381	chr6:28176188~28176674:+
ACC	cis	rs17826219	0.706	rs9905827	ENSG00000263531.1	RP13-753N3.1	5.18	3.68e-06	0.0196	1.13	0.58	Body mass index;	chr17:30865150	chr17:30863921~30864940:-
ACC	cis	rs172166	0.694	rs2791332	ENSG00000199851.2	U3	5.18	3.71e-06	0.0197	0.65	0.58	Cardiac Troponin-T levels;	chr6:28141010	chr6:28015568~28015777:+
ACC	cis	rs9487094	0.666	rs1074765	ENSG00000260273.1	RP11-425D10.10	-5.18	3.71e-06	0.0198	-0.68	-0.58	Height;	chr6:109360458	chr6:109382795~109383666:+
ACC	cis	rs9399137	0.507	rs4289677	ENSG00000232876.1	CTA-212D2.2	-5.18	3.71e-06	0.0198	-0.7	-0.58	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134954347	chr6:135055033~135060550:+
ACC	cis	rs2739330	0.76	rs1007888	ENSG00000218537.1	MIF-AS1	5.17	3.76e-06	0.02	0.64	0.58	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23898914	chr22:23894426~23898930:-
ACC	cis	rs1799949	1	rs8176103	ENSG00000198496.9	NBR2	-5.17	3.83e-06	0.0203	-0.79	-0.58	Menopause (age at onset);	chr17:43115033	chr17:43125610~43153671:+
ACC	cis	rs4853012	0.941	rs78128123	ENSG00000217702.2	RP11-287D1.4	5.17	3.83e-06	0.0203	0.73	0.58	Gestational age at birth (maternal effect);	chr2:74120398	chr2:74130583~74135395:+
ACC	cis	rs1799949	1	rs11651341	ENSG00000198496.9	NBR2	-5.17	3.84e-06	0.0203	-0.77	-0.58	Menopause (age at onset);	chr17:43350693	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs34572725	ENSG00000198496.9	NBR2	-5.17	3.84e-06	0.0203	-0.77	-0.58	Menopause (age at onset);	chr17:43351298	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs4534897	ENSG00000198496.9	NBR2	-5.17	3.84e-06	0.0203	-0.77	-0.58	Menopause (age at onset);	chr17:43354440	chr17:43125610~43153671:+
ACC	cis	rs17711722	0.503	rs453835	ENSG00000226824.5	RP4-756H11.3	5.16	3.86e-06	0.0204	0.76	0.58	Calcium levels;	chr7:66046172	chr7:66654538~66669855:+
ACC	cis	rs1799949	0.683	rs55737636	ENSG00000198496.9	NBR2	-5.16	3.87e-06	0.0204	-0.75	-0.58	Menopause (age at onset);	chr17:43112722	chr17:43125610~43153671:+
ACC	cis	rs597539	0.652	rs496616	ENSG00000250508.1	RP11-757G1.6	-5.16	3.88e-06	0.0205	-0.94	-0.58	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68905332	chr11:68870664~68874542:+
ACC	cis	rs4835473	0.932	rs5016160	ENSG00000251600.4	RP11-673E1.1	5.16	3.88e-06	0.0205	0.79	0.58	Immature fraction of reticulocytes;	chr4:143738305	chr4:143912331~143982454:+
ACC	cis	rs6452524	0.618	rs1871203	ENSG00000249664.1	CTD-2227C6.2	5.16	3.91e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83059567	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs7722924	ENSG00000249664.1	CTD-2227C6.2	5.16	3.91e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83060223	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs10051445	ENSG00000249664.1	CTD-2227C6.2	5.16	3.91e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83060280	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs6867727	ENSG00000249664.1	CTD-2227C6.2	5.16	3.91e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83061333	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs7723639	ENSG00000249664.1	CTD-2227C6.2	5.16	3.91e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83062610	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs2306336	ENSG00000249664.1	CTD-2227C6.2	5.16	3.91e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83064964	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.589	rs6882386	ENSG00000249664.1	CTD-2227C6.2	5.16	3.91e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83065555	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs6860752	ENSG00000249664.1	CTD-2227C6.2	5.16	3.91e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83065587	chr5:83012285~83013109:-
ACC	cis	rs597539	0.652	rs501799	ENSG00000250508.1	RP11-757G1.6	-5.16	3.93e-06	0.0205	-0.94	-0.58	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68863772	chr11:68870664~68874542:+
ACC	cis	rs6452524	0.648	rs27364	ENSG00000249664.1	CTD-2227C6.2	5.16	3.93e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83052137	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs10462394	ENSG00000249664.1	CTD-2227C6.2	5.16	3.93e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83058735	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs3899556	ENSG00000249664.1	CTD-2227C6.2	5.16	3.93e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83067862	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.56	rs6895174	ENSG00000249664.1	CTD-2227C6.2	5.16	3.93e-06	0.0205	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83071606	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs6452506	ENSG00000249664.1	CTD-2227C6.2	5.16	3.96e-06	0.0207	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83075844	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs1993948	ENSG00000249664.1	CTD-2227C6.2	5.16	3.96e-06	0.0207	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83076461	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs2075685	ENSG00000249664.1	CTD-2227C6.2	5.16	3.96e-06	0.0207	0.63	0.58	Hypertension (SNP x SNP interaction);	chr5:83076846	chr5:83012285~83013109:-
ACC	cis	rs7188445	0.932	rs17767742	ENSG00000261390.4	RP11-345M22.2	-5.15	4e-06	0.0209	-0.74	-0.58	Urate levels;	chr16:79715108	chr16:79715232~79770563:-
ACC	cis	rs858239	0.738	rs13225593	ENSG00000230658.1	KLHL7-AS1	5.15	4.02e-06	0.0209	0.7	0.58	Cerebrospinal fluid biomarker levels;	chr7:23220688	chr7:23101228~23105703:-
ACC	cis	rs858239	0.738	rs7807879	ENSG00000230658.1	KLHL7-AS1	5.15	4.02e-06	0.0209	0.7	0.58	Cerebrospinal fluid biomarker levels;	chr7:23220969	chr7:23101228~23105703:-
ACC	cis	rs9487094	0.67	rs6911700	ENSG00000260273.1	RP11-425D10.10	5.15	4.02e-06	0.0209	0.67	0.58	Height;	chr6:109676091	chr6:109382795~109383666:+
ACC	cis	rs7174755	0.743	rs4777035	ENSG00000260657.2	RP11-315D16.4	-5.15	4.02e-06	0.0209	-0.6	-0.58	Major depressive disorder;	chr15:68312831	chr15:68267792~68277994:-
ACC	cis	rs12022452	0.822	rs6600343	ENSG00000238287.1	RP11-656D10.3	-5.15	4.05e-06	0.021	-0.9	-0.58	Age-related hearing impairment (SNP x SNP interaction);	chr1:40562538	chr1:40493157~40508661:-
ACC	cis	rs17572109	0.666	rs4674297	ENSG00000261338.2	RP11-378A13.1	5.15	4.06e-06	0.0211	0.88	0.58	Platelet count;Platelet distribution width;Mean platelet volume;	chr2:218364424	chr2:218255319~218257366:+
ACC	cis	rs9399137	0.507	rs61738647	ENSG00000232876.1	CTA-212D2.2	-5.15	4.09e-06	0.0213	-0.68	-0.58	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134961597	chr6:135055033~135060550:+
ACC	cis	rs9399135	1	rs9399135	ENSG00000232876.1	CTA-212D2.2	-5.15	4.09e-06	0.0213	-0.63	-0.58	Red blood cell count;	chr6:135047176	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs9399129	ENSG00000232876.1	CTA-212D2.2	-5.15	4.1e-06	0.0213	-0.61	-0.58	Red blood cell count;	chr6:134964010	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs4896119	ENSG00000232876.1	CTA-212D2.2	-5.15	4.1e-06	0.0213	-0.61	-0.58	Red blood cell count;	chr6:134972253	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs4896121	ENSG00000232876.1	CTA-212D2.2	-5.15	4.1e-06	0.0213	-0.61	-0.58	Red blood cell count;	chr6:134972507	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.933	rs7755680	ENSG00000232876.1	CTA-212D2.2	-5.15	4.1e-06	0.0213	-0.61	-0.58	Red blood cell count;	chr6:134973121	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs4895436	ENSG00000232876.1	CTA-212D2.2	-5.15	4.1e-06	0.0213	-0.61	-0.58	Red blood cell count;	chr6:134973863	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs4896122	ENSG00000232876.1	CTA-212D2.2	-5.15	4.1e-06	0.0213	-0.61	-0.58	Red blood cell count;	chr6:134973943	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs9376075	ENSG00000232876.1	CTA-212D2.2	-5.15	4.1e-06	0.0213	-0.61	-0.58	Red blood cell count;	chr6:134975825	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.935	rs4273704	ENSG00000232876.1	CTA-212D2.2	-5.15	4.1e-06	0.0213	-0.61	-0.58	Red blood cell count;	chr6:134976382	chr6:135055033~135060550:+
ACC	cis	rs9487094	0.961	rs1040284	ENSG00000260273.1	RP11-425D10.10	5.15	4.13e-06	0.0214	0.72	0.58	Height;	chr6:109352730	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.961	rs11153174	ENSG00000260273.1	RP11-425D10.10	5.15	4.13e-06	0.0214	0.72	0.58	Height;	chr6:109352852	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.961	rs34202013	ENSG00000260273.1	RP11-425D10.10	5.15	4.13e-06	0.0214	0.72	0.58	Height;	chr6:109353355	chr6:109382795~109383666:+
ACC	cis	rs9322193	0.566	rs5024811	ENSG00000231760.4	RP11-350J20.5	-5.15	4.14e-06	0.0214	-0.75	-0.58	Lung cancer;	chr6:149924898	chr6:149796151~149826294:-
ACC	cis	rs916888	0.821	rs199499	ENSG00000214401.4	KANSL1-AS1	5.14	4.2e-06	0.0217	0.92	0.58	Cognitive function;Multiple system atrophy;Post bronchodilator FEV1;Intelligence (multi-trait analysis);	chr17:46788132	chr17:46193576~46196723:+
ACC	cis	rs9399135	0.967	rs1041481	ENSG00000232876.1	CTA-212D2.2	-5.14	4.2e-06	0.0217	-0.59	-0.58	Red blood cell count;	chr6:135013925	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs6902438	ENSG00000232876.1	CTA-212D2.2	-5.14	4.2e-06	0.0217	-0.59	-0.58	Red blood cell count;	chr6:135015449	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.935	rs6908681	ENSG00000232876.1	CTA-212D2.2	-5.14	4.2e-06	0.0217	-0.59	-0.58	Red blood cell count;	chr6:135016595	chr6:135055033~135060550:+
ACC	cis	rs1799949	0.965	rs4793233	ENSG00000198496.9	NBR2	-5.14	4.22e-06	0.0217	-0.78	-0.58	Menopause (age at onset);	chr17:43358069	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs4793234	ENSG00000198496.9	NBR2	-5.14	4.22e-06	0.0217	-0.78	-0.58	Menopause (age at onset);	chr17:43358815	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs4793236	ENSG00000198496.9	NBR2	-5.14	4.22e-06	0.0217	-0.78	-0.58	Menopause (age at onset);	chr17:43359072	chr17:43125610~43153671:+
ACC	cis	rs36715	0.953	rs36706	ENSG00000245937.6	LINC01184	5.14	4.25e-06	0.0219	0.79	0.58	Breast cancer;	chr5:128221006	chr5:127940426~128083172:-
ACC	cis	rs1799949	1	rs34942571	ENSG00000198496.9	NBR2	-5.13	4.29e-06	0.0221	-0.76	-0.58	Menopause (age at onset);	chr17:43121362	chr17:43125610~43153671:+
ACC	cis	rs2486288	0.656	rs2413771	ENSG00000259520.4	CTD-2651B20.3	5.13	4.36e-06	0.0224	0.66	0.58	Glomerular filtration rate;	chr15:45260942	chr15:45251580~45279251:-
ACC	cis	rs1577917	0.655	rs9444352	ENSG00000203875.9	SNHG5	5.13	4.36e-06	0.0225	0.62	0.58	Response to antipsychotic treatment;	chr6:85547817	chr6:85660950~85678736:-
ACC	cis	rs858239	0.932	rs1624451	ENSG00000230658.1	KLHL7-AS1	-5.13	4.37e-06	0.0225	-0.67	-0.58	Cerebrospinal fluid biomarker levels;	chr7:23222816	chr7:23101228~23105703:-
ACC	cis	rs858239	0.896	rs1637192	ENSG00000230658.1	KLHL7-AS1	5.13	4.37e-06	0.0225	0.67	0.58	Cerebrospinal fluid biomarker levels;	chr7:23220895	chr7:23101228~23105703:-
ACC	cis	rs9322193	0.607	rs12527391	ENSG00000231760.4	RP11-350J20.5	5.13	4.44e-06	0.0228	0.81	0.58	Lung cancer;	chr6:149882156	chr6:149796151~149826294:-
ACC	cis	rs4718428	1	rs1830070	ENSG00000226824.5	RP4-756H11.3	-5.12	4.46e-06	0.0229	-0.7	-0.58	Corneal structure;	chr7:66884684	chr7:66654538~66669855:+
ACC	cis	rs9399135	0.967	rs4637662	ENSG00000232876.1	CTA-212D2.2	-5.12	4.46e-06	0.0229	-0.61	-0.58	Red blood cell count;	chr6:134977020	chr6:135055033~135060550:+
ACC	cis	rs172166	0.611	rs203883	ENSG00000199851.2	U3	5.12	4.48e-06	0.023	0.66	0.58	Cardiac Troponin-T levels;	chr6:28110578	chr6:28015568~28015777:+
ACC	cis	rs172166	0.611	rs203882	ENSG00000199851.2	U3	5.12	4.48e-06	0.023	0.66	0.58	Cardiac Troponin-T levels;	chr6:28110724	chr6:28015568~28015777:+
ACC	cis	rs172166	0.694	rs1770131	ENSG00000199851.2	U3	5.12	4.48e-06	0.023	0.66	0.58	Cardiac Troponin-T levels;	chr6:28118635	chr6:28015568~28015777:+
ACC	cis	rs1799949	1	rs2037075	ENSG00000198496.9	NBR2	-5.12	4.48e-06	0.023	-0.78	-0.58	Menopause (age at onset);	chr17:43153809	chr17:43125610~43153671:+
ACC	cis	rs12022452	0.591	rs12042242	ENSG00000238287.1	RP11-656D10.3	5.12	4.54e-06	0.0233	0.78	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr1:40528201	chr1:40493157~40508661:-
ACC	cis	rs2882667	0.964	rs2288824	ENSG00000253404.1	AC034243.1	5.11	4.61e-06	0.0236	0.88	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:138962707	chr5:138744434~138753309:-
ACC	cis	rs3931020	1	rs3931020	ENSG00000272864.1	RP11-17E13.2	-5.11	4.63e-06	0.0236	-0.72	-0.58	Resistin levels;	chr1:74769633	chr1:74698769~74699333:-
ACC	cis	rs7188445	0.932	rs7203756	ENSG00000261390.4	RP11-345M22.2	5.11	4.63e-06	0.0236	0.7	0.58	Urate levels;	chr16:79711709	chr16:79715232~79770563:-
ACC	cis	rs9487094	0.626	rs4141930	ENSG00000260273.1	RP11-425D10.10	5.11	4.67e-06	0.0238	0.72	0.58	Height;	chr6:109739615	chr6:109382795~109383666:+
ACC	cis	rs7115242	0.8	rs4245168	ENSG00000254851.1	RP11-109L13.1	-5.11	4.67e-06	0.0238	-0.92	-0.58	Age-related disease endophenotypes;Age-related diseases, mortality and associated endophenotypes;	chr11:117011922	chr11:117135528~117138582:+
ACC	cis	rs9487094	0.922	rs2275650	ENSG00000260273.1	RP11-425D10.10	5.11	4.7e-06	0.024	0.72	0.58	Height;	chr6:109347085	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.885	rs3818934	ENSG00000260273.1	RP11-425D10.10	5.11	4.7e-06	0.024	0.72	0.58	Height;	chr6:109347277	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.961	rs9487068	ENSG00000260273.1	RP11-425D10.10	5.11	4.7e-06	0.024	0.72	0.58	Height;	chr6:109350642	chr6:109382795~109383666:+
ACC	cis	rs2723242	0.582	rs13016705	ENSG00000233762.3	AC007969.5	5.11	4.76e-06	0.0242	0.53	0.58	Platelet distribution width;	chr2:171087310	chr2:171517270~171517716:-
ACC	cis	rs6452524	0.618	rs4266384	ENSG00000249664.1	CTD-2227C6.2	5.11	4.76e-06	0.0242	0.64	0.58	Hypertension (SNP x SNP interaction);	chr5:83080872	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs1478487	ENSG00000249664.1	CTD-2227C6.2	5.11	4.76e-06	0.0242	0.64	0.58	Hypertension (SNP x SNP interaction);	chr5:83080900	chr5:83012285~83013109:-
ACC	cis	rs9487094	0.626	rs11153213	ENSG00000260273.1	RP11-425D10.10	5.1	4.81e-06	0.0244	0.7	0.58	Height;	chr6:109693890	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12201356	ENSG00000260273.1	RP11-425D10.10	5.1	4.81e-06	0.0244	0.7	0.58	Height;	chr6:109694672	chr6:109382795~109383666:+
ACC	cis	rs9326248	0.53	rs1351452	ENSG00000254851.1	RP11-109L13.1	5.1	4.81e-06	0.0244	0.89	0.58	Blood protein levels;	chr11:117072638	chr11:117135528~117138582:+
ACC	cis	rs9322193	0.923	rs958953	ENSG00000268592.3	RAET1E-AS1	5.1	4.87e-06	0.0246	0.68	0.58	Lung cancer;	chr6:149840735	chr6:149863494~149919507:+
ACC	cis	rs2739330	0.753	rs4822452	ENSG00000225282.1	AP000350.6	5.1	4.88e-06	0.0247	0.57	0.58	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23912176	chr22:23926900~23929574:+
ACC	cis	rs7617773	0.963	rs12495221	ENSG00000229759.1	MRPS18AP1	-5.09	4.95e-06	0.025	-0.64	-0.58	Coronary artery disease;	chr3:48137688	chr3:48256350~48256938:-
ACC	cis	rs3750552	0.898	rs10867357	ENSG00000224958.4	PGM5-AS1	5.09	4.96e-06	0.025	0.72	0.58	Bipolar disorder;	chr9:69324515	chr9:68355189~68357852:-
ACC	cis	rs3750552	0.799	rs6559468	ENSG00000224958.4	PGM5-AS1	5.09	4.96e-06	0.025	0.72	0.58	Bipolar disorder;	chr9:69324930	chr9:68355189~68357852:-
ACC	cis	rs9487094	0.67	rs34928881	ENSG00000260273.1	RP11-425D10.10	5.09	5e-06	0.0251	0.68	0.58	Height;	chr6:109526846	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs10782163	ENSG00000260273.1	RP11-425D10.10	5.09	5e-06	0.0251	0.68	0.58	Height;	chr6:109533040	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs10457195	ENSG00000260273.1	RP11-425D10.10	5.09	5e-06	0.0251	0.68	0.58	Height;	chr6:109534269	chr6:109382795~109383666:+
ACC	cis	rs950027	0.549	rs12909409	ENSG00000259520.4	CTD-2651B20.3	5.09	5.05e-06	0.0251	0.67	0.58	Response to fenofibrate (adiponectin levels);	chr15:45316384	chr15:45251580~45279251:-
ACC	cis	rs1799949	0.501	rs2343819	ENSG00000198496.9	NBR2	-5.09	5.05e-06	0.0251	-0.76	-0.58	Menopause (age at onset);	chr17:43332285	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.501	rs35399157	ENSG00000198496.9	NBR2	-5.09	5.05e-06	0.0251	-0.76	-0.58	Menopause (age at onset);	chr17:43334234	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.602	rs4600503	ENSG00000198496.9	NBR2	-5.09	5.05e-06	0.0251	-0.76	-0.58	Menopause (age at onset);	chr17:43336956	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.501	rs9675035	ENSG00000198496.9	NBR2	-5.09	5.05e-06	0.0251	-0.76	-0.58	Menopause (age at onset);	chr17:43337648	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs11649954	ENSG00000198496.9	NBR2	-5.09	5.05e-06	0.0251	-0.76	-0.58	Menopause (age at onset);	chr17:43342667	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs1824889	ENSG00000198496.9	NBR2	-5.09	5.05e-06	0.0251	-0.76	-0.58	Menopause (age at onset);	chr17:43344508	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs35956818	ENSG00000198496.9	NBR2	-5.09	5.05e-06	0.0251	-0.76	-0.58	Menopause (age at onset);	chr17:43345617	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.93	rs4584865	ENSG00000198496.9	NBR2	-5.09	5.05e-06	0.0251	-0.76	-0.58	Menopause (age at onset);	chr17:43347551	chr17:43125610~43153671:+
ACC	cis	rs9399137	0.507	rs6940258	ENSG00000232876.1	CTA-212D2.2	-5.09	5.06e-06	0.0252	-0.68	-0.58	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:135044994	chr6:135055033~135060550:+
ACC	cis	rs9322193	0.847	rs56103941	ENSG00000268592.3	RAET1E-AS1	5.09	5.09e-06	0.0253	0.67	0.58	Lung cancer;	chr6:149816095	chr6:149863494~149919507:+
ACC	cis	rs1799949	1	rs4793231	ENSG00000198496.9	NBR2	-5.08	5.14e-06	0.0255	-0.76	-0.58	Menopause (age at onset);	chr17:43350101	chr17:43125610~43153671:+
ACC	cis	rs7208859	0.673	rs999796	ENSG00000263531.1	RP13-753N3.1	5.08	5.24e-06	0.026	1.13	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30832386	chr17:30863921~30864940:-
ACC	cis	rs2486288	0.656	rs2413774	ENSG00000259520.4	CTD-2651B20.3	5.08	5.26e-06	0.026	0.65	0.58	Glomerular filtration rate;	chr15:45257225	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs2413772	ENSG00000259520.4	CTD-2651B20.3	5.08	5.26e-06	0.026	0.65	0.58	Glomerular filtration rate;	chr15:45257664	chr15:45251580~45279251:-
ACC	cis	rs1799949	0.965	rs7212284	ENSG00000198496.9	NBR2	-5.08	5.27e-06	0.0261	-0.82	-0.58	Menopause (age at onset);	chr17:43053924	chr17:43125610~43153671:+
ACC	cis	rs7208859	0.673	rs999797	ENSG00000263531.1	RP13-753N3.1	5.08	5.29e-06	0.0262	1.11	0.58	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30832311	chr17:30863921~30864940:-
ACC	cis	rs9322193	0.847	rs868375	ENSG00000268592.3	RAET1E-AS1	5.07	5.3e-06	0.0262	0.69	0.58	Lung cancer;	chr6:149844905	chr6:149863494~149919507:+
ACC	cis	rs1153858	0.723	rs4580098	ENSG00000259520.4	CTD-2651B20.3	-5.07	5.32e-06	0.0263	-0.77	-0.58	Homoarginine levels;	chr15:45304711	chr15:45251580~45279251:-
ACC	cis	rs2608053	0.529	rs2648876	ENSG00000224722.3	RP11-255B23.1	5.07	5.33e-06	0.0264	0.66	0.58	Hodgkin's lymphoma;	chr8:128060720	chr8:127086263~127087510:-
ACC	cis	rs2880765	0.835	rs7169429	ENSG00000259295.5	CSPG4P12	5.07	5.33e-06	0.0264	0.72	0.58	Coronary artery disease;	chr15:85493417	chr15:85191438~85213905:+
ACC	cis	rs9399135	0.66	rs4472368	ENSG00000232876.1	CTA-212D2.2	-5.07	5.33e-06	0.0264	-0.66	-0.58	Red blood cell count;	chr6:134953094	chr6:135055033~135060550:+
ACC	cis	rs2882667	0.628	rs13173618	ENSG00000253404.1	AC034243.1	5.07	5.35e-06	0.0264	0.92	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:138804091	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.628	rs13154573	ENSG00000253404.1	AC034243.1	5.07	5.35e-06	0.0264	0.92	0.58	Age-related hearing impairment (SNP x SNP interaction);	chr5:138812375	chr5:138744434~138753309:-
ACC	cis	rs1799949	0.965	rs8176130	ENSG00000198496.9	NBR2	-5.07	5.39e-06	0.0266	-0.77	-0.58	Menopause (age at onset);	chr17:43106026	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs8176120	ENSG00000198496.9	NBR2	-5.07	5.39e-06	0.0266	-0.77	-0.58	Menopause (age at onset);	chr17:43109216	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs8176109	ENSG00000198496.9	NBR2	-5.07	5.39e-06	0.0266	-0.77	-0.58	Menopause (age at onset);	chr17:43113759	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.896	rs8176098	ENSG00000198496.9	NBR2	-5.07	5.39e-06	0.0266	-0.77	-0.58	Menopause (age at onset);	chr17:43116189	chr17:43125610~43153671:+
ACC	cis	rs9399135	0.66	rs4440481	ENSG00000232876.1	CTA-212D2.2	-5.07	5.4e-06	0.0266	-0.67	-0.58	Red blood cell count;	chr6:134955558	chr6:135055033~135060550:+
ACC	cis	rs6921919	0.583	rs2071965	ENSG00000216901.1	AL022393.7	5.07	5.42e-06	0.0267	0.74	0.58	Autism spectrum disorder or schizophrenia;	chr6:28435448	chr6:28176188~28176674:+
ACC	cis	rs9487094	0.62	rs7768973	ENSG00000260273.1	RP11-425D10.10	5.07	5.43e-06	0.0267	0.67	0.57	Height;	chr6:109424122	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.666	rs9480956	ENSG00000260273.1	RP11-425D10.10	5.07	5.43e-06	0.0267	0.67	0.57	Height;	chr6:109424305	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs12214147	ENSG00000260273.1	RP11-425D10.10	5.07	5.43e-06	0.0267	0.67	0.57	Height;	chr6:109425054	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs17070591	ENSG00000260273.1	RP11-425D10.10	5.07	5.43e-06	0.0267	0.67	0.57	Height;	chr6:109426518	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.666	rs7751582	ENSG00000260273.1	RP11-425D10.10	5.07	5.43e-06	0.0267	0.67	0.57	Height;	chr6:109427644	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs9487103	ENSG00000260273.1	RP11-425D10.10	5.07	5.43e-06	0.0267	0.67	0.57	Height;	chr6:109430292	chr6:109382795~109383666:+
ACC	cis	rs9399137	0.529	rs7739722	ENSG00000232876.1	CTA-212D2.2	-5.06	5.5e-06	0.0269	-0.67	-0.57	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134961087	chr6:135055033~135060550:+
ACC	cis	rs9487094	0.6	rs9372213	ENSG00000260273.1	RP11-425D10.10	5.06	5.5e-06	0.0269	0.65	0.57	Height;	chr6:109370985	chr6:109382795~109383666:+
ACC	cis	rs1002796	0.762	rs72788807	ENSG00000234936.1	AC010883.5	-5.06	5.57e-06	0.0272	-0.96	-0.57	Immunoglobulin A vasculitis;	chr2:43093084	chr2:43229573~43233394:+
ACC	cis	rs9399135	0.967	rs1854865	ENSG00000232876.1	CTA-212D2.2	-5.06	5.58e-06	0.0273	-0.6	-0.57	Red blood cell count;	chr6:135039162	chr6:135055033~135060550:+
ACC	cis	rs1799949	0.965	rs8176323	ENSG00000198496.9	NBR2	-5.06	5.58e-06	0.0273	-0.82	-0.57	Menopause (age at onset);	chr17:43043694	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs8176322	ENSG00000198496.9	NBR2	-5.06	5.58e-06	0.0273	-0.82	-0.57	Menopause (age at onset);	chr17:43043756	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs12516	ENSG00000198496.9	NBR2	-5.06	5.58e-06	0.0273	-0.82	-0.57	Menopause (age at onset);	chr17:43044391	chr17:43125610~43153671:+
ACC	cis	rs9487094	0.67	rs12194061	ENSG00000260273.1	RP11-425D10.10	5.06	5.65e-06	0.0275	0.68	0.57	Height;	chr6:109546439	chr6:109382795~109383666:+
ACC	cis	rs6920372	0.731	rs2357124	ENSG00000260273.1	RP11-425D10.10	5.06	5.65e-06	0.0275	0.68	0.57	Height;	chr6:109551060	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.696	rs11153188	ENSG00000260273.1	RP11-425D10.10	5.06	5.65e-06	0.0275	0.68	0.57	Height;	chr6:109558247	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs11752791	ENSG00000260273.1	RP11-425D10.10	5.06	5.65e-06	0.0275	0.68	0.57	Height;	chr6:109564443	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs4490694	ENSG00000260273.1	RP11-425D10.10	5.06	5.65e-06	0.0275	0.68	0.57	Height;	chr6:109571489	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12214639	ENSG00000260273.1	RP11-425D10.10	5.06	5.65e-06	0.0275	0.68	0.57	Height;	chr6:109576414	chr6:109382795~109383666:+
ACC	cis	rs1799949	1	rs1060915	ENSG00000198496.9	NBR2	-5.06	5.66e-06	0.0276	-0.77	-0.57	Menopause (age at onset);	chr17:43082453	chr17:43125610~43153671:+
ACC	cis	rs11155671	0.53	rs9371544	ENSG00000268592.3	RAET1E-AS1	5.06	5.66e-06	0.0276	0.67	0.57	Testicular germ cell tumor;	chr6:149896224	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.566	rs6912330	ENSG00000231760.4	RP11-350J20.5	-5.06	5.67e-06	0.0276	-0.8	-0.57	Lung cancer;	chr6:149908811	chr6:149796151~149826294:-
ACC	cis	rs7188445	1	rs7188445	ENSG00000261390.4	RP11-345M22.2	-5.06	5.68e-06	0.0276	-0.75	-0.57	Urate levels;	chr16:79701090	chr16:79715232~79770563:-
ACC	cis	rs9322193	0.884	rs1108889	ENSG00000268592.3	RAET1E-AS1	5.05	5.73e-06	0.0279	0.68	0.57	Lung cancer;	chr6:149845433	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.847	rs880246	ENSG00000268592.3	RAET1E-AS1	5.05	5.73e-06	0.0279	0.68	0.57	Lung cancer;	chr6:149845972	chr6:149863494~149919507:+
ACC	cis	rs6921919	0.583	rs7764722	ENSG00000216901.1	AL022393.7	5.05	5.76e-06	0.0279	0.73	0.57	Autism spectrum disorder or schizophrenia;	chr6:28386756	chr6:28176188~28176674:+
ACC	cis	rs1799949	0.965	rs1842147	ENSG00000198496.9	NBR2	-5.05	5.77e-06	0.0279	-0.76	-0.57	Menopause (age at onset);	chr17:43357824	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs9911630	ENSG00000198496.9	NBR2	-5.05	5.78e-06	0.0279	-0.8	-0.57	Menopause (age at onset);	chr17:43036325	chr17:43125610~43153671:+
ACC	cis	rs7208859	0.725	rs9910051	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30834184	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11655623	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30835155	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11654331	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30837999	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs73277960	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30850423	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73277964	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30852183	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11652409	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30855689	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9896095	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30860479	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs58920731	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30864728	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73277984	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30869115	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73277986	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30869179	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs12103588	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30870442	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.614	rs9914534	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30875646	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs4131618	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30877783	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11658344	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30880727	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9900144	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30881371	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs11656121	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30887025	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11650973	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30887027	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs78799101	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30888142	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73263788	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30889472	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs56085216	ENSG00000263531.1	RP13-753N3.1	5.05	5.79e-06	0.0279	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30890216	chr17:30863921~30864940:-
ACC	cis	rs1799949	0.864	rs60309406	ENSG00000198496.9	NBR2	-5.05	5.8e-06	0.028	-0.77	-0.57	Menopause (age at onset);	chr17:43358297	chr17:43125610~43153671:+
ACC	cis	rs7208859	0.623	rs11657662	ENSG00000263531.1	RP13-753N3.1	-5.05	5.88e-06	0.0283	-1.18	-0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30749329	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9912440	ENSG00000263531.1	RP13-753N3.1	5.05	5.88e-06	0.0283	1.18	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30821754	chr17:30863921~30864940:-
ACC	cis	rs597539	0.652	rs668576	ENSG00000250508.1	RP11-757G1.6	-5.04	5.93e-06	0.0286	-0.94	-0.57	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68900740	chr11:68870664~68874542:+
ACC	cis	rs597539	0.652	rs482172	ENSG00000250508.1	RP11-757G1.6	-5.04	5.93e-06	0.0286	-0.94	-0.57	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68900969	chr11:68870664~68874542:+
ACC	cis	rs2739330	0.828	rs4822454	ENSG00000218537.1	MIF-AS1	5.04	5.98e-06	0.0287	0.64	0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23913021	chr22:23894426~23898930:-
ACC	cis	rs9322193	0.923	rs2342765	ENSG00000268592.3	RAET1E-AS1	5.04	6.03e-06	0.0289	0.7	0.57	Lung cancer;	chr6:149858873	chr6:149863494~149919507:+
ACC	cis	rs36715	1	rs36710	ENSG00000245937.6	LINC01184	5.04	6.05e-06	0.029	0.77	0.57	Breast cancer;	chr5:128223752	chr5:127940426~128083172:-
ACC	cis	rs36715	0.953	rs42916	ENSG00000245937.6	LINC01184	5.04	6.05e-06	0.029	0.77	0.57	Breast cancer;	chr5:128224967	chr5:127940426~128083172:-
ACC	cis	rs36715	0.904	rs36712	ENSG00000245937.6	LINC01184	5.04	6.05e-06	0.029	0.77	0.57	Breast cancer;	chr5:128225441	chr5:127940426~128083172:-
ACC	cis	rs2283792	1	rs6928	ENSG00000224086.5	LL22NC03-86G7.1	-5.04	6.09e-06	0.0292	-0.68	-0.57	Multiple sclerosis;	chr22:21760715	chr22:21938293~21977632:+
ACC	cis	rs494459	0.838	rs555639	ENSG00000278376.1	RP11-158I9.8	5.03	6.1e-06	0.0292	0.49	0.57	Height;	chr11:118758322	chr11:118791254~118793137:+
ACC	cis	rs2739330	0.761	rs5760176	ENSG00000231271.1	AP000350.8	-5.03	6.13e-06	0.0293	-0.68	-0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005875	chr22:23949918~23954042:+
ACC	cis	rs6921919	0.583	rs740622	ENSG00000216901.1	AL022393.7	5.03	6.13e-06	0.0293	0.75	0.57	Autism spectrum disorder or schizophrenia;	chr6:28430514	chr6:28176188~28176674:+
ACC	cis	rs9399137	0.507	rs6569986	ENSG00000232876.1	CTA-212D2.2	-5.03	6.21e-06	0.0297	-0.66	-0.57	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134990503	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs13197750	ENSG00000232876.1	CTA-212D2.2	-5.03	6.21e-06	0.0297	-0.66	-0.57	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134991242	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs7761964	ENSG00000232876.1	CTA-212D2.2	-5.03	6.21e-06	0.0297	-0.66	-0.57	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134993127	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs11753673	ENSG00000232876.1	CTA-212D2.2	-5.03	6.21e-06	0.0297	-0.66	-0.57	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134995338	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs12663447	ENSG00000232876.1	CTA-212D2.2	-5.03	6.21e-06	0.0297	-0.66	-0.57	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134995888	chr6:135055033~135060550:+
ACC	cis	rs9399137	0.507	rs4895437	ENSG00000232876.1	CTA-212D2.2	-5.03	6.21e-06	0.0297	-0.66	-0.57	Mean corpuscular volume;Hemoglobin levels;Mean corpuscular hemoglobin;Glycated hemoglobin levels;Platelet count;Hematology traits;F-cell distribution;HbA2 levels;	chr6:134996216	chr6:135055033~135060550:+
ACC	cis	rs6921919	0.609	rs9461455	ENSG00000216901.1	AL022393.7	5.03	6.22e-06	0.0297	0.72	0.57	Autism spectrum disorder or schizophrenia;	chr6:28361954	chr6:28176188~28176674:+
ACC	cis	rs9326248	0.53	rs9919599	ENSG00000254851.1	RP11-109L13.1	-5.03	6.26e-06	0.0299	-1.03	-0.57	Blood protein levels;	chr11:116874768	chr11:117135528~117138582:+
ACC	cis	rs9322193	0.607	rs4869755	ENSG00000231760.4	RP11-350J20.5	5.02	6.32e-06	0.0299	0.81	0.57	Lung cancer;	chr6:149886347	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.639	rs4869756	ENSG00000231760.4	RP11-350J20.5	5.02	6.32e-06	0.0299	0.81	0.57	Lung cancer;	chr6:149886360	chr6:149796151~149826294:-
ACC	cis	rs10256972	0.684	rs2363279	ENSG00000229043.2	AC091729.9	-5.02	6.32e-06	0.0299	-0.59	-0.57	Endometriosis;Longevity;	chr7:1056507	chr7:1160374~1165267:+
ACC	cis	rs9908552	0.586	rs902966	ENSG00000262905.1	RP5-1029F21.2	5.02	6.39e-06	0.0302	0.58	0.57	Schizophrenia;	chr17:1330341	chr17:552566~553417:+
ACC	cis	rs2739330	0.731	rs5751792	ENSG00000231271.1	AP000350.8	5.02	6.39e-06	0.0302	0.68	0.57	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005096	chr22:23949918~23954042:+
ACC	cis	rs9487094	0.626	rs1322124	ENSG00000260273.1	RP11-425D10.10	5.02	6.5e-06	0.0306	0.65	0.57	Height;	chr6:109741670	chr6:109382795~109383666:+
ACC	cis	rs1153858	0.723	rs1719238	ENSG00000259520.4	CTD-2651B20.3	5.02	6.52e-06	0.0307	0.76	0.57	Homoarginine levels;	chr15:45302568	chr15:45251580~45279251:-
ACC	cis	rs9487094	0.961	rs12193493	ENSG00000260273.1	RP11-425D10.10	5.01	6.54e-06	0.0307	0.72	0.57	Height;	chr6:109371573	chr6:109382795~109383666:+
ACC	cis	rs7208859	0.623	rs28556733	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30756927	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.5	rs28452421	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Body mass index;	chr17:30756962	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs28433704	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30757267	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs28779471	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30757351	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11658022	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30758341	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.5	rs61685770	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Body mass index;	chr17:30758695	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs57486336	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30758713	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.706	rs55764512	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Body mass index;	chr17:30758740	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.524	rs73988172	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30759314	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs12103440	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30759639	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs12103508	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30759763	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.524	rs11653605	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30761367	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs11657777	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30764767	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73269913	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30765165	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs7217984	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30765748	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.524	rs8065744	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30772431	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.706	rs8071236	ENSG00000263531.1	RP13-753N3.1	5.01	6.57e-06	0.0307	1.15	0.57	Body mass index;	chr17:30772984	chr17:30863921~30864940:-
ACC	cis	rs7174755	0.923	rs4777036	ENSG00000260657.2	RP11-315D16.4	-5.01	6.61e-06	0.0308	-0.58	-0.57	Major depressive disorder;	chr15:68313230	chr15:68267792~68277994:-
ACC	cis	rs4718428	1	rs12534637	ENSG00000226824.5	RP4-756H11.3	-5.01	6.63e-06	0.0309	-0.69	-0.57	Corneal structure;	chr7:66862667	chr7:66654538~66669855:+
ACC	cis	rs9326248	0.569	rs10892082	ENSG00000254851.1	RP11-109L13.1	-5.01	6.74e-06	0.0314	-0.97	-0.57	Blood protein levels;	chr11:117168609	chr11:117135528~117138582:+
ACC	cis	rs1150668	0.796	rs9468372	ENSG00000216901.1	AL022393.7	5	6.78e-06	0.0315	0.67	0.57	Pubertal anthropometrics;	chr6:28411584	chr6:28176188~28176674:+
ACC	cis	rs2486288	0.656	rs8039354	ENSG00000259520.4	CTD-2651B20.3	-5	6.79e-06	0.0315	-0.66	-0.57	Glomerular filtration rate;	chr15:45259558	chr15:45251580~45279251:-
ACC	cis	rs7208859	0.623	rs3752019	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30824687	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73271869	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30825203	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs73271872	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30825210	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs56146117	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30826307	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.568	rs9907834	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Body mass index;	chr17:30826995	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73271887	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30827917	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9898858	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30829193	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs55658077	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30829501	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9899692	ENSG00000263531.1	RP13-753N3.1	5	6.79e-06	0.0315	1.13	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30829921	chr17:30863921~30864940:-
ACC	cis	rs4835473	0.932	rs13147386	ENSG00000251600.4	RP11-673E1.1	5	6.8e-06	0.0315	0.78	0.57	Immature fraction of reticulocytes;	chr4:143736586	chr4:143912331~143982454:+
ACC	cis	rs8037818	1	rs4544214	ENSG00000276724.1	RP11-1000B6.7	5	6.84e-06	0.0316	0.55	0.57	Obesity-related traits;	chr15:32639703	chr15:32583612~32584312:+
ACC	cis	rs1799949	0.55	rs2343818	ENSG00000198496.9	NBR2	-5	6.87e-06	0.0317	-0.75	-0.57	Menopause (age at onset);	chr17:43332406	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.526	rs4352088	ENSG00000198496.9	NBR2	-5	6.87e-06	0.0317	-0.75	-0.57	Menopause (age at onset);	chr17:43337311	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs34633610	ENSG00000198496.9	NBR2	-5	6.87e-06	0.0317	-0.75	-0.57	Menopause (age at onset);	chr17:43342017	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.965	rs11654051	ENSG00000198496.9	NBR2	-5	6.87e-06	0.0317	-0.75	-0.57	Menopause (age at onset);	chr17:43342288	chr17:43125610~43153671:+
ACC	cis	rs1799949	0.93	rs56729776	ENSG00000198496.9	NBR2	-5	6.87e-06	0.0317	-0.75	-0.57	Menopause (age at onset);	chr17:43344763	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs9646417	ENSG00000198496.9	NBR2	-5	6.87e-06	0.0317	-0.75	-0.57	Menopause (age at onset);	chr17:43346885	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs1545764	ENSG00000198496.9	NBR2	-5	6.87e-06	0.0317	-0.75	-0.57	Menopause (age at onset);	chr17:43347197	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs9646412	ENSG00000198496.9	NBR2	-5	6.87e-06	0.0317	-0.75	-0.57	Menopause (age at onset);	chr17:43348525	chr17:43125610~43153671:+
ACC	cis	rs11155671	0.53	rs9371544	ENSG00000231760.4	RP11-350J20.5	5	6.92e-06	0.0319	0.65	0.57	Testicular germ cell tumor;	chr6:149896224	chr6:149796151~149826294:-
ACC	cis	rs9399135	0.66	rs9389248	ENSG00000232876.1	CTA-212D2.2	-5	6.96e-06	0.0321	-0.63	-0.57	Red blood cell count;	chr6:134961518	chr6:135055033~135060550:+
ACC	cis	rs6921919	0.583	rs9468370	ENSG00000216901.1	AL022393.7	4.99	7.05e-06	0.0325	0.7	0.57	Autism spectrum disorder or schizophrenia;	chr6:28401163	chr6:28176188~28176674:+
ACC	cis	rs2486288	0.656	rs11637838	ENSG00000259520.4	CTD-2651B20.3	4.99	7.07e-06	0.0325	0.65	0.57	Glomerular filtration rate;	chr15:45258459	chr15:45251580~45279251:-
ACC	cis	rs4835473	0.932	rs5016159	ENSG00000251600.4	RP11-673E1.1	4.99	7.08e-06	0.0326	0.76	0.57	Immature fraction of reticulocytes;	chr4:143738362	chr4:143912331~143982454:+
ACC	cis	rs7208859	0.623	rs9906957	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30830737	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9889968	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30893110	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs61348930	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30894745	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.614	rs28758251	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30896294	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9899943	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30896907	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11080138	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30897524	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73265612	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30898965	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs2433	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30899210	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11658435	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30901543	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs73265624	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30905048	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs9914271	ENSG00000263531.1	RP13-753N3.1	4.99	7.1e-06	0.0326	1.12	0.57	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30905607	chr17:30863921~30864940:-
ACC	cis	rs858239	0.899	rs10085838	ENSG00000230658.1	KLHL7-AS1	4.99	7.1e-06	0.0326	0.7	0.57	Cerebrospinal fluid biomarker levels;	chr7:23258796	chr7:23101228~23105703:-
ACC	cis	rs9487094	0.67	rs12192268	ENSG00000260273.1	RP11-425D10.10	4.99	7.15e-06	0.0327	0.68	0.57	Height;	chr6:109690255	chr6:109382795~109383666:+
ACC	cis	rs172166	0.652	rs476167	ENSG00000199851.2	U3	4.99	7.18e-06	0.0328	0.67	0.57	Cardiac Troponin-T levels;	chr6:28098110	chr6:28015568~28015777:+
ACC	cis	rs172166	0.694	rs203892	ENSG00000199851.2	U3	4.99	7.18e-06	0.0328	0.67	0.57	Cardiac Troponin-T levels;	chr6:28099418	chr6:28015568~28015777:+
ACC	cis	rs172166	0.694	rs188105	ENSG00000199851.2	U3	4.99	7.18e-06	0.0328	0.67	0.57	Cardiac Troponin-T levels;	chr6:28103615	chr6:28015568~28015777:+
ACC	cis	rs2608053	0.529	rs2720660	ENSG00000224722.3	RP11-255B23.1	-4.99	7.21e-06	0.0329	-0.64	-0.57	Hodgkin's lymphoma;	chr8:128048996	chr8:127086263~127087510:-
ACC	cis	rs4835473	0.932	rs1450236	ENSG00000251600.4	RP11-673E1.1	-4.99	7.26e-06	0.0329	-0.75	-0.57	Immature fraction of reticulocytes;	chr4:143783069	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs62339580	ENSG00000251600.4	RP11-673E1.1	-4.99	7.26e-06	0.0329	-0.75	-0.57	Immature fraction of reticulocytes;	chr4:143785090	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs13129702	ENSG00000251600.4	RP11-673E1.1	4.99	7.26e-06	0.0329	0.75	0.57	Immature fraction of reticulocytes;	chr4:143785132	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs62339581	ENSG00000251600.4	RP11-673E1.1	-4.99	7.26e-06	0.0329	-0.75	-0.57	Immature fraction of reticulocytes;	chr4:143785172	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs7666368	ENSG00000251600.4	RP11-673E1.1	-4.99	7.26e-06	0.0329	-0.75	-0.57	Immature fraction of reticulocytes;	chr4:143785372	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs7690428	ENSG00000251600.4	RP11-673E1.1	-4.99	7.26e-06	0.0329	-0.75	-0.57	Immature fraction of reticulocytes;	chr4:143785400	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34781605	ENSG00000251600.4	RP11-673E1.1	-4.99	7.26e-06	0.0329	-0.75	-0.57	Immature fraction of reticulocytes;	chr4:143785486	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs11100810	ENSG00000251600.4	RP11-673E1.1	-4.99	7.26e-06	0.0329	-0.75	-0.57	Immature fraction of reticulocytes;	chr4:143787518	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs4383567	ENSG00000251600.4	RP11-673E1.1	4.99	7.26e-06	0.0329	0.75	0.57	Immature fraction of reticulocytes;	chr4:143788873	chr4:143912331~143982454:+
ACC	cis	rs9322193	0.962	rs3805752	ENSG00000268592.3	RAET1E-AS1	4.98	7.46e-06	0.0334	0.66	0.57	Lung cancer;	chr6:149795490	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.847	rs12210605	ENSG00000268592.3	RAET1E-AS1	4.98	7.46e-06	0.0334	0.66	0.57	Lung cancer;	chr6:149817267	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.923	rs9371199	ENSG00000268592.3	RAET1E-AS1	4.98	7.46e-06	0.0334	0.66	0.57	Lung cancer;	chr6:149817526	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.962	rs7740784	ENSG00000268592.3	RAET1E-AS1	4.98	7.46e-06	0.0334	0.66	0.57	Lung cancer;	chr6:149833364	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.962	rs2342764	ENSG00000268592.3	RAET1E-AS1	4.98	7.46e-06	0.0334	0.66	0.57	Lung cancer;	chr6:149835068	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.886	rs4870049	ENSG00000268592.3	RAET1E-AS1	4.98	7.46e-06	0.0334	0.66	0.57	Lung cancer;	chr6:149837058	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.607	rs7764677	ENSG00000231760.4	RP11-350J20.5	4.98	7.48e-06	0.0335	0.8	0.57	Lung cancer;	chr6:149906197	chr6:149796151~149826294:-
ACC	cis	rs763121	0.925	rs17032	ENSG00000273076.1	RP3-508I15.22	4.98	7.5e-06	0.0336	0.57	0.57	Menopause (age at onset);	chr22:38734838	chr22:38743495~38743910:+
ACC	cis	rs7188445	0.932	rs17689455	ENSG00000261390.4	RP11-345M22.2	-4.97	7.6e-06	0.034	-0.68	-0.57	Urate levels;	chr16:79712438	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.899	rs7195321	ENSG00000261390.4	RP11-345M22.2	-4.97	7.6e-06	0.034	-0.75	-0.57	Urate levels;	chr16:79701065	chr16:79715232~79770563:-
ACC	cis	rs9487094	0.67	rs12199154	ENSG00000260273.1	RP11-425D10.10	-4.97	7.61e-06	0.034	-0.66	-0.57	Height;	chr6:109501793	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12212476	ENSG00000260273.1	RP11-425D10.10	4.97	7.61e-06	0.034	0.66	0.57	Height;	chr6:109501402	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12198938	ENSG00000260273.1	RP11-425D10.10	4.97	7.61e-06	0.034	0.66	0.57	Height;	chr6:109501429	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs13220915	ENSG00000260273.1	RP11-425D10.10	4.97	7.61e-06	0.034	0.66	0.57	Height;	chr6:109503623	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.626	rs10457192	ENSG00000260273.1	RP11-425D10.10	4.97	7.61e-06	0.034	0.66	0.57	Height;	chr6:109507271	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.6	rs10457193	ENSG00000260273.1	RP11-425D10.10	4.97	7.61e-06	0.034	0.66	0.57	Height;	chr6:109507364	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.558	rs10457194	ENSG00000260273.1	RP11-425D10.10	4.97	7.61e-06	0.034	0.66	0.57	Height;	chr6:109507366	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs1476388	ENSG00000260273.1	RP11-425D10.10	4.97	7.61e-06	0.034	0.66	0.57	Height;	chr6:109518783	chr6:109382795~109383666:+
ACC	cis	rs684232	0.901	rs1741275	ENSG00000262920.4	RP11-1260E13.1	-4.97	7.63e-06	0.0341	-0.58	-0.57	Prostate cancer;	chr17:727123	chr17:321392~322453:+
ACC	cis	rs4718428	0.924	rs6971897	ENSG00000226824.5	RP4-756H11.3	-4.97	7.67e-06	0.0342	-0.69	-0.57	Corneal structure;	chr7:66947787	chr7:66654538~66669855:+
ACC	cis	rs296381	0.561	rs62128815	ENSG00000259108.2	CTD-3098H1.2	4.97	7.74e-06	0.0345	1.19	0.57	Blood metabolite levels;	chr19:47846001	chr19:47863483~47865341:-
ACC	cis	rs36715	1	rs36697	ENSG00000245937.6	LINC01184	4.96	7.85e-06	0.035	0.76	0.57	Breast cancer;	chr5:128213921	chr5:127940426~128083172:-
ACC	cis	rs36715	0.951	rs36698	ENSG00000245937.6	LINC01184	4.96	7.85e-06	0.035	0.76	0.57	Breast cancer;	chr5:128214057	chr5:127940426~128083172:-
ACC	cis	rs8040855	0.965	rs4843027	ENSG00000259295.5	CSPG4P12	-4.96	7.87e-06	0.0351	-0.72	-0.57	Bulimia nervosa;	chr15:85171892	chr15:85191438~85213905:+
ACC	cis	rs4835473	0.932	rs11721495	ENSG00000251600.4	RP11-673E1.1	-4.96	7.89e-06	0.0351	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143767216	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs7689374	ENSG00000251600.4	RP11-673E1.1	-4.96	7.89e-06	0.0351	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143769567	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs6537183	ENSG00000251600.4	RP11-673E1.1	-4.96	7.89e-06	0.0351	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143770441	chr4:143912331~143982454:+
ACC	cis	rs597539	0.617	rs686348	ENSG00000250508.1	RP11-757G1.6	-4.96	7.89e-06	0.0351	-0.96	-0.57	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68869528	chr11:68870664~68874542:+
ACC	cis	rs597539	0.652	rs686877	ENSG00000250508.1	RP11-757G1.6	-4.96	7.89e-06	0.0351	-0.96	-0.57	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68869701	chr11:68870664~68874542:+
ACC	cis	rs597539	0.652	rs579136	ENSG00000250508.1	RP11-757G1.6	-4.96	7.89e-06	0.0351	-0.96	-0.57	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68870008	chr11:68870664~68874542:+
ACC	cis	rs597539	0.652	rs10792001	ENSG00000250508.1	RP11-757G1.6	-4.96	7.89e-06	0.0351	-0.96	-0.57	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68870269	chr11:68870664~68874542:+
ACC	cis	rs597539	0.652	rs613128	ENSG00000250508.1	RP11-757G1.6	-4.96	7.89e-06	0.0351	-0.96	-0.57	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68870590	chr11:68870664~68874542:+
ACC	cis	rs597539	0.616	rs473997	ENSG00000250508.1	RP11-757G1.6	-4.96	7.89e-06	0.0351	-0.96	-0.57	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68872013	chr11:68870664~68874542:+
ACC	cis	rs11155671	0.53	rs6557133	ENSG00000268592.3	RAET1E-AS1	4.96	7.97e-06	0.0353	0.71	0.57	Testicular germ cell tumor;	chr6:149874248	chr6:149863494~149919507:+
ACC	cis	rs6921919	0.515	rs1558205	ENSG00000216901.1	AL022393.7	-4.95	8.06e-06	0.0357	-0.74	-0.57	Autism spectrum disorder or schizophrenia;	chr6:28414485	chr6:28176188~28176674:+
ACC	cis	rs858239	0.676	rs3807459	ENSG00000230658.1	KLHL7-AS1	4.95	8.07e-06	0.0357	0.75	0.57	Cerebrospinal fluid biomarker levels;	chr7:23350132	chr7:23101228~23105703:-
ACC	cis	rs507080	0.769	rs2077173	ENSG00000278376.1	RP11-158I9.8	-4.95	8.08e-06	0.0358	-0.55	-0.57	Serum metabolite levels;	chr11:118621876	chr11:118791254~118793137:+
ACC	cis	rs507080	0.769	rs11603616	ENSG00000278376.1	RP11-158I9.8	-4.95	8.08e-06	0.0358	-0.55	-0.57	Serum metabolite levels;	chr11:118625350	chr11:118791254~118793137:+
ACC	cis	rs507080	0.769	rs483283	ENSG00000278376.1	RP11-158I9.8	-4.95	8.08e-06	0.0358	-0.55	-0.57	Serum metabolite levels;	chr11:118635684	chr11:118791254~118793137:+
ACC	cis	rs507080	0.769	rs570836	ENSG00000278376.1	RP11-158I9.8	-4.95	8.08e-06	0.0358	-0.55	-0.57	Serum metabolite levels;	chr11:118641444	chr11:118791254~118793137:+
ACC	cis	rs9322193	0.923	rs7769101	ENSG00000268592.3	RAET1E-AS1	4.95	8.14e-06	0.0358	0.67	0.57	Lung cancer;	chr6:149848768	chr6:149863494~149919507:+
ACC	cis	rs507080	0.769	rs571001	ENSG00000278376.1	RP11-158I9.8	-4.95	8.15e-06	0.0359	-0.54	-0.57	Serum metabolite levels;	chr11:118629457	chr11:118791254~118793137:+
ACC	cis	rs3812049	0.737	rs1112956	ENSG00000245937.6	LINC01184	-4.95	8.2e-06	0.036	-0.72	-0.57	Lymphocyte counts;Red cell distribution width;	chr5:128098106	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.784	rs6889311	ENSG00000245937.6	LINC01184	4.95	8.2e-06	0.036	0.72	0.57	Lymphocyte counts;Red cell distribution width;	chr5:128095593	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.826	rs2409110	ENSG00000245937.6	LINC01184	4.95	8.2e-06	0.036	0.72	0.57	Lymphocyte counts;Red cell distribution width;	chr5:128097355	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.693	rs9327468	ENSG00000245937.6	LINC01184	4.95	8.2e-06	0.036	0.72	0.57	Lymphocyte counts;Red cell distribution width;	chr5:128106169	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.784	rs1560637	ENSG00000245937.6	LINC01184	4.95	8.2e-06	0.036	0.72	0.57	Lymphocyte counts;Red cell distribution width;	chr5:128112374	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.784	rs2617617	ENSG00000245937.6	LINC01184	4.95	8.2e-06	0.036	0.72	0.57	Lymphocyte counts;Red cell distribution width;	chr5:128119316	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.784	rs2568928	ENSG00000245937.6	LINC01184	-4.95	8.29e-06	0.0364	-0.72	-0.57	Lymphocyte counts;Red cell distribution width;	chr5:128151911	chr5:127940426~128083172:-
ACC	cis	rs6921919	0.551	rs13201753	ENSG00000216901.1	AL022393.7	4.95	8.29e-06	0.0364	0.71	0.57	Autism spectrum disorder or schizophrenia;	chr6:28363351	chr6:28176188~28176674:+
ACC	cis	rs442309	0.687	rs10822052	ENSG00000238280.1	RP11-436D10.3	4.95	8.32e-06	0.0365	0.64	0.57	Vogt-Koyanagi-Harada syndrome;	chr10:62696010	chr10:62793562~62805887:-
ACC	cis	rs7188445	0.932	rs17767491	ENSG00000261390.4	RP11-345M22.2	-4.95	8.32e-06	0.0365	-0.73	-0.57	Urate levels;	chr16:79711590	chr16:79715232~79770563:-
ACC	cis	rs8013143	1	rs11846575	ENSG00000279656.1	RP11-298I3.6	-4.94	8.36e-06	0.0366	-0.78	-0.57	Reticulocyte fraction of red cells;Reticulocyte count;Red cell distribution width;	chr14:23022075	chr14:23023083~23024217:-
ACC	cis	rs8013143	1	rs8013143	ENSG00000279656.1	RP11-298I3.6	-4.94	8.36e-06	0.0366	-0.78	-0.57	Reticulocyte fraction of red cells;Reticulocyte count;Red cell distribution width;	chr14:23025068	chr14:23023083~23024217:-
ACC	cis	rs8013143	1	rs941718	ENSG00000279656.1	RP11-298I3.6	-4.94	8.36e-06	0.0366	-0.78	-0.57	Reticulocyte fraction of red cells;Reticulocyte count;Red cell distribution width;	chr14:23025839	chr14:23023083~23024217:-
ACC	cis	rs8013143	0.961	rs7147308	ENSG00000279656.1	RP11-298I3.6	-4.94	8.36e-06	0.0366	-0.78	-0.57	Reticulocyte fraction of red cells;Reticulocyte count;Red cell distribution width;	chr14:23028420	chr14:23023083~23024217:-
ACC	cis	rs113525195	1	rs113525195	ENSG00000279656.1	RP11-298I3.6	-4.94	8.36e-06	0.0366	-0.78	-0.57	High light scatter reticulocyte count;High light scatter reticulocyte percentage of red cells;Mean corpuscular hemoglobin;	chr14:23030112	chr14:23023083~23024217:-
ACC	cis	rs4972806	0.849	rs2857535	ENSG00000226363.3	HAGLROS	-4.94	8.45e-06	0.037	-0.63	-0.57	IgG glycosylation;	chr2:176171483	chr2:176177717~176179008:+
ACC	cis	rs9487094	0.666	rs9480958	ENSG00000260273.1	RP11-425D10.10	-4.94	8.46e-06	0.037	-0.65	-0.57	Height;	chr6:109432968	chr6:109382795~109383666:+
ACC	cis	rs9322193	0.884	rs7769115	ENSG00000268592.3	RAET1E-AS1	4.94	8.47e-06	0.037	0.66	0.57	Lung cancer;	chr6:149848796	chr6:149863494~149919507:+
ACC	cis	rs4835473	0.932	rs4835279	ENSG00000251600.4	RP11-673E1.1	-4.94	8.47e-06	0.037	-0.74	-0.57	Immature fraction of reticulocytes;	chr4:143788917	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs5016158	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143738472	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs5016157	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143738587	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs11100808	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143762728	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs7661407	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143762982	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1562777	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143763676	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1562778	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143763816	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1562779	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143763999	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1597441	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143764158	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1597442	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143764359	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1597443	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143764406	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1597444	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143764547	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs60038202	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143764662	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34886773	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143764678	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1450230	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143765118	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34683160	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143765227	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs72946226	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143765238	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34230433	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143765253	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs7696869	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143765855	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs7698287	ENSG00000251600.4	RP11-673E1.1	-4.94	8.52e-06	0.037	-0.78	-0.57	Immature fraction of reticulocytes;	chr4:143765859	chr4:143912331~143982454:+
ACC	cis	rs2486288	0.656	rs11632724	ENSG00000259520.4	CTD-2651B20.3	4.94	8.56e-06	0.0371	0.63	0.56	Glomerular filtration rate;	chr15:45258593	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs11632651	ENSG00000259520.4	CTD-2651B20.3	4.94	8.56e-06	0.0371	0.63	0.56	Glomerular filtration rate;	chr15:45258640	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs11637920	ENSG00000259520.4	CTD-2651B20.3	4.94	8.56e-06	0.0371	0.63	0.56	Glomerular filtration rate;	chr15:45258707	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs11632777	ENSG00000259520.4	CTD-2651B20.3	4.94	8.56e-06	0.0371	0.63	0.56	Glomerular filtration rate;	chr15:45258847	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs11632778	ENSG00000259520.4	CTD-2651B20.3	4.94	8.56e-06	0.0371	0.63	0.56	Glomerular filtration rate;	chr15:45258858	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs11632752	ENSG00000259520.4	CTD-2651B20.3	4.94	8.56e-06	0.0371	0.63	0.56	Glomerular filtration rate;	chr15:45258942	chr15:45251580~45279251:-
ACC	cis	rs10256972	0.732	rs1574108	ENSG00000229043.2	AC091729.9	-4.94	8.57e-06	0.0371	-0.59	-0.56	Endometriosis;Longevity;	chr7:1066169	chr7:1160374~1165267:+
ACC	cis	rs10256972	0.732	rs12701856	ENSG00000229043.2	AC091729.9	-4.94	8.57e-06	0.0371	-0.59	-0.56	Endometriosis;Longevity;	chr7:1068071	chr7:1160374~1165267:+
ACC	cis	rs961253	1	rs8124724	ENSG00000205181.5	LINC00654	4.94	8.61e-06	0.0373	0.68	0.56	Colorectal cancer;	chr20:6422874	chr20:5496067~5504613:-
ACC	cis	rs8037818	1	rs4643284	ENSG00000276724.1	RP11-1000B6.7	-4.94	8.63e-06	0.0373	-0.59	-0.56	Obesity-related traits;	chr15:32639897	chr15:32583612~32584312:+
ACC	cis	rs4835473	0.932	rs12512649	ENSG00000251600.4	RP11-673E1.1	-4.94	8.64e-06	0.0373	-0.78	-0.56	Immature fraction of reticulocytes;	chr4:143736745	chr4:143912331~143982454:+
ACC	cis	rs2880765	0.835	rs7161880	ENSG00000259295.5	CSPG4P12	4.93	8.66e-06	0.0373	0.7	0.56	Coronary artery disease;	chr15:85475515	chr15:85191438~85213905:+
ACC	cis	rs6452524	0.618	rs6452502	ENSG00000249664.1	CTD-2227C6.2	4.93	8.69e-06	0.0373	0.65	0.56	Hypertension (SNP x SNP interaction);	chr5:83074578	chr5:83012285~83013109:-
ACC	cis	rs2739330	0.796	rs1006771	ENSG00000225282.1	AP000350.6	4.93	8.74e-06	0.0375	0.58	0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23971817	chr22:23926900~23929574:+
ACC	cis	rs2739330	0.828	rs2186366	ENSG00000225282.1	AP000350.6	-4.93	8.75e-06	0.0375	-0.57	-0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911926	chr22:23926900~23929574:+
ACC	cis	rs10740039	0.883	rs2393676	ENSG00000237233.2	TMEM26-AS1	-4.93	8.75e-06	0.0375	-0.93	-0.56	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;	chr10:60630500	chr10:61452639~61481956:+
ACC	cis	rs858239	0.899	rs28458177	ENSG00000230658.1	KLHL7-AS1	4.93	8.75e-06	0.0375	0.69	0.56	Cerebrospinal fluid biomarker levels;	chr7:23255253	chr7:23101228~23105703:-
ACC	cis	rs875971	0.545	rs4441996	ENSG00000226824.5	RP4-756H11.3	4.93	8.77e-06	0.0375	0.77	0.56	Aortic root size;	chr7:66123233	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs316324	ENSG00000226824.5	RP4-756H11.3	4.93	8.77e-06	0.0375	0.77	0.56	Aortic root size;	chr7:66145627	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs316323	ENSG00000226824.5	RP4-756H11.3	4.93	8.77e-06	0.0375	0.77	0.56	Aortic root size;	chr7:66146002	chr7:66654538~66669855:+
ACC	cis	rs8040855	0.794	rs4843024	ENSG00000259295.5	CSPG4P12	-4.93	8.78e-06	0.0375	-0.74	-0.56	Bulimia nervosa;	chr15:85162669	chr15:85191438~85213905:+
ACC	cis	rs7188445	0.871	rs11150187	ENSG00000261390.4	RP11-345M22.2	4.93	8.83e-06	0.0377	0.7	0.56	Urate levels;	chr16:79670515	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.871	rs8047723	ENSG00000261390.4	RP11-345M22.2	4.93	8.83e-06	0.0377	0.7	0.56	Urate levels;	chr16:79671018	chr16:79715232~79770563:-
ACC	cis	rs7551345	0.653	rs6672915	ENSG00000269967.1	RP11-84A19.4	4.93	8.85e-06	0.0378	0.71	0.56	Schizophrenia;	chr1:31218514	chr1:31851913~31921841:-
ACC	cis	rs9322193	0.607	rs3798763	ENSG00000231760.4	RP11-350J20.5	4.93	8.94e-06	0.0381	0.81	0.56	Lung cancer;	chr6:149889964	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.607	rs12204653	ENSG00000231760.4	RP11-350J20.5	4.93	8.94e-06	0.0381	0.81	0.56	Lung cancer;	chr6:149891885	chr6:149796151~149826294:-
ACC	cis	rs9487094	0.961	rs11967108	ENSG00000260273.1	RP11-425D10.10	4.92	8.95e-06	0.0382	0.69	0.56	Height;	chr6:109354040	chr6:109382795~109383666:+
ACC	cis	rs4835473	0.9	rs35670120	ENSG00000251600.4	RP11-673E1.1	-4.92	9.02e-06	0.0382	-0.74	-0.56	Immature fraction of reticulocytes;	chr4:143787041	chr4:143912331~143982454:+
ACC	cis	rs7188445	1	rs7190187	ENSG00000261390.4	RP11-345M22.2	-4.92	9.03e-06	0.0382	-0.77	-0.56	Urate levels;	chr16:79701281	chr16:79715232~79770563:-
ACC	cis	rs9487094	0.67	rs1998811	ENSG00000260273.1	RP11-425D10.10	4.92	9.03e-06	0.0382	0.7	0.56	Height;	chr6:109490935	chr6:109382795~109383666:+
ACC	cis	rs597539	0.652	rs592697	ENSG00000250508.1	RP11-757G1.6	-4.92	9.06e-06	0.0382	-0.96	-0.56	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68882596	chr11:68870664~68874542:+
ACC	cis	rs597539	0.652	rs654071	ENSG00000250508.1	RP11-757G1.6	-4.92	9.06e-06	0.0382	-0.96	-0.56	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;	chr11:68885964	chr11:68870664~68874542:+
ACC	cis	rs10256972	0.621	rs2363285	ENSG00000229043.2	AC091729.9	-4.92	9.06e-06	0.0382	-0.58	-0.56	Endometriosis;Longevity;	chr7:1052008	chr7:1160374~1165267:+
ACC	cis	rs7188445	0.871	rs7202770	ENSG00000261390.4	RP11-345M22.2	-4.92	9.11e-06	0.0384	-0.7	-0.56	Urate levels;	chr16:79672643	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.835	rs1424231	ENSG00000261390.4	RP11-345M22.2	-4.92	9.11e-06	0.0384	-0.7	-0.56	Urate levels;	chr16:79672854	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.871	rs16950997	ENSG00000261390.4	RP11-345M22.2	-4.92	9.11e-06	0.0384	-0.7	-0.56	Urate levels;	chr16:79673733	chr16:79715232~79770563:-
ACC	cis	rs1799949	0.931	rs34410138	ENSG00000198496.9	NBR2	-4.92	9.13e-06	0.0384	-0.71	-0.56	Menopause (age at onset);	chr17:43127753	chr17:43125610~43153671:+
ACC	cis	rs6452524	0.618	rs6452503	ENSG00000249664.1	CTD-2227C6.2	4.92	9.17e-06	0.0386	0.63	0.56	Hypertension (SNP x SNP interaction);	chr5:83074596	chr5:83012285~83013109:-
ACC	cis	rs6452524	0.618	rs6452504	ENSG00000249664.1	CTD-2227C6.2	4.92	9.17e-06	0.0386	0.63	0.56	Hypertension (SNP x SNP interaction);	chr5:83074625	chr5:83012285~83013109:-
ACC	cis	rs9487094	0.67	rs7755941	ENSG00000260273.1	RP11-425D10.10	4.92	9.26e-06	0.0389	0.69	0.56	Height;	chr6:109494148	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.626	rs7773950	ENSG00000260273.1	RP11-425D10.10	4.92	9.26e-06	0.0389	0.69	0.56	Height;	chr6:109494237	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.6	rs3799842	ENSG00000260273.1	RP11-425D10.10	4.92	9.26e-06	0.0389	0.92	0.56	Height;	chr6:109471826	chr6:109382795~109383666:+
ACC	cis	rs2882667	0.628	rs13162420	ENSG00000253404.1	AC034243.1	4.91	9.27e-06	0.0389	0.91	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:138839070	chr5:138744434~138753309:-
ACC	cis	rs2882667	0.628	rs13167462	ENSG00000253404.1	AC034243.1	4.91	9.27e-06	0.0389	0.91	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:138841572	chr5:138744434~138753309:-
ACC	cis	rs2739330	0.76	rs1002286	ENSG00000218537.1	MIF-AS1	-4.91	9.31e-06	0.039	-0.6	-0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23915150	chr22:23894426~23898930:-
ACC	cis	rs6921919	0.583	rs6928771	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28407432	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs6928773	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28407433	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.525	rs6929825	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28411182	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs35599905	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28411886	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs1124131	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28412471	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs6899389	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28413363	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs6922374	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28413495	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs6899603	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28413528	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs6922429	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28413568	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs6922169	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28415155	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.559	rs13210866	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28416065	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.609	rs36018474	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28417752	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs13201726	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28417774	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.525	rs11760133	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28418962	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs2027361	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28420531	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs4642462	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28421474	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs3800328	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28423066	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.609	rs67211468	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28424210	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs35560946	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28427660	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs740621	ENSG00000216901.1	AL022393.7	4.91	9.34e-06	0.039	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28430010	chr6:28176188~28176674:+
ACC	cis	rs2882667	0.929	rs17207828	ENSG00000253404.1	AC034243.1	4.91	9.38e-06	0.0391	0.81	0.56	Age-related hearing impairment (SNP x SNP interaction);	chr5:138964146	chr5:138744434~138753309:-
ACC	cis	rs2880765	0.835	rs4360875	ENSG00000259295.5	CSPG4P12	4.91	9.44e-06	0.0393	0.68	0.56	Coronary artery disease;	chr15:85497163	chr15:85191438~85213905:+
ACC	cis	rs9487094	0.626	rs2025148	ENSG00000260273.1	RP11-425D10.10	4.91	9.52e-06	0.0396	0.69	0.56	Height;	chr6:109706740	chr6:109382795~109383666:+
ACC	cis	rs7208859	0.623	rs383436	ENSG00000263531.1	RP13-753N3.1	4.91	9.53e-06	0.0396	1.13	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30632161	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.714	rs11650821	ENSG00000263531.1	RP13-753N3.1	4.91	9.53e-06	0.0396	1.13	0.56	Body mass index;	chr17:30641132	chr17:30863921~30864940:-
ACC	cis	rs9487094	0.626	rs3799845	ENSG00000260273.1	RP11-425D10.10	4.91	9.55e-06	0.0396	0.68	0.56	Height;	chr6:109706514	chr6:109382795~109383666:+
ACC	cis	rs8040855	0.599	rs4643289	ENSG00000259295.5	CSPG4P12	-4.91	9.59e-06	0.0398	-0.69	-0.56	Bulimia nervosa;	chr15:85183483	chr15:85191438~85213905:+
ACC	cis	rs983545	0.8	rs4685400	ENSG00000272498.1	RP11-415F23.3	4.9	9.65e-06	0.04	0.63	0.56	Blood protein levels;	chr3:16905959	chr3:16339308~16339871:+
ACC	cis	rs9326248	0.731	rs90192	ENSG00000254851.1	RP11-109L13.1	-4.9	9.68e-06	0.0401	-0.8	-0.56	Blood protein levels;	chr11:117188631	chr11:117135528~117138582:+
ACC	cis	rs8040855	0.894	rs6496770	ENSG00000259295.5	CSPG4P12	-4.9	9.69e-06	0.0401	-0.74	-0.56	Bulimia nervosa;	chr15:85161890	chr15:85191438~85213905:+
ACC	cis	rs17826219	0.636	rs2449770	ENSG00000263531.1	RP13-753N3.1	4.9	9.81e-06	0.0404	1.12	0.56	Body mass index;	chr17:30774046	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.524	rs59913838	ENSG00000263531.1	RP13-753N3.1	4.9	9.81e-06	0.0404	1.12	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30774545	chr17:30863921~30864940:-
ACC	cis	rs2486288	0.656	rs9921025	ENSG00000259520.4	CTD-2651B20.3	4.9	9.82e-06	0.0405	0.64	0.56	Glomerular filtration rate;	chr15:45254404	chr15:45251580~45279251:-
ACC	cis	rs7188445	0.932	rs73575079	ENSG00000261390.4	RP11-345M22.2	-4.9	9.83e-06	0.0405	-0.71	-0.56	Urate levels;	chr16:79711344	chr16:79715232~79770563:-
ACC	cis	rs9487094	0.666	rs7748669	ENSG00000260273.1	RP11-425D10.10	4.9	9.84e-06	0.0405	0.64	0.56	Height;	chr6:109424139	chr6:109382795~109383666:+
ACC	cis	rs3812049	0.737	rs1993878	ENSG00000245937.6	LINC01184	4.9	9.89e-06	0.0407	0.71	0.56	Lymphocyte counts;Red cell distribution width;	chr5:128141279	chr5:127940426~128083172:-
ACC	cis	rs4972806	0.739	rs10834	ENSG00000226363.3	HAGLROS	-4.9	9.89e-06	0.0407	-0.61	-0.56	IgG glycosylation;	chr2:176177359	chr2:176177717~176179008:+
ACC	cis	rs6921919	0.583	rs6908137	ENSG00000216901.1	AL022393.7	4.9	9.93e-06	0.0407	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28402616	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs4254981	ENSG00000216901.1	AL022393.7	4.9	9.93e-06	0.0407	0.73	0.56	Autism spectrum disorder or schizophrenia;	chr6:28403625	chr6:28176188~28176674:+
ACC	cis	rs684232	0.901	rs450289	ENSG00000262920.4	RP11-1260E13.1	-4.89	9.94e-06	0.0407	-0.57	-0.56	Prostate cancer;	chr17:726656	chr17:321392~322453:+
ACC	cis	rs2919009	0.664	rs10510083	ENSG00000236762.1	RP11-159H3.1	-4.89	9.96e-06	0.0407	-0.75	-0.56	Obesity-related traits;	chr10:120925013	chr10:121133090~121133723:-
ACC	cis	rs9322193	0.772	rs7738696	ENSG00000268592.3	RAET1E-AS1	4.89	1e-05	0.0407	0.65	0.56	Lung cancer;	chr6:149848985	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.884	rs7743823	ENSG00000268592.3	RAET1E-AS1	4.89	1e-05	0.0407	0.65	0.56	Lung cancer;	chr6:149849744	chr6:149863494~149919507:+
ACC	cis	rs2739330	0.761	rs5760176	ENSG00000218537.1	MIF-AS1	-4.89	1e-05	0.0407	-0.69	-0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005875	chr22:23894426~23898930:-
ACC	cis	rs875971	0.528	rs801213	ENSG00000226824.5	RP4-756H11.3	4.89	1e-05	0.0407	0.8	0.56	Aortic root size;	chr7:66549931	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs801212	ENSG00000226824.5	RP4-756H11.3	4.89	1e-05	0.0407	0.8	0.56	Aortic root size;	chr7:66550643	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs801199	ENSG00000226824.5	RP4-756H11.3	4.89	1e-05	0.0407	0.8	0.56	Aortic root size;	chr7:66560286	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs1638724	ENSG00000226824.5	RP4-756H11.3	4.89	1e-05	0.0407	0.8	0.56	Aortic root size;	chr7:66575494	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs1267814	ENSG00000226824.5	RP4-756H11.3	4.89	1e-05	0.0407	0.8	0.56	Aortic root size;	chr7:66579422	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs13311962	ENSG00000226824.5	RP4-756H11.3	4.89	1e-05	0.0407	0.8	0.56	Aortic root size;	chr7:66603142	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs17138156	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66249708	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs1547529	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66258859	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs11767262	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66302237	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs3735147	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66505541	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs6950988	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66511428	chr7:66654538~66669855:+
ACC	cis	rs875971	0.597	rs11763224	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66518628	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs73152714	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66534641	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs4718364	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66536353	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs6961853	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66537035	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs1796226	ENSG00000226824.5	RP4-756H11.3	-4.89	1e-05	0.0407	-0.8	-0.56	Aortic root size;	chr7:66622723	chr7:66654538~66669855:+
ACC	cis	rs9487094	0.67	rs2277114	ENSG00000260273.1	RP11-425D10.10	4.89	1e-05	0.0407	0.66	0.56	Height;	chr6:109506513	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.626	rs12195904	ENSG00000260273.1	RP11-425D10.10	4.89	1.01e-05	0.0408	0.68	0.56	Height;	chr6:109494760	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs1406899	ENSG00000260273.1	RP11-425D10.10	4.89	1.01e-05	0.0408	0.68	0.56	Height;	chr6:109495102	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs11153183	ENSG00000260273.1	RP11-425D10.10	4.89	1.01e-05	0.0408	0.68	0.56	Height;	chr6:109496073	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs11754455	ENSG00000260273.1	RP11-425D10.10	4.89	1.01e-05	0.0408	0.68	0.56	Height;	chr6:109496680	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs2024849	ENSG00000260273.1	RP11-425D10.10	4.89	1.01e-05	0.0408	0.68	0.56	Height;	chr6:109497088	chr6:109382795~109383666:+
ACC	cis	rs983545	0.586	rs9880307	ENSG00000272498.1	RP11-415F23.3	4.89	1.01e-05	0.0408	0.63	0.56	Blood protein levels;	chr3:16933118	chr3:16339308~16339871:+
ACC	cis	rs983545	0.586	rs4685404	ENSG00000272498.1	RP11-415F23.3	4.89	1.01e-05	0.0408	0.63	0.56	Blood protein levels;	chr3:16937150	chr3:16339308~16339871:+
ACC	cis	rs6452524	0.618	rs6452501	ENSG00000249664.1	CTD-2227C6.2	4.89	1.02e-05	0.0408	0.61	0.56	Hypertension (SNP x SNP interaction);	chr5:83068681	chr5:83012285~83013109:-
ACC	cis	rs2880765	0.835	rs7180213	ENSG00000259295.5	CSPG4P12	4.89	1.02e-05	0.0408	0.69	0.56	Coronary artery disease;	chr15:85477956	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.835	rs11638498	ENSG00000259295.5	CSPG4P12	4.89	1.02e-05	0.0408	0.69	0.56	Coronary artery disease;	chr15:85479787	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.835	rs4526974	ENSG00000259295.5	CSPG4P12	4.89	1.02e-05	0.0408	0.69	0.56	Coronary artery disease;	chr15:85481053	chr15:85191438~85213905:+
ACC	cis	rs4835473	0.932	rs5015760	ENSG00000251600.4	RP11-673E1.1	-4.89	1.02e-05	0.0408	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143737955	chr4:143912331~143982454:+
ACC	cis	rs2739330	0.731	rs5751792	ENSG00000218537.1	MIF-AS1	4.89	1.02e-05	0.0408	0.69	0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005096	chr22:23894426~23898930:-
ACC	cis	rs1799949	1	rs16942	ENSG00000198496.9	NBR2	-4.89	1.02e-05	0.0409	-0.77	-0.56	Menopause (age at onset);	chr17:43091983	chr17:43125610~43153671:+
ACC	cis	rs77204473	0.655	rs11216183	ENSG00000254851.1	RP11-109L13.1	4.89	1.03e-05	0.0411	1.33	0.56	Sum eosinophil basophil counts;Eosinophil counts;	chr11:116910829	chr11:117135528~117138582:+
ACC	cis	rs7188445	0.932	rs3813582	ENSG00000261390.4	RP11-345M22.2	-4.88	1.03e-05	0.0413	-0.66	-0.56	Urate levels;	chr16:79715456	chr16:79715232~79770563:-
ACC	cis	rs9322193	0.923	rs4870050	ENSG00000268592.3	RAET1E-AS1	4.88	1.03e-05	0.0413	0.65	0.56	Lung cancer;	chr6:149838917	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.962	rs7752089	ENSG00000268592.3	RAET1E-AS1	4.88	1.03e-05	0.0413	0.65	0.56	Lung cancer;	chr6:149839298	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.923	rs4242279	ENSG00000268592.3	RAET1E-AS1	4.88	1.03e-05	0.0413	0.65	0.56	Lung cancer;	chr6:149839815	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.923	rs4870052	ENSG00000268592.3	RAET1E-AS1	4.88	1.03e-05	0.0413	0.65	0.56	Lung cancer;	chr6:149839978	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.962	rs2275045	ENSG00000268592.3	RAET1E-AS1	4.88	1.03e-05	0.0413	0.65	0.56	Lung cancer;	chr6:149842775	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.923	rs2184370	ENSG00000268592.3	RAET1E-AS1	4.88	1.03e-05	0.0413	0.65	0.56	Lung cancer;	chr6:149843242	chr6:149863494~149919507:+
ACC	cis	rs3812049	0.826	rs34576922	ENSG00000245937.6	LINC01184	-4.88	1.05e-05	0.042	-0.73	-0.56	Lymphocyte counts;Red cell distribution width;	chr5:128028411	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.826	rs6860245	ENSG00000245937.6	LINC01184	-4.88	1.05e-05	0.042	-0.73	-0.56	Lymphocyte counts;Red cell distribution width;	chr5:128032306	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.784	rs2250127	ENSG00000245937.6	LINC01184	-4.88	1.05e-05	0.042	-0.73	-0.56	Lymphocyte counts;Red cell distribution width;	chr5:128053152	chr5:127940426~128083172:-
ACC	cis	rs2486288	0.656	rs6493144	ENSG00000259520.4	CTD-2651B20.3	-4.88	1.05e-05	0.042	-0.66	-0.56	Glomerular filtration rate;	chr15:45281291	chr15:45251580~45279251:-
ACC	cis	rs1799949	1	rs4793197	ENSG00000198496.9	NBR2	-4.88	1.06e-05	0.0424	-0.75	-0.56	Menopause (age at onset);	chr17:43079885	chr17:43125610~43153671:+
ACC	cis	rs507080	0.961	rs4457789	ENSG00000278376.1	RP11-158I9.8	-4.87	1.07e-05	0.0425	-0.5	-0.56	Serum metabolite levels;	chr11:118668461	chr11:118791254~118793137:+
ACC	cis	rs875971	0.571	rs160641	ENSG00000226824.5	RP4-756H11.3	4.87	1.08e-05	0.0426	0.77	0.56	Aortic root size;	chr7:66112359	chr7:66654538~66669855:+
ACC	cis	rs9322193	0.607	rs9383941	ENSG00000231760.4	RP11-350J20.5	-4.87	1.08e-05	0.0426	-0.76	-0.56	Lung cancer;	chr6:149912100	chr6:149796151~149826294:-
ACC	cis	rs2880765	0.743	rs11630410	ENSG00000259295.5	CSPG4P12	4.87	1.08e-05	0.0426	0.7	0.56	Coronary artery disease;	chr15:85461510	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.71	rs11630457	ENSG00000259295.5	CSPG4P12	4.87	1.08e-05	0.0426	0.7	0.56	Coronary artery disease;	chr15:85461570	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.743	rs16940052	ENSG00000259295.5	CSPG4P12	4.87	1.08e-05	0.0426	0.7	0.56	Coronary artery disease;	chr15:85463443	chr15:85191438~85213905:+
ACC	cis	rs9487094	0.67	rs2024852	ENSG00000260273.1	RP11-425D10.10	4.87	1.08e-05	0.0426	0.68	0.56	Height;	chr6:109498586	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs2024853	ENSG00000260273.1	RP11-425D10.10	4.87	1.08e-05	0.0426	0.68	0.56	Height;	chr6:109498751	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs13203587	ENSG00000260273.1	RP11-425D10.10	4.87	1.08e-05	0.0426	0.68	0.56	Height;	chr6:109499759	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.67	rs12197180	ENSG00000260273.1	RP11-425D10.10	4.87	1.08e-05	0.0426	0.68	0.56	Height;	chr6:109500687	chr6:109382795~109383666:+
ACC	cis	rs4835473	0.932	rs1450235	ENSG00000251600.4	RP11-673E1.1	4.87	1.08e-05	0.0426	0.76	0.56	Immature fraction of reticulocytes;	chr4:143782927	chr4:143912331~143982454:+
ACC	cis	rs7208859	0.623	rs55724095	ENSG00000263531.1	RP13-753N3.1	4.87	1.09e-05	0.0427	1.1	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30826040	chr17:30863921~30864940:-
ACC	cis	rs17826219	0.568	rs9903854	ENSG00000263531.1	RP13-753N3.1	4.87	1.09e-05	0.0427	1.1	0.56	Body mass index;	chr17:30826980	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs80355557	ENSG00000263531.1	RP13-753N3.1	4.87	1.09e-05	0.0427	1.1	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30827403	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.623	rs9911173	ENSG00000263531.1	RP13-753N3.1	4.87	1.09e-05	0.0427	1.1	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30827732	chr17:30863921~30864940:-
ACC	cis	rs950027	0.62	rs1346267	ENSG00000259520.4	CTD-2651B20.3	-4.87	1.09e-05	0.0428	-0.66	-0.56	Response to fenofibrate (adiponectin levels);	chr15:45398791	chr15:45251580~45279251:-
ACC	cis	rs4713118	0.513	rs149972	ENSG00000199851.2	U3	4.87	1.1e-05	0.0429	0.6	0.56	Parkinson's disease;	chr6:28015449	chr6:28015568~28015777:+
ACC	cis	rs4713118	0.513	rs149975	ENSG00000199851.2	U3	4.87	1.1e-05	0.0429	0.6	0.56	Parkinson's disease;	chr6:28018562	chr6:28015568~28015777:+
ACC	cis	rs1023500	0.505	rs134886	ENSG00000205702.9	CYP2D7	-4.87	1.1e-05	0.0429	-0.57	-0.56	Schizophrenia;	chr22:42277850	chr22:42140203~42144577:-
ACC	cis	rs2732480	0.5	rs7966829	ENSG00000258273.1	RP11-370I10.4	-4.86	1.1e-05	0.043	-0.75	-0.56	Red blood cell count;Hematocrit;Hemoglobin concentration;	chr12:48221820	chr12:48333755~48333901:-
ACC	cis	rs3812049	0.532	rs251391	ENSG00000245937.6	LINC01184	4.86	1.11e-05	0.0431	0.74	0.56	Lymphocyte counts;Red cell distribution width;	chr5:128202424	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.532	rs251390	ENSG00000245937.6	LINC01184	4.86	1.11e-05	0.0431	0.74	0.56	Lymphocyte counts;Red cell distribution width;	chr5:128202654	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.532	rs251389	ENSG00000245937.6	LINC01184	4.86	1.11e-05	0.0431	0.74	0.56	Lymphocyte counts;Red cell distribution width;	chr5:128206185	chr5:127940426~128083172:-
ACC	cis	rs3812049	0.532	rs251216	ENSG00000245937.6	LINC01184	4.86	1.11e-05	0.0431	0.74	0.56	Lymphocyte counts;Red cell distribution width;	chr5:128207588	chr5:127940426~128083172:-
ACC	cis	rs7188445	0.871	rs8048928	ENSG00000261390.4	RP11-345M22.2	-4.86	1.11e-05	0.0431	-0.7	-0.56	Urate levels;	chr16:79671039	chr16:79715232~79770563:-
ACC	cis	rs4835473	0.932	rs2218791	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.68	-0.56	Immature fraction of reticulocytes;	chr4:143749300	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs12512202	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143771248	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs6843671	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143772041	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs35395070	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143772283	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs34614750	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143772369	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs35002497	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143772952	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs13119630	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143773901	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1450233	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143774710	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs4308330	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143774761	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs11725708	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143775683	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs17762299	ENSG00000251600.4	RP11-673E1.1	-4.86	1.12e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143777196	chr4:143912331~143982454:+
ACC	cis	rs7208859	0.673	rs999798	ENSG00000263531.1	RP13-753N3.1	4.86	1.13e-05	0.0431	1.1	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30831822	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs12949860	ENSG00000263531.1	RP13-753N3.1	4.86	1.13e-05	0.0431	1.1	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30896014	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11650305	ENSG00000263531.1	RP13-753N3.1	4.86	1.13e-05	0.0431	1.1	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30902343	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11654914	ENSG00000263531.1	RP13-753N3.1	4.86	1.13e-05	0.0431	1.1	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30902406	chr17:30863921~30864940:-
ACC	cis	rs4835473	0.932	rs34324222	ENSG00000251600.4	RP11-673E1.1	-4.85	1.15e-05	0.0431	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143784572	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34950821	ENSG00000251600.4	RP11-673E1.1	-4.85	1.15e-05	0.0431	-0.78	-0.56	Immature fraction of reticulocytes;	chr4:143738174	chr4:143912331~143982454:+
ACC	cis	rs9487094	0.626	rs11153215	ENSG00000260273.1	RP11-425D10.10	4.85	1.15e-05	0.0431	0.69	0.56	Height;	chr6:109732518	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.626	rs2273752	ENSG00000260273.1	RP11-425D10.10	4.85	1.15e-05	0.0431	0.69	0.56	Height;	chr6:109738307	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.626	rs12201444	ENSG00000260273.1	RP11-425D10.10	4.85	1.15e-05	0.0431	0.69	0.56	Height;	chr6:109738751	chr6:109382795~109383666:+
ACC	cis	rs4835473	0.808	rs13134564	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143738763	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.838	rs13134571	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143738771	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs13139738	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143738828	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs17018165	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143738849	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.808	rs2060652	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143739129	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.808	rs2060653	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143739132	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.897	rs2060654	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143739155	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs2060655	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143739159	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs2060656	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143739330	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.864	rs67749935	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143739852	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs66934100	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143739872	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs4257605	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143740081	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs4498094	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143740097	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs4325971	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143740167	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs4443230	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143740372	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs4637344	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143740434	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs56277406	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143740620	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs13143879	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143740901	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs36086465	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143742738	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs873430	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143742953	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs873431	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143743035	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs899903	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143743551	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs2323191	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143744472	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs1375982	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143745764	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs4835237	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143746349	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs56084616	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143746697	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.966	rs11722639	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143746884	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.966	rs11722673	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143746946	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs6821979	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143748091	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs6838887	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143748130	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1982392	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143748604	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1982393	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143748736	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs9683880	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143748787	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs7687976	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143749171	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs7683287	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143749270	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.712	rs2198000	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143750005	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs2198002	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143750028	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs6853460	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143750392	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs6853676	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143750495	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs6848393	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143750537	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs971390	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143751264	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.868	rs971391	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143751324	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs971392	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143751384	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.838	rs35978782	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143751713	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34060266	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143751766	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs35300159	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143751768	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs13139419	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143751862	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.868	rs13106052	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143751995	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs13134401	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752008	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs13106287	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752091	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs13134679	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752187	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs13108134	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752213	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs34406317	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752237	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs35863996	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752260	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs6836896	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752404	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs2874983	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752589	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs2874984	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752622	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs2323192	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752646	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs2323193	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143752812	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34152627	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143753205	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs35670108	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143753280	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs6832005	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143754284	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.838	rs55963933	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143755048	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.868	rs35243309	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143755116	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs34790336	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143755284	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs35740243	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143755395	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs4395452	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143755678	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.741	rs6537180	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143755984	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.741	rs6537181	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143755995	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs6814065	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143756233	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs6816347	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143756674	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.808	rs6847256	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143757032	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.868	rs57413073	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143757852	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34732468	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143758009	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs12510395	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143758107	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs12513087	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143758551	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs12513119	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143758619	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs12513130	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143758666	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs935732	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143759164	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.868	rs7681891	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143759289	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.771	rs34069296	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143759656	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.897	rs7687915	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143759801	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1993015	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143760202	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs1993016	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143760217	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1993017	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143760285	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs1375983	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143760423	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1375984	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143760510	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1375985	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143760556	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs17018200	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143760866	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs11100805	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143760979	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.868	rs56115009	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761073	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs10857406	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761216	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs10857407	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761226	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs10857408	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761333	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs10857409	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761461	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs10857410	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761566	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs10857411	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761599	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1006406	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761710	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1562776	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143761999	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34697602	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143762499	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs34618381	ENSG00000251600.4	RP11-673E1.1	-4.85	1.16e-05	0.0431	-0.76	-0.56	Immature fraction of reticulocytes;	chr4:143762612	chr4:143912331~143982454:+
ACC	cis	rs2880765	0.743	rs12906308	ENSG00000259295.5	CSPG4P12	-4.85	1.16e-05	0.0431	-0.7	-0.56	Coronary artery disease;	chr15:85464828	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.743	rs8039049	ENSG00000259295.5	CSPG4P12	4.85	1.16e-05	0.0431	0.7	0.56	Coronary artery disease;	chr15:85464398	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.743	rs8039631	ENSG00000259295.5	CSPG4P12	4.85	1.16e-05	0.0431	0.7	0.56	Coronary artery disease;	chr15:85464700	chr15:85191438~85213905:+
ACC	cis	rs763121	0.962	rs138703	ENSG00000273076.1	RP3-508I15.22	4.85	1.17e-05	0.0431	0.58	0.56	Menopause (age at onset);	chr22:38736743	chr22:38743495~38743910:+
ACC	cis	rs17711722	0.51	rs11767457	ENSG00000226824.5	RP4-756H11.3	-4.85	1.17e-05	0.0431	-0.75	-0.56	Calcium levels;	chr7:65825628	chr7:66654538~66669855:+
ACC	cis	rs9399135	0.622	rs3817776	ENSG00000232876.1	CTA-212D2.2	4.85	1.17e-05	0.0431	0.61	0.56	Red blood cell count;	chr6:134935618	chr6:135055033~135060550:+
ACC	cis	rs2117029	0.619	rs2753	ENSG00000258017.1	RP11-386G11.10	-4.85	1.18e-05	0.0433	-0.65	-0.56	Intelligence (multi-trait analysis);	chr12:49127889	chr12:49127782~49147869:+
ACC	cis	rs9322193	0.884	rs9480009	ENSG00000268592.3	RAET1E-AS1	4.84	1.18e-05	0.0434	0.64	0.56	Lung cancer;	chr6:149758502	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.923	rs10747276	ENSG00000268592.3	RAET1E-AS1	4.84	1.18e-05	0.0434	0.64	0.56	Lung cancer;	chr6:149758739	chr6:149863494~149919507:+
ACC	cis	rs9322193	0.962	rs7818	ENSG00000268592.3	RAET1E-AS1	4.84	1.19e-05	0.0437	0.67	0.56	Lung cancer;	chr6:149810956	chr6:149863494~149919507:+
ACC	cis	rs4835473	0.897	rs1817027	ENSG00000251600.4	RP11-673E1.1	-4.84	1.19e-05	0.0437	-0.77	-0.56	Immature fraction of reticulocytes;	chr4:143713336	chr4:143912331~143982454:+
ACC	cis	rs10875746	0.903	rs11168414	ENSG00000240399.1	RP1-228P16.1	-4.84	1.19e-05	0.0437	-0.77	-0.56	Longevity (90 years and older);	chr12:48118548	chr12:48054813~48055591:-
ACC	cis	rs3812049	0.784	rs7734927	ENSG00000245937.6	LINC01184	4.84	1.2e-05	0.0439	0.71	0.56	Lymphocyte counts;Red cell distribution width;	chr5:128118043	chr5:127940426~128083172:-
ACC	cis	rs9322193	0.886	rs4870055	ENSG00000268592.3	RAET1E-AS1	4.84	1.2e-05	0.044	0.65	0.56	Lung cancer;	chr6:149848433	chr6:149863494~149919507:+
ACC	cis	rs7188445	1	rs11150189	ENSG00000261390.4	RP11-345M22.2	-4.84	1.21e-05	0.0442	-0.72	-0.56	Urate levels;	chr16:79700330	chr16:79715232~79770563:-
ACC	cis	rs12022452	0.63	rs3795346	ENSG00000238287.1	RP11-656D10.3	-4.84	1.21e-05	0.0443	-0.81	-0.56	Age-related hearing impairment (SNP x SNP interaction);	chr1:40508753	chr1:40493157~40508661:-
ACC	cis	rs6921919	0.583	rs7764737	ENSG00000216901.1	AL022393.7	4.84	1.22e-05	0.0444	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28386838	chr6:28176188~28176674:+
ACC	cis	rs2408955	0.568	rs12099462	ENSG00000258273.1	RP11-370I10.4	4.84	1.22e-05	0.0444	0.76	0.56	Glycated hemoglobin levels;	chr12:48109321	chr12:48333755~48333901:-
ACC	cis	rs1799949	1	rs2271573	ENSG00000198496.9	NBR2	-4.84	1.22e-05	0.0445	-0.75	-0.56	Menopause (age at onset);	chr17:43175604	chr17:43125610~43153671:+
ACC	cis	rs6921919	0.583	rs1054372	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28368965	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs9468354	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28370024	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs7773051	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28372539	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs12697938	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28373322	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs13437294	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28373758	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.609	rs9468357	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28374276	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs34513104	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28375566	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs9461456	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28376039	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.525	rs9468360	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28376661	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs16894021	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28377249	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs11751693	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28377306	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs7749736	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28378254	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.525	rs9468361	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28378541	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs7775132	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28379236	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs3734563	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28381948	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs1591913	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28383951	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs7759191	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28385657	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs9461458	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28388098	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.609	rs9468365	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28390189	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs1361385	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28390543	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs1416918	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28390558	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs9468367	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28392469	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs9461459	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28394139	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs28360638	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28394552	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs9468368	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28397172	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs2041230	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28397738	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.609	rs1005127	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28399881	chr6:28176188~28176674:+
ACC	cis	rs853679	0.515	rs4580862	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Depression;	chr6:28399886	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs4357130	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28399906	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs11755942	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28401760	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.583	rs6907950	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28402469	chr6:28176188~28176674:+
ACC	cis	rs6921919	0.525	rs16894095	ENSG00000216901.1	AL022393.7	4.83	1.23e-05	0.0445	0.71	0.56	Autism spectrum disorder or schizophrenia;	chr6:28422453	chr6:28176188~28176674:+
ACC	cis	rs7174755	1	rs7174755	ENSG00000260657.2	RP11-315D16.4	-4.83	1.23e-05	0.0445	-0.59	-0.56	Major depressive disorder;	chr15:68304789	chr15:68267792~68277994:-
ACC	cis	rs4835473	0.897	rs11728121	ENSG00000251600.4	RP11-673E1.1	4.83	1.23e-05	0.0446	0.81	0.56	Immature fraction of reticulocytes;	chr4:143707079	chr4:143912331~143982454:+
ACC	cis	rs9487094	0.961	rs12206928	ENSG00000260273.1	RP11-425D10.10	4.83	1.24e-05	0.0449	0.68	0.56	Height;	chr6:109357908	chr6:109382795~109383666:+
ACC	cis	rs4718428	1	rs4718421	ENSG00000226824.5	RP4-756H11.3	-4.83	1.25e-05	0.045	-0.67	-0.56	Corneal structure;	chr7:66885313	chr7:66654538~66669855:+
ACC	cis	rs12022452	1	rs12048678	ENSG00000238287.1	RP11-656D10.3	-4.83	1.25e-05	0.0451	-0.91	-0.56	Age-related hearing impairment (SNP x SNP interaction);	chr1:40482096	chr1:40493157~40508661:-
ACC	cis	rs2739330	0.789	rs5760109	ENSG00000225282.1	AP000350.6	4.83	1.25e-05	0.0452	0.55	0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910751	chr22:23926900~23929574:+
ACC	cis	rs2739330	0.828	rs2186366	ENSG00000218537.1	MIF-AS1	-4.83	1.26e-05	0.0455	-0.62	-0.56	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23911926	chr22:23894426~23898930:-
ACC	cis	rs7188445	0.932	rs17689159	ENSG00000261390.4	RP11-345M22.2	-4.82	1.27e-05	0.0456	-0.74	-0.56	Urate levels;	chr16:79708493	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.932	rs73575076	ENSG00000261390.4	RP11-345M22.2	-4.82	1.27e-05	0.0456	-0.74	-0.56	Urate levels;	chr16:79710251	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.932	rs17767383	ENSG00000261390.4	RP11-345M22.2	-4.82	1.27e-05	0.0456	-0.74	-0.56	Urate levels;	chr16:79710504	chr16:79715232~79770563:-
ACC	cis	rs763121	0.889	rs4820335	ENSG00000273076.1	RP3-508I15.22	-4.82	1.27e-05	0.0456	-0.67	-0.56	Menopause (age at onset);	chr22:38539922	chr22:38743495~38743910:+
ACC	cis	rs7208859	0.623	rs60890550	ENSG00000263531.1	RP13-753N3.1	4.82	1.27e-05	0.0456	1.07	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30703843	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.673	rs11653955	ENSG00000263531.1	RP13-753N3.1	4.82	1.27e-05	0.0456	1.07	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30706274	chr17:30863921~30864940:-
ACC	cis	rs7208859	0.573	rs55661352	ENSG00000263531.1	RP13-753N3.1	4.82	1.27e-05	0.0456	1.07	0.56	Mean corpuscular hemoglobin;Mean corpuscular volume;	chr17:30718610	chr17:30863921~30864940:-
ACC	cis	rs9487094	1	rs10872032	ENSG00000260273.1	RP11-425D10.10	4.82	1.28e-05	0.0459	0.68	0.56	Height;	chr6:109355573	chr6:109382795~109383666:+
ACC	cis	rs3812049	0.611	rs251393	ENSG00000245937.6	LINC01184	4.82	1.29e-05	0.046	0.74	0.56	Lymphocyte counts;Red cell distribution width;	chr5:128197393	chr5:127940426~128083172:-
ACC	cis	rs7188445	0.932	rs11150191	ENSG00000261390.4	RP11-345M22.2	-4.82	1.29e-05	0.0461	-0.73	-0.56	Urate levels;	chr16:79700390	chr16:79715232~79770563:-
ACC	cis	rs9322193	0.884	rs880245	ENSG00000268592.3	RAET1E-AS1	-4.82	1.3e-05	0.0465	-0.65	-0.56	Lung cancer;	chr6:149846262	chr6:149863494~149919507:+
ACC	cis	rs9487094	0.644	rs910730	ENSG00000260273.1	RP11-425D10.10	4.82	1.3e-05	0.0466	0.66	0.56	Height;	chr6:109447092	chr6:109382795~109383666:+
ACC	cis	rs950027	0.62	rs1145076	ENSG00000259520.4	CTD-2651B20.3	-4.82	1.31e-05	0.0468	-0.66	-0.56	Response to fenofibrate (adiponectin levels);	chr15:45392310	chr15:45251580~45279251:-
ACC	cis	rs17801127	0.636	rs10933118	ENSG00000231969.1	AC144449.1	-4.81	1.31e-05	0.0469	-0.76	-0.56	Liver enzyme levels (alanine transaminase);	chr2:149704914	chr2:149587196~149848233:+
ACC	cis	rs4835473	0.932	rs12509642	ENSG00000251600.4	RP11-673E1.1	-4.81	1.32e-05	0.0469	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143737080	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.801	rs76574827	ENSG00000251600.4	RP11-673E1.1	-4.81	1.32e-05	0.0469	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143737303	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.832	rs62337616	ENSG00000251600.4	RP11-673E1.1	-4.81	1.32e-05	0.0469	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143737307	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.832	rs66717029	ENSG00000251600.4	RP11-673E1.1	-4.81	1.32e-05	0.0469	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143737318	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.864	rs17750354	ENSG00000251600.4	RP11-673E1.1	-4.81	1.32e-05	0.0469	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143737352	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs5015759	ENSG00000251600.4	RP11-673E1.1	-4.81	1.32e-05	0.0469	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143738050	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs5015758	ENSG00000251600.4	RP11-673E1.1	-4.81	1.32e-05	0.0469	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143738052	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs34569841	ENSG00000251600.4	RP11-673E1.1	-4.81	1.32e-05	0.0469	-0.73	-0.56	Immature fraction of reticulocytes;	chr4:143738060	chr4:143912331~143982454:+
ACC	cis	rs9487094	0.601	rs4945831	ENSG00000260273.1	RP11-425D10.10	4.81	1.32e-05	0.0469	0.66	0.56	Height;	chr6:109440234	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.689	rs1476387	ENSG00000260273.1	RP11-425D10.10	4.81	1.32e-05	0.0469	0.66	0.56	Height;	chr6:109443332	chr6:109382795~109383666:+
ACC	cis	rs7950069	0.68	rs17118229	ENSG00000246100.3	LINC00900	-4.81	1.32e-05	0.0469	-1.01	-0.56	Orofacial clefts;	chr11:115310047	chr11:115754248~115760627:-
ACC	cis	rs9399135	0.967	rs6923765	ENSG00000232876.1	CTA-212D2.2	4.81	1.33e-05	0.0472	0.58	0.55	Red blood cell count;	chr6:135014038	chr6:135055033~135060550:+
ACC	cis	rs2486288	0.656	rs8039540	ENSG00000259520.4	CTD-2651B20.3	4.81	1.34e-05	0.0473	0.63	0.55	Glomerular filtration rate;	chr15:45259644	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs8040185	ENSG00000259520.4	CTD-2651B20.3	4.81	1.34e-05	0.0473	0.63	0.55	Glomerular filtration rate;	chr15:45259883	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs1060896	ENSG00000259520.4	CTD-2651B20.3	4.81	1.34e-05	0.0473	0.63	0.55	Glomerular filtration rate;	chr15:45262069	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs11632419	ENSG00000259520.4	CTD-2651B20.3	4.81	1.34e-05	0.0473	0.63	0.55	Glomerular filtration rate;	chr15:45265258	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs2271438	ENSG00000259520.4	CTD-2651B20.3	4.81	1.34e-05	0.0473	0.63	0.55	Glomerular filtration rate;	chr15:45265270	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs11854365	ENSG00000259520.4	CTD-2651B20.3	4.81	1.34e-05	0.0473	0.63	0.55	Glomerular filtration rate;	chr15:45265885	chr15:45251580~45279251:-
ACC	cis	rs4835473	0.932	rs6858195	ENSG00000251600.4	RP11-673E1.1	-4.81	1.34e-05	0.0474	-0.75	-0.55	Immature fraction of reticulocytes;	chr4:143768444	chr4:143912331~143982454:+
ACC	cis	rs12022452	0.591	rs16827359	ENSG00000238287.1	RP11-656D10.3	4.81	1.34e-05	0.0474	0.86	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr1:40535766	chr1:40493157~40508661:-
ACC	cis	rs2117029	0.553	rs731350	ENSG00000258017.1	RP11-386G11.10	-4.81	1.34e-05	0.0474	-0.66	-0.55	Intelligence (multi-trait analysis);	chr12:49130804	chr12:49127782~49147869:+
ACC	cis	rs2880765	0.835	rs11856869	ENSG00000259295.5	CSPG4P12	4.81	1.34e-05	0.0474	0.69	0.55	Coronary artery disease;	chr15:85485866	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.835	rs6497206	ENSG00000259295.5	CSPG4P12	4.81	1.34e-05	0.0474	0.69	0.55	Coronary artery disease;	chr15:85485994	chr15:85191438~85213905:+
ACC	cis	rs4835473	0.838	rs4271960	ENSG00000251600.4	RP11-673E1.1	-4.81	1.34e-05	0.0474	-0.83	-0.55	Immature fraction of reticulocytes;	chr4:143763591	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.808	rs2323198	ENSG00000251600.4	RP11-673E1.1	-4.81	1.34e-05	0.0474	-0.83	-0.55	Immature fraction of reticulocytes;	chr4:143763595	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.9	rs2323199	ENSG00000251600.4	RP11-673E1.1	-4.81	1.34e-05	0.0474	-0.83	-0.55	Immature fraction of reticulocytes;	chr4:143763606	chr4:143912331~143982454:+
ACC	cis	rs2486288	0.656	rs11639349	ENSG00000259520.4	CTD-2651B20.3	4.81	1.34e-05	0.0474	0.72	0.55	Glomerular filtration rate;	chr15:45276062	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs1706768	ENSG00000259520.4	CTD-2651B20.3	4.81	1.34e-05	0.0474	0.72	0.55	Glomerular filtration rate;	chr15:45277245	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs12440356	ENSG00000259520.4	CTD-2651B20.3	-4.81	1.34e-05	0.0474	-0.72	-0.55	Glomerular filtration rate;	chr15:45275331	chr15:45251580~45279251:-
ACC	cis	rs1002796	1	rs11124916	ENSG00000234936.1	AC010883.5	4.81	1.35e-05	0.0476	0.82	0.55	Immunoglobulin A vasculitis;	chr2:43087274	chr2:43229573~43233394:+
ACC	cis	rs875971	0.545	rs1796222	ENSG00000226824.5	RP4-756H11.3	4.81	1.36e-05	0.0476	0.8	0.55	Aortic root size;	chr7:66592167	chr7:66654538~66669855:+
ACC	cis	rs875971	0.502	rs1796227	ENSG00000226824.5	RP4-756H11.3	4.81	1.36e-05	0.0476	0.8	0.55	Aortic root size;	chr7:66622032	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs2420612	ENSG00000226824.5	RP4-756H11.3	-4.81	1.36e-05	0.0476	-0.8	-0.55	Aortic root size;	chr7:66536825	chr7:66654538~66669855:+
ACC	cis	rs1799949	1	rs4793190	ENSG00000198496.9	NBR2	-4.81	1.36e-05	0.0476	-0.81	-0.55	Menopause (age at onset);	chr17:43048092	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs8176297	ENSG00000198496.9	NBR2	-4.81	1.36e-05	0.0476	-0.81	-0.55	Menopause (age at onset);	chr17:43051308	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs8176296	ENSG00000198496.9	NBR2	-4.81	1.36e-05	0.0476	-0.81	-0.55	Menopause (age at onset);	chr17:43051574	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs4793191	ENSG00000198496.9	NBR2	-4.81	1.36e-05	0.0476	-0.81	-0.55	Menopause (age at onset);	chr17:43052360	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs4793192	ENSG00000198496.9	NBR2	-4.81	1.36e-05	0.0476	-0.81	-0.55	Menopause (age at onset);	chr17:43052373	chr17:43125610~43153671:+
ACC	cis	rs1799949	1	rs8176289	ENSG00000198496.9	NBR2	-4.81	1.36e-05	0.0476	-0.81	-0.55	Menopause (age at onset);	chr17:43054039	chr17:43125610~43153671:+
ACC	cis	rs983545	0.548	rs1348109	ENSG00000272498.1	RP11-415F23.3	4.8	1.36e-05	0.0478	0.63	0.55	Blood protein levels;	chr3:16908022	chr3:16339308~16339871:+
ACC	cis	rs7188445	1	rs11150190	ENSG00000261390.4	RP11-345M22.2	-4.8	1.36e-05	0.0478	-0.73	-0.55	Urate levels;	chr16:79700352	chr16:79715232~79770563:-
ACC	cis	rs2739330	0.828	rs5760107	ENSG00000225282.1	AP000350.6	4.8	1.36e-05	0.0479	0.55	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910410	chr22:23926900~23929574:+
ACC	cis	rs875971	0.545	rs17138149	ENSG00000226824.5	RP4-756H11.3	-4.8	1.37e-05	0.0479	-0.79	-0.55	Aortic root size;	chr7:66228193	chr7:66654538~66669855:+
ACC	cis	rs4835473	0.9	rs4054634	ENSG00000251600.4	RP11-673E1.1	-4.8	1.38e-05	0.0479	-0.75	-0.55	Immature fraction of reticulocytes;	chr4:143787045	chr4:143912331~143982454:+
ACC	cis	rs7188445	0.932	rs17767904	ENSG00000261390.4	RP11-345M22.2	-4.8	1.38e-05	0.0479	-0.65	-0.55	Urate levels;	chr16:79716078	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.932	rs73575095	ENSG00000261390.4	RP11-345M22.2	-4.8	1.38e-05	0.0479	-0.65	-0.55	Urate levels;	chr16:79716435	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.899	rs58722186	ENSG00000261390.4	RP11-345M22.2	-4.8	1.38e-05	0.0479	-0.65	-0.55	Urate levels;	chr16:79717694	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.899	rs57652769	ENSG00000261390.4	RP11-345M22.2	-4.8	1.38e-05	0.0479	-0.65	-0.55	Urate levels;	chr16:79720079	chr16:79715232~79770563:-
ACC	cis	rs7188445	0.932	rs4575545	ENSG00000261390.4	RP11-345M22.2	-4.8	1.38e-05	0.0479	-0.65	-0.55	Urate levels;	chr16:79721549	chr16:79715232~79770563:-
ACC	cis	rs9399135	0.967	rs7763836	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135041240	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs6569990	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135044680	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs13191501	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135045742	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs6908512	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135046619	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs34546690	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135048571	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs11755229	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135048775	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs9389261	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135050010	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs9376085	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135050086	chr6:135055033~135060550:+
ACC	cis	rs9399135	0.967	rs9373122	ENSG00000232876.1	CTA-212D2.2	-4.8	1.4e-05	0.0479	-0.59	-0.55	Red blood cell count;	chr6:135052396	chr6:135055033~135060550:+
ACC	cis	rs9322193	0.607	rs9371228	ENSG00000231760.4	RP11-350J20.5	-4.8	1.4e-05	0.0479	-0.79	-0.55	Lung cancer;	chr6:149921977	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.566	rs4870118	ENSG00000231760.4	RP11-350J20.5	-4.8	1.4e-05	0.0479	-0.79	-0.55	Lung cancer;	chr6:149923877	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.566	rs4869767	ENSG00000231760.4	RP11-350J20.5	-4.8	1.4e-05	0.0479	-0.79	-0.55	Lung cancer;	chr6:149923974	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.566	rs4869768	ENSG00000231760.4	RP11-350J20.5	-4.8	1.4e-05	0.0479	-0.79	-0.55	Lung cancer;	chr6:149924067	chr6:149796151~149826294:-
ACC	cis	rs9322193	0.566	rs3922947	ENSG00000231760.4	RP11-350J20.5	-4.8	1.4e-05	0.0479	-0.79	-0.55	Lung cancer;	chr6:149924856	chr6:149796151~149826294:-
ACC	cis	rs2739330	0.731	rs5751792	ENSG00000206090.4	AP000350.7	4.8	1.4e-05	0.0479	0.57	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:24005096	chr22:23939998~23942798:+
ACC	cis	rs9487094	0.961	rs11153175	ENSG00000260273.1	RP11-425D10.10	4.79	1.41e-05	0.0481	0.71	0.55	Height;	chr6:109361318	chr6:109382795~109383666:+
ACC	cis	rs9487094	0.848	rs7372	ENSG00000260273.1	RP11-425D10.10	4.79	1.41e-05	0.0481	0.71	0.55	Height;	chr6:109366911	chr6:109382795~109383666:+
ACC	cis	rs1153858	0.668	rs63603561	ENSG00000259520.4	CTD-2651B20.3	4.79	1.41e-05	0.0484	0.73	0.55	Homoarginine levels;	chr15:45301125	chr15:45251580~45279251:-
ACC	cis	rs9322193	0.923	rs10782318	ENSG00000268592.3	RAET1E-AS1	4.79	1.42e-05	0.0485	0.63	0.55	Lung cancer;	chr6:149754137	chr6:149863494~149919507:+
ACC	cis	rs4835473	0.838	rs6832094	ENSG00000251600.4	RP11-673E1.1	-4.79	1.42e-05	0.0485	-0.76	-0.55	Immature fraction of reticulocytes;	chr4:143795388	chr4:143912331~143982454:+
ACC	cis	rs2486288	0.656	rs11629807	ENSG00000259520.4	CTD-2651B20.3	4.79	1.42e-05	0.0485	0.63	0.55	Glomerular filtration rate;	chr15:45254839	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.587	rs12899942	ENSG00000259520.4	CTD-2651B20.3	4.79	1.42e-05	0.0485	0.63	0.55	Glomerular filtration rate;	chr15:45255082	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs12899058	ENSG00000259520.4	CTD-2651B20.3	4.79	1.42e-05	0.0485	0.63	0.55	Glomerular filtration rate;	chr15:45255126	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs12904150	ENSG00000259520.4	CTD-2651B20.3	4.79	1.42e-05	0.0485	0.63	0.55	Glomerular filtration rate;	chr15:45255407	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs9920290	ENSG00000259520.4	CTD-2651B20.3	4.79	1.42e-05	0.0485	0.63	0.55	Glomerular filtration rate;	chr15:45255837	chr15:45251580~45279251:-
ACC	cis	rs2486288	0.656	rs11854325	ENSG00000259520.4	CTD-2651B20.3	4.79	1.42e-05	0.0485	0.63	0.55	Glomerular filtration rate;	chr15:45256761	chr15:45251580~45279251:-
ACC	cis	rs4835473	0.932	rs13152209	ENSG00000251600.4	RP11-673E1.1	4.79	1.43e-05	0.0485	0.74	0.55	Immature fraction of reticulocytes;	chr4:143776088	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs10016223	ENSG00000251600.4	RP11-673E1.1	4.79	1.43e-05	0.0485	0.74	0.55	Immature fraction of reticulocytes;	chr4:143777429	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs17694797	ENSG00000251600.4	RP11-673E1.1	-4.79	1.43e-05	0.0485	-0.74	-0.55	Immature fraction of reticulocytes;	chr4:143778812	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs35947975	ENSG00000251600.4	RP11-673E1.1	-4.79	1.43e-05	0.0485	-0.74	-0.55	Immature fraction of reticulocytes;	chr4:143778969	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.778	rs75562808	ENSG00000251600.4	RP11-673E1.1	-4.79	1.43e-05	0.0485	-0.74	-0.55	Immature fraction of reticulocytes;	chr4:143779065	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.669	rs75704080	ENSG00000251600.4	RP11-673E1.1	-4.79	1.43e-05	0.0485	-0.74	-0.55	Immature fraction of reticulocytes;	chr4:143779066	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs1375987	ENSG00000251600.4	RP11-673E1.1	-4.79	1.43e-05	0.0485	-0.74	-0.55	Immature fraction of reticulocytes;	chr4:143779622	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.932	rs7687151	ENSG00000251600.4	RP11-673E1.1	-4.79	1.43e-05	0.0485	-0.74	-0.55	Immature fraction of reticulocytes;	chr4:143781681	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.808	rs4054643	ENSG00000251600.4	RP11-673E1.1	-4.79	1.43e-05	0.0485	-0.74	-0.55	Immature fraction of reticulocytes;	chr4:143787329	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.838	rs34819068	ENSG00000251600.4	RP11-673E1.1	-4.79	1.43e-05	0.0485	-0.74	-0.55	Immature fraction of reticulocytes;	chr4:143787330	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.897	rs11100812	ENSG00000251600.4	RP11-673E1.1	4.79	1.43e-05	0.0485	0.74	0.55	Immature fraction of reticulocytes;	chr4:143790400	chr4:143912331~143982454:+
ACC	cis	rs875971	0.545	rs316316	ENSG00000226824.5	RP4-756H11.3	4.79	1.43e-05	0.0485	0.8	0.55	Aortic root size;	chr7:66149270	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs316305	ENSG00000226824.5	RP4-756H11.3	4.79	1.43e-05	0.0485	0.8	0.55	Aortic root size;	chr7:66152984	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs316306	ENSG00000226824.5	RP4-756H11.3	4.79	1.43e-05	0.0485	0.8	0.55	Aortic root size;	chr7:66153687	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs2460427	ENSG00000226824.5	RP4-756H11.3	4.79	1.43e-05	0.0485	0.8	0.55	Aortic root size;	chr7:66154218	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs10950025	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66158946	chr7:66654538~66669855:+
ACC	cis	rs875971	0.52	rs12666485	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66160135	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs67688847	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66161064	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs7787063	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66164012	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs12673308	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66166374	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs67397473	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66168318	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs10950027	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66169164	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs73376401	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66174841	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs73378304	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66175760	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs6460276	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66182290	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs67775320	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66193792	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs6460281	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66216128	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs2420456	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66280619	chr7:66654538~66669855:+
ACC	cis	rs875971	0.545	rs7783889	ENSG00000226824.5	RP4-756H11.3	-4.79	1.43e-05	0.0485	-0.8	-0.55	Aortic root size;	chr7:66283366	chr7:66654538~66669855:+
ACC	cis	rs4835473	0.897	rs6537167	ENSG00000251600.4	RP11-673E1.1	4.79	1.43e-05	0.0486	0.72	0.55	Immature fraction of reticulocytes;	chr4:143691323	chr4:143912331~143982454:+
ACC	cis	rs875971	0.502	rs6460311	ENSG00000226824.5	RP4-756H11.3	4.79	1.44e-05	0.0488	0.82	0.55	Aortic root size;	chr7:66646886	chr7:66654538~66669855:+
ACC	cis	rs2739330	0.828	rs5760108	ENSG00000225282.1	AP000350.6	4.79	1.45e-05	0.049	0.53	0.55	Liver enzyme levels (gamma-glutamyl transferase);	chr22:23910481	chr22:23926900~23929574:+
ACC	cis	rs2880765	0.743	rs4551990	ENSG00000259295.5	CSPG4P12	4.79	1.45e-05	0.049	0.69	0.55	Coronary artery disease;	chr15:85472056	chr15:85191438~85213905:+
ACC	cis	rs4835473	0.897	rs11727223	ENSG00000251600.4	RP11-673E1.1	4.79	1.45e-05	0.0491	0.74	0.55	Immature fraction of reticulocytes;	chr4:143707090	chr4:143912331~143982454:+
ACC	cis	rs4835473	0.897	rs6835827	ENSG00000251600.4	RP11-673E1.1	4.79	1.45e-05	0.0491	0.74	0.55	Immature fraction of reticulocytes;	chr4:143712803	chr4:143912331~143982454:+
ACC	cis	rs2880765	0.714	rs6497187	ENSG00000259295.5	CSPG4P12	4.78	1.46e-05	0.0494	0.69	0.55	Coronary artery disease;	chr15:85468119	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.743	rs6497191	ENSG00000259295.5	CSPG4P12	4.78	1.46e-05	0.0494	0.69	0.55	Coronary artery disease;	chr15:85468270	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.743	rs6416598	ENSG00000259295.5	CSPG4P12	4.78	1.46e-05	0.0494	0.69	0.55	Coronary artery disease;	chr15:85468617	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.743	rs8032488	ENSG00000259295.5	CSPG4P12	4.78	1.46e-05	0.0494	0.69	0.55	Coronary artery disease;	chr15:85469537	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.743	rs8028240	ENSG00000259295.5	CSPG4P12	4.78	1.46e-05	0.0494	0.69	0.55	Coronary artery disease;	chr15:85470017	chr15:85191438~85213905:+
ACC	cis	rs2880765	0.743	rs6497194	ENSG00000259295.5	CSPG4P12	4.78	1.46e-05	0.0494	0.69	0.55	Coronary artery disease;	chr15:85470885	chr15:85191438~85213905:+
ACC	cis	rs9399135	0.933	rs28384512	ENSG00000232876.1	CTA-212D2.2	-4.78	1.48e-05	0.0499	-0.57	-0.55	Red blood cell count;	chr6:135055094	chr6:135055033~135060550:+
ACC	trans	rs941207	0.756	rs2950388	ENSG00000121089.4	NACA3P	-13.78	5.39e-19	1.87e-09	-1.35	-0.89	Platelet count;	chr12:56639569	chr4:164943290~164943937:+
ACC	trans	rs941207	0.756	rs9634246	ENSG00000121089.4	NACA3P	-13.78	5.39e-19	1.87e-09	-1.35	-0.89	Platelet count;	chr12:56640604	chr4:164943290~164943937:+
ACC	trans	rs941207	0.756	rs2950394	ENSG00000121089.4	NACA3P	-13.78	5.39e-19	1.87e-09	-1.35	-0.89	Platelet count;	chr12:56644548	chr4:164943290~164943937:+
ACC	trans	rs941207	0.756	rs7315472	ENSG00000121089.4	NACA3P	-13.78	5.39e-19	1.87e-09	-1.35	-0.89	Platelet count;	chr12:56648276	chr4:164943290~164943937:+
ACC	trans	rs941207	0.756	rs67046307	ENSG00000121089.4	NACA3P	-13.78	5.39e-19	1.87e-09	-1.35	-0.89	Platelet count;	chr12:56651152	chr4:164943290~164943937:+
ACC	trans	rs941207	0.756	rs10876915	ENSG00000121089.4	NACA3P	-13.78	5.39e-19	1.87e-09	-1.35	-0.89	Platelet count;	chr12:56655280	chr4:164943290~164943937:+
ACC	trans	rs941207	0.756	rs1465081	ENSG00000121089.4	NACA3P	-13.78	5.39e-19	1.87e-09	-1.35	-0.89	Platelet count;	chr12:56656390	chr4:164943290~164943937:+
ACC	trans	rs941207	0.789	rs2958145	ENSG00000121089.4	NACA3P	-13.78	5.39e-19	1.87e-09	-1.35	-0.89	Platelet count;	chr12:56662290	chr4:164943290~164943937:+
ACC	trans	rs6477998	0.535	rs3750535	ENSG00000238072.1	RP11-305M3.2	12.05	1.13e-16	2.87e-07	0.99	0.86	Hematology traits;	chr9:113297453	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.58	rs10981715	ENSG00000238072.1	RP11-305M3.2	11.66	3.99e-16	8.19e-07	0.94	0.85	Hematology traits;	chr9:113287218	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.58	rs4979233	ENSG00000238072.1	RP11-305M3.2	11.62	4.49e-16	8.19e-07	0.97	0.85	Hematology traits;	chr9:113295501	chr7:129410113~129410370:-
ACC	trans	rs1816752	0.905	rs9511266	ENSG00000237917.1	PARP4P1	11.49	6.89e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24438366	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.817	rs7985394	ENSG00000237917.1	PARP4P1	11.49	6.89e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24438714	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.789	rs7986037	ENSG00000237917.1	PARP4P1	11.49	6.89e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24438715	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs7995492	ENSG00000237917.1	PARP4P1	11.48	7.15e-16	8.19e-07	0.83	0.85	Obesity-related traits;	chr13:24438885	chrY:26594851~26634652:-
ACC	trans	rs941207	0.756	rs2958153	ENSG00000121089.4	NACA3P	11.44	8.14e-16	8.19e-07	1.3	0.85	Platelet count;	chr12:56687733	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.905	rs7995909	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24439159	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs6490927	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24439802	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs6490928	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24439921	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs6490929	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24440114	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs3825449	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24440303	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs7998797	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24440850	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs7981337	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24440915	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs7981480	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24440966	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.837	rs4769355	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24441059	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs4770680	ENSG00000237917.1	PARP4P1	11.42	8.83e-16	8.19e-07	0.82	0.85	Obesity-related traits;	chr13:24441110	chrY:26594851~26634652:-
ACC	trans	rs6477998	0.557	rs11789755	ENSG00000238072.1	RP11-305M3.2	11.35	1.1e-15	9.98e-07	0.95	0.84	Hematology traits;	chr9:113292796	chr7:129410113~129410370:-
ACC	trans	rs941207	0.756	rs7978685	ENSG00000121089.4	NACA3P	11.25	1.54e-15	1.25e-06	1.29	0.84	Platelet count;	chr12:56709370	chr4:164943290~164943937:+
ACC	trans	rs941207	0.724	rs4788	ENSG00000121089.4	NACA3P	11.25	1.54e-15	1.25e-06	1.29	0.84	Platelet count;	chr12:56712876	chr4:164943290~164943937:+
ACC	trans	rs941207	0.756	rs2958149	ENSG00000121089.4	NACA3P	11.25	1.54e-15	1.25e-06	1.29	0.84	Platelet count;	chr12:56716008	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.905	rs9511260	ENSG00000237917.1	PARP4P1	11.16	2.03e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24437038	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs7320102	ENSG00000237917.1	PARP4P1	11.16	2.03e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24437435	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs7339140	ENSG00000237917.1	PARP4P1	11.16	2.03e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24437764	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs9511261	ENSG00000237917.1	PARP4P1	11.16	2.03e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24437880	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs9511262	ENSG00000237917.1	PARP4P1	11.16	2.03e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24437885	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs13428	ENSG00000237917.1	PARP4P1	11.16	2.08e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24435303	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs8000215	ENSG00000237917.1	PARP4P1	11.16	2.08e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24435648	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.905	rs11839006	ENSG00000237917.1	PARP4P1	11.16	2.08e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24435893	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs2033955	ENSG00000237917.1	PARP4P1	11.16	2.08e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24436406	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.87	rs2033954	ENSG00000237917.1	PARP4P1	11.16	2.08e-15	1.32e-06	0.8	0.84	Obesity-related traits;	chr13:24436429	chrY:26594851~26634652:-
ACC	trans	rs941207	0.724	rs1979325	ENSG00000121089.4	NACA3P	11.1	2.52e-15	1.55e-06	1.27	0.84	Platelet count;	chr12:56728152	chr4:164943290~164943937:+
ACC	trans	rs941207	1	rs941207	ENSG00000121089.4	NACA3P	-11.04	3.05e-15	1.84e-06	-1.29	-0.84	Platelet count;	chr12:56629500	chr4:164943290~164943937:+
ACC	trans	rs941207	0.855	rs2256341	ENSG00000121089.4	NACA3P	-11.03	3.17e-15	1.86e-06	-1.3	-0.84	Platelet count;	chr12:56599930	chr4:164943290~164943937:+
ACC	trans	rs941207	0.805	rs2958139	ENSG00000121089.4	NACA3P	-11.03	3.17e-15	1.86e-06	-1.3	-0.84	Platelet count;	chr12:56610884	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.509	rs10459247	ENSG00000121089.4	NACA3P	-11.01	3.36e-15	1.94e-06	-1.29	-0.84	Platelet distribution width;	chr12:56777732	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.805	rs61614647	ENSG00000237917.1	PARP4P1	10.93	4.47e-15	2.47e-06	0.81	0.83	Obesity-related traits;	chr13:24441829	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.774	rs55888616	ENSG00000237917.1	PARP4P1	10.93	4.47e-15	2.47e-06	0.81	0.83	Obesity-related traits;	chr13:24441954	chrY:26594851~26634652:-
ACC	trans	rs2950393	0.929	rs7973157	ENSG00000121089.4	NACA3P	-10.91	4.66e-15	2.5e-06	-1.14	-0.83	Platelet distribution width;	chr12:56655409	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs1466382	ENSG00000121089.4	NACA3P	-10.91	4.68e-15	2.5e-06	-1.1	-0.83	Platelet distribution width;	chr12:56723050	chr4:164943290~164943937:+
ACC	trans	rs6477998	0.58	rs2296073	ENSG00000238072.1	RP11-305M3.2	10.91	4.73e-15	2.5e-06	0.95	0.83	Hematology traits;	chr9:113299348	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.557	rs3750534	ENSG00000238072.1	RP11-305M3.2	10.76	7.7e-15	3.8e-06	0.96	0.83	Hematology traits;	chr9:113297844	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.58	rs3750533	ENSG00000238072.1	RP11-305M3.2	10.76	7.7e-15	3.8e-06	0.96	0.83	Hematology traits;	chr9:113297941	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.58	rs3750532	ENSG00000238072.1	RP11-305M3.2	10.76	7.7e-15	3.8e-06	0.96	0.83	Hematology traits;	chr9:113298207	chr7:129410113~129410370:-
ACC	trans	rs2950393	0.857	rs9989034	ENSG00000121089.4	NACA3P	10.69	9.8e-15	4.72e-06	1.13	0.83	Platelet distribution width;	chr12:56674508	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.875	rs1050110	ENSG00000237917.1	PARP4P1	10.58	1.42e-14	6.77e-06	0.8	0.83	Obesity-related traits;	chr13:24435347	chrY:26594851~26634652:-
ACC	trans	rs2950393	0.804	rs2926752	ENSG00000121089.4	NACA3P	10.56	1.52e-14	7.06e-06	1.12	0.83	Platelet distribution width;	chr12:56710144	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.777	rs2958148	ENSG00000121089.4	NACA3P	10.56	1.52e-14	7.06e-06	1.12	0.83	Platelet distribution width;	chr12:56710153	chr4:164943290~164943937:+
ACC	trans	rs6477998	0.58	rs7027833	ENSG00000238072.1	RP11-305M3.2	10.54	1.63e-14	7.36e-06	0.96	0.83	Hematology traits;	chr9:113301377	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.58	rs9299214	ENSG00000238072.1	RP11-305M3.2	10.46	2.17e-14	9.6e-06	0.94	0.82	Hematology traits;	chr9:113273416	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.603	rs10117451	ENSG00000238072.1	RP11-305M3.2	10.46	2.17e-14	9.6e-06	0.94	0.82	Hematology traits;	chr9:113273610	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.58	rs10759638	ENSG00000238072.1	RP11-305M3.2	-10.4	2.61e-14	1.14e-05	-0.94	-0.82	Hematology traits;	chr9:113280212	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.58	rs11552582	ENSG00000238072.1	RP11-305M3.2	10.37	2.92e-14	1.25e-05	0.93	0.82	Hematology traits;	chr9:113282718	chr7:129410113~129410370:-
ACC	trans	rs1816752	0.713	rs7336357	ENSG00000237917.1	PARP4P1	10.31	3.56e-14	1.44e-05	0.81	0.82	Obesity-related traits;	chr13:24443452	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.683	rs7330532	ENSG00000237917.1	PARP4P1	10.31	3.56e-14	1.44e-05	0.81	0.82	Obesity-related traits;	chr13:24443453	chrY:26594851~26634652:-
ACC	trans	rs941207	0.756	rs2926743	ENSG00000121089.4	NACA3P	10.26	4.22e-14	1.51e-05	1.24	0.82	Platelet count;	chr12:56720316	chr4:164943290~164943937:+
ACC	trans	rs10716881	1	rs10716881	ENSG00000121089.4	NACA3P	-10.17	5.86e-14	2.05e-05	-1.13	-0.82	High light scatter reticulocyte count;	chr12:56644387	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.929	rs7980835	ENSG00000121089.4	NACA3P	10.14	6.47e-14	2.12e-05	1.15	0.81	Platelet distribution width;	chr12:56676847	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.929	rs10747769	ENSG00000121089.4	NACA3P	10.14	6.47e-14	2.12e-05	1.15	0.81	Platelet distribution width;	chr12:56677056	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs898611	ENSG00000121089.4	NACA3P	-10.13	6.59e-14	2.12e-05	-1.09	-0.81	Platelet distribution width;	chr12:56769532	chr4:164943290~164943937:+
ACC	trans	rs6477998	0.58	rs12343629	ENSG00000238072.1	RP11-305M3.2	10.13	6.64e-14	2.12e-05	0.9	0.81	Hematology traits;	chr9:113279301	chr7:129410113~129410370:-
ACC	trans	rs941207	0.756	rs7313074	ENSG00000121089.4	NACA3P	-10.12	6.78e-14	2.13e-05	-1.22	-0.81	Platelet count;	chr12:56760705	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs898609	ENSG00000121089.4	NACA3P	10.06	8.49e-14	2.52e-05	1.09	0.81	Platelet distribution width;	chr12:56713026	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs4902	ENSG00000121089.4	NACA3P	10.06	8.49e-14	2.52e-05	1.09	0.81	Platelet distribution width;	chr12:56714419	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs2926748	ENSG00000121089.4	NACA3P	10.06	8.49e-14	2.52e-05	1.09	0.81	Platelet distribution width;	chr12:56715628	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.905	rs9511264	ENSG00000237917.1	PARP4P1	-10.06	8.55e-14	2.52e-05	-0.79	-0.81	Obesity-related traits;	chr13:24438079	chrY:26594851~26634652:-
ACC	trans	rs2950393	0.804	rs2958127	ENSG00000121089.4	NACA3P	10.05	8.75e-14	2.52e-05	1.09	0.81	Platelet distribution width;	chr12:56720523	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs2035081	ENSG00000121089.4	NACA3P	10.05	8.75e-14	2.52e-05	1.09	0.81	Platelet distribution width;	chr12:56732095	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs10783796	ENSG00000121089.4	NACA3P	10.05	8.75e-14	2.52e-05	1.09	0.81	Platelet distribution width;	chr12:56733387	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs2958130	ENSG00000121089.4	NACA3P	10.05	8.75e-14	2.52e-05	1.09	0.81	Platelet distribution width;	chr12:56746722	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.905	rs1348110	ENSG00000237917.1	PARP4P1	10.01	1.02e-13	2.72e-05	0.78	0.81	Obesity-related traits;	chr13:24406537	chrY:26594851~26634652:-
ACC	trans	rs2950393	0.804	rs2290894	ENSG00000121089.4	NACA3P	10	1.04e-13	2.72e-05	1.1	0.81	Platelet distribution width;	chr12:56714911	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.777	rs2926747	ENSG00000121089.4	NACA3P	10	1.04e-13	2.72e-05	1.1	0.81	Platelet distribution width;	chr12:56716147	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.895	rs2958123	ENSG00000121089.4	NACA3P	10	1.05e-13	2.72e-05	1.13	0.81	Platelet distribution width;	chr12:56668441	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.929	rs2290893	ENSG00000121089.4	NACA3P	10	1.05e-13	2.72e-05	1.13	0.81	Platelet distribution width;	chr12:56684836	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs3214051	ENSG00000121089.4	NACA3P	10	1.05e-13	2.72e-05	1.1	0.81	Platelet distribution width;	chr12:56725452	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.777	rs7966391	ENSG00000121089.4	NACA3P	10	1.05e-13	2.72e-05	1.1	0.81	Platelet distribution width;	chr12:56745272	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.777	rs12828563	ENSG00000121089.4	NACA3P	9.98	1.12e-13	2.8e-05	1.08	0.81	Platelet distribution width;	chr12:56709378	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.806	rs3816218	ENSG00000237917.1	PARP4P1	9.98	1.13e-13	2.8e-05	0.8	0.81	Obesity-related traits;	chr13:24443033	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.712	rs6490932	ENSG00000237917.1	PARP4P1	9.98	1.13e-13	2.8e-05	0.8	0.81	Obesity-related traits;	chr13:24443313	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.59	rs61947036	ENSG00000237917.1	PARP4P1	9.98	1.13e-13	2.8e-05	0.8	0.81	Obesity-related traits;	chr13:24443544	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.746	rs9511270	ENSG00000237917.1	PARP4P1	9.98	1.13e-13	2.8e-05	0.8	0.81	Obesity-related traits;	chr13:24444542	chrY:26594851~26634652:-
ACC	trans	rs2950393	0.929	rs10876916	ENSG00000121089.4	NACA3P	9.92	1.37e-13	3.27e-05	1.16	0.81	Platelet distribution width;	chr12:56692728	chr4:164943290~164943937:+
ACC	trans	rs941207	0.526	rs12229457	ENSG00000121089.4	NACA3P	-9.91	1.42e-13	3.33e-05	-1.18	-0.81	Platelet count;	chr12:56639896	chr4:164943290~164943937:+
ACC	trans	rs941207	0.526	rs2950393	ENSG00000121089.4	NACA3P	-9.91	1.42e-13	3.33e-05	-1.18	-0.81	Platelet count;	chr12:56642239	chr4:164943290~164943937:+
ACC	trans	rs13177918	0.677	rs57890152	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150441909	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.75	rs58256223	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442456	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.75	rs59354956	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442457	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.686	rs12654827	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442527	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13160685	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442768	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13161099	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442799	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.629	rs13161261	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442844	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13161417	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442937	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13161156	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443023	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13181401	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443033	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs4541646	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443355	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs3900644	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443359	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs2070844	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444222	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs2073472	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444504	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.629	rs2070842	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444660	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13171800	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444792	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs2070841	ENSG00000224114.1	RP11-343H5.4	9.82	1.91e-13	3.89e-05	1.14	0.81	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444908	chr1:206695837~206696269:-
ACC	trans	rs941207	0.547	rs56183434	ENSG00000121089.4	NACA3P	9.8	2.05e-13	4.14e-05	1.2	0.81	Platelet count;	chr12:56676145	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs1026565	ENSG00000121089.4	NACA3P	9.78	2.24e-13	4.52e-05	1.08	0.8	Platelet distribution width;	chr12:56744044	chr4:164943290~164943937:+
ACC	trans	rs13177918	0.677	rs13177951	ENSG00000224114.1	RP11-343H5.4	9.76	2.38e-13	4.64e-05	1.13	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446376	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13177970	ENSG00000224114.1	RP11-343H5.4	9.76	2.38e-13	4.64e-05	1.13	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446447	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13164105	ENSG00000224114.1	RP11-343H5.4	9.76	2.38e-13	4.64e-05	1.13	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446503	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs4841	ENSG00000224114.1	RP11-343H5.4	9.76	2.38e-13	4.64e-05	1.13	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446963	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs13183077	ENSG00000224114.1	RP11-343H5.4	9.76	2.38e-13	4.64e-05	1.13	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447009	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs3797622	ENSG00000224114.1	RP11-343H5.4	9.76	2.38e-13	4.64e-05	1.13	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447535	chr1:206695837~206696269:-
ACC	trans	rs2950393	0.927	rs11171914	ENSG00000121089.4	NACA3P	-9.75	2.47e-13	4.72e-05	-1.17	-0.8	Platelet distribution width;	chr12:56649462	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs2958132	ENSG00000121089.4	NACA3P	9.68	3.12e-13	5.94e-05	1.07	0.8	Platelet distribution width;	chr12:56750749	chr4:164943290~164943937:+
ACC	trans	rs941207	0.526	rs2950390	ENSG00000121089.4	NACA3P	9.66	3.4e-13	6.41e-05	1.16	0.8	Platelet count;	chr12:56661507	chr4:164943290~164943937:+
ACC	trans	rs941207	0.526	rs11171916	ENSG00000121089.4	NACA3P	-9.64	3.66e-13	6.87e-05	-1.17	-0.8	Platelet count;	chr12:56653236	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.895	rs2958154	ENSG00000121089.4	NACA3P	-9.62	3.86e-13	6.93e-05	-1.16	-0.8	Platelet distribution width;	chr12:56671929	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.895	rs2926740	ENSG00000121089.4	NACA3P	9.62	3.86e-13	6.93e-05	1.16	0.8	Platelet distribution width;	chr12:56666751	chr4:164943290~164943937:+
ACC	trans	rs941207	0.526	rs7303216	ENSG00000121089.4	NACA3P	9.62	3.86e-13	6.93e-05	1.16	0.8	Platelet count;	chr12:56680909	chr4:164943290~164943937:+
ACC	trans	rs941207	0.507	rs7297289	ENSG00000121089.4	NACA3P	9.62	3.86e-13	6.93e-05	1.16	0.8	Platelet count;	chr12:56682703	chr4:164943290~164943937:+
ACC	trans	rs941207	0.526	rs4759028	ENSG00000121089.4	NACA3P	9.62	3.86e-13	6.93e-05	1.16	0.8	Platelet count;	chr12:56686399	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.837	rs9318530	ENSG00000237917.1	PARP4P1	-9.59	4.26e-13	7.57e-05	-0.77	-0.8	Obesity-related traits;	chr13:24424419	chrY:26594851~26634652:-
ACC	trans	rs1816752	1	rs9511265	ENSG00000237917.1	PARP4P1	9.58	4.55e-13	8.05e-05	0.8	0.8	Obesity-related traits;	chr13:24438221	chrY:26594851~26634652:-
ACC	trans	rs2950393	0.804	rs7980317	ENSG00000121089.4	NACA3P	9.51	5.82e-13	9.84e-05	1.06	0.8	Platelet distribution width;	chr12:56764399	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs7967600	ENSG00000121089.4	NACA3P	9.51	5.82e-13	9.84e-05	1.06	0.8	Platelet distribution width;	chr12:56768208	chr4:164943290~164943937:+
ACC	trans	rs13177918	0.651	rs13184111	ENSG00000224114.1	RP11-343H5.4	9.47	6.61e-13	0.00011	1.11	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150434649	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.626	rs12186649	ENSG00000224114.1	RP11-343H5.4	9.47	6.61e-13	0.00011	1.11	0.8	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150438963	chr1:206695837~206696269:-
ACC	trans	rs13177918	0.677	rs57890152	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150441909	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.75	rs58256223	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442456	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.75	rs59354956	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442457	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.686	rs12654827	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442527	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13160685	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442768	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13161099	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442799	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.629	rs13161261	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442844	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13161417	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442937	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13161156	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443023	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13181401	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443033	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs4541646	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443355	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs3900644	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443359	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs2070844	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444222	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs2073472	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444504	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.629	rs2070842	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444660	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13171800	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444792	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs2070841	ENSG00000239528.1	RPS14P8	9.32	1.13e-12	0.000163	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444908	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.651	rs13184111	ENSG00000239528.1	RPS14P8	9.29	1.22e-12	0.000174	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150434649	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.626	rs12186649	ENSG00000239528.1	RPS14P8	9.29	1.22e-12	0.000174	0.97	0.79	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150438963	chr5:116562562~116562930:+
ACC	trans	rs2950393	0.929	rs2958155	ENSG00000121089.4	NACA3P	9.29	1.26e-12	0.000178	1.12	0.79	Platelet distribution width;	chr12:56670761	chr4:164943290~164943937:+
ACC	trans	rs2950393	0.804	rs1131514	ENSG00000121089.4	NACA3P	-9.27	1.34e-12	0.00019	-1.06	-0.79	Platelet distribution width;	chr12:56739356	chr4:164943290~164943937:+
ACC	trans	rs13177918	0.677	rs13177951	ENSG00000239528.1	RPS14P8	9.09	2.48e-12	0.000338	0.96	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446376	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13177970	ENSG00000239528.1	RPS14P8	9.09	2.48e-12	0.000338	0.96	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446447	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13164105	ENSG00000239528.1	RPS14P8	9.09	2.48e-12	0.000338	0.96	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446503	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs4841	ENSG00000239528.1	RPS14P8	9.09	2.48e-12	0.000338	0.96	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446963	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs13183077	ENSG00000239528.1	RPS14P8	9.09	2.48e-12	0.000338	0.96	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447009	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs3797622	ENSG00000239528.1	RPS14P8	9.09	2.48e-12	0.000338	0.96	0.78	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447535	chr5:116562562~116562930:+
ACC	trans	rs941207	0.762	rs10450	ENSG00000121089.4	NACA3P	9.03	3.15e-12	0.000426	1.1	0.78	Platelet count;	chr12:56590822	chr4:164943290~164943937:+
ACC	trans	rs1816752	0.819	rs7985478	ENSG00000237917.1	PARP4P1	9	3.51e-12	0.000472	0.74	0.78	Obesity-related traits;	chr13:24417135	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.837	rs7139748	ENSG00000237917.1	PARP4P1	8.98	3.78e-12	0.000503	0.74	0.78	Obesity-related traits;	chr13:24411531	chrY:26594851~26634652:-
ACC	trans	rs941207	0.507	rs73337030	ENSG00000121089.4	NACA3P	-8.87	5.57e-12	0.000726	-1.11	-0.78	Platelet count;	chr12:56652410	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs6581107	ENSG00000121089.4	NACA3P	-8.85	5.89e-12	0.000762	-1.1	-0.78	Platelet count;	chr12:56801197	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs7315786	ENSG00000121089.4	NACA3P	-8.85	5.89e-12	0.000762	-1.1	-0.78	Platelet count;	chr12:56801595	chr4:164943290~164943937:+
ACC	trans	rs13177918	0.677	rs3857421	ENSG00000224114.1	RP11-343H5.4	-8.84	6.11e-12	0.000788	-1.17	-0.77	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443584	chr1:206695837~206696269:-
ACC	trans	rs1816752	0.819	rs1981276	ENSG00000237917.1	PARP4P1	8.81	6.87e-12	0.000844	0.73	0.77	Obesity-related traits;	chr13:24409361	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.755	rs1981277	ENSG00000237917.1	PARP4P1	8.81	6.87e-12	0.000844	0.73	0.77	Obesity-related traits;	chr13:24409375	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.837	rs57052031	ENSG00000237917.1	PARP4P1	8.81	6.87e-12	0.000844	0.73	0.77	Obesity-related traits;	chr13:24409730	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.712	rs9507335	ENSG00000237917.1	PARP4P1	8.81	6.87e-12	0.000844	0.73	0.77	Obesity-related traits;	chr13:24409766	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.774	rs2862895	ENSG00000237917.1	PARP4P1	8.81	6.87e-12	0.000844	0.73	0.77	Obesity-related traits;	chr13:24410328	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.811	rs9507337	ENSG00000237917.1	PARP4P1	8.81	6.87e-12	0.000844	0.73	0.77	Obesity-related traits;	chr13:24410807	chrY:26594851~26634652:-
ACC	trans	rs941207	0.542	rs11171978	ENSG00000121089.4	NACA3P	8.79	7.48e-12	0.000844	1.1	0.77	Platelet count;	chr12:56800015	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs4277148	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56787071	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs6581102	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56790632	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs6581103	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56790641	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs12370142	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56790801	chr4:164943290~164943937:+
ACC	trans	rs12367822	0.956	rs9706160	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet aggregation;	chr12:56791119	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs2888095	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56793689	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs2888096	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56793851	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs6581106	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56796759	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs1813109	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56798079	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs7311381	ENSG00000121089.4	NACA3P	-8.79	7.48e-12	0.000844	-1.1	-0.77	Platelet count;	chr12:56800286	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs2126068	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56804716	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs67808059	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56805228	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs1870674	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56805721	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs11171980	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56806397	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs12366897	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56808329	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs12367312	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56809369	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs12367339	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56809521	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs12367822	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56810376	chr4:164943290~164943937:+
ACC	trans	rs941207	0.542	rs11171983	ENSG00000121089.4	NACA3P	-8.76	8.17e-12	0.000896	-1.09	-0.77	Platelet count;	chr12:56814461	chr4:164943290~164943937:+
ACC	trans	rs3749237	0.595	rs3870338	ENSG00000197582.5	GPX1P1	8.75	8.56e-12	0.000936	0.95	0.77	Resting heart rate;	chr3:49519618	chrX:13378735~13379340:-
ACC	trans	rs1816752	0.748	rs6490912	ENSG00000237917.1	PARP4P1	8.67	1.14e-11	0.00121	0.72	0.77	Obesity-related traits;	chr13:24408941	chrY:26594851~26634652:-
ACC	trans	rs2950393	0.804	rs11171951	ENSG00000121089.4	NACA3P	8.59	1.52e-11	0.00157	1.03	0.77	Platelet distribution width;	chr12:56718853	chr4:164943290~164943937:+
ACC	trans	rs13177918	0.677	rs57890152	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150441909	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.75	rs58256223	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442456	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.75	rs59354956	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442457	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.686	rs12654827	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442527	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13160685	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442768	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13161099	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442799	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.629	rs13161261	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442844	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13161417	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442937	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13161156	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443023	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13181401	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443033	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs4541646	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443355	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs3900644	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443359	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs2070844	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444222	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs2073472	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444504	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.629	rs2070842	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444660	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13171800	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444792	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs2070841	ENSG00000213058.3	RP4-765C7.2	8.49	2.13e-11	0.00195	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150444908	chr1:178411616~178411972:+
ACC	trans	rs9467773	0.62	rs2451732	ENSG00000242375.1	RP11-498P14.3	-8.48	2.22e-11	0.00195	-0.81	-0.76	Intelligence (multi-trait analysis);	chr6:26622676	chr9:97195351~97197687:-
ACC	trans	rs941207	0.542	rs10876928	ENSG00000121089.4	NACA3P	-8.48	2.24e-11	0.00195	-1.05	-0.76	Platelet count;	chr12:56813646	chr4:164943290~164943937:+
ACC	trans	rs8081395	0.805	rs1295927	ENSG00000187870.7	RNFT1P3	8.45	2.52e-11	0.00218	0.78	0.76	White blood cell count;	chr17:59852174	chr17:20743333~20754501:-
ACC	trans	rs13177918	0.651	rs13184111	ENSG00000213058.3	RP4-765C7.2	8.42	2.81e-11	0.00241	1.07	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150434649	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.626	rs12186649	ENSG00000213058.3	RP4-765C7.2	8.42	2.81e-11	0.00241	1.07	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150438963	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.557	rs12520101	ENSG00000224114.1	RP11-343H5.4	8.38	3.26e-11	0.00278	1.08	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150431360	chr1:206695837~206696269:-
ACC	trans	rs941207	0.514	rs6581105	ENSG00000121089.4	NACA3P	-8.35	3.62e-11	0.00308	-1.11	-0.76	Platelet count;	chr12:56792184	chr4:164943290~164943937:+
ACC	trans	rs13177918	0.677	rs13177951	ENSG00000213058.3	RP4-765C7.2	8.33	3.84e-11	0.00323	1.06	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446376	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13177970	ENSG00000213058.3	RP4-765C7.2	8.33	3.84e-11	0.00323	1.06	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446447	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13164105	ENSG00000213058.3	RP4-765C7.2	8.33	3.84e-11	0.00323	1.06	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446503	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs4841	ENSG00000213058.3	RP4-765C7.2	8.33	3.84e-11	0.00323	1.06	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446963	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs13183077	ENSG00000213058.3	RP4-765C7.2	8.33	3.84e-11	0.00323	1.06	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447009	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.677	rs3797622	ENSG00000213058.3	RP4-765C7.2	8.33	3.84e-11	0.00323	1.06	0.76	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150447535	chr1:178411616~178411972:+
ACC	trans	rs9467773	0.62	rs2504567	ENSG00000242375.1	RP11-498P14.3	8.32	3.99e-11	0.00333	0.78	0.76	Intelligence (multi-trait analysis);	chr6:26662692	chr9:97195351~97197687:-
ACC	trans	rs1816752	0.819	rs4770664	ENSG00000237917.1	PARP4P1	8.31	4.08e-11	0.00335	0.7	0.76	Obesity-related traits;	chr13:24414695	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.819	rs4770665	ENSG00000237917.1	PARP4P1	8.31	4.08e-11	0.00335	0.7	0.76	Obesity-related traits;	chr13:24414810	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.721	rs7399656	ENSG00000237917.1	PARP4P1	8.31	4.08e-11	0.00335	0.7	0.76	Obesity-related traits;	chr13:24415708	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.749	rs77832754	ENSG00000237917.1	PARP4P1	8.31	4.08e-11	0.00335	0.7	0.76	Obesity-related traits;	chr13:24416016	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.633	rs8002387	ENSG00000237917.1	PARP4P1	8.31	4.08e-11	0.00335	0.7	0.76	Obesity-related traits;	chr13:24416306	chrY:26594851~26634652:-
ACC	trans	rs941207	0.542	rs11171979	ENSG00000121089.4	NACA3P	-8.29	4.49e-11	0.00365	-1.06	-0.75	Platelet count;	chr12:56802199	chr4:164943290~164943937:+
ACC	trans	rs928391	0.681	rs12145743	ENSG00000227183.3	HDGFP1	8.24	5.29e-11	0.00421	0.86	0.75	Platelet count;	chr1:156730859	chrX:131646639~131646890:+
ACC	trans	rs3749237	0.595	rs1050088	ENSG00000197582.5	GPX1P1	-8.18	6.69e-11	0.00507	-0.89	-0.75	Resting heart rate;	chr3:49533449	chrX:13378735~13379340:-
ACC	trans	rs1816752	0.819	rs4769349	ENSG00000237917.1	PARP4P1	-8.17	6.75e-11	0.0051	-0.74	-0.75	Obesity-related traits;	chr13:24408694	chrY:26594851~26634652:-
ACC	trans	rs13253073	0.723	rs1130569	ENSG00000260318.1	COX6CP1	8.15	7.32e-11	0.0052	1.22	0.75	Glucose homeostasis traits;	chr8:99887565	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs35429753	ENSG00000260318.1	COX6CP1	8.15	7.32e-11	0.0052	1.22	0.75	Glucose homeostasis traits;	chr8:99891015	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs1130474	ENSG00000260318.1	COX6CP1	8.15	7.32e-11	0.0052	1.22	0.75	Glucose homeostasis traits;	chr8:99892049	chr16:11903923~11904137:-
ACC	trans	rs3749237	0.595	rs1568661	ENSG00000197582.5	GPX1P1	8.14	7.72e-11	0.00542	0.88	0.75	Resting heart rate;	chr3:49483525	chrX:13378735~13379340:-
ACC	trans	rs13177918	0.677	rs3857421	ENSG00000239528.1	RPS14P8	-8.12	8.32e-11	0.00583	-0.99	-0.75	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443584	chr5:116562562~116562930:+
ACC	trans	rs6477998	0.535	rs10981712	ENSG00000238072.1	RP11-305M3.2	8.1	8.87e-11	0.00619	0.87	0.75	Hematology traits;	chr9:113283846	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.676	rs10981698	ENSG00000238072.1	RP11-305M3.2	8.09	9.02e-11	0.00622	0.84	0.75	Hematology traits;	chr9:113233500	chr7:129410113~129410370:-
ACC	trans	rs13177918	0.557	rs12520101	ENSG00000239528.1	RPS14P8	8.09	9.08e-11	0.00623	0.93	0.75	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150431360	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.677	rs3857421	ENSG00000213058.3	RP4-765C7.2	-8.08	9.58e-11	0.00634	-1.13	-0.75	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443584	chr1:178411616~178411972:+
ACC	trans	rs1816752	0.783	rs7317439	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24410939	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.819	rs7316961	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24411039	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.819	rs7317504	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24411287	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.783	rs7317712	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24411365	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.783	rs7139527	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24411374	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.819	rs9511240	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24411768	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.819	rs7988388	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24412675	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.875	rs7993132	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24412903	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.792	rs7330956	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24413174	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.777	rs6490915	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24413724	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.712	rs2862898	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24414323	chrY:26594851~26634652:-
ACC	trans	rs1816752	0.652	rs2902356	ENSG00000237917.1	PARP4P1	8.08	9.6e-11	0.00634	0.7	0.75	Obesity-related traits;	chr13:24414333	chrY:26594851~26634652:-
ACC	trans	rs13177918	0.911	rs12186451	ENSG00000239528.1	RPS14P8	8.06	1.03e-10	0.00663	0.91	0.75	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150432625	chr5:116562562~116562930:+
ACC	trans	rs9467773	0.62	rs2101581	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26622541	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2451731	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26624594	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs9295701	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26627280	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2494700	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26631078	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.584	rs1021372	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26632216	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.583	rs1021373	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26632229	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2451744	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26633235	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2494701	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26634204	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs1027204	ENSG00000242375.1	RP11-498P14.3	8.06	1.03e-10	0.00663	0.76	0.75	Intelligence (multi-trait analysis);	chr6:26639385	chr9:97195351~97197687:-
ACC	trans	rs13177918	0.906	rs12652032	ENSG00000239528.1	RPS14P8	8.05	1.05e-10	0.00672	0.92	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442060	chr5:116562562~116562930:+
ACC	trans	rs13177918	1	rs13161334	ENSG00000239528.1	RPS14P8	8.05	1.05e-10	0.00672	0.92	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443110	chr5:116562562~116562930:+
ACC	trans	rs13177918	1	rs35007082	ENSG00000239528.1	RPS14P8	8.05	1.05e-10	0.00672	0.92	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150445015	chr5:116562562~116562930:+
ACC	trans	rs1816752	0.819	rs7400583	ENSG00000237917.1	PARP4P1	8.04	1.08e-10	0.00688	0.68	0.74	Obesity-related traits;	chr13:24415916	chrY:26594851~26634652:-
ACC	trans	rs7949030	0.626	rs11231144	ENSG00000186676.3	EEF1GP1	8.03	1.13e-10	0.00715	0.86	0.74	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62560566	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.626	rs11231141	ENSG00000186676.3	EEF1GP1	8.02	1.19e-10	0.00755	0.81	0.74	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62558793	chr7:125033453~125035301:+
ACC	trans	rs8081395	0.576	rs1292032	ENSG00000187870.7	RNFT1P3	7.97	1.4e-10	0.00835	0.75	0.74	White blood cell count;	chr17:59914982	chr17:20743333~20754501:-
ACC	trans	rs3749237	0.595	rs11130192	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49429773	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.537	rs4459909	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49431784	chrX:13378735~13379340:-
ACC	trans	rs13096760	1	rs13096760	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Intelligence (multi-trait analysis);	chr3:49439373	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs11130196	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49452716	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs885592	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49460450	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs10865955	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49462396	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs4855839	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49470414	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs35701831	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49477567	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.636	rs1568662	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49483830	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs4855864	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49484541	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs3924462	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49486803	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs4855861	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49488529	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs4855859	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49488867	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs7643845	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49493278	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs7637999	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49497682	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs11130199	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49501366	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.576	rs3877784	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49501984	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs12489092	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49513481	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.555	rs7637665	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49514862	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs3870337	ENSG00000197582.5	GPX1P1	7.96	1.48e-10	0.00837	0.86	0.74	Resting heart rate;	chr3:49519662	chrX:13378735~13379340:-
ACC	trans	rs9467773	0.62	rs9461275	ENSG00000242375.1	RP11-498P14.3	7.92	1.7e-10	0.00949	0.75	0.74	Intelligence (multi-trait analysis);	chr6:26590573	chr9:97195351~97197687:-
ACC	trans	rs13177918	1	rs13177918	ENSG00000239528.1	RPS14P8	7.91	1.79e-10	0.00991	0.91	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446307	chr5:116562562~116562930:+
ACC	trans	rs13177918	0.906	rs12652032	ENSG00000224114.1	RP11-343H5.4	7.9	1.82e-10	0.00999	1.04	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442060	chr1:206695837~206696269:-
ACC	trans	rs13177918	1	rs13161334	ENSG00000224114.1	RP11-343H5.4	7.9	1.82e-10	0.00999	1.04	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443110	chr1:206695837~206696269:-
ACC	trans	rs13177918	1	rs35007082	ENSG00000224114.1	RP11-343H5.4	7.9	1.82e-10	0.00999	1.04	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150445015	chr1:206695837~206696269:-
ACC	trans	rs6732160	0.574	rs12465780	ENSG00000236165.1	PRADC1P1	-7.89	1.89e-10	0.0104	-0.67	-0.74	Intelligence (multi-trait analysis);	chr2:73244884	chr3:36976316~36976840:+
ACC	trans	rs9467773	0.549	rs9467805	ENSG00000242375.1	RP11-498P14.3	7.89	1.9e-10	0.0104	0.75	0.74	Intelligence (multi-trait analysis);	chr6:26583138	chr9:97195351~97197687:-
ACC	trans	rs13177918	1	rs13177918	ENSG00000224114.1	RP11-343H5.4	7.88	1.98e-10	0.0108	1.04	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446307	chr1:206695837~206696269:-
ACC	trans	rs3749237	0.595	rs6784820	ENSG00000197582.5	GPX1P1	-7.87	2.08e-10	0.0113	-0.82	-0.74	Resting heart rate;	chr3:49413431	chrX:13378735~13379340:-
ACC	trans	rs13177918	0.512	rs34113080	ENSG00000224114.1	RP11-343H5.4	7.86	2.12e-10	0.0115	1.13	0.74	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150429201	chr1:206695837~206696269:-
ACC	trans	rs6477998	0.676	rs4979225	ENSG00000238072.1	RP11-305M3.2	7.85	2.16e-10	0.0117	0.82	0.74	Hematology traits;	chr9:113225130	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.651	rs10121845	ENSG00000238072.1	RP11-305M3.2	7.85	2.16e-10	0.0117	0.82	0.74	Hematology traits;	chr9:113227443	chr7:129410113~129410370:-
ACC	trans	rs9467773	0.583	rs2498380	ENSG00000242375.1	RP11-498P14.3	-7.84	2.27e-10	0.0117	-0.79	-0.74	Intelligence (multi-trait analysis);	chr6:26643768	chr9:97195351~97197687:-
ACC	trans	rs6477998	0.627	rs10114381	ENSG00000238072.1	RP11-305M3.2	7.83	2.34e-10	0.0119	0.82	0.74	Hematology traits;	chr9:113213692	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.651	rs10114423	ENSG00000238072.1	RP11-305M3.2	7.83	2.34e-10	0.0119	0.82	0.74	Hematology traits;	chr9:113213751	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.676	rs10817460	ENSG00000238072.1	RP11-305M3.2	7.83	2.34e-10	0.0119	0.82	0.74	Hematology traits;	chr9:113214118	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.603	rs7859189	ENSG00000238072.1	RP11-305M3.2	7.83	2.34e-10	0.0119	0.82	0.74	Hematology traits;	chr9:113217389	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.676	rs6477997	ENSG00000238072.1	RP11-305M3.2	7.83	2.34e-10	0.0119	0.82	0.74	Hematology traits;	chr9:113218833	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.627	rs3810914	ENSG00000238072.1	RP11-305M3.2	7.83	2.34e-10	0.0119	0.82	0.74	Hematology traits;	chr9:113219441	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.676	rs4978536	ENSG00000238072.1	RP11-305M3.2	7.83	2.34e-10	0.0119	0.82	0.74	Hematology traits;	chr9:113220123	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.676	rs10817470	ENSG00000238072.1	RP11-305M3.2	7.82	2.42e-10	0.0122	0.85	0.74	Hematology traits;	chr9:113252129	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.676	rs10759631	ENSG00000238072.1	RP11-305M3.2	7.82	2.45e-10	0.0122	0.84	0.74	Hematology traits;	chr9:113233764	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.676	rs10081797	ENSG00000238072.1	RP11-305M3.2	7.82	2.45e-10	0.0122	0.84	0.74	Hematology traits;	chr9:113237973	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.676	rs10759632	ENSG00000238072.1	RP11-305M3.2	7.82	2.45e-10	0.0122	0.84	0.74	Hematology traits;	chr9:113238703	chr7:129410113~129410370:-
ACC	trans	rs13253073	0.723	rs4626565	ENSG00000260318.1	COX6CP1	7.8	2.6e-10	0.0126	1.29	0.73	Glucose homeostasis traits;	chr8:99878314	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs7844439	ENSG00000260318.1	COX6CP1	7.8	2.6e-10	0.0126	1.29	0.73	Glucose homeostasis traits;	chr8:99878567	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs7813557	ENSG00000260318.1	COX6CP1	7.8	2.6e-10	0.0126	1.29	0.73	Glucose homeostasis traits;	chr8:99878665	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs4510829	ENSG00000260318.1	COX6CP1	7.8	2.6e-10	0.0126	1.29	0.73	Glucose homeostasis traits;	chr8:99878982	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs1135382	ENSG00000260318.1	COX6CP1	7.8	2.6e-10	0.0126	1.29	0.73	Glucose homeostasis traits;	chr8:99879402	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs7828241	ENSG00000260318.1	COX6CP1	7.8	2.6e-10	0.0126	1.29	0.73	Glucose homeostasis traits;	chr8:99880417	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs7812991	ENSG00000260318.1	COX6CP1	7.8	2.6e-10	0.0126	1.29	0.73	Glucose homeostasis traits;	chr8:99884095	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs12548840	ENSG00000260318.1	COX6CP1	7.8	2.6e-10	0.0126	1.29	0.73	Glucose homeostasis traits;	chr8:99885580	chr16:11903923~11904137:-
ACC	trans	rs8081395	0.707	rs1024637	ENSG00000187870.7	RNFT1P3	-7.8	2.62e-10	0.0127	-0.77	-0.73	White blood cell count;	chr17:59961532	chr17:20743333~20754501:-
ACC	trans	rs7949030	0.596	rs11231138	ENSG00000186676.3	EEF1GP1	7.8	2.62e-10	0.0127	0.8	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62548723	chr7:125033453~125035301:+
ACC	trans	rs8081395	0.741	rs2645462	ENSG00000187870.7	RNFT1P3	7.8	2.65e-10	0.0127	0.74	0.73	White blood cell count;	chr17:59906198	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.711	rs1292034	ENSG00000187870.7	RNFT1P3	7.8	2.65e-10	0.0127	0.74	0.73	White blood cell count;	chr17:59912499	chr17:20743333~20754501:-
ACC	trans	rs7949030	0.626	rs61296092	ENSG00000186676.3	EEF1GP1	7.79	2.74e-10	0.013	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62553366	chr7:125033453~125035301:+
ACC	trans	rs8081395	0.775	rs2526355	ENSG00000187870.7	RNFT1P3	7.78	2.82e-10	0.0132	0.74	0.73	White blood cell count;	chr17:59875872	chr17:20743333~20754501:-
ACC	trans	rs1292048	1	rs1292048	ENSG00000187870.7	RNFT1P3	7.78	2.82e-10	0.0132	0.74	0.73	Red cell distribution width;	chr17:59877710	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.741	rs180532	ENSG00000187870.7	RNFT1P3	7.77	3e-10	0.014	0.75	0.73	White blood cell count;	chr17:59925936	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.741	rs180530	ENSG00000187870.7	RNFT1P3	7.77	3e-10	0.014	0.75	0.73	White blood cell count;	chr17:59926233	chr17:20743333~20754501:-
ACC	trans	rs7949030	0.626	rs7943191	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62561079	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.626	rs11231145	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62561382	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.626	rs71490390	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62561713	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.626	rs7124057	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62566624	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.626	rs1061093	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62567436	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.626	rs72927213	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62583726	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.626	rs11231154	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62594821	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.591	rs11231156	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62598982	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.591	rs12049914	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62601964	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.591	rs35156678	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62602409	chr7:125033453~125035301:+
ACC	trans	rs7949030	0.596	rs71490394	ENSG00000186676.3	EEF1GP1	7.74	3.28e-10	0.015	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62602683	chr7:125033453~125035301:+
ACC	trans	rs1816752	0.819	rs6490917	ENSG00000237917.1	PARP4P1	7.71	3.65e-10	0.0163	0.68	0.73	Obesity-related traits;	chr13:24423119	chrY:26594851~26634652:-
ACC	trans	rs8081395	0.801	rs2777895	ENSG00000187870.7	RNFT1P3	-7.7	3.79e-10	0.0168	-0.8	-0.73	White blood cell count;	chr17:59802249	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.769	rs12449331	ENSG00000187870.7	RNFT1P3	-7.7	3.79e-10	0.0168	-0.8	-0.73	White blood cell count;	chr17:59806285	chr17:20743333~20754501:-
ACC	trans	rs6477998	0.868	rs10513189	ENSG00000238072.1	RP11-305M3.2	7.7	3.86e-10	0.0171	0.82	0.73	Hematology traits;	chr9:113227941	chr7:129410113~129410370:-
ACC	trans	rs3749237	0.595	rs1464568	ENSG00000197582.5	GPX1P1	7.69	3.96e-10	0.0174	0.86	0.73	Resting heart rate;	chr3:49420833	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs4855873	ENSG00000197582.5	GPX1P1	7.69	3.96e-10	0.0174	0.86	0.73	Resting heart rate;	chr3:49421681	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.595	rs1464566	ENSG00000197582.5	GPX1P1	7.69	3.96e-10	0.0174	0.86	0.73	Resting heart rate;	chr3:49421943	chrX:13378735~13379340:-
ACC	trans	rs13177918	0.512	rs34113080	ENSG00000239528.1	RPS14P8	7.68	4.11e-10	0.0181	0.97	0.73	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150429201	chr5:116562562~116562930:+
ACC	trans	rs941207	0.542	rs1903370	ENSG00000121089.4	NACA3P	-7.67	4.21e-10	0.0184	-1.01	-0.73	Platelet count;	chr12:56812900	chr4:164943290~164943937:+
ACC	trans	rs9467773	0.62	rs2451741	ENSG00000242375.1	RP11-498P14.3	7.67	4.24e-10	0.0185	0.75	0.73	Intelligence (multi-trait analysis);	chr6:26629176	chr9:97195351~97197687:-
ACC	trans	rs13177918	0.911	rs12186451	ENSG00000224114.1	RP11-343H5.4	7.67	4.25e-10	0.0185	1.02	0.73	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150432625	chr1:206695837~206696269:-
ACC	trans	rs9467773	1	rs9467779	ENSG00000242375.1	RP11-498P14.3	-7.67	4.25e-10	0.0185	-0.77	-0.73	Intelligence (multi-trait analysis);	chr6:26536459	chr9:97195351~97197687:-
ACC	trans	rs6477998	0.513	rs10981720	ENSG00000238072.1	RP11-305M3.2	7.67	4.26e-10	0.0185	0.87	0.73	Hematology traits;	chr9:113293831	chr7:129410113~129410370:-
ACC	trans	rs7949030	0.59	rs12225213	ENSG00000186676.3	EEF1GP1	7.66	4.37e-10	0.0188	0.79	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62582776	chr7:125033453~125035301:+
ACC	trans	rs6477998	0.874	rs10739390	ENSG00000238072.1	RP11-305M3.2	7.62	5.04e-10	0.0215	0.78	0.73	Hematology traits;	chr9:113226209	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.9	rs7850357	ENSG00000238072.1	RP11-305M3.2	7.62	5.06e-10	0.0216	0.8	0.73	Hematology traits;	chr9:113222319	chr7:129410113~129410370:-
ACC	trans	rs13253073	0.657	rs35135010	ENSG00000260318.1	COX6CP1	7.62	5.13e-10	0.0217	1.26	0.73	Glucose homeostasis traits;	chr8:99864209	chr16:11903923~11904137:-
ACC	trans	rs13253073	0.723	rs34830464	ENSG00000260318.1	COX6CP1	7.62	5.13e-10	0.0217	1.26	0.73	Glucose homeostasis traits;	chr8:99866638	chr16:11903923~11904137:-
ACC	trans	rs8081395	0.741	rs1292056	ENSG00000187870.7	RNFT1P3	7.62	5.15e-10	0.0217	0.74	0.73	White blood cell count;	chr17:59881686	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.741	rs1292055	ENSG00000187870.7	RNFT1P3	7.62	5.15e-10	0.0217	0.74	0.73	White blood cell count;	chr17:59881707	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.741	rs1292053	ENSG00000187870.7	RNFT1P3	-7.61	5.19e-10	0.0218	-0.74	-0.73	White blood cell count;	chr17:59886176	chr17:20743333~20754501:-
ACC	trans	rs7949030	0.688	rs11231155	ENSG00000186676.3	EEF1GP1	7.6	5.46e-10	0.0228	0.78	0.73	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);	chr11:62598147	chr7:125033453~125035301:+
ACC	trans	rs13177918	0.871	rs11745194	ENSG00000239528.1	RPS14P8	7.6	5.56e-10	0.0231	0.84	0.73	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150458065	chr5:116562562~116562930:+
ACC	trans	rs6477998	0.535	rs4979232	ENSG00000238072.1	RP11-305M3.2	-7.59	5.64e-10	0.0234	-0.87	-0.73	Hematology traits;	chr9:113286594	chr7:129410113~129410370:-
ACC	trans	rs13177918	0.906	rs12652032	ENSG00000213058.3	RP4-765C7.2	7.58	5.83e-10	0.0241	1.03	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150442060	chr1:178411616~178411972:+
ACC	trans	rs13177918	1	rs13161334	ENSG00000213058.3	RP4-765C7.2	7.58	5.83e-10	0.0241	1.03	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150443110	chr1:178411616~178411972:+
ACC	trans	rs13177918	1	rs35007082	ENSG00000213058.3	RP4-765C7.2	7.58	5.83e-10	0.0241	1.03	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150445015	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.871	rs11745133	ENSG00000239528.1	RPS14P8	7.57	6.03e-10	0.0249	0.83	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150457826	chr5:116562562~116562930:+
ACC	trans	rs9467773	1	rs1001687	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26572990	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs1570059	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26573097	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs1570060	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26573334	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs1977201	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26573446	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs6456735	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26573921	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.967	rs1321482	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26574926	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs9467798	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26575469	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs1570061	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26575758	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs12665431	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26577080	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs12663883	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26577098	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs12663894	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26577142	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.967	rs6913877	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26577260	chr9:97195351~97197687:-
ACC	trans	rs9467773	1	rs6913462	ENSG00000242375.1	RP11-498P14.3	7.56	6.34e-10	0.0257	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26577302	chr9:97195351~97197687:-
ACC	trans	rs13177918	0.512	rs34113080	ENSG00000213058.3	RP4-765C7.2	7.56	6.42e-10	0.026	1.11	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150429201	chr1:178411616~178411972:+
ACC	trans	rs6477998	0.934	rs4979223	ENSG00000238072.1	RP11-305M3.2	7.55	6.5e-10	0.0263	0.8	0.72	Hematology traits;	chr9:113219836	chr7:129410113~129410370:-
ACC	trans	rs13177918	0.911	rs12186451	ENSG00000213058.3	RP4-765C7.2	7.54	6.94e-10	0.0279	1.02	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150432625	chr1:178411616~178411972:+
ACC	trans	rs3749237	0.595	rs11720264	ENSG00000197582.5	GPX1P1	7.54	6.95e-10	0.0279	0.84	0.72	Resting heart rate;	chr3:49542914	chrX:13378735~13379340:-
ACC	trans	rs3749237	0.576	rs4241406	ENSG00000197582.5	GPX1P1	7.54	6.95e-10	0.0279	0.84	0.72	Resting heart rate;	chr3:49562993	chrX:13378735~13379340:-
ACC	trans	rs13253073	0.723	rs12548542	ENSG00000260318.1	COX6CP1	7.53	7.13e-10	0.0285	1.23	0.72	Glucose homeostasis traits;	chr8:99890167	chr16:11903923~11904137:-
ACC	trans	rs13177918	0.871	rs11745194	ENSG00000224114.1	RP11-343H5.4	7.51	7.49e-10	0.0297	0.96	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150458065	chr1:206695837~206696269:-
ACC	trans	rs6477998	0.966	rs10759637	ENSG00000238072.1	RP11-305M3.2	7.51	7.6e-10	0.0301	0.84	0.72	Hematology traits;	chr9:113262744	chr7:129410113~129410370:-
ACC	trans	rs928391	0.681	rs9427242	ENSG00000227183.3	HDGFP1	-7.5	7.86e-10	0.031	-0.9	-0.72	Platelet count;	chr1:156755209	chrX:131646639~131646890:+
ACC	trans	rs6477998	0.676	rs4979224	ENSG00000238072.1	RP11-305M3.2	7.5	7.87e-10	0.031	0.8	0.72	Hematology traits;	chr9:113219998	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.932	rs4129395	ENSG00000238072.1	RP11-305M3.2	7.5	7.9e-10	0.031	0.82	0.72	Hematology traits;	chr9:113213109	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.966	rs7859354	ENSG00000238072.1	RP11-305M3.2	7.5	7.9e-10	0.031	0.82	0.72	Hematology traits;	chr9:113214165	chr7:129410113~129410370:-
ACC	trans	rs6477998	1	rs10739388	ENSG00000238072.1	RP11-305M3.2	7.5	7.9e-10	0.031	0.82	0.72	Hematology traits;	chr9:113214895	chr7:129410113~129410370:-
ACC	trans	rs13177918	1	rs13177918	ENSG00000213058.3	RP4-765C7.2	7.47	8.85e-10	0.0343	1.02	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150446307	chr1:178411616~178411972:+
ACC	trans	rs13177918	0.871	rs11745133	ENSG00000224114.1	RP11-343H5.4	7.46	9.02e-10	0.0349	0.94	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150457826	chr1:206695837~206696269:-
ACC	trans	rs8081395	0.836	rs2150879	ENSG00000187870.7	RNFT1P3	-7.46	9.17e-10	0.0355	-0.79	-0.72	White blood cell count;	chr17:59781849	chr17:20743333~20754501:-
ACC	trans	rs3749237	0.615	rs11130202	ENSG00000197582.5	GPX1P1	7.45	9.53e-10	0.0366	0.84	0.72	Resting heart rate;	chr3:49529282	chrX:13378735~13379340:-
ACC	trans	rs6477998	0.903	rs7041615	ENSG00000238072.1	RP11-305M3.2	7.45	9.59e-10	0.0368	0.79	0.72	Hematology traits;	chr9:113244747	chr7:129410113~129410370:-
ACC	trans	rs6477998	1	rs10759636	ENSG00000238072.1	RP11-305M3.2	7.45	9.66e-10	0.037	0.82	0.72	Hematology traits;	chr9:113256497	chr7:129410113~129410370:-
ACC	trans	rs6477998	0.535	rs10817475	ENSG00000238072.1	RP11-305M3.2	7.44	9.79e-10	0.0375	0.88	0.72	Hematology traits;	chr9:113296774	chr7:129410113~129410370:-
ACC	trans	rs9467773	1	rs10484442	ENSG00000242375.1	RP11-498P14.3	7.43	1.01e-09	0.0384	0.76	0.72	Intelligence (multi-trait analysis);	chr6:26555651	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.549	rs9461273	ENSG00000242375.1	RP11-498P14.3	-7.43	1.02e-09	0.0389	-0.73	-0.72	Intelligence (multi-trait analysis);	chr6:26584298	chr9:97195351~97197687:-
ACC	trans	rs1432089	0.817	rs2163615	ENSG00000273855.1	RP11-133K1.12	7.42	1.04e-09	0.0397	0.88	0.72	Endometriosis;	chr4:170877724	chr15:40285468~40285909:-
ACC	trans	rs9467773	0.62	rs2504592	ENSG00000242375.1	RP11-498P14.3	7.42	1.07e-09	0.0406	0.74	0.72	Intelligence (multi-trait analysis);	chr6:26640723	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2504599	ENSG00000242375.1	RP11-498P14.3	7.42	1.07e-09	0.0406	0.74	0.72	Intelligence (multi-trait analysis);	chr6:26640832	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2504540	ENSG00000242375.1	RP11-498P14.3	7.42	1.07e-09	0.0406	0.74	0.72	Intelligence (multi-trait analysis);	chr6:26641398	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2451737	ENSG00000242375.1	RP11-498P14.3	7.41	1.11e-09	0.0417	0.74	0.72	Intelligence (multi-trait analysis);	chr6:26618813	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.596	rs2494693	ENSG00000242375.1	RP11-498P14.3	7.41	1.11e-09	0.0417	0.74	0.72	Intelligence (multi-trait analysis);	chr6:26618998	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2494694	ENSG00000242375.1	RP11-498P14.3	7.41	1.11e-09	0.0417	0.74	0.72	Intelligence (multi-trait analysis);	chr6:26619100	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.595	rs2451736	ENSG00000242375.1	RP11-498P14.3	7.41	1.11e-09	0.0417	0.74	0.72	Intelligence (multi-trait analysis);	chr6:26620316	chr9:97195351~97197687:-
ACC	trans	rs9467773	0.62	rs2494696	ENSG00000242375.1	RP11-498P14.3	7.41	1.11e-09	0.0417	0.74	0.72	Intelligence (multi-trait analysis);	chr6:26620666	chr9:97195351~97197687:-
ACC	trans	rs8081395	0.741	rs1292051	ENSG00000187870.7	RNFT1P3	7.41	1.12e-09	0.042	0.72	0.72	White blood cell count;	chr17:59886562	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.836	rs2063353	ENSG00000187870.7	RNFT1P3	-7.4	1.14e-09	0.0422	-0.76	-0.72	White blood cell count;	chr17:59811831	chr17:20743333~20754501:-
ACC	trans	rs6477998	0.966	rs7851395	ENSG00000238072.1	RP11-305M3.2	7.4	1.14e-09	0.0422	0.81	0.72	Hematology traits;	chr9:113240184	chr7:129410113~129410370:-
ACC	trans	rs6477998	1	rs7038769	ENSG00000238072.1	RP11-305M3.2	7.4	1.14e-09	0.0422	0.81	0.72	Hematology traits;	chr9:113245303	chr7:129410113~129410370:-
ACC	trans	rs6477998	1	rs7022397	ENSG00000238072.1	RP11-305M3.2	7.4	1.14e-09	0.0422	0.81	0.72	Hematology traits;	chr9:113245397	chr7:129410113~129410370:-
ACC	trans	rs13177918	0.581	rs2245384	ENSG00000213058.3	RP4-765C7.2	7.39	1.18e-09	0.0433	0.98	0.72	Visceral adipose tissue/subcutaneous adipose tissue ratio;	chr5:150437705	chr1:178411616~178411972:+
ACC	trans	rs6477998	0.676	rs10981693	ENSG00000238072.1	RP11-305M3.2	-7.39	1.19e-09	0.0436	-0.79	-0.72	Hematology traits;	chr9:113223137	chr7:129410113~129410370:-
ACC	trans	rs8081395	0.801	rs12938273	ENSG00000187870.7	RNFT1P3	-7.36	1.33e-09	0.0481	-0.76	-0.71	White blood cell count;	chr17:59824291	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.836	rs1295926	ENSG00000187870.7	RNFT1P3	-7.36	1.33e-09	0.0481	-0.76	-0.71	White blood cell count;	chr17:59832012	chr17:20743333~20754501:-
ACC	trans	rs8081395	0.836	rs1292061	ENSG00000187870.7	RNFT1P3	-7.36	1.33e-09	0.0481	-0.76	-0.71	White blood cell count;	chr17:59833869	chr17:20743333~20754501:-
ACC	trans	rs542925	1	rs9375584	ENSG00000235290.1	HLA-W	-7.35	1.36e-09	0.0491	-0.89	-0.71	Caudate activity during reward;	chr6:128649628	chr6:29956596~29958570:+